| ID | CAS | Name | Synonyms | Description |
|---|---|---|---|---|
| 1 | 1009119-64-5 | BMS-790052 | CS-32 BMS-7052 BMS-790052 Daclatasvir Daclatasvir (BMS-790052) DACLATASVIR (BMS-790052) dimethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl)bis(1H-imidazole-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, dimethyl ester Methyl [(2S)-1-{(2S)-2-[5-(4'-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1H-imidazol-5-yl}-4-biphenylyl)-1H-imidazol-2-yl]-1-pyrrolidinyl}-3-methyl-1-oxo-2-butanyl]c arbamate | Intermediates;Pharmaceutical intermediates |
| 2 | 101-89-3 | Fast Garnet GBC salt | CI 37210 CI NO 7210 CI NO 37210 Fast GBC Salt Fast Garnet GBC Salt Fast Garnet GBC salt O-AMINOAZOTOLUENE DIAZOTATE Fast Garnet GBC sulfate salt O-AMINOAZOTOLUENE, DIAZONIUM SALT C.I. Azoic Diazo Component 4, sulfate salt 2-Methyl-4-(o-tolylazo)benzenediazonium hydrogen sulphate 2-Methyl-4-([2-methylphenyl]azo)benzenediazonium salt, 4-Amino-2μ,3-dimethylazobenzene diazotated, Azoic Diazo No. 4 | Pigments;Standards;Dyes and Pigments;Chemical reagents;Staining agents and dyes;Hematology and histology;Other biochemical reagents;Biochemical reagents-pigments;General biochemical reagents-biologica |
| 3 | 101385-69-7 | 2-chloro-1,3-dimethylimidazolidinium hexafluorophosphate | CIP 2-Chloro-1,3-dimethy 2-CHLORO-1,3-DIMETHYLIMIDAZOLINIUM PF6 2-Chloro-1,3-dimethylimidazolinium hexafluorophosphate 2-CHLORO-1,3-DIMETHYLIMIDAZOLINIUM HEXAFLUOROPHOSPHATE 2-Chlor-1,3-dimethyl-imidazolidinium-hexafluorophosphat 2-CHLORO-1,3-DIMETHYLIMIDAZOLIDINIUM HEXAFLUOROPHOSPHATE 2-Chloro-1,3-dimethylimidazolidinium hexafluorophosphate 2-chloro-1,3-dimethylimidazolidinium hexafluorophosphate 2-CHLORO-1,3-DIMETHYL-2-IMIDAZOLINIUM HEXAFLUOROPHOSPHATE 2-chloro-1,3-dimethylimidazolidin-1-ium hexafluorophosphate | Biochemistry;Inorganic salt;Peptide Synthesis;Synthetic Organic Chemistry;Inorganic Chemical Engineering;Condensation & Active Esterification;Coupling Reactions (Peptide Synthesis) |
| 4 | 102783-51-7 | 2'-deoxycytidine 5'-triphosphate disodium salt | dCTP.Na3 dCTP, 100mM Solution 2'-DeoxyCTP DisodiuM 2'-deoxycytidine 5'-triphosphate disodium salt 2'-Deoxycytidine-5'-triphospate,trisodium salt 2'-Deoxycytidine-5'-triphospate, trisodium salt 2'-Deoxycytidine-5'-triphosphate, 100MM Solution 2-Deoxycytidine-5-triphosphoric acid disodium salt 2'-Deoxycytidine-5'-Triphosphoric Acid Disodium Salt 2'-Deoxycytidine-5'-triphosphoric acid disodium salt 2′-Deoxycytidine 5′-triphosphate disodium salt,dCTP-Na2 2'-Deoxycytidine 5'-(Tetrahydrogen Triphosphate) DisodiuM Salt 2'-Deoxycytidine-5'-triphosphate(dCTP),trisodium salt,dihydrate 2'-DEOXY-CYTIDINE-5'-TRIPHOSPHATE TETRASODIUM SALT, SOLUTION 100 mM, MOLECULAR BIOLOGY GR disodium 2'-deoxy-5'-O-[hydroxy({[(hydroxyphosphinato)oxy]phosphinato}oxy)phosphoryl]cytidine | Pharma;nucleoside;Nucleotides;Heterocycles;Inorganic salt;Bases & Related Reagents;Carbohydrates & Derivatives;Inorganic Chemical Engineering;Phosphorylating and Phosphitylating Agents |
| 5 | 102830-49-9 | BOC-D-CYS(BZL)-OH | BOC-D-CYS(BZL)-OH BOC-(S)-BENZYL-D-CYS BOC-D-CYSTEINE(BZL)-OH BOC-S-BENZYL-D-CYSTEINE N-ALPHA-T-BUTOXYCARBONYL-S-D-CYSTEINE N-tert-Butoxycarbonyl-S-benzyl-D-cysteine S-benzyl-N-(tert-butoxycarbonyl)-D-cysteine BOC-(R)-2-AMINO-3-(S-BENZYLTHIO)PROPANOIC ACID N-alpha-t-Butyloxycarbonyl-S-benzyl-D-cysteine | Amino Acids;Intermediates;Amino Acid Derivatives;Pharmaceutical intermediates |
| 6 | 103404-87-1 | 4-(2-hydroxyethyl)piperazine-1-ethane-sulfon.ac. hemiso.S | HEPES, SODIUM HEPES NA-SALT HEPES hemisodium salt 4-(2-hydroxyethyl)piperazine-1-ethane-sulfon.ac. hemiso.S sodium 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonate 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID SODIUM SALT 4-(2-HYDROXYETHYL)-1-PIPERAZINEETHANESULFONIC ACID, DISODIUM SALT 4-(2-HYDROXYETHYL)-1-PIPERAZINEETHANESULFONIC ACID HEMISODIUM SALT 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid hemisodium salt 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID HEMISODIUM SALT 2-[4-(2-HYDROXYETHYL)-1-PIPERAZINYL]ETHANESULFONIC ACID SODIUM SALT 4-(2-HYDROXYETHYL)-1-PIPERAZINEETHANE-SULFONIC ACID HALF-SODIUM SALT HEPES, hemisodium salt N-(2-Hydroxyethyl)piperazine-N-(2-ethanesulfonic acid), hemisodium salt HEPES, hemisodium salt, Molecular Biology Grade N-(2-Hydroxyethyl)piperazine-N-(2-ethanesulfonic acid), hemisodium salt, Molecular Biology Grade | buffer;Organic raw materials;Carboxylic acid compounds;Pharmaceutical Intermediates |
| 7 | 110448-33-4 | 1-(5-Iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4 -diazepine, hydrochloride | ML ML7 ML 7 CS-755 ML-7, HCl ML-7 HYDROCHLORIDE ML 7 HYDROCHLORIDE 1-(5-IODONAPHTHALENE-1-SULFONYL)HOMOPIPERAZINE, HCL 1-(5-IODONAPHTHALENE-1-SULFONYL)-1H-HEXAHYDRO-1,4-DIAZEPINE 1-(5-IODONAPHTHALENE-1-SULFONYL)-1H-HEXAHYDRO-1,4-DIAZEPINE HCL 1-(5-IODONAPHTHALENE-1-SULFONYL)-1H-HEXAHYDRO-1,4-DIAZEPINE HYDROCHLORIDE 1-(5-Iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-Diazepine hydrochloride 1-(5-Iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4 -diazepine, hydrochloride | Inhibitors;All Inhibitors;Organic materials;Hydrocarbon compounds;Protein Kinase Inhibitors and Activators |
| 8 | 111082-76-9 | Boc-D-3-Benzothienylalanine | Boc-D-Bta-OH BOC-D-ALA(3-BZT)-OH RARECHEM BK PT 0207 BOC-D-3-BENZOTHIENYLALA BOC-D-3-BENZOTHIENYLALANINE Boc-D-3-Benzothienylalanine BOC-D-ALA(3-BENZOTHIENYL)-OH BOC-D-3-(3-BENZOTHIENYL)ALANINE boc-β-(3-benzothienyl)-d-ala-oh BOC-3-(3-BENZOTHIENYL)-D-ALA-OH BOC-3-(3-BENZOTHIENYL)-D-ALANINE BOC-D-ALA-BETA-(3-BENZOTHIENYL)-OH 3-Benzo[b]thiophen-3-yl-D-alanine, N-BOC protected N-ALPHA-T-BUTOXYCARBONYL-3-(3-BENZOTHIENYL)-D-ALANINE NALPHA-tert-Butoxycarbonyl-3-(3-benzothienyl)-D-alanine 3-(1-benzothiophen-3-yl)-N-(tert-butoxycarbonyl)-D-alanine (R)-3-(benzo[b]thiophen-3-yl)-2-(tert-butoxycarbonylamino)propanoic acid (2R)-3-(3-benzylthiophen-2-yl)-2-{[(tert-butoxy)carbonyl]aMino}propanoic acid | a-amino;Amino Acids;Intermediates;Amino Acid Derivatives;Pharmaceutical intermediates;Phenylalanine analogs and other aromatic alpha amino acids |
| 9 | 111300-06-2 | Boc-Trans-4-Aminocyclohexanol | Boc-Trans-4-Aminocyclohexanol BOC-TRANS-4-AMINOCYCLOHEXANOL TRANS-4-BOC-AMINOCYCLOHEXANOL Trans-4-Boc-Aminocyclohexanol TRANS-4-N-BOC-AMINOCYCLOHEXANOL Trans-4-N-Boc-Aminocyclohexanol TRANS-4-BOC-AMINO-1-CYCLOHEXANOL Trans-4-Boc-Amino-1-Cyclohexanol N-T-BOC-TRANS-4-AMINO CYCLOHEXANOL N-T-Boc-Trans-4-Amino Cyclohexanol tert-butyl (4-hydroxycyclohexyl)carbamate Trans-T-Butyl-4-Hydroxycyclohexylcarbamate TRANS-T-BUTYL-4-HYDROXYCYCLOHEXYLCARBAMATE Tert-Butyl Trans-4-Hydroxycyclohexylcarbamate TERT-BUTYL TRANS-4-HYDROXYCYCLOHEXYLCARBAMATE tert-butyl (cis-4-hydroxycyclohexyl)carbamate N-benzyl-1-methoxy-N-[(trimethylsilyl)methyl]methanamine Trans-(4-Hydroxy-Cyclohexyl)-Carbamic Acid Tert-Butyl Ester TRANS-(4-HYDROXY-CYCLOHEXYL)-CARBAMIC ACID TERT-BUTYL ESTER | Alcohols;pharmacetical;pharmaceutical;API intermediates;Organic materials |
| 10 | 112883-42-8 | Fmoc-N-Methyl-L-Norleucine | Fmoc-N-Me-Nle Fmoc-Menle-Oh Fmoc-L-Menle-Oh Fmoc-N-Me-Nle-Oh Fmoc-N-Me-Nle-OH Fmoc-Meacpo(2)-Oh Fmoc-N-Methyl-L-Norleucine FMOC-N-METHYL-L-NORLEUCINE Fmoc-L-Mench[Ch3(Ch2)3]-Cooh N-Alpha-Fmoc-N-Alpha-Methyl-L-Norleucine N-ALPHA-FMOC-N-ALPHA-METHYL-L-NORLEUCINE N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-norleucine N-Alpha-(9-Fluorenylmethoxycarbonyl)-N-Alpha-Methyl-L-Norleucine N-Alpha-(9-Fluorenylmethyloxycarbonyl)-N-Alpha-Methyl-L-Norleucine (S)-2-((((9H-Fluoren-9-yl)Methoxy)carbonyl)(Methyl)aMino)hexanoic acid (2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}(methyl)amino)hexanoic acid N-Alpha-(9-Fluorenylmethoxycarbonyl)-N-Alpha-Methyl-L-2-Aminocaproic Acid | Amino Acids;Intermediates;Pharmaceutical intermediates |
| 11 | 1163-36-6 | clemizole hydrochloride | p48 CS-1763 allercur allercurehydrochloride clemizole hydrochloride Clemizole hydrochloride 1-P-CHLOROBENZYL-2-[1-PYRROLIDINYL]-METHYLBENZIMIDAZOLE HYDROCHLORIDE 1-{[1-(4-chlorobenzyl)-1H-benzimidazol-2-yl]methyl}pyrrolidinium chloride 1-[(4-chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)benzimidazole,hydrochloride 1-[(4-Chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)benzoimidazole hydrochloride 1-[(4-Chlorophenyl)methyl]-2-(1-pyrrolidinylmethyl)-1H-benzimidazole hydrochloride 1-[4-Chlorophenyl)methyl]-2-(1-pyrrolidinylmethyl)-1H-benzimidazole, Monohydrochloride | Inhibitors;Inorganic salt;Inorganic Chemical Engineering |
| 12 | 117903-25-0 | BOC-MENLE-OH | BOC-MENLE-OH BOC-L-MENLE-OH BOC-N-ME-NLE-OH BOC-MEAHX(2)-OH BOC-MEACPO(2)-OH BOC-N-ME-NORLEUCINE Boc-N-methyl-L-norleucine BOC-N-ALPHA-METHYL-L-NORLEUCINE BOC-N-ME-L-2-AMINOHEXANOIC ACID N-(tert-butoxycarbonyl)-N-methyl-L-norleucine | amino acids;Intermediates;N-Methyl Amino Acids;Amino Acid Derivatives;Pharmaceutical intermediates |
| 13 | 118811-03-3 | 2-(2-Hydroxy-Ethyl)-Piperidine-1-Carboxylic Acid Tert-Butyl Ester | BOC-2-(2-PIPERIDYL)ETHANOL Boc-2-(2-Piperidyl)Ethanol N-Boc-2-Piperidin-2-Yl-Ethanol N-BOC-2-HYDROXYETHYLPIPERIDINE N-BOC-2-PIPERIDIN-2-YL-ETHANOL N-Boc-2-Hydroxyethylpiperidine N-BOC-2-(2-HYDROXYETHYL)PIPERIDINE N-Boc-2-(2-Hydroxyethyl)Piperidine 2-(2-HYDROXYETHYL)-1-BOC-PIPERIDINE 2-(2-Hydroxyethyl)-1-Boc-Piperidine 1-Boc-2-(2-hydroxyethyl)-piperidine 1-Boc-2-(2-Hydroxy-Ethyl)-Piperidine 1-BOC-2-(2-HYDROXY-ETHYL)-PIPERIDINE tert-butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate tert-butyl 2-(2-hydroxyethyl)piperazine-1-carboxylate 2-(2-HYDROXY-ETHYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER 2-(2-Hydroxy-Ethyl)-Piperidine-1-Carboxylic Acid Tert-Butyl Ester | Alcohols;pharmacetical;Organic materials |
| 14 | 1206524-85-7 | MK-5172 | MK-5172 Grazoprevir Intermediate 5 (1aR,5S,8S,10R,22aR)-5-tert-butyl-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,1 (33R,35S,91R,92R,5S)-5-(tert-butyl)-17-methoxy-4,7-dioxo-2,8-dioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopropanacyclotetradecaphane-35-carboxylicacid (1aR,5S,8R,10S,22aR)-5-tert-butyl-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid (1aR,5S,8S,10R,22aR)-5-(1,1-Dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid 8H-7,10-Methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-diMethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-Methoxy-3,6-dioxo-,(1aR,5S,8S,10R,22aR)- | Spot supply;intermediates;MK-5172 intermediate |
| 15 | 122235-70-5 | Boc-Dap(Fmoc)-OH | Boc-Dap(Fmoc)-OH BOC-DAP(FMOC)-OH Boc-Dpr(Fmoc)-OH Boc-Dapa(FMoc)-OH Boc-L-2,3-Diaminopropionic acid(Fmoc) N-Boc-N-Fmoc-(S)-2,3-diaminopropionic acid N-α-Boc-N-β-Fmoc-L-2,3-diamiopropionic acid N-.ALPHA.-BOC-N-.BETA.-FMOC-L-2,3-DIAMIOPROPIONIC ACID (S)-2,3-Diaminopropanoic acid, N2-BOC, N3-FMOC protected 3-[(9H-Fluoren-9-ylmethoxycarbonyl)amino]-L-alanine, N-BOC protected Boc-3-(Fmoc-amino)-L-alanine, Nα-Boc-Nβ-Fmoc-L-2,3-diaminopropionic acid NALPHA-tert-Butoxycarbonyl-NB-9-fluorenylmethoxycarbonyl-L-2,3-diaminopropi 3-[(tert-butoxycarbonyl)amino]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-alanine N-(tert-butoxycarbonyl)-3-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-L-alanine | amino acid;Amino Acids;Intermediates;Unusual amino acids;Pharmaceutical intermediates |
| 16 | 123333-64-2 | CHLOROPHENOL RED SODIUM SALT | CHLOROPHENOL RED SODIUM SALT CHLOROPHENOL RED, WATER SOLUBLE dichlorophenol sulfonaphthalein DICHLOROPHENOLSULFONEPHTHALEIN, SODIUM SALT 3',3'-DICHLOROPHENOLSULFONPHTHALEIN SODIUM SALT 3',3''-DICHLOROPHENOLSULFONPHTHALEIN SODIUM SALT 3',3'-DICHLOROPHENOLSULFONEPHTHALEIN SODIUM SALT 3',3''-DICHLOROPHENOLSULFONEPHTHALEIN SODIUM SALT CHLOROPHENOL RED, SODIUM SALT, WATER SOLUBLE, PURE CHLOROPHENOL RED, SODIUM SALTCHLOROPHENOL RED, SODIUM SALTCHLOROPHENOL RED, SODIUM SALT Sodium 2-chloro-4-(3-(3-chloro-4-hydroxyphenyl)-1,1-dioxido-3H-benzo[c][1,2]oxathiol-3-yl)phenolate 2-[(Z)-(3-chloro-4-hydroxyphenyl)(3-chloro-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]benzenesulfonate | pH Indicators;Indicator (pH);Stains and dyes;Sulfonephthalein;Analytical Chemistry;Hematology and histology |
| 17 | 125-31-5 | Xylenol Blue | Xylenol Blue P-XYLENOL BLUE XYLENOL BLUE FREE ACID P-XYLENOL BLUE INDICATOR p-Xylenolsulphonephthalein XYLENOL BLUE, INDICATOR GRADE 1,4-DIMETHYL-5-HYDROXYBENZENESULFONPHTHALEIN 4,4-(3H-2,1-benzoxathiol-3-ylidene)bis(2,5-dimethylphenol) S,S-dioxide 4,4'-(1,1-dioxido-3H-2,1-benzoxathiole-3,3-diyl)bis(2,5-dimethylphenol) phenol,4,4'-(3h-2,1-benzoxathiol-3-ylidene)bis[2,5-dimethyl-,s,s-dioxide 2-[(Z)-(2,5-dimethyl-4-oxocyclohexa-2,5-dien-1-ylidene)(4-hydroxy-2,5-dimethylphenyl)methyl]benzenesulfonic acid | Organics;pH Indicators;Indicator (pH);Sulfonephthalein;Analytical Chemistry;Organic raw materials;Phenolic alcohol compounds |
| 18 | 125238-99-5 | Fmoc-Dab(Boc)-OH | Fmoc-Dab(Boc) FMOC-L-DAB(BOC) Fmoc-Dab(Boc)-OH Fmoc-Dbu(Boc)-OH FMOC-DAB(BOC)-OH FMOC-L-2,4-DIAMINOBUTYRIC ACID(BOC) Fmoc-L-2,4-Diaminobutyric acid(Boc) FMOC-4-BOC-L-2,4-DIAMINOBUTYRIC ACID Fmoc-4-Boc-L-2,4-diaminobutyric acid N-Fmoc-N-Boc-L-2,4-diaminobutyric acid NA-FMOC-NG-BOC-(S)-2,4-DIAMINOBUTYRIC ACID L-2,4-Diaminobutanoic acid, N4-BOC, N2-FMOC protected N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N-GAMMA-T-BUTYLOXYCARBONYL-L-2,4-DIAMINOBUTYRIC ACID (2S)-4-[(tert-butoxycarbonyl)amino]-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}butanoic acid N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N-GAMMA-TERT-BUTYLOXYCARBONYL-L-2,4-DIAMINOBUTYRIC ACID | amino acid;Amino Acids;Intermediates;Unusual amino acids;Pharmaceutical intermediates |
| 19 | 127095-92-5 | boc-3-cyclohexyl-D-alanine hydrate | BOC-D-CHA-OH Boc-D-Cha-OH . H2O Boc-D-Cha-OH hydrate BOC-D-3-Cyclohexyl Alanine Boc-(R)-3-Cyclohexylalanine BOC-BETA-CYCLOHEXYL-D-ALA-OH BOC-BETA-CYCLOHEXYL-D-ALANINE (Tert-Butoxy)Carbonyl D-Cha-OH Boc-.beta.-cyclohexyl-D-Ala-OH boc-3-cyclohexyl-D-alanine hydrate BOC-BETA-CYCLOHEXYL-D-ALANINE MONOHYDRATE Boc-beta-cyclohexyl-D-alanine monohydrate Boc-D-Cha-OH OR Boc-3-cyclohexyl-D-alanine (R)-2-(Boc-amino)-3-cyclohexylpropionic Acid N-(tert-butoxycarbonyl)-3-cyclohexyl-D-alanine | Peptide;Synthesis;Amino acids;Protected amino acids;Unnatural amino acids;Chemical intermediates;Pharmaceutical intermediates;Unnatural amino acids and derivatives |
| 20 | 13085-50-2 | 2'-deoxycytidine 5'-monophosphate, disodium salt | dCMP.Na2 D-CMP SODIUM SALT DEOXYCYTIDYLIC ACID SODIUM SALT 2-deoxycytidine 5-(disodium phosphate) 2'-deoxycytidine 5'-monophosphate disodium salt 2'-Deoxycytidine-5'-monophosphate disodium salt 2'-Deoxycytidine-5'-monophosphate,disodium salt 2'-deoxycytidine 5'-monophosphate, disodium salt 2'-deoxycytidine 5'-monophosphate* sodium sigma G 2'-DEOXYCYTIDINE 5'-MONOPHOSPHATE* SODIU M SIGMA GRA 2''-Deoxycytidine-5''-monophosphoric acid sodium salt 2''-DEOXYCYTIDINE-5''-MONOPHOSPHATE DISODIUM SALT (DCMP) | Pharmaceutical;Inorganic salt;Inorganic Chemical Engineering |
| 21 | 131543-23-2 | WIN 55,212-2 MESYLATE | WIN55 CS-754 WIN552122 WIN-552122 212-2Mesylate Sildenafil Mesylate WIN 55,212-2 MESYLATE R(+)-WIN 55,212-2 MESYLATE R(+)-WIN 55,212-2 ,MESYLATE HIGH AFFINIT Y CANNABI (R)-(+)-(2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1.2.3-de]-1,4-benzoxazin-6-yl)-1-naphthalenylmethanonemesy R(+)-[2,3-DIHYDRO-5-METHYL-3-[(MORPHOLINYL)METHYL]PYRROLO[1,2,3-DE]-1,4-BENZOXAZINYL]-(1-NAPHTHALENYL)METHANONE MESYLATE (R)-(+)-[2,3-DIHYDRO-5-METHYL-3-(4-MORPHOLINYLMETHYL)PYRROLO[1,2,3-DE]-1,4-BENZOXAZIN-6-YL]-1-NAPHTHALENYLMETHANONE MESYLATE [(3R)-5-methyl-3-(morpholin-4-ylmethyl)-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl](naphthalen-1-yl)methanone methanesulfonate (R)-(+)-[2,3-Dihydro-5-methyl-3[(4-morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate salt | Cannabinoid;Cannabinoid receptor;Organic raw materials;Carboxylic acid compounds |
| 22 | 131766-22-8 | Fmoc-D-Cys(tBu)-OH | FMOC-D-CYS(TBU)-OH Fmoc-D-Cys(tBu)-OH FMOC-(S)-T-BUTYL-D-CYS FMOC-D-CYSTEINE(TBU)-OH FMOC-(S)-TERT-BUTYL-D-CYS FMOC-S-T-BUTYL-D-CYSTEINE Fmoc-S-tert-butyl-D-cysteine N-ALPHA-FMOC-S-TERT-BUTYL-D-CYSTEINE FMOC-(S)-2-AMINO-3-(S-T-BUTYLTHIO)BUTANOIC ACID N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-S-T-BUTYL-D-CYSTEINE | Intermediates;Pharmaceutical intermediates |
| 23 | 1328-51-4 | Solvent Blue 38 | Fast Blue MBSN Soluble Blue38 Solvent Blue 38 SOLVENT BLUE 38 Luxol(R) Fast Blue Luxol fast blue mbs C.I. Solvent Blue 38 Luxol Fast Blue MBSNpure LUXOL(R) FAST BLUE MBSN, PURE SOLVENT BLUE 38 PRACTICAL GRADE Disulfo copper phthalocyanine amine salt | Solvent Dyestuff;Dyes and pigments;UVCBs-organic-metal salts |
| 24 | 1328-53-6 | Phthalocyanine Green G | 74260 C.I. 74260 Phthalo green Pigment Geen 7 FAST GREEN PHG Rembrandt green Pigment Green 42 thalo green no.1 Phthalocyanine Green C.I. Pigment Green 7 C.I. Pigment Green 42 pacific green no.6491 Phthalocyanine Green G Non-flocculating Green G Pigment Phthalocyanine Green G Polychloro copper phthalocyanine Phthalocyanine Green (yellow shade) | ;Pigment;UVCBs-organometallic;Intermediates of Dyes and Pigments |
| 25 | 1393-92-6 | Litmus | LACMUS LITMUS Litmus Lackmus CI 1242 Tornasol Tournesol LITMUS POWDER LITMUS SOLUTION LITMUS SOLUTION RED LITMUS SOLUTION BLUE LITMUS SOLUTION ACCORDING TO KUBEL AND TIEMANN | Pigments;Titration;pH Indica;Indicators;J-K-LTitration;Stains and Dyes;Environmental kits;Stains&Dyes, A to;Analytical reagents;Acid-base indicator |
| 26 | 142326-59-8 | L-701,324 | L-701 CS-2045 L-701,324 L-701,304 7-Chloro-4-hydroxy-3-(3-phenoxy)phenyl-2(H)-quinolinone 7-chloro-1-(4-hydroxy-3-phenoxyphenyl)quinolin-2(1H)-one 7-chloro-4-hydroxy-3-(3-phenoxyphenyl)-1H-quinolin-2-one 7-CHLORO-4-HYDROXY-3-(3-PHENOXY)PHENYL-2(1H)-QUINOLINONE 7-CHLORO-4-HYDROXY-3-(3-PHENOXY )PHENYLQUINOLIN-2[1H]-ONE | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 27 | 144072-29-7 | BOC-4-AMINOBENZYLALCOHOL | 4-benzyl alcohol BOC-4-AMINOBENZYLALCOHOL 4-(Boc-aMino)benzyl alcohol tert-Butyl (4-(hydroxymethyl) TERT-BUTYL 4-(HYDROXYMETHYL)PHENYLCARBAMATE tert-butyl N-[4-(hydroxyMethyl)phenyl]carbaMate CarbaMic acid N-[4-(hydroxyMethyl)phenyl]-1,1-diMethyl ester Carbamic acid, N-[4-(hydroxymethyl)phenyl]-, 1,1-dimethylethyl ester | CMLLYL;Alcohols;Organic materials |
| 28 | 145-94-8 | Chlorindanol | Lanesta NSC-158565 Chlorindanol 7-CHLORO-4-INDANOL 7-CHLORO-2,3-DIHYDRO-1H-INDEN-4-OL 7-chloro-2,3-dihydro-1H-Inden-4-ol 1H-Inden-4-ol, 7-chloro-2,3-dihydro- | SIMDAX;Heterocyclic rings;Small molecule inhibitors;Synthetic material intermediates |
| 29 | 14676-01-8 | 3-(Boc-amino)-3-phenylpropionic acid | RARECHEM AK HT T302 DL-N-BOC-BETA-PHENYLALANINE 3-N-BOC-3-PHENYLPROPIONIC ACID (3R)-3-(benzylammonio)butanoate (3S)-3-(benzylammonio)butanoate BOC-3-AMINO-3-PHENYLPROPIONIC ACID 3-N-BOC-AMINO-3-PHENYLPROPIONIC ACID 3-(BOC-AMINO)-3-PHENYLPROPIONIC ACID 3-(Boc-amino)-3-phenylpropionic acid BOC-DL-3-PHENYL-3-AMINO-PROPIONIC ACID 3-TERT-BUTOXYCARBONYLAMINO-3-PHENYL-PROPIONIC ACID | Intermediates;Pharmaceutical intermediates |
| 30 | 146998-31-4 | 4-((4-(DIMETHYLAMINO)PHENYL)AZO)BENZOIC ACID, SUCCINIMIDYL ESTER | DABCYL-OSU DABCYL-NHS DABCYL, SE DABCYL ACID, SE DABCYL SUCCINIMIDE ESTER DABCYL-N-SUCCINIMIDYL ESTER DABCYL N-HYDROXYSUCCINIMIDE ESTER -2,5-Dioxopyrrolidin-1-yl 4-((4-(dimethylamino) 4-[4-(Dimethylamino)phenylazo]benzoic acid N-succinimidyl ester 4-((4-(DIMETHYLAMINO)PHENYL)AZO)BENZOIC ACID, SUCCINIMIDYL ESTER 4-(DIMETHYLAMINO)AZOBENZENE-4'-CARBOXYLIC ACID N-SUCCINIMIDYL ESTER 1-{[(4-{(E)-[4-(dimethylamino)phenyl]diazenyl}phenyl)carbonyl]oxy}pyrrolidine-2,5-dione | Intermediates;Fluorescent Dyes;Pharmaceutical intermediates |
| 31 | 147201-04-5 | 5'-O-(4,4-Dimethoxytrityl)-2'-O-[(tert-butyl)dimethylsilyl]-N-isobutyrylguanosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite | i-bu-rG Phosphoramidite 2'-TBDMS-rG(N-ibu)Phosphoramidite 2'-TBDMS-ibu-G-CE-Phosphoramidite 2'-TBDMS-rG(N-ibu)Phosphoramidite 5'-O-DMT-2'-TBDMS-rG(N-iBu)-3'-CEDPA DMT-2′O-TBDMS-rG(ib) Phosphoramidite 5'-O-(4,4-Dimethoxytrityl)-2'-O-[(tert-butyl)dimethylsilyl]-N-isobutyrylguanosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite (2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-(tert-butyldimethylsilyloxy)-5-(2-isobutyramido-6-oxo-1H-purin-9(6H)-yl)tetrahydrofuran-3-yl 2-cyanoethyl diisopropylphosphoramidite | Pharmaceutical;Amino compounds;Organic raw materials |
| 32 | 149003-01-0 | Dexrazoxane hydrochloride | Totect Zinecard Cardioxan Cardioxane Dexrazoxane HCl UNII-5346058Q7S Dexrazoxane HCL ICRF-187 hydrochloride ICRF 187 hydrochloride ICRF-187 (ADR-529) HCl Dexrazoxane hydrochloride Dexrazoxane HCl (ICRF-187, ADR-529) Dexrazoxane hydrochloride (ICRF-187, ADR-529) 4,4'-(2S)-propane-1,2-diyldipiperazine-2,6-dione hydrochloride (S)-4,4'-(1-Methyl-1,2-ethanediyl)bis-2,6-piperazinedione hydrochloride (S)-4,4'-(1-Methyl-1,2-Ethanediyl)Bis-2,6-Piperazinedione Hydrochloride 2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, hydrochloride, (S)- | Inhibitors;Inorganic salt;Inorganic Chemical Engineering |
| 33 | 154235-83-3 | Ampalex | CX516 Ampalex BDP 12 BDP-12(Ampalex) AMPAKINE CX516 1-(6-Quinoxalinylcarbonyl)piperidine 1-(quinoxalin-6-ylcarbonyl)piperidine 1-(QUINOXALIN-6-YLCARBONYL)PIPERIDINE 6-(Piperidin-1-ylcarbonyl)quinoxaline Piperidin-1-yl-quinoxalin-6-ylmethanone piperidin-1-yl(quinoxalin-6-yl)methanone Methanone, 1-piperidinyl-6-quinoxalinyl- ABT-224,piperidine, 1-(6-quinoxalinylcarbonyl)- ABT-224,PIPERIDINE, 1-(6-QUINOXALINYLCARBONYL)- | Aromatics;Intermedi;Inhibitors;Heterocycles;Ion channels;Pharmaceuticals;API intermediates;Membrane transport;Small molecule inhibitors;Intermediates & Fine Chemicals |
| 34 | 154902-51-9 | BOC-L-3-BENZOTHIENYLALANINE | BOC-BTA-OH RARECHEM BK PT 0204 BOC-L-3-BENZOTHIENYLALA Boc-L-3-Benzothienylalanine BOC-L-3-BENZOTHIENYLALANINE BOC-L-3-(3-BENZOTHIENYL)ALANINE BOC-3-(3-BENZOTHIENYL)-L-ALANINE N-ALPHA-T-BOC-BETA-(3-BENZOTHIENYL)-L-ALANINE N-ALPHA-T-BUTOXYCARBONYL-3-(3-BENZOTHIENYL)-L-ALANINE 3-(1-benzothiophen-3-yl)-N-(tert-butoxycarbonyl)-L-alanine | a-amino;Amino Acids;Intermediates;Amino Acid Derivatives;Pharmaceutical intermediates;Phenylalanine analogs and other aromatic alpha amino acids |
| 35 | 157634-00-9 | N-Boc-piperidine-2-methanol | BOC-2-PIPERIDYLMETHANOL N-Boc-2-piperidinemethanol N-Boc-piperidine-2-methanol n-boc-piperidine-2-methanol N-Boc-2-Piperidine Methanol 1-Boc-2-hydroxymethylpiperidine 1-BOC-2-HYDROXYMETHYL-PIPERIDINE 1-Boc-2-Hydroxymethyl Piperidine N-Boc-2-(hydroxymethyl)piperidine 2-HYDROXYMETHYL-1-N-BOC-PIPERIDINE tert-Butyl 2-(hydroxymethyl)piperidine-1-carboxylate 2-HYDROXYMETHYL-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER 2-HYDROXYMETHYL-PIPERIDINE-1-CARBOXYLIC ACID Tert-Butyl ester Tert-Butyl 2-(HYDROXYMETHYL)TETRAHYDRO-1(2H)-PYRIDINECARBOXYLATE TERT-BUTYL 2-(HYDROXYMETHYL)TETRAHYDRO-1(2H)-PYRIDINECARBOXYLATE | Piperidine;pharmacetical;Organic materials;Organic acid esters;Heterocyclic Compounds |
| 36 | 159610-93-2 | Fmoc-Ser(Me)-OH | FMoc-Ser(Me)-OH Fmoc-Ser(Me)-OH FMOC-L-SER(ME)-OH FMOC-O-METHYL-L-SER Fmoc-O-methyl-L-serine FMOC-(S)-2-AMINO-3-METHOXYPROPIONIC ACID FMOC-(S)-2-AMINO-3-METHOXYLPROPANOIC ACID N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-O-METHYL-L-SERINE (2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-methoxypropanoic acid | Intermediates;unnatural amino acids;Pharmaceutical intermediates |
| 37 | 161308-36-7 | hepbs | EPBS hepbs HEPBS 4-(2-hydroxyethyl)-1-piperazinebutanesulfonicacid N-(2-Hydroxyethyl)piperazine-N'-(4-butanesulfonic acid) N-[2-HYDROXYETHYL]PIPERAZINE-N'-[4-BUTANESULFONIC ACID] 4-(4-(2-Hydroxyethyl)piperazin-1-yl)butane-1-sulfonic acid 4-[4-(2-hydroxyethyl)-1-piperazinyl]-1-butanesulfonic acid HEPBS, N-(2-Hydroxyethyl)piperazine-N'-(4-butanesulfonic acid) | Organic raw materials;Carboxylic acid compounds;Pharmaceutical Intermediates |
| 38 | 161420-87-7 | Fmoc-Dab-OH | Fmoc-Dab FMOC-DAB-OH Fmoc-Dab-OH FMOC-L-DAB-OH Fmoc-Dab-Oh Hcl FMOC-DAB-OH HCL FMOC-L-2,4-DIAMINOBUTYRIC ACID FMOC-ALPHA,GAMMA-DIAMINOBUTYRIC ACID FMOC-L-ALPHA,GAMMA-DIAMINOBUTYRIC ACID N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-L-2,4-DIAMINOBUTYRIC ACID N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-L-ALPHA, GAMMA-DIAMINOBUTYRIC ACID | Amino;Pharmaceutical intermediates;Non-natural amino acids and extremely derivatives;Aromatic alcohol Aromatic Alcohols, ultra-dry solvent, pharmaceutical research and development and intermediates |
| 39 | 16208-51-8 | Dimesna | Dimesna 16208-51-8 Mesna EP Impurity D DIMESNA(SUBJECTTOPATENTFREE) Disodium 2,2'-dithiodiethanesulfonate Bis(2-sulfoethyl)disulfide disodium salt Disodium 2,2`-dithio-bis-ethane sulphonate Disodium 2,2'-disulfanediyldiethanesulfonate 2,2'-Dithiobis(ethanesulfonic acid sodium) salt DIMESNA (DISODIUM 2,2'-DITHIOBISETHANE SULFONATE) 2,2'-dithiobis(ethanesulfonic acid), disodium salt | Other APIs;Aliphatics;Organic materials;Organometallic compounds;Sulfur & Selenium Compounds |
| 40 | 163795-75-3 | sybr(R) green I nucleic acid gel stain | SYBR GREEN I SYBR(R) GREEN I Green-DNA Dye,SYBR Green I SDNA-Nucleic acids stain dye SYBR?Green I nucleic acid gel stain SYBR(R) GREEN I NUCLEI ACID GEL STAIN sybr(R) green I nucleic acid gel stain SYBR(R) GREEN I NUCLEIC ACID GEL STAIN SYBR(R) GREEN I NUCLEIC ACID GEL STAIN, 500 UL | Organic acids;Organic materials |
| 41 | 1643-29-4 | 3-(4-iodophenyl)propionic acid | 4-Iodohydrocinnamic acid 3-(4-Iodphenyl)propionsSre 3-(4-Iodphenyl)propionicacid 4-Iodo-benzenepropanoic acid 3-(4-IODOPHENYL)PROPANOIC ACID Benzenepropanoic acid, 4-iodo- 3-(4-iodophenyl)propanoic acid 3-(4-IODOPHENYL)PROPIONIC ACID 3-(4-iodophenyl)propionic acid | Organic acids;Carboxylic Acids;Carboxylic Acids;Organic materials;Drug Intermediates;Phenyls & Phenyl-Het;Phenyls & Phenyl-Het;Aromatic Propionic Acids |
| 42 | 165377-44-6 | 1-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine dihydrochloride | SA-4503 Sa-4503 SA-4503(2HCl) SA 4503 (dihydrochloride) Cutamesine HCl (SA-4503 HCl) 1-(3,4-Dimethoxyphenethyl)-4-(3-phenylpropyl)piperazinedihydrochloride 1-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine hydrochloride 1-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine dihydrochloride 1-[2-(3,4-DiMethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine dihydrochloride SA-4503,1-(3,4-DIMETHOXYPHENETHYL)-4-(3-PHENYLPROPYL)PIPERAZINE DIHYDROCHLORIDE | Piperazine;Pharmaceutical intermediates |
| 43 | 1667-99-8 | Chrome Azurol S | C.I. 43825 Mordantblue ChomeazurolS Chromazurol S PolytropeblueB Mordant Blue 29 Chrome Azurol S Chrome Cyanine BLA C.I. Mordant Blue 29 Chrome Azurol S, pure CHROMAZUROL S (C.I. No 43825 ) C.I. Mordant Blue 29, trisodium salt (8CI) CHROME AZUROL S INDICATOR FOR METAL TITRATION Benzoic acid, 5-(3-carboxy-5-methyl-4-oxo-2,5-cyclohexadien-1-ylidene)(2,6-dichloro-3-sulfophenyl)methyl-2-hydroxy-3-methyl-, trisodium salt trisodium 5-[(E)-(3-carboxylato-5-methyl-4-oxocyclohexa-2,5-dien-1-ylidene)(2,6-dichloro-3-sulfonatophenyl)methyl]-2-hydroxy-3-methylbenzoate trisodium 5-[(Z)-(3-carboxylato-5-methyl-4-oxocyclohexa-2,5-dien-1-ylidene)(2,6-dichloro-3-sulfonatophenyl)methyl]-2-hydroxy-3-methylbenzoate | Pigments;Biostains;Intermediates;Dyes and Dyes;Chemical Reagents;Chelating Reagents;Analytical Chemistry;Hematology and Histology;Bipyridyls, etc. (Chelat;Other Biochemical Reagents |
| 44 | 168427-74-5 | (2R,3S,4S,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-(2-methoxyethoxy)tetrahydrofuran-3-ol | 2'-O-MOE-A 2'-O-MOE-ADENOSINE 2'-O-Moe-Adenosine 2'-O-Methoxyethyl-adenosine 2'-O-(2-METHOXYETHYL)ADENOSINE 2'-O-(2-Methoxyethyl)-adenosine Adenosine, 2'-O-(2-Methoxyethyl)- (2R,3S,4S,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-(2-methoxyethoxy)tetrahydrofuran-3-ol (2R,3R,4R,5R)-5-(6-Amino-9H-purin-9-yl)-2-(hydroxy-methyl)-4-(2-methoxyethoxy)tetrahydrofuran- (2R,3R,4R,5R)-5-(6-Amino-9H-purin-9-yl)-2-(hydroxy-methyl)-4-(2-methoxyethoxy)tetrahydrofuran-3-o (2R,3R,4R,5R)-5-(6-AMino-9H-purin-9-yl)-2-(hydroxyMethyl)-4-(2-Methoxyethoxy)tetrahydrofuran-3-ol | Nucleoside;Nucleotides;Heterocycles;Chemical raw materials;Bases & Related Reagents;Carbohydrates & Derivatives |
| 45 | 169037-23-4 | 5-(trifluoromethoxy)isatin | BUTTPARK 34 7-90 5-(trifluoromethoxy)isatin 5-(TRIFLUOROMETHOXY)ISATIN 5-(Trifluoromethoxyl)-isatin 5-(Trifluoromethoxy)indole-2,3-dione 5-(trifluoromethoxy)indoline-2,3-dione 5-(Trifluoromethoxy)indoline-2,3-dione 5-(TRIFLUOROMETHOXYL)INDOLINE-2,3-DIONE 5-(trifluoroMethoxy)-2,3-dihydro-1H-indole-2,3-dione 5-(Trifluoromethoxy)-1H-indole-2,3-dione, 5-(Trifluoromethoxy)indoline-2,3-dione, 2,3-Dihydro-2,3-dioxo-5-(trifluoromethoxy)-1H-indole | blocks;Indoles;Building Blocks;IndolesOxindoles;Organic fluoride;Fused Ring Systems;Organic raw materials;Heterocyclic Building Blocks;Indane/Indanone and Derivatives |
| 46 | 170098-38-1 | Alvimopan dihydrate | Entereg Alvimopan hydrate Alvimopan dihydrate 156053-89-3 (Anhydrous) N-{(2S)-2-Benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]propanoyl}glycine N-{(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl}glycine dihydrate 2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperi dyl]propanoyl]amino]acetic acid dihydrate Glycine, N-((2S)-2-(((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-, dihydrate (((2S)-2-(((3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenylpropanoyl)amino)acetic acid dihydrate [[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl]-3-phenylpropanoyl]amino]acetic acid dihydrate [[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl]-3-phenylpropanoyl]amino]acetic acid dehydrate 2-([(2S)-2-([(3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl)-3-phenylpropanoyl]amino)acetic acid dihydrate | API;Chemical intermediates |
| 47 | 177966-60-8 | fmoc-3-(3-benzothienyl)-L-alanine | Fmoc-Beta-(3-Benzothien Fmoc-L-3-Benzothienylala Fmoc-L-3-benzothienylalanine FMOC-L-3-BENZOTHIENYLALANINE fmoc-3-(3-benzothienyl)-L-alanine Fmoc-beta-(3-benzothienyl)-Ala-OH N-Fmoc-S-(Benzothien-3-yl)-alanine N-Fmoc-3-(benzo[b]thiophen-3-yl)-L-alanine (9H-Fluoren-9-yl)MethOxy]Carbonyl L-3-Benzothienylalanine 3-(1-benzothiophen-3-yl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-alanine (αS)-α-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]benzo[b]thiophene-3-propanoic acid 3-(1-benzothiophen-3-yl)-2-[[9H-fluoren-9-ylmethoxy(oxo)methyl]amino]propanoic acid (2S)-3-(1-benzothiophen-3-yl)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoic acid | a-amino;Amino Acids;Intermediates;Amino Acid Derivatives;Pharmaceutical intermediates;Phenylalanine analogs and other aromatic alpha amino acids |
| 48 | 181632-25-7 | 6-Chloro-5-methyl-1-[[2-(2-methylpyrid-3-yloxy)pyrid-5-yl]carbamoyl]indoline hydrate dihydrochloride, 6-Chloro-2,3-dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl)oxy]-3-pyridinyl]-1H-indole-1-carboxyamide hydrate dihydrochloride | SB 242084 SB242084 diHCl SB242084 hydrate dihydrochloride SB242084 hydrate dihydrochloride 6-Chloro-5-methyl-1-[(2-[2-methylpyrid-3-yloxy]pyrid-5yl)carbamoyl]indoline dihydrochloride 6-Chloro-5-methyl-N-(6-((2-methylpyridin-3-yl)oxy)pyridin-3-yl)indoline-1-carboxamide dihydrochlo 6-Chloro-5-methyl-1-[[2-(2-methylpyrid-3-yloxy)pyrid-5-yl]carbamoyl]indoline dihydrochloride hydrate 6-Chloro-2,3-dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl)oxy]-3-pyridinyl]-1H-indole-1-carboxyamidedihydrochloride 6-Chloro-2,3-dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl)oxy]-3-pyridinyl]-1H-indole-1-carboxyamide dihydrochloride 6-Chloro-2,3-dihydro-5-Methyl-N-[6-[(2-Methyl-3-pyridinyl)oxy]-3-pyridinyl]-1H-indole-1-carboxaMide Dihydrochloride Hydrate 6-Chloro-2,3-dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl)oxy]-3-pyridinyl]-1H-indole-1-carboxyamide dihydrochloride hydrate 6-Chloro-5-methyl-1-[[2-(2-methylpyrid-3-yloxy)pyrid-5-yl]carbamoyl]indoline hydrate dihydrochloride, 6-Chloro-2,3-dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl)oxy]-3-pyridinyl]-1H-indole-1-carboxyamide hydrate dihydrochloride 6-Chloro-5-methyl-1-[[2-(2-methylpyrid-3-yloxy)pyrid-5-yl]carbamoyl]indoline hydrate dihydrochloride, 6-Chloro-2,3-dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl)oxy]-3-pyridinyl]-1H-indole-1-carboxyamide hydrate dihydrochloride | Amino compounds;Organic raw materials |
| 49 | 182004-65-5 | 2-[2-[4-(4-NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA MESYLATE | KB-R7943 KB-R7943 MESYLATE 2-[2-[4-(4-NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA MESYLATE S-[4-[(4-Nitrobenzyl)oxy]phenethyl]isothiourea Methanesulfonate 4-((4-Nitrobenzyl)oxy)phenethyl carbaMiMidothioate Methanesulfonate 2-(2-(4-(4-NITROBENZYLOXY)PHENYL)ETHYL)ISOTHIOUREA, METHANE SULFONATE Carbamimidothioic acid 2-[4-[(4-nitrophenyl)methoxy]phenyl]ethyl ester methanesulfonate Carbamimidothioic acid 2-[4-[(4-nitrophenyl)methoxy]phenyl]ethyl ester monomethanesulfonate | Signalling;Organic materials;Hydrocarbon compounds;Ion transporter and other ion channel |
| 50 | 18378-20-6 | 7-Benzylamino-4-nitrobenz-2-oxa-1,3-diazole | BBD 4-Benzylamino-7-nitrobenzofurazan BENZYLAMINO-4-NlTROBENZ-2-OXA-1,3-DIAZOLE BENZYLAMINO-4-NITROBENZ-2-OXA-1,3-DIAZOLE 4-Benzylamino-7-nitro-2,1,3-benzoxadiazole 4-BENZYLAMINO-7-NITROBENZ-2-OXA-1,3-DIAZOLE 7-Benzylamino-4-nitrobenz-2-oxa-1,3-diazole 7-BENZYLAMINO-4-NITROBENZ-2-OXA-1,3-DIAZOLE 4-Benzylamino-7-nitrobenz-2-oxa-1,3-diazole N-benzyl-7-nitro-2,1,3-benzoxadiazol-4-amine 4-Benzofurazanamine, 7-nitro-N-(phenylmethyl)- BBD, 7-Benzylamino-4-nitrobenz-2-oxa-1,3-diazole 4-Nitro-N-(phenylmethyl)-2,1,3-benzoxadiazol-7-amine | marker;Intermediates;Pharmaceutical intermediates |
| 51 | 18385-69-8 | 4H-1-Benzopyran-4-one, 2,3-dihydro-7-methyl- | 7-Methyl-2,3-dihydrochroMen-4-one 2,3-Dihydro-7-methyl-4H-1-benzopyran-4-one 7-Methyl-2,3-dihydro-4H-1-benzopyran-4-one 4H-1-Benzopyran-4-one, 2,3-dihydro-7-methyl- | Pyran;Pharmaceutical intermediates |
| 52 | 185106-16-5 | N-{2-[bis(1-methylethyl)amino]ethyl}-2-{[(2-hydroxy-4,5-dimethoxyphenyl)carbonyl]amino}-1,3-thiazole-4-carboxamide | Acofide AcotiaMide Acotiamide ACOTIAMIDUM Acotiamide formate salt N-(2-(Diisopropylamino)ethyl)-2-(2-hydroxy-4,5-dimethoxybenzamido)thiazole-4-carboxamide N-[2-[Bis(1-methylethyl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-4-thiazolecarboxamide 4-Thiazolecarboxamide, N-[2-[bis(1-methylethyl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]- N-(2-(diisopropylamino)ethyl)-2-(2-hydroxy-4,5-dimethoxybenzamido)thiazole-4-carboxamide hydrochloride N-{2-[bis(1-methylethyl)amino]ethyl}-2-{[(2-hydroxy-4,5-dimethoxyphenyl)carbonyl]amino}-1,3-thiazole-4-carboxamide | API;Base form;Impurity reference substance;Reference substance-impurity reference substance |
| 53 | 189937-46-0 | FMOC-D-3,3-DIPHENYLALANINE | FMOC-D-DPH-OH RARECHEM BK PT 0198 FMOC-D-(3-PHENYL)PHE-OH FMOC-D-3,3-DIPHENYLALANINE Fmoc-3,3-Diphenyl-D-alanine N-FMOC-BETA-PHENYL-D-PHENYLALANINE N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-D-3,3-DIPHENYLALANINE N-(9-FLUORENYLMETHOXYCARBONYL)-BETA-PHENYL-D-PHENYLALANINE N-[(9H-fluoren-9-ylmethoxy)carbonyl]-beta-phenyl-L-phenylalanine N-[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]-BETA-PHENYL-D-PHENYLALANINE 2-[[9H-fluoren-9-ylmethoxy(oxo)methyl]amino]-3,3-diphenylpropanoic acid | Peptide;a-amino;Amino Acids;Intermediates;unnatural amino acids;Amino Acid Derivatives;Pharmaceutical intermediates;Phenylalanine analogs and other aromatic alpha amino acids |
| 54 | 1934-20-9 | Crocein Orange G | C.I. 15970 Croceinorange ACID ORANGE 12 Acid orange 12 CROCEIN ORANGE G Crocein Orange G CROCEINE ORANGE G C.I. Food Orange 1 ACID ORANGE 12 DYE Acid Orange 12 Dye C.I. Acid Orange 12 (7CI) Crocein Orange G, Biological stain C.I. Acid Orange 12, monosodium salt (8CI) 6-HYDROXY-5-PHENYLAZO-2-NAPHTHALENESULFONIC ACID 1-PHENYLAZO-2-NAPHTHOL-6-SULFONIC ACID SODIUM SALT sodium 6-hydroxy-5-phenylazo-2-naphthalenesulphonate 6-Hydroxy-5-phenylazo-2-naphthalenesulfonic acid, sodium salt sodium (5Z)-6-oxo-5-(2-phenylhydrazinylidene)-5,6-dihydronaphthalene-2-sulfonate | Pigments;Colorants;Dyes and dyes;Chemical reagents;Biochemical reagents;Natural Plant Extract;Natural Plant Extract;Hematology and histology;Biochemical reagents-pig;Other biochemical reagents |
| 55 | 193693-67-3 | (R)-1-FMOC-PIPERIDINE-3-CARBOXYLIC ACID | FMOC-D-NIPC-OH FMOC-(R)-NIP-OH (r)-fmoc-nip-oh FMOC-(R)-NIPECOTIC ACID FMOC-(R)-PIPERIDINE 3-CARBOXYLIC ACID (R)-N-FMOC-PIPERIDINE-3-CARBOXYLIC ACID (R)-1-FMOC-PIPERIDINE-3-CARBOXYLIC ACID N-(9-FLUORENYLMETHOXYCARBONYL)-D-NIPECOTIC ACID N-(9-FLUORENYLMETHOXYCARBONYL)-(R)-NIPECOTIC ACID (R)-N-(9-FLUORENYLMETHYLOXYCARBONYL)-NIPECOTIC ACID N-(9-FLUORENYLMETHOXYCARBONYL)-D-3-PIPERIDINECARBOXYLIC ACID (R)-N-(9-FLUORENYLMETHYLOXYCARBONYL)-PIPERIDINE-3-CARBOXYLIC ACID N-(9-FLUORENYLMETHOXYCARBONYL)-N-(R)-PIPERIDINE-3-CARBOXYLIC ACID (R)-PIPERIDINE-1,3-DICARBOXYLIC ACID 1-(9H-FLUOREN-9-YLMETHYL) ESTER (R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)piperidine-3-carboxylic acid | Organic raw materials;Carboxylic acid compounds |
| 56 | 19608-29-8 | CB-03-01 | CB-03-1 CB-03-01 Clascoterone 17alpha-propionate CB-03-01 17alpha-propionate 17 alpha-propionate (CB-03-01) Cortexolone 17-alpha-propionate 21-Hydroxy-17-(1-oxopropoxy)pregn-4-ene-3,20-dione 17alpha-propio17-(1-oxopropoxy)pregn-4-ene-3,20-dione | ;API;APIS;Raw materials;Intermediates;Pharmaceutical anticancer;Hair growth and washing series;Scientific research raw materials;Signal transduction pathway kinase inhibitor |
| 57 | 197632-75-0 | FMOC-METRP(BOC)-OH | FMOC-METRP(BOC)-OH FMOC-N-ME-TRP(BOC)-OH FMoc-N-Me-L-Trp(Boc)-OH FMOC-N-ME-TRYPTOPHAN(BOC)-OH FMOC-N-ME-TRP(BOC)-OH TRIFLUOROACETATE SALT FMOC-N-ME-TRYPTOPHAN(BOC)-OH TRIFLUOROACETATE SALT N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-N-ALPHA-METHYL-N-IN-T-BUTOXYCARBONYL-L-TRYPTOPHAN 1-[(1,1-Dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-tryptophan (S)-2-((((9H-Fluoren-9-yl)Methoxy)carbonyl)(Methyl)aMino)-3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)propanoic acid | amino acids;Intermediates;Pharmaceutical intermediates |
| 58 | 205445-56-3 | Boc-D-3-Cyanophe | Boc-D-3-Cyanophe BOC-D-3-CYANOPHE BOC-D-PHE(M-CN)-OH BOC-D-PHE(3-CN)-OH BOC-M-CYANO-D-PHE-OH Boc-D-3-Cyanophenylalanine BOC-D-3-CYANOPHENYLALANINE Boc-3-Cyano-D-phenylalanine BOC-3-CYANO-D-PHENYLALANINE N-ALPHA-T-BUTOXYCARBONYL-D-(3-CYANOPHENYL)ALANINE (R)-2-(tert-butoxycarbonylamino)-3-(3-cyanophenyl)propanoic acid | a-amino;Amino Acids;Intermediates;Amino Acid Derivatives;Pharmaceutical intermediates;Phenylalanine analogs and other aromatic alpha amino acids |
| 59 | 205526-32-5 | Fmoc-L-Pentafluorophe | Fmoc-Phe(F5)-OH FMOC-PHE(F 5)-OH FMOC-L-PHE(F5)-OH Fmoc-L-Pentafluorophe FMOC-L-PENTAFLUOROPHE FMOC-PENTAFLUORO-L-PHE-OH FMOC-L-PENTAFLUOROPHENYLALANINE Fmoc-L-Pentafluorophenylalanine FMOC-PENTAFLUORO-L-PHENYLALANINE Fmoc-pentafluoro-L-phenylalanine Fmoc-3-Pentafluorophenyl-L-alanine N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-L-PENTAFLUOROPHENYLALANINE N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-L-PENTAFLUORO-PHENYLALANINE | a-amino;Amino Acids;Intermediates;Pharmaceutical intermediates;Phenylalanine analogs and other aromatic alpha amino acids |
| 60 | 205526-36-9 | (S)-N-FMOC-3-Cyanophenylalanine | RARECHEM BK PT 0153 Fmoc-L-3-Cyanophenylalanine FMOC-L-3-CYANOPHENYLALANINE Fmoc-3-Cyano-L-phenylalanine FMOC-3-CYANO-L-PHENYLALANINE N-FMOC-M-CYANO-L-PHENYLALANINE (S)-N-FMOC-3-Cyanophenylalanine (S)-N-FMOC-3-CYANOPHENYLALANINE N-(9-FLUORENYLMETHOXYCARBONYL)-3-CYANOPHENYL-L-ALANINE N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-M-CYANO-L-PHENYLALANINE N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-3-CYANO-L-PHENYLALANINE (S)-2-(FLUORENYLMETHOXYCARBONYLAMINO)-3-(3-CYANOPHENYL)PROPANOIC ACID | a-amino;Amino Acids;Intermediates;Amino Acid Derivatives;Pharmaceutical intermediates;Phenylalanine analogs and other aromatic alpha amino acids |
| 61 | 207738-08-7 | 3,3',5,5'-tetramethylbiphenyl-4,4'-diamine hydrochloride hydrate | TMB-2HCL-2HO TMB*2HCL*2H2O TMB2HC1 hydrate 5'-Tetramethylbenzidine 2HCl 2H20 3,3',5,5'-tetramethylbenzidine·2HCl·2H2O 3,3',5,5'-tetramethylbiphenyl-4,4'-diamine hydrochloride hydrate | Amino compounds;Organic raw materials |
| 62 | 209518-16-1 | N,N-Bis(4-sulfobutyl)-3,5-dimethylaniline disodium salt | MADB madb MADB ROBIOT Sodium 4,4'-((3,5-dimethylphenyl) N,N-Bis(4-sulfobutyl)-3,5-dimethylaniline disodium salt MADB (N,N-BIS(4-SULFOBUTYL)-3,5-DIMETHYLANILINE DISODIUM SALT) 4-[3,5-dimethyl-N-(4-sulfonatobutyl)anilino]butane-1-sulfonate SodiuM 4,4'-((3,5-diMethylphenyl)azanediyl)bis(butane-1-sulfonate) 4,4'-[(3,5-Dimethylphenyl)imino]bis-1-butanesulfonic acid disodium salt | Amino compounds;Organic raw materials |
| 63 | 210282-30-7 | Fmoc-L-2-Nitrophe | FMOC-L-PHE(2-NO2) Fmoc-L-2-Nitrophe FMOC-L-2-NITROPHE FMOC-PHE(2-NO2)-OH FMOC-L-2-NITROPHE-OH Fmoc-L-2-Nitrophenylalanine FMOC-L-2-NITROPHENYLALANINE FMOC-2-NITRO-L-PHENYLALANINE Fmoc-2-Nitro-L-phenylalanine 2-Nitro-L-phenylalanine, N-FMOC protected (S)-N-BETA-(9-FLUORENYLMETHOXYCARBONYL)-2-AMINO-3-(2-NITRO-PHENYL)-PROPIONIC ACID | Amino Acids;Intermediates;Amino Acid Derivatives;Pharmaceutical intermediates;Phenylalanine analogs and other aromatic alpha amino acids |
| 64 | 2150-48-3 | 3,6-bis(diethylamino)xanthylium chloride | CI 45010 PYRONIN B C.I. 45010 PYRONINE B Pyronine B Etetraethyl PYRONIN B CERTIFIED Pyronin B,pure,certified PYRONIN B FERRIC CHLORIDE COMPLEX 3,6-bis(diethylamino)xanthylium chloride (6-(diethylamino)-3h-xanthen-3-ylidene)diethyl-ammoniuchloride N-[6-(diethylamino)-3H-xanthen-3-ylidene]-N-ethylethanaminium chloride | P;Xanthene;Pigments;Stains and Dyes;Chemical reagents;Stains&Dyes, A to;Biochemical reagents;Hematology and histology;Staining agents and dyes;Hematology and Histology |
| 65 | 2181-04-6 | canrenoic acid potassium | Canrenoate POTASSIUM CANRENOATE Potassium canrenoate Canrenoate Potassium canrenoic acid potassium Canrenone, potassium salt CANRENOIC ACID POTASSIUM SALT 17-HYDROXY-3-OXOPREGNA-4,6-DIENE-21-CARBOXYLIC ACID 17-HYDROXY-3-OXOPREGNA-4,6-DIENE-21-CARBOXYLIC ACID POTASSIUM SALT 4,6-ANDROSTADIEN-17ALPHA-YL-PROPIONIC ACID-17BETA-OL-3-ONE POTASSIUM SALT potassium 3-[(10R,13S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoate (non-preferred name) potassium 3-[(8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoate (non-preferred name) | CHENIX;Organic materials;Organometallic compounds |
| 66 | 22252-43-3 | 7-Amino-3-methyl-3-cephem-4-carboxylic acid | 7-ADCA Cefazedone Impurity 13 Cefalexin EP Impurity B Cefadroxil EP Impurity B 7-Aminodeacetoxycephalosporanic ccid 7-Aminodesacetoxycephalosporanic acid 7-Amino-3-deacetoxycephalosporanic acid 7-Amino-3-methyl-3-cephem-4-carboxylic acid Cephalexin EP Impurity B (Cephalexin Impurity B, 7-ADCA) Cefadroxil EP Impurity B (Cephalexin Impurity B, 7-ADCA) 7-Amino-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7-Amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (6S,7S)-7-ammonio-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (6R,7R)-7-amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (6R-trans)-7-Amino-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid (6R-trans)-7-amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, 7-aMino-3-Methyl-8-oxo-, (6R,7R)- Cefadroxil Related Compound B (25 mg) ((6R,7R)-7-amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid) | Biochemis;Intermediates;Pharmaceutical intermediates;Various Metabolites and Impurities;Antibiotics for Research and Experimental Use;beta-Lactams (Antibiotics for Research and Experimental Use) |
| 67 | 223777-15-9 | 1-[(2R,3S,4S,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl]pyrimidine-2,4-dione | 2'-O-MOE-rU 2'-O-MOE Uridine 2'-O-(2-Methoxyethy)uridine 2'-O-(2-Methoxyethyl)uridine 2'-O-(2-methoxyethyl)-Uridine Uridine, 2'-O-(2-methoxyethyl)- 1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)oxolan-2-yl]pyrimidine-2,4-dione 1-[(2R,3S,4S,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl]pyrimidine-2,4-dione | Nucleotides;Nucleosides;Heterocycles;Bases & Related Reagents;Carbohydrates & Derivatives |
| 68 | 2353-45-9 | dihydrogen (ethyl)[4-[4-[ethyl(3-sulphonatobenzyl)amino](4-hydroxy-2-sulphonatobenzhydrylidene]cyclohexa-2,5-dien-1-ylidene](3-sulphonatobenzyl)ammonium, disodium salt | C.I. 42053 Food Green 3 Fast Green FCF C.I. Food Green 3 disodium 2-[(E)-{4-[ethyl(3-sulfonatobenzyl)amino]phenyl}{(4E)-4-[ethyl(3-sulfonatobenzyl)iminio]cyclohexa-2,5-dien-1-ylidene}methyl]-5-hydroxybenzenesulfonate dihydrogen (ethyl)[4-[4-[ethyl(3-sulphonatobenzyl)amino](4-hydroxy-2-sulphonatobenzhydrylidene]cyclohexa-2,5-dien-1-ylidene](3-sulphonatobenzyl)ammonium, disodium salt sodium 3-({[(1E,4E)-4-({4-[(4-ethoxyphenyl)amino]phenyl}{4-[ethyl(3-sulfonatobenzyl)amino]-2-methylphenyl}methylidene)-3-methylcyclohexa-2,5-dien-1-ylidene](ethyl)ammonio}methyl)benzenesulfonate | ;Organics;Analytical Chemistry |
| 69 | 241479-67-4 | Isavuconazole | BAL-4815 RO-0094815 Isavucozole Isaconazole Isavuconazole Isavuconazonium Isavuconazole(BAL-4815 4-(2-((2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)thiazol-4-yl)benzonitrile 4-[2-[(2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl]benzonitrile 4-[2-[(2R)-(2,5-Difluorophenyl)-2-hydroxy-(1R)-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]thiazol-4-yl]benzonitrile 4-[2-[(1R,2R)-2-(2,5-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile | ;API;Aromatics;Heterocycles;Antibacterial;Chiral Reagents;Intermediates &;Antifungal drugs;Medical raw materials;Small molecule inhibitors |
| 70 | 2516-05-4 | Methylene Violet (Bernthsen) | CI 52041 C.I. 52041 Methylene Violet Methylenevioletdye SAFRANIN 6B BLUISH Methylene Violet (Bernthsen) METHYLENE VIOLET (BERNTHSEN) CERTIFIED 7-(dimethylamino)-3H-phenothiazin-3-one Methylene Violet, certified, Bernthsen, pure Methylene Violet (Bernthsen), high purity biological stain, pure METHYLENE VIOLET (BERNTHSEN), CERTIFIED BY THE BIOLOGICAL STAIN COMMISSION | M;Basic dyes;Phenothiazine;Stains and Dyes;Dyes and pigments;Stains&Dyes, A to;Hematology and Histology;Certified Stains&DyesStains and Dyes |
| 71 | 2538-85-4 | Palatine Chrome Black 6BN | Calcon CALCONE calcon(R) C.I. 15705 Zinchrome R Mordantblack Mordant Black 17 C.I. Mordant Black 17 Eriochrome blue-black R Mordant Black 17 (15705) Palatine Chrome Black 6BN C.I. Mordant Black 17, monosodium salt (8CI) 1(2-hydroxy-1-naphthylazo)2-*naphthol-4-sulfonic 1-(2-Hydroxy-1-naphthylazo)-2-naphthol-4-sulfonic acid zinc salt sodium 3-hydroxy-4-(2-hydroxy-1-naphthylazo)-1-naphthalenesulphonate 3-Hydroxy-4-(2-hydroxy-1-naphthylazo)-1-naphthalenesulfonic acid, sodium salt sodium 3-hydroxy-4-[(E)-(2-hydroxynaphthalen-1-yl)diazenyl]naphthalene-1-sulfonate sodium (4E)-4-[(2-hydroxynaphthalen-1-yl)hydrazono]-3-oxo-3,4-dihydronaphthalene-1-sulfonate | Azo Compounds;Dyes and Pigments |
| 72 | 260367-12-2 | 5-(9-Fluorenylmethyloxycarbonylamino)-3-oxapentanoic acid | FMOC-O1PEN-OH Fmoc-5-amino-3-oxapentanoic acid [2-(FMOC-AMINO)ETHOXY]ACETIC ACID 5-(FMOC-AMINO)-3-OXAPENTANOIC ACID 5-(9-Fluorenylmethyloxycarbonylamino)-3-oxapentanoic acid 5-(9-FLUORENYLMETHYLOXYCARBONYL-AMINO)-3-OXAPENTANOIC ACID 5-(9-FLUORENYLMETHYLOXYCARBONYL-AMINO)-3-OXAPEMTANOIC ACID 5-(9-FLUOROENYLMETHYLOXYCARBONYL-AMINO)-3-OXAPEMTANOIC ACID 5-(9-Fluorenylmethyloxycarbonyl-amino)-3-oxapentanoic acid, [2-(Fmoc-amino)ethoxy]acetic acid | Intermediates;Pharmaceutical intermediates |
| 73 | 261380-28-3 | Boc-D-2-cyanophenylalanine | BOC-D-2-CYANOPHE BOC-D-PHE(2-CN)-OH Boc-D-Phe(2-CN)-OH RARECHEM BK PT 0149 BOC-O-CYANO-D-PHE-OH BOC-D-2-CYANOPHENYLALANINE Boc-D-2-cyanophenylalanine BOC-2-CYANO-D-PHENYLALANINE Boc-2-Cyano-D-phenylalanine N-ALPHA-T-BUTOXYCARBONYL-D-(2-CYANOPHENYL)ALANINE | a-amino;Amino Acids;Intermediates;Amino Acid Derivatives;Pharmaceutical intermediates;Phenylalanine analogs and other aromatic alpha amino acids |
| 74 | 27262-47-1 | Levobupivacaine | Chirocaine Levobupivacaine 1-butylpiperidine 1-Butyl-N-(2,6-dimet Levobupivacaine base 2',6'-Pipecoloxylidide, 1-butyl-, L-(-)- 1-Butyl-N-(2,6-dimethylphenyl)-piperidine-2-carboxamide (2S)-1-Butyl-N-(2,6-diMethylphenyl)-2-piperidinecarboxaMide (2S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide (2S)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2α-carboxamide (2S)-1-Butyl-N-(2,6-dimethylphenyl)-piperidine-2-carboxamide | Inter;Inhibitors;Chiral Reagents;Pharmaceuticals;Chemical reagents;Chemical intermediates;Local anesthesia series;Small molecule inhibitors;Pharmaceutical anesthetics;Intermediates & Fine Chemicals |
| 75 | 27599-63-9 | fluoresceinamine, mixture of isomers | FLUORESCEINAMINE 4-AMINOFLUORESCEIN 5(6)-Aminofluorescein FLUORESCEINAMINE ISOMER I FLUORESCEINAMINE, ISOMER 1 4-AMINOFLUORESCEIN ISOMER I 5-AMINOFLUORESCEIN ISOMER I fluoresceinamine, mixture of isomers Fluoresceinamine, mixture of isomers, (Aminofluorescein) 5-amino-3',6'-dihydroxy-3H-spiro[2-benzofuran-1,9'-xanthen]-3-one ammonium 6'-hydroxy-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthen]-3'-olate 5-AMINO-3',6'-DIHYDROXYSPIRO[ISOBENZOFURAN-1(3H),9'-(9H)XANTHEN]-3-ONE | Intermediates;Pharmaceutical intermediates |
| 76 | 283173-50-2 | 6H-Pyrrolo[4,3,2-ef][2]benzazepin-6-one,8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]- | Rikapbu AG014447 Rucaparib AG 014447 Rucaparib(AG-014447) 8-FLUOR-2-{4-[(METHYLAMINO)METHYL]FENYL}-1,3,4,5-TETRAHYDRO-6HAZEPINO[5,4,3-CD]INDOOL-6-ON 8-fluoro-2-(4-((methylamino)methyl)phenyl)-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one 8-Fluoro-2-[4-[(methylamino)methyl]phenyl]-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one 6H-Azepino[5,4,3-cd]indol-6-one,8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]- 6H-Pyrrolo[4,3,2-ef][2]benzazepin-6-one,8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]- 6H-Pyrrolo[4,3,2-ef][2]benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]- | Intermediates;Pharmaceutical intermediates |
| 77 | 288617-71-0 | (2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-2-methylpent-4-enoic acid | FMoc-α-Me-Gly(Allyl)-OH (S)-N-FMOC-Α-ALLYLALANINE (S)-N-Fmoc-alpha-allylalanine Fmoc-alpha-methyl-L-allylglycine (S)-N-Fmoc-α-2-n-propenylalanine (S)-N-Fmoc-2-(2'-propenyl)alanine (S)-N-Fmoc-2-(2'-propylenyl)alanine (S)-N-(9-Fluorenylmethylcarbamate)-2-(2'-propylenyl)alanine (2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-2-methylpent-4-enoic acid (2S)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-4-pentenoic acid | Intermediates;α-Methyl Amino Acids;Pharmaceutical intermediates |
| 78 | 288617-75-4 | (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-methyl-dec-9-enoic acid | FMoc-α-Me-Gly(Octenyl)-OH Fmoc-(S)-2-(7-octenyl)alanine (S)-N-FMOC-Α-(7-OCTENYL)ALANINE (S)-N-Fmoc-2-(7'-Octenyl)Alanine (S)-N-Fmoc-2-(7'-octenyl) alanine Fmoc-(S)-2-amino-2-methyldec-9-enoic acid (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-methyl-dec-9-enoic acid (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-methyldec-9-enoic acid (2S)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-9-decenoic acid | Intermediates;α-Methyl Amino Acids;Pharmaceutical intermediates |
| 79 | 288617-76-5 | Fmoc-alpha-allyl-D-alanine | Fmoc-alpha-All-L-Ala-OH (R)-N-FMOC-Α-ALLYLALANINE FMoc-α-Me-D-Gly(Allyl)-OH Fmoc-alpha-allyl-D-alanine (R)-N-Fmoc-alpha-allylalanine Fmoc-alpha-methyl-D-allylglycine (R)-N-Fmoc-2-(2'-propenyl)alanine (R)-N-FMOC-2-(2'-PROPYLENYL)ALANINE (R)-N-Fmoc-2-(2'-propylenyl)alanine (R)-N-Fmoc-2-(2'-Propylenyl)Alanine (R)-N-(9-Fluorenylmethylcarbamate)-2-(2'-propylenyl)alanine (2R)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-4-pentenoic acid (2R)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-2-methylpent-4-enoic acid | Intermediates;α-Methyl Amino Acids;unnatural amino acids;Pharmaceutical intermediates |
| 80 | 3348-03-6 | 6-carboxyfluorescein diacetate | 6-carboxyfluorescein diacetate 6-CARBOXYFLUORESCEIN DIACETATE 6-CARBOXY-DI-O-ACETYLFLUORESCEIN 6-Carboxy-di-O-acetylfluorescein, 6-CFDA 3-Oxo-3',6'-diacetoxyspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-6-carboxylic acid 3',6'-Diacetoxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-6-carboxylic acid 3',6'-Bis(acetyloxy)-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-6-carboxylic acid | marker;Others;Xanthene;Fluorescent;Biochemical reagents;Enzymes and coenzymes |
| 81 | 33869-21-5 | lacmoid | lacmoid LACMOID CI 51400 CI NO 51400 IRIS BLUE B RESORCIN BLUE RESORCINOL BLUE FLUORESCENT BLUE Fluorescent Blue ACID FLUORESCENT BLUE Fluorescent Sapphine Blue | J-K-L;Miscellaneous;Dyes and Pigments;Stains and Dyes;Stains&Dyes, A to |
| 82 | 34701-33-2 | (R)-4-Methyl-3-pentylamine | (R)-3-Methylbutan-2-aMine (R)-3-METHYL-2-BUTYLAMINE (2R)-3-methylbutan-2-amine (R)-4-Methyl-3-pentylamine (R)-(+)-3-METHYL-2-BUTYLAMINE R-(-)-2-amino-3-methyl butane (R)-(-)-3-Methyl-2-butylamine (R)-(-)-3-METHYL-2-BUTYLAMINE 2-ButanaMine,3-Methyl-, (2R)- (R)-(-)-2-Amino-3-methylbutane (R)-(-)-3-Methyl-2-butylamine, ChiPros | Chiral block;Organic block;General reagent |
| 83 | 34702-60-8 | Boc-pentafluoro-Phe-OH | Boc-pentafluoro-Phe-OH Boc-Pentafluoro-L-Phe-OH Boc-L-Pentafluoro-phe-OH Boc-L-Pentafluorophenylalanine BOC-L-PENTAFLUOROPHENYLALANINE Boc-pentafluoro-L-phenylalanine Boc-3-(Pentafluorophenyl)-L-alanine L-PENTAFLUOROPHENYLALANINE, BOC PROTECTED (S)-Boc-2-amino-3-(pentafluorophenyl)propionic acid N-ALPHA-T-BUTYLOXYCARBONYL-L-PENTAFLUOROPHENYLALANINE (2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(2,3,4,5,6-pentafluorophenyl)propanoic acid | a-amino;Amino Acids;Intermediates;Amino Acid Derivatives;Pharmaceutical intermediates;Phenylalanine analogs and other aromatic alpha amino acids |
| 84 | 352351-63-4 | Fmoc-2-methyl-D-phenylalanine | Cbz-L-2-Me-Phe-OH FMOC-D-2ME(PHE)-OH FMOC-O-ME-D-PHE-OH FMOC-D-2-METHYLPHE Fmoc-D-2-Me-Phe-OH FMOC-D-PHE(2-ME)-OH FMOC-D-PHE(O-ME)-OH FMOC-D-2-METHYLPHENYLALANINE Fmoc-D-2-Methylphenylalanine FMOC-2-METHYL-D-PHENYLALANINE Fmoc-2-methyl-D-phenylalanine | a-amino;Amino Acids;Intermediates;Amino Acid Derivatives;Pharmaceutical intermediates;Phenylalanine analogs and other aromatic alpha amino acids |
| 85 | 3618-63-1 | eriochrome red B | C.I. 18760 Mordant Red 7 Eriochromered eriochrome red B Acid Chrome Red B Acid Mordant Red B C.I.Mordant Red 11 C.I. Mordant Red 7 C.I. Mordant Red 7, monosodium salt (8CI) sodium 3-hydroxy-4-[(E)-(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)diazenyl]naphthalene-1-sulfonate (4Z)-4-[(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)hydrazono]-3-oxo-3,4-dihydronaphthalene-1-sulfonic acid sodium (4Z)-4-[2-(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)hydrazinylidene]-3-oxo-3,4-dihydronaphthalene-1-sulfonate | Mordant dyes;Biological dyes;Dyes and pigments |
| 86 | 3624-68-8 | Mordant Blue 9 | CI 14855 C.I. 14855 Mordant Blue 9 MORDANT BLUE 9 C.I.Mordantblue9 AcidmordantblueA3R C.I. Mordant Blue 9 AcidchromenavyblueRRN Mordant Blue 9 (C.I.) Acid mordant Blue 9 Acid Mordant Navy Blue RRL Acid Mordant Navy Blue RRN C.I. Mordant Blue 9, disodium salt 1-naphthalenesulfonicacid,6-[(5-chloro-2-hydroxy-3-sulfophenyl)azo]-5-hydroxy sodium 6-(5-chloro-2-hydroxy-4-sulphophenylazo)-5-hydroxynaphthalene-1-sulphonate 6-(5-Chloro-2-hydroxy-4-sulfophenylazo)-5-hydroxy-1-naphthalenesulfonic acid disodium salt 6-(5-Chloro-2-Hydroxy-4-Sulfophenylazo)-5-Hydroxy-1-Naphthalenesulfonic Acid Disodium Salt 6-(5-Chloro-2-hydroxy-4-sulfophenylazo)-5-hydroxy-1-naphthalenesulfonic acid, disodium salt disodium (6E)-6-[2-(5-chloro-2-hydroxy-3-sulfonatophenyl)hydrazinylidene]-5-oxo-5,6-dihydronaphthalene-1-sulfonate | Dyes and Pigments;Dyes and pigments |
| 87 | 405911-09-3 | 2-[3-[3-[N-[2-Chloro-3-(trifluoromethyl)benzyl]-N-(2,2-diphenylethyl)amino]propoxy]phenyl]acetic acid | GW3965 GW-3965 GW 3965 HYDROCHLORIDE 2-(3-(3-((2-Chloro-3-(trifluoromethyl)benzyl)(2,2-diphenylethyl)-amino)propoxy)phenyl)acetic a [3-(3-{[2-chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino}propoxy)phenyl]acetic acid 2-(3-(3-((2-Chloro-3-(trifluoromethyl)benzyl)(2,2-diphenylethyl)-amino)propoxy)phenyl)acetic acid 2-[3-[3-[N-[2-Chloro-3-(trifluoromethyl)benzyl]-N-(2,2-diphenylethyl)amino]propoxy]phenyl]acetic acid Benzeneacetic acid,3-[3-[[[2-chloro-3-(trifluoromethyl)phenyl]methyl](2,2-diphenylethyl)amino]propoxy]- [3-(3-{[2-chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino}propoxy)phenyl]acetic acid hydrochloride 3-[3-[n-(2-chloro-3-trifluoroMethylbenzyl)-(2,2-diphenylethyl)aMino]propvloxy]phenylacetic acid hydrochloride 3-[3-[n-(2-chloro-3-trifluoromethylbenzyl)-(2,2-diphenylethyl)amino]propvloxy]phenylacetic acid hydrochloride 3-[3-[N-(2-CHLORO-3-TRIFLUOROMETHYLBENZYL)-(2,2-DIPHENYLETHYL)AMINO]PROPYLOXY]PHENYLACETIC ACID HYDROCHLORIDE 3-[3-[[[2-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]METHYL](2,2-DIPHENYLETHYL)AMINO]PROPOXY]BENZENEACETIC ACID HYDROCHLORIDE | Inhibitor;Intermediates;Pharmaceutical intermediates |
| 88 | 45234-13-7 | N(alpha)-boc-L-citrulline | Boc-Cit-OH BOC-CIT-OH Boc-L-Cit-OH nα-boc-l-citrulline NALPHA-BOC-L-CITRULLINE N(alpha)-boc-L-citrulline N-ALPHA-T-BUTOXYCARBONYL-L-CITRULLINE NALPHA-tert-Butoxycarbonyl-L-citrulline N~2~-(tert-butoxycarbonyl)-N~5~-carbamoyl-L-ornithine N-ALPHA-T-BUTOXYCARBONYL, DELTA-CARBAMOYL-L-ORNITHINE (2S)-2-{[(tert-butoxy)carbonyl]amino}-5-(carbamoylamino)pentanoic acid 5-(carbamoylamino)-2-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]pentanoic acid | Intermediates;Pharmaceutical intermediates |
| 89 | 453562-69-1 | Motesanib | AMG 706 CS-1108 AMG-706 motesanib Motesanib Motesanib Base AMG-706(Motesanib) Motesanib (AMG-706) Base) N-(3,3-diMethylindolin-6-yl){2-[(4-pyridylMethyl)-aMino](3-pyridyl)}-carboxaMide N-(2,3-Dihydro-3,3-dimethyl-1H-indol-6-yl)-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide N-(3,3-dimethyl-2,3-dihydro-1H-indol-6-yl)-2-[(pyridin-4-ylmethyl)amino]pyridine-3-carboxamide 3-PyridinecarboxaMide, N-(2,3-dihydro-3,3-diMethyl-1H-indol-6-yl)-2-[(4-pyridinylMethyl)aMino]- | API;Inh;Inhibitors;Antineoplastic;Cell biology reagents;Protein tyrosine kinase;Small molecule inhibitor;Scientific research reagents;Small molecule inhibitor, natural product;Signal transduction path |
| 90 | 496775-61-2 | Eltrombopag | Sb497115 Promacta Sb-497115 Eltrombopag Unii-S56D65xj9g Eltrombopag [inn] (E)-3'-(2-(1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxybiphenyl-3-carboxylic acid (1,1'-Biphenyl)-3-carboxylic acid, 3'-((2Z)-(1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene)hydrazino)-2'-hydroxy- 3'-[2-[(2Z)-1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid | AP;Agonist;Aromatics;Inhibitors;Heterocycles;Pharmaceuticals;Pharmaceutical bulk drugs;Small molecule inhibitors;Platelet receptor agonists;Pharmaceutical raw materials |
| 91 | 509088-69-1 | KRP-203 | KRP203 KRP-203 KRP203 KRP-203 (hydrochloride) 2-Amino-2-[2-[2-chloro-4-[[3-(phenylmethoxy)phenyl]thio]phenyl]ethyl]-1,3-propanediol 2-AMINO-2-[2-[2-CHLORO-4-[[3-(PHENYLMETHOXY)PHENYL]THIO]PHENYL]ETHYL]-1,3-PROPANEDIOL HCL 2-AMINO-2-(4-((3-(BENZYLOXY)PHENYL)THIO)-2-CHLOROPHENETHYL)PROPANE-1,3-DIOL HYDROCHLORIDE 2-Amino-2-(4-((3-(benzyloxy)phenyl)thio)-2-chloro-phenethyl)propane-1,3-diol hydrochloride 2-Amino-2-(2-(4-(3-benzyloxyphenylthio)-2-chlorophenyl)ethyl)-1,3-propanediol hydrochloride 2-Amino-2-[2-[2-chloro-4-[[3-(phenylmethoxy)phenyl]thio]phenyl]ethyl]-1,3-propanediol Hydrochloride 2-Amino-2-[2-[2-chloro-4-[[3-(phenylmethoxy)phenyl]thio]phenyl]ethyl]-1,3-propanediol hydrochloride 2-amino-2-[2-(4-{[3-(benzyloxy)phenyl]sulfanyl}-2-chlorophenyl)ethyl]propane-1,3-diol hydrochloride | Amines;Aromatics;Pharmaceuticals;Sulfur & Selenium Compounds;Pharmaceutical raw materials;Intermediates & Fine Chemicals |
| 92 | 50984-88-8 | P-xylenolphthaleine | p-Xylenolphthalein P-XYLENOLPHTHALEIN P-xylenolphthaleine p-xylenolphthalein (pH 9.0-10.5) 2',5',2'',5''-TETRAMETHYLPHENOLPHTHALEIN 3,3-bis(4-hydroxy-2,5-dimethylphenyl)-2-benzofuran-1(3H)-one 3,3-Bis(4-hydroxy-2,5-dimethylphenyl)isobenzofuran-1(3H)-one 3,3-Bis(4-hydroxy-2,5-dimethylphenyl)-1(3H)-isobenzofuranone 3,3-Bis(2,5-dimethyl-4-hydroxyphenyl)isobenzofuran-1(3H)-one 4,4'-[(3-Oxo-1,3-dihydroisobenzofuran)-1,1-diyl]bis(2,5-dimethylphenol) | Phthalein;Organic raw materials;Phenolic alcohol compounds |
| 93 | 51391-96-9 | 5-Methylcyclocytidine hydrochlorine | HCI Cmc·Hci CMC.HCL CMC.HCI CMC.HCl 2,2'-Anhydro-5-Me-C.Hcl 5-Methylcyclocytidine hydrochlorine 2,2'-Cyclo-5-Methylcytidine hydrochloride 2-(hydroxymethyl)-6-imino-7-methyl-2,3,3a,9a-tetrahydrofuro[1,2][1,3]oxazolo[3,4-a]pyrimidin-3-ol | Organic materials;Hydrocarbon compounds |
| 94 | 52-66-4 | DL-Penicillamine | dl-valin Penicillamine AKOS NCG1-0051 DL-Penicillamine DL-PENICILLAMINE dl-3-mercaptovaline 3-mercapto-dl-valin 3-mercapto-dl-valine DL-beta-mercaptovaline 3,3-Dimethyl-DL-cysteine 3,3-Dimethyl-DL-cysteine~3-Mercapto-DL-valine | Amino Aids;Amino Acids;Antibiotics;Amino acids;Biochemistry;Analytical Chemistry;Biochemical reagents;Organic intermediates;Chemical raw materials;Small molecule inhibitors |
| 95 | 52450-18-7 | 3'-amino-3'-deoxythymidine | 3-AMT Whi-02 Nsc620059 Aids000909 Ni 2-110-2 3'-NH2-ddT Aids-000909 3'-Aminothymidine Zidovudine Impurity 1 3'-Amino-3'-deoxythymidine 3'-amino-3'-deoxythymidine Thymidine, 3'-amino-3'-deoxy- 3'-Amino-2',3'-dideoxythymidine 1-[(2R,4S,5S)-4-Amino-5-(Hydroxymethyl)Oxolan-2-Yl]-5-Methylpyrimidine-2,4-Dione 1-[(2R,4S,5S)-4-Amino-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione | Nucleotides;Intermediates;Pharmaceuticals;Metabolites & Impurities;Bases & Related Reagents;Pharmaceutical intermediates;Intermediates & Fine Chemicals |
| 96 | 52815-19-7 | 3-[(tert-butoxycarbonyl)amino]butanoic acid | BOC-D,L-BETA-ABU-OH BOC-DL-3-AMINOBUTYRIC ACID Boc-DL-3-aminobutanoic acid BOC-DL-BETA-AMINOBUTYRIC ACID 3-(tert-butoxycarbonyl)butanoic acid 3-TERT-BUTOXYCARBONYLAMINO-BUTYRIC ACID N-BETA-T-BOC-D,L-BETA-AMINOBUTYRIC ACID 3-((tert-butoxycarbonyl)amino)butanic acid 3-[(tert-butoxycarbonyl)amino]butanoic acid (3S)-3-[(tert-butoxycarbonyl)amino]butanoate (3R)-3-[(tert-butoxycarbonyl)amino]butanoate | pharmacetical;Intermediates;Pharmaceutical intermediates |
| 97 | 541503-81-5 | vicriviroc malate | CS-599 vicriviroc malate Vicriviroc Malate 1-((4,6-dimethyl-5-pyrimidinyl)carbonyl)-4-((3s)-4-((1r)-2-methoxy-1-(4-(trifluoromethyl)phenyl)ethyl)-3-methyl-1-piperazinyl)-4-methylpiperidine malate 1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]-4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methylpiperidine malate | Pyrimidine;ProteaseInhibitors;Pharmaceutical intermediates |
| 98 | 5423-07-4 | Nitrazine Yellow | CI 14890 CI NO 14890 NITRAZOL YELLOW Nitrazine Yellow NITRAZINE YELLOW 2-[2,4-DINITROPHENYLAZO]NAPHTHOL-3,6-DISULFONIC ACID DISODIUM SALT 2-(2,4-DINITROPHENYLAZO)-1-NAPHTHOL-3,6-DISULFONIC ACID, DISODIUM SALT 2-(2,4-DINITROPHENYLAZO)-1-HYDROXYNAPHTHALENE-3,6-DISULFONIC ACID DISODIUM SALT 3-(2,4-DINITROPHENYLAZO)-4-HYDROXY-2,7-NAPHTHALENEDISULFONIC ACID, DISODIUM SALT | Azo;Reagents;Chemical;Titration;Analytical purity;Acid-base indicator;Analytical reagents;Biochemical reagents;Chemical raw materials;Other biochemical reagents |
| 99 | 54375-47-2 | 4-methylcoumarin-6-ylmethyliminodiacetic acid | CALCEIN BLUE TIMTEC-BB SBB002950 UMBELLIFERONE COMPLEXONE 4-methylcoumarin-6-ylmethyliminodiacetic acid 4-METHYLUMBELLIFERONE-8-METHYLIMINODIACETIC ACID B-METHYLUMBELLIFERONE METHYLENEIMINODIACETIC ACID 4-METHYLUMBELLIFERONE METHYLENEIMINODIACETIC ACID 4-METHYLUMBELLIFERONE-6-METHYLENEIMINODIACETIC ACID 4-METHYLUMBELLIFERONE-8-METHYLENEIMINODIACETIC ACID | Coumarin;Complexones;Organic acids;Organic materials;Chelating Reagents;Analytical Chemistry;Photometric Reagents (Complexone) |
| 100 | 5438-36-8 | 5-Iodovanillin | AKOS B004179 5-Iodovanillin 5-IODOVANILLIN AKOS BBS-00004640 TIMTEC-BB SBB006927 OTAVA-BB BB0107930009 4-Hydroxy-3-iodo-5-methoxybenzaldehyde 4-HYDROXY-5-IODO-3-METHOXYBENZALDEHYDE 4-HYDROXY-3-IODO-5-METHOXYBENZALDEHYDE 4-hydroxy-3-iodo-5-methoxy-benzaldehyd | C8;Aldehydes;Carbonyl Compounds;Carbonyl Compounds;Biochemical reagents;Aromatic Aldehydes & Derivatives (substituted) |
| 101 | 55804-66-5 | ethyl 2,3,6,7-tetrahydro-11-oxo-1H,5H,11H-[1]benzopyrano[6,7,8-ij]quinolizine-10-carboxylate | CCRIS 4963 NSC 338967 Coumarin 504 Coumarin 314 Exciton Coumarin 504 2,3,5,6-1h,4h-tetrahydro-9-carbethoxyquinolizino-[9,9a,1-gh]coumarin Coumarin 504, 2,3,5,6-1H,4H-Tetrahydro-9-carbethoxyquinolizino-[9,9a,1-gh]coumarin Ethyl 2,3,6,7-tetrahydro-11-oxo-1H,5H,11H-(1)benzopyrano(6,7,8-ij)quinolizine-10-carboxylate ethyl 2,3,6,7-tetrahydro-11-oxo-1H,5H,11H-[1]benzopyrano[6,7,8-ij]quinolizine-10-carboxylate ethyl 11-oxo-2,3,6,7-tetrahydro-1H,5H,11H-pyrano[2,3-f]pyrido[3,2,1-ij]quinoline-10-carboxylate 2,3,6,7-Tetrahydro-11-oxo-1H,5H,11H-[1]benzopyrano[6,7,8-ij]quinolizine-10-carboxylic acid ethyl ester 11-Oxo-2,3,6,7-tetrahydro-1H,5H,11H-[1]benzopyrano[6,7,8-ij]quinolizine-10-carboxylic acid ethyl ester 1H,5H,11H-(1)Benzopyrano(6,7,8-ij)quinolizine-10-carboxylic acid, 2,3,6,7-tetrahydro-11-oxo-, ethyl ester | Photon and optical materials;Organic chemical raw materials |
| 102 | 574-93-6 | 29H,31H-phthalocyanine | 74100 P.B.16 LT-N222 C.I.Pigment Blue 16 29H,30H-phthalocyanine 29H,31H-phthalocyanine Phthalo Blue (Metal free) (1Z,10Z,19Z,29Z)-2,11,20,37,38,39,40-heptaazanonacyclo[28.6.1.1~3,10~.1~12,19~.1~21,28~.0~4,9~.0~13,18~.0~22,27~.0~31,36~]tetraconta-1,3(40),4,6,8,10,12(39),13,15,17,19,21,23,25,27,29,31,33,35-nonadecaene (non-preferred name) | ;Organics;Porphyrins;Phthalocyanines;Achiral Nitrogen;Functional Materials;Highly Purified Reagents;Phthalonitriles & Naphthalonitriles |
| 103 | 58969-01-0 | Basic Fuchsine | AFB STAIN ROSANILINE Fuchsin(e) Magenta Red FUCHSIN BASIC ROSANILINE HCL Basic Fuchsine BASIC VIOLET 14 HCL MAGENTA HYDROCHLORIDE Basic Violet 14 (42510) ROSANILINE HYDROCHLORIDE BASIC FUCHSIN HYDROCHLORIDE BASIC VIOLET 14, HYDROCHLORIDE | Reagent |
| 104 | 61-80-3 | 2-Amino-5-chlorobenzoxazole | Zoxine Zoxamin usafma-12 Zoxazolamine ZOXAZOLAMINE TIMTEC-BB SBB003874 2-Amino-5-chlorobenzoxazole 2-AMINO-5-CHLOROBENZOXAZOLE 5-chlorobenzoxazol-2-ylamine 5-chloro-1,3-benzoxazol-2-amine 2-Amino-5-chlorobenzoxazoleZoxazolamine | Amines;SPLENDA;Heterocycles;Miscellaneous;Pharmaceuticals;Small molecule inhibitors;Intermediates & Fine Chemicals |
| 105 | 623142-96-1 | N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]-2-methoxyphenyl]-N'-[1-(2-thiazolyl)ethyl]urea | KI20227 Ki20227 CS-1094 KI 20227 KI-20227 N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]-2-methoxyphenyl]-N'-[1-(2-thiazolyl)ethyl]urea 1-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)-2-methoxyphenyl)-3-(1-(thiazol-2-yl)ethyl)urea 1-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2-methoxyphenyl]-3-[1-(1,3-thiazol-2-yl)ethyl]urea Urea, N-[4-[(6,7-diMethoxy-4-quinolinyl)oxy]-2-Methoxyphenyl]-N'-[1-(2-thiazolyl)ethyl]- | Quinoline;Pharmaceutical intermediates |
| 106 | 6262-21-1 | 4,5,6,7-tetrachlorofluorescein | Tetrachlorofluorescein Tetrachloro fluorescein 4,5,6,7-tetrachlorofluorescein 3,4,5,6-Tetrachlorofluorescein 2,3,4,5-tetrachloro-6-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid 4,5,6,7-tetrachloro-3,6-dihydroxy-3H-spiro[2-benzofuran-1,9-xanthen]-3-one 4,5,6,7-Tetrachloro-3,6-dihydroxyspiro(isobenzofuran-1(3H),9-(9H)xanthene)-3-one Spiro(isobenzofuran-1(3H),9-(9H)xanthen)-3-one, 4,5,6,7-tetrachloro-3',6'-dihydroxy- | T-U-V;, A to;Stains&Dyes;Stains and Dyes |
| 107 | 62625-29-0 | o-Cresol Red, sodium salt | Cresol Red Cresolsodiumsalt Cresol Red sodium salt LABOTEST-BB LT00159735 CRESOL RED SODIUM SALT o-Cresol Red, sodium salt CRESOL RED, WATER SOLUBLE 2-CRESOLSULFONEPHTHALEIN SODIUM SALT o-Cresolsulphonephthalein sodium salt phenol,4,4'-(3h-2,1-benzoxathiol-3-ylidene)bis[2-methyl-,s,s-dioxide,monosod Sodium hydrogen 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis(2-methylphenolate) S,S-dioxide sodium 4-[3-(4-hydroxy-3-methylphenyl)-1,1-dioxido-3H-2,1-benzoxathiol-3-yl]-2-methylphenolate 2-[(Z)-(4-hydroxy-3-methylphenyl)(3-methyl-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]benzenesulfonate sodium 2-[(Z)-(4-hydroxy-3-methylphenyl)(3-methyl-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]benzenesulfonate | C;pH Indicators;Indicator (pH);Sulfonephthalein;Stains and Dyes;Stains&Dyes, A to;Analytical Chemistry;Organic raw materials;Phenolic alcohol compounds |
| 108 | 71145-03-4 | Methyl 2,6-dimethyl-3-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-5-carboxylate | Methyl 2,6-dimethyl-3-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-5-carboxylate methyl 2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-[TRIFLUOROMETHYL]PHENYL)PYRIDINE-3-CARBOXYLIC ACID METHYL ESTER 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-[2'-(TRIFLUOROMETHYL)PHENYL]-3-PYRIDINECARBOXYLIC ACID METHYL ESTER 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-[2-(TRIFLUOROMETHYL)PHENYL]-3-PYRIDINECARBOXYLIC ACID, METHYL ESTER 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-diMethyl-5-nitro-4-[2-(trifluoroMethyl)phenyl]-, Methyl ester | Inhibitors;Calcium channel |
| 109 | 73630-08-7 | 2,2'-(ethylenedioxy)dianiline-N,N,N',N'-tetraacet | CS-966 BAPTA 4K BAPTA(K+ SALT) BAPTA POTASSIUM BAPTA TETRAPOTASSIUM SALT BAPTA, tetrapotassium salt 2,2'-(ethylenedioxy)dianiline-N,N,N',N'-tetraacet 1,2-BIS(O-AMINOPHENOXY)ETHANE-N,N,N',N'-TETRAACETIC ACID POTASSIUM SALT 1,2-BIS(2-AMINOPHENOXY)ETHANE-N,N,N',N'-TETRAACETIC ACID TETRAPOTASSIUM SALT 1,2-Bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetrapotassium salt tetrapotassium 2,2',2'',2'''-[ethane-1,2-diylbis(oxybenzene-2,1-diylnitrilo)]tetraacetate | Amines;Aromatics;Intermediates;Chelating Agents & Ligands;Pharmaceutical intermediates;Fluorescent Labels & Indicators |
| 110 | 761423-87-4 | Ipragliflozin | Ipragliflozin Ipragliflozin impuity IpragliflozinL-Proline Ipragliflozin (ASP1941) (1S)-1,5-Anhydro-1-C-[3-[(1-benzothiophen-2-yl)methyl]-4-fluorophenyl]-D-glucitol Ipragliflozin, (1S)-1,5-Anhydro-1-C-[3-[(1-benzothiophen-2-yl)Methyl]-4-fluorophenyl]-D-glucitol | Inhibitors;Chemical reagents;Iglifloin intermediate;Small molecule inhibitors;Small molecule inhibitors, natural products;Reference substance-impurity reference substance |
| 111 | 76265-70-8 | Fmoc-Met(O)-OH | FMOC-MET(O)-OH Fmoc-Met(O)-OH FMOC-L-MET(O)-OH FMOC-METHIONINE(O)-OH Fmoc-L-methionine sulfoxide FMOC-L-METHIONINE SULFOXIDE Fmoc-L-methionine-sulfoxide FMOC-L-METHIONINE-DL-SULFOXIDE N-ALPHA-FMOC-L-METHIONINE-SULFOXIDE N-ALPHA-FMOC-L-METHIONINE-DL-SULFOXIDE (2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-methanesulfinylbutanoic acid | Intermediates;Pharmaceutical intermediates |
| 112 | 76387-70-7 | Boc-D-Dap-OH | BOC-D-DAP-OH Boc-D-Dap-OH N-t-BOC--amino-D-alanine N-t-BOC-?amino-D-alanine N-T-BOC-BETA-AMINO-D-ALANINE Boc-D-2,3-Diaminopropionic Acid N-α-Boc-D-2,3-diaminopropionic acid N-ALPHA-BOC-D-DIAMINOPROPIONIC ACID N-ALPHA-BOC-D-2,3-DIAMINOPROPIONIC ACID N-ALPHA-BOC-(R)-2,3-DIAMINOPROPIONIC ACID N-ALPHA-T-BUTOXYCARBONYL-D-2,3-DIAMINOPROPIONIC ACID (2R)-3-ammonio-2-[(tert-butoxycarbonyl)amino]propanoate N-ALPHA-TERT-BUTYLOXYCARBONYL-D-2,3-DIAMINOPROPIONIC ACID | Intermediates;Pharmaceutical intermediates |
| 113 | 76778-22-8 | 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine | GBR 12935 GBR-12935 1-(2-benzhydryloxyethyl)-4-(3-phenylpropyl)piperazine 1-Hydrocinnamyl-4-[2-(diphenylmethoxy)ethyl]piperazine 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenylpropyl)piperazine 1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)- Piperazine, 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenylpropyl)- 1-(2-(Benzhydryloxy)ethyl)-4-(3-phenylpropyl)piperazine Maleate 1-(2-Diphenylmethoxyethyl)-4-(3-phenylpropyl)piperazinedihydrochloride GBR-12935, 1-(2 -(diphenylMethoxy) ethyl) -4-(3-phenylpropyl) piperazine N-[3-tert-Butyl-1-(4-Methylphenyl)-1H-pyrazol-5-yl]-N-[4-[2-(4-Morpholinyl)ethoxy]naphthalen-1-yl]urea | Piperazine;Dopamine receptor;Pharmaceutical intermediates |
| 114 | 77172-72-6 | 3,4,5,6-Tetrabromophenolsulfonephthalein | Nsc624919 Aids044105 Aids-044105 Tetrabromosulfonephthalein 4,5,6,7-Tetrabromophenolsulfophthalein 4,5,6,7-Tetrabromophenolsulfonephthalein 3,4,5,6-Tetrabromophenolsulfonephthalein 4,5,6,7-Tetrabromo-3,3-bis(p-hydroxyphenyl)-3H-2,1-benzoxathiole 1,1-dioxide | T-U-V;Sains and Dyes;Stains and Dyes;Sains & Dyes, A to;Stains&Dyes, A to;Chemical raw materials;In vitro diagnostic reagents;Pharmaceutical raw materials;Diagnostic reagent series-diagnostic reag |
| 115 | 773092-05-0 | Acotiamide hydrochloride trihydrate | Ym-443 YM-443 ACOTIAMIDE HCL Acotiamide HCl Unii-nmw7447A9a Acotiamide hydrochloride hydrate Acotamine hydrochloride trihydrate AcotiaMide hydrochloride trihydrate Acotiamide hydrochloride trihydrate N-(2-(Diisopropylamino)ethyl)-2-((2-hydroxy-4,5-dimethoxybenzoyl)amino)-1,3-thiazole-4-carboxyamide monohydrochloride trihydrate | API;Inhibitors;Inorganic salt;Inorganic Chemical Engineering |
| 116 | 81029-05-2 | Brilliant cresyl blue | CI 51010 BRILLLIANT BLUE C Brilliant cresy blue brillantcresylblueadl Brilliant cresyl blue BRILLIANT CRESYL BLUE Brilliant Cresyl Blue Brilliant crysyl blue ALD FORMERLY LISTED AS BRILLIANT CRESYL BLUE BRILLIANT CRESYL BLUE ZINC CHLORIDE DOUBLE SALT N-(7,9-diamino-6-methyl-3H-phenoxazin-3-ylidene)-N-ethylethanaminium N-(7,9-diamino-6-methyl-5a,9a-dihydro-3H-phenoxazin-3-ylidene)-N-ethylethanaminium chloride | B;Pigments;Chemicals;Stains and Dyes;Chemical reagents;Stains&Dyes, A to;Biochemical reagents;Hematology and histology;Staining agents and dyes;Biochemical reagents-pigments |
| 117 | 817204-33-4 | 2'-deoxy-2'-fluoro-2'-C-methylcytidine | R1656 R 1656 R-1656 PSI 6130 PSI6130 PSI-6130 PSI 6130 2'-deoxy-2'-fluoro-2'-C-methylcytidine (2'R)-2'-deoxy-2'-fluoro-2'-methyl-Cytidine ethyl 4-broMo-1-Methyl-1H-pyrrole-2-carboxylate 4-Amino-1-((2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyr | apis;Metabolism;Pharmaceutical intermediates |
| 118 | 82692-93-1 | TOOS | TOOS TOOS, SODIUM SALT N-ETHYL-N-SULFOHYDROXYPROPYL-M-TOLUIDINE SODIUM SALT N-ETHYL-N-SULPHOHYDROXYPROPYL-M-TOLUIDINE, SODIUM SALT N-ETHYL-N-(2-HYDROXY-3-SULFOPROPYL)-3-TOLUIDINE SODIUM SALT 3-(n-ethyl-3-methylanilino)-2-hydroxypropansulf.acidso-salt N-ETHYL-N-(2-HYDROXY-3-SULFOPROPYL)-M-TOLUIDINE SODIUM SALT Sodium 3-(N-ethyl-3-methylanilino)-2-hydroxypropanesulfonate N-Ethyl -N-(2-hydroxy-3-sulfopropyl)-m-toluidine sodium salt N-ethyl-N-(2-hydroxy-3-sulfopropyl)-m-toluidine, sodium salt sodium 3-[ethyl(3-methylphenyl)amino]-2-hydroxypropane-1-sulfonate 3-(N-ETHYL-M-TOLUIDINO)-2-HYDROXYPROPANE-SULFONIC ACID SODIUM SALT 3-(N-ETHYL-3-METHYLANILINO)-2-HYDROXYPROPANESULFONIC ACID SODIUM SALT 3-(N-ethyl-methylanilino)-2-hydroxy Propane sulfonic acid, Sodium Salt 3-[ethyl(3-methylphenyl)amino]-2-hydroxy-1-propanesulfonicacimonosodiums | detergent;Amino compounds;Organic raw materials;Pharmaceutical Raw Materials |
| 119 | 82692-96-4 | ADOS | ADOS AORVUOOOJJFCOC-UHFFFAOYSA-N Sodium 3-(ethyl(3-methoxyphenyl) -2-hydroxypropane-1-sulfonate dihydrate sodium salt of N-ethyl-N-(2-hydroxy-3-sulfopropyl)-m-anisidine N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3-methoxyaniline sodium salt dihydrate n-ethyl-n-(2-hydroxy-3-sulfopropyl)-3-methoxyaniline sodium salt dihydrate N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3-methoxyaniline, sodium salt, dihydrate Sodium 3-(ethyl(3-methoxyphenyl)amino)-2-hydroxypropane-1-sulfonate dihydrate N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3-Methoxyaniline sodiuM salt dihydrate (ADOS) Sodium 3-(N-Ethyl-3-methoxyanilino)-2-hydroxy-1-propanesulfonate [for Biochemical Research] | Amino compounds;Organic raw materials |
| 120 | 82692-97-5 | N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethylaniline sodium salt monohydrate | MAOS MAOS (N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethylaniline so N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethylaniline sodium salt N-ETHYL-N-(2-HYDROXY-3-SULFOPROPYL)-3,5-DIMETHYLANILINE, SODIUM SALT sodium salt of 3,5-dimethyl-N-ethyl-N-(2-hydroxy-3-sulfopropyl)aniline Sodium 3-((3,5-Dimethylphenyl)(Ethyl)Amino)-2-Hydroxypropane-1-Sulfonate N-ETHYL-N-(2-HYDROXY-3-SULFOPROPYL)-3,5-DIMETHYLANILINE SODIUM SALT MONOHYDRATE N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethylaniline sodium salt monohydrate MAOS (N-ETHYL-N-(2-HYDROXY-3-SULFOPROPYL)-3,5-DIMETHYLANILINE SODIUM SALT MONOHYDRATE | Amino compounds;Organic raw materials |
| 121 | 842133-18-0 | canagliflozin | Cageline canagliflozin Cagliflozin heMihydrate Canagliflozin heMihydrate Canagliflozin heMihydrates 1-(β-D-glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienyl-methyl) benzene (1s)-1,5-anhydro-1-c-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4-methylphenyl)-d-glucitol (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol Hemihydrate | API;Raw drugs;Canagliflozi;Canagliflozin;API of bulk drug;Chemical bulk drug;Cagliflozin intermediate;Candagliazine hemihydrate;Pharmaceutical inhibitors;Raw drugs and intermediates |
| 122 | 84358-12-3 | 1-(tert-butoxycarbonyl)-3-piperidine-carboxylic acid | BOC-NIP BOC-NIP-OH Boc-DL-Nip-OH BOC-DL-NIP-OH BOC-DL-NIPC-OH BOC-DL-PIC(3)-OH BOC-(R,S)-NIP-OH BOC-DL-NIPECOTIC ACID N-Boc-DL-nipecotic acid BOC-3-CARBOXYPIPERIDINE 1-Boc-piperidine-3-carboxylicacid 1-Boc-3-piperidinecarboxylic acid 1-BOC-PIPERIDINE-3-CARBOXYLIC ACID 1-Boc-piperidine-3-carboxylic acid 1-(tert-Butoxycarbonyl)-3-piperidinecarboxylic acid 1-(tert-butoxycarbonyl)-3-piperidine-carboxylic acid 1,3-Piperidinedicarboxylic acid, 1-(1,1-dimethylethyl) ester N-(tert-Butoxycarbonyl)nipecotic acid~1-(tert-Butoxycarbonyl)piperidine-3-carboxylic acid Boc-DL-Nip-OH~N-(tert-Butoxycarbonyl)nipecotic acid~1-(tert-Butoxycarbonyl)piperidine-3-carboxylic acid | Organic acids;Organic materials |
| 123 | 84358-13-4 | 1-boc-piperidine-4-carboxylic acid | Boc-Inp-OH Boc-DL-Inp-OH RARECHEM AH CK 0061 N-Boc-Isonipecotic acid N-BOC-ISONIPECOTIC ACID N-BOC-DL-ISONIPECOTIC ACID 1-Boc-piperidine-4-carboxylicacid 1-Boc-4-piperidinecarboxylic acid N-BOC-4-Piperidinecarboxylic acid 1-Boc-4-piperidine carboxylic acid N-Boc-Piperidine-4-Carboxylic Acid 1-boc-piperidine-4-carboxylic acid N-BOC-PIPERIDINE-4-CARBOXYLIC ACID Boc-4-Piperidinecarboxylic Acid, 1- 1-N-BOC-PIPERIDINE-4-CARBOXYLIC ACID 1-(Tert-butoxycarbonyl)-carboxylic acid 1-(tert-Butoxycarbonyl)isonipecotic acid N-Tert-Butyloxycarbonyl-Isonipecotic Acid N-TERT-BUTYLOXYCARBONYL-ISONIPECOTIC ACID N-T-Butoxycarbonyl-Hexahydroisonicotinic Acid N-T-BUTOXYCARBONYL-HEXAHYDROISONICOTINIC ACID N-T-BUTOXYCARBONYL-PIPERIDINE-4-CARBOXYLIC ACID 1-(tert-butoxycarbonyl)piperidine-4-carboxylate N-T-Butoxycarbonyl-Piperidine-4-Carboxylic Acid N-Tert-Butoxycarbonyl-4-Piperidinecarboxylic Acid N-TERT-BUTOXYCARBONYL-4-PIPERIDINECARBOXYLIC ACID 1-(TERT-BUTOXYCARBONYL)PIPERIDINE-4-CARBOXYLIC ACID 1-(tert-Butoxycarbonyl)piperidine-4-carboxylic acid Piperidine-1,4-dicarboxylic acid 1-tert-butyl ester N-TERT-BUTYLOXYCARBONYL-PIPERIDINE-4-CARBOXYLIC ACID 1,4-Piperidinedicarboxylic Acid 1-(Tert-Butyl) Ester N-Tert-Butyloxycarbonyl-Piperidine-4-Carboxylic Acid 1-(1,1-Dimethylethyl)1,4-Piperidinedicarboxylic Acid | Piperidine;Carboxylic Acids;Carboxylic Acids;Piperidine Series;PiperidineDerivative;Organic raw materials;Carboxylic acid compounds;Pyrans, Piperidines &Piperazines;Pyrans, Piperidines & Piperazin |
| 124 | 848821-76-1 | 2-Pyrrolidinemethanol, a,a-bis[3,5-bis(trifluoromethyl)phenyl]-, (2S)- | Bis(3,5-bis(trifluoroMethyl)phenyl)(pyrrolidin-2-yl)Methanol (S)-Bis(3,5-bis(trifluoromethyl)phenyl)(pyrrolidin-2-yl)methanol (S)-α,α-Bis[3,5-bis(trifluoromethyl)phenyl]-2-pyrrolidinemethanol (S)-2-{Bis[3,5-bis(trifluoromethyl)phenyl]hydroxymethyl}pyrrolidine 2-Pyrrolidinemethanol, a,a-bis[3,5-bis(trifluoromethyl)phenyl]-, (2S)- 2-PyrrolidineMethanol, a,a-bis[3,5-bis(trifluoroMethyl)phenyl]-, (2S)- (S)-alpha,alpha-Bis[3,5-bis(trifluoromethyl)phenyl]-2-pyrrolidinemethanol | Alcohols;Organic materials |
| 125 | 85375-15-1 | N-(4,4-Diphenyl-3-butenyl)nipecotic acid hydrochloride | skf-89976a SKF89976AHCl SKF 89976A HYDROCHLORIDE l-SKF89976A hydrochloride d,l-SKF89976A hydrochloride N-(4,4-Diphenyl-3-butenyl)nipecotic acid hydrochloride 4-(3-Carboxypiperidine)-1,1-diphenyl-1-butene hydrochloride 1-(4,4-DIPHENYL-3-BUTENYL)-3-PIPERIDINECARBOXYLIC ACID HYDROCHLORIDE 1-(4,4-Diphenyl-3-butenyl)-3-piperidinecarboxylic acid hydrochloride 1-(4,4-Diphenylbut-3-en-1-yl)piperidine-3-carboxylic acid hydrochloride 1-(4,4-Diphenyl-3-buten-1-yl)-3-piperidinecarboxylic acid hydrochloride 1-(4,4-diphenylbut-3-en-1-yl)piperidine-3-carboxylic acid hydrochloride | GABA;Organic acids;Organic materials;GABA/Glycine receptor |
| 126 | 85642-13-3 | Boc-L-alanine amide | Boc-Ala-NH2 BOC-ALA-NH2 BOC-L-ALA-NH2 BOC-Beta-ala-NH2 Boc-L-alanine amide N-t-Butyloxycarbonyl-L-alanine amide N-tert-Butoxycarbonyl-L-alanine amide N-tert-Butoxycarbonyl-L-alanine amide N~2~-(tert-butoxycarbonyl)-L-alaninamide N-alpha-t-Butyloxycarbonyl-beta-alanine amide tert-butyl (1S)-2-amino-1-methyl-2-oxoethylcarbamate | Intermediates;Pharmaceutical intermediates |
| 127 | 861393-28-4 | Benzeneacetamide, N-[1-[[(cyanoamino)(5-quinolinylimino)methyl]amino]-2,2-dimethylpropyl]-3,4-dimethoxy- | A 740003 A-740003 (E)-N-(1-((Cyanamido(quinolin-5-ylamino)methylene)amino)-2,2-dimethylpropyl)-2-(3,4-dimethoxyp N-[1-[[(Cyanoamino)(5-quinolinylimino)methyl]amino]-2,2-dimethylpropyl]-3,4-dimethoxybenzeneacetamide N-[1-[[(Cyanoamino)(5-quinolinylamino)methylene]amino]-2,2-dimethylpropyl]-3,4-dimethoxybenzeneacetamide Benzeneacetamide, N-[1-[[(cyanoamino)(5-quinolinylimino)methyl]amino]-2,2-dimethylpropyl]-3,4-dimethoxy- N-(1-{[(cyanoimino)(5-quinolinylamino) methyl] amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide Benzeneacetamide, N-[1-[[(cyanoamino)(5-quinolinylamino)methylene]amino]-2,2-dimethylpropyl]-3,4-dimethoxy- A-740003 N-[1-[[(Cyanoamino)(5-quinolinylimino)methyl]amino]-2,2-dimethylpropyl]-3,4-dimethoxybenzeneacetamide N-[1-[[(Cyanoamino)(5-quinolinylimino)methyl]amino]-2,2-dimethylpropyl]-3,4-dimethoxybenzeneacetamide A-740003 | |
| 128 | 865466-24-6 | Narlaprevir | SCH900518 Sch 900518 SCH-900518 SCH 900518 Narlaprevir Sch 900518 Narlaprevir Narlaprevir(SCH 900518 ) (1R,2S,5S)-N-[(1S)-1-[(Cyclopropylamino)oxoacetyl]pentyl]-3-[(2S)-2-[[[[1-[[(1,1-dimethylethyl)sulfonyl]methyl]cyclohexyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide 3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[(1S)-1-[2-(cyclopropylamino)-2-oxoacetyl]pentyl]-3-[(2S)-2-[[[[1-[[(1,1-dimethylethyl)sulfonyl]methyl]cyclohexyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-, (1R,2S,5S)- | Metabolism |
| 129 | 869886-67-9 | 4-[5-Chloro-2-[(1-methylethyl)amino]-4-pyridinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide | VRT752271 Ulixertinib VRT752271 HCl VRT-752271(Ulixertinib) Ulixertinib (BVD-523,VRT752271) 4-[5-Chloro-2-[(1-methylethyl)amino]-4-pyridinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide 1H-Pyrrole-2-carboxaMide, 4-[5-chloro-2-[(1-Methylethyl)aMino]-4-pyridinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]- 4-[5-Chloro-2-[(1-methylethyl)amino]-4-pyridinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide VRT752271 | Intermediates;Pharmaceutical intermediates |
| 130 | 89-24-7 | 5-Phenylhydantoin | NSC 27302 AI3-61187 5-Phenyl- Phenylhydantoin 5-Phenylhydantoin 5-PHENYLHYDANTOIN Hydantoin 5-Phenyl 5-Phenylhydantoin (100 mg) Hydantoin, 5-phenyl- (8CI) 5-phenylimidazolidine-2,4-dione 4-Phenylimidazolidine-2,5-dione 2,4-Imidazolidinedione, 5-phenyl- | Metabolites & Impurities;Hydantoins & Derivatives;Other heterocyclic rings;Small molecule inhibitors;Hydantoins and Derivatives;Hydantoins & Derivatives, Metabolites & Impurities |
| 131 | 91809-66-4 | 5-Carboxytetramethylrhodamine | 5-TAMRA CS-1311 5-CarboxytetraMethyl 5-Carboxytetramethylrhodamine 5-CARBOXYTETRAMETHYLRHODAMINE*(SINGLE ISOMER) 5-TAMRA [5-Carboxytetramethylrhodamine] *Single isomer* 9-(2,4-Dicarboxyphenyl)-3,6-bis(diMethylaMino)xanthyliuM 2-(3,6-Bis(diMethylaMino)xanthyliuM-9-yl)-5-carboxybenzoate 3-carboxy-4-[6-(dimethylamino)-3-(dimethyliminio)-3H-xanthen-9-yl]benzoate | Others;Fluorescent dyes;Organic chemistry;Biochemical reagents;Fluorescent labeling dyes;Other biochemical reagents;Fluorescent Labels & Indicators;Intermediates in synthetic materials |
| 132 | 92623-85-3 | Milnacipran | IXEL F 2207 Milnacipran Midalcipran MILNACIPRAN HYDROCHLORIDE 2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide 2β-(Aminomethyl)-N,N-diethyl-1-phenyl-1β-cyclopropanecarboxamide 2β-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1β-carboxamide (1R,2S)-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide (±)-cis-2-Aminomethyl-N,N-diethyl-1-phenylcyclopropane-1-carboxamide (1S,2R)-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide (1R,2S)-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, (1R,2S)- (1R,2S)-REL-2-(AMINOMETHYL)-N,N-DIMETHYL-1-PHENYLCYCLOPROPANECARBOXAMIDE HYDROCHLORIDE | Other APIs;Plant extract;Raw materials;Pharmaceutical raw materials;Standard substance-standard substance of traditional Chinese medicine |
| 133 | 945212-26-0 | (2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-methyl-dec-9-enoic acid | 945212-26-0 FMoc-α-Me-D-Gly(Octenyl)-OH (R)-N-FMOC-Α-(7-OCTENYL)ALANINE (R)-N-Fmoc-α-(7-octenyl)alanine (R)-N-Fmoc-2-(7'-octenyl)alanine (R)-N-Fmoc-2-(7'-octenyl) alanine (R)-N-(9-Fluorenylmethylcarbamate)-2-(2'-octenyl)alanine (2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-methyl-dec-9-enoic acid (2R)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-9-decenoic acid (R)-2-((((9H-Fluoren-9-yl)Methoxy)carbonyl)aMino)-2-Methyldec-9-enoic acid (2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2-methyldec-9-enoic acid | Intermediates;α-Methyl Amino Acids;Pharmaceutical intermediates |
| 134 | 945667-22-1 | Saxagliptin monohydrate | CS-1180 BMS477118 hydrate BMS 477118 hydrate Saxagliptin hydrate Saxagliptin monohydrate Saxagliptin hydrate Unii-9gb927lajw (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile hydrate (1s,3s,5s)-2-((2s)-2-amino-2-(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile hydrate Saxagliptin hydrate (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile hydrate | API;Saxagliptin h;Saxagliptin hydrate;Organic intermediates;API and intermediates;Heterocyclic compounds;saxagliptin monohydrate;Small molecule inhibitors;Pharmaceutical raw materials;Impurity referen |
| 135 | 968-93-4 | testolactone | testolactone TESTOLACTONE Testolactone -TESTOLACTONE 1-dehydrotestololactone 1,2-dehydrotestololactone 1,2-didehydro-testololacton delta(1)-dehydrotestolactone 17alpha-oxo-d-homo-1,4-androstadiene-3,17-dione 17-secoandrosta-1,4-dien-17-oicacid,13-hydroxy-3-oxo-1delta-lactone 1,2,3,4,4a,4b,7,9,10,10a-decahydro-2-hydroxy-2,4b-dimethyl-7-oxo-1-phenanthren (4aS,10bS)-10a,12a-dimethyl-3,4,4a,5,6,10a,10b,11,12,12a-decahydro-2H-naphtho[2,1-f]chromene-2,8(4bH)-dione | Steroids;Inhibitors;Pharmaceuticals;Cell biology reagents;Pharmaceutical intermediates;Pharmaceutical raw materials;Intermediates & Fine Chemicals |
| 136 | 56926-94-4 | Boc-Ser(Tos)-OMe | Boc-Ser(Tos)-OMe BOC-SER(TOS)-OME BOC-SER(TOS)-OCH3 BOC-L-SER(OTS)-OME Boc-L-Ser(Tos)-OCH3 (Tert-Butoxy)Carbonyl Ser(Tos)-OMe methyl N-(tert-butoxycarbonyl)-O-tosyl-L-serinate L-Serine,N-[(1,1-diMethylethoxy)carbonyl]-O-[(4-Methylphenyl)sulfonyl]-, Methyl ester | Chemical biology;Boc-Amino acid series;Amino Acid Derivatives;Protecting amino acids;Amino acid derivatives;Boc-Amino acid series;Boc-protected amino acids;Boc-Amino Acids and Derivative |
| 137 | 1270138-40-3 | NSI-189 | NSI-189 (4-benzylpiperazin-1-yl)-[2-(3-methylbutylamino)pyridin-3-yl] (4-BENZYLPIPERAZIN-1-YL)(2-(ISOPENTYLAMINO)PYRIDIN-3-YL)METHANONE (4-BENZYLPIPERAZIN-1-YL)-[2-(3-METHYLBUTYLAMINO)PYRIDIN-3-YL]METHANONE [2-[(3-Methylbutyl)amino]-3-pyridinyl][4-(phenylmethyl)-1-piperazinyl]methanone [2-[(3-Methylbutyl)amino]-3-pyridinyl][4-(phenylmethyl)-1-piperazinyl]methanone NSI189 NSI-189 [2-[(3-Methylbutyl)amino]-3-pyridinyl][4-(phenylmethyl)-1-piperazinyl]methanone | API;Compounds;Inhibitors;Customized;Raw materials;Health care additives;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 138 | 300842-64-2 | ACC-789 | ACC789 ACC-789 Acc-789 ACC 789 ZK 202650 ZK-202650 NVP-ACC-789 NVP-ACC-789 ACC-789 (NVP-ACC789) N-(3-Bromo-4-methylphenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine N-(3-Bromo-4-methylphenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine | |
| 139 | 1228690-19-4 | AM966 | AM966 AM 966 AM-966 CS-2784 {4'-[4-({[(1R)-1-(2-Chlorophenyl)ethoxy]carbonyl}amino)-3-methyl-1,2-oxazol-5-yl]-4-biphenylyl}acetic acid 4'-[4-[[[(1R)-1-(2-Chlorophenyl)ethoxy]carbonyl]amino]-3-methyl-5-isoxazolyl]-[1,1'-biphenyl]-4-acetic acid [1,1'-BIPHENYL]-4-ACETIC ACID, 4'-[4-[[[(1R)-1-(2-CHLOROPHENYL)ETHOXY]CARBONYL]AMINO]-3-METHYL-5-ISOXAZOLYL]- (R)-2-(4'-(4-(((1-(2-chlorophenyl)ethoxy)carbonyl)aMino)-3-Methylisoxazol-5-yl)-[1,1'-biphenyl]-4-yl)acetic acid | LPA inhibitor molecule;G protein-coupled receptor & G protein |
| 140 | 1621862-70-1 | CPI-1205 | CPDB1215 CPI-1205 LIRAMETOSTAT CPI-1205 (CPI 1205 Lirametostat ( CPI-1205 ) N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]ethyl]indole-3-carboxamide (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide 1H-Indole-3-carboxamide, N-[(1,2-dihydro-4-methoxy-6-methyl-2-oxo-3-pyridinyl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)-4-piperidinyl]ethyl]- | inhibitors;Cell biology reagents |
| 141 | 166247-63-8 | 7-Deaza-7-Iodo-2'-deoxyadeonsine | 7-I-7-Deaza-dA 7-DEAZA-7-I-2'-DA 5-Iodo-2'-deoxytubercidin 7-DEAZA-7-IODO-2'-DEOXYADENOSINE 7-Iodo-7-deaza-2'-deoxyadenosine 7-Deaza-7-Iodo-2'-deoxyadeonsine 7-(2-Deoxy-beta-D-erythro-pentofuranosyl)-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-4-amine (2R,3S,5R)-5-(4-Amino-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol | Amines;Aromatics;Nucleosides;Heterocycles;Pharmaceuticals;Chemical reagents;Modified nucleosides;Other biochemical reagents;Intermediates & Fine Chemicals;Amines, Aromatics, Heterocycles, Pharmace |
| 142 | 1672665-49-4 | PT2385 | PT2385 CS-2108 PT 2385 PT-2385 (S)-3-(2,2-Difluoro-1-hydroxy-7-methanesulfonyl-indan-4-yloxy)-5-fluoro-benzonitrile Benzonitrile, 3-[[(1S)-2,2-difluoro-2,3-dihydro-1-hydroxy-7-(methylsulfonyl)-1H-inden-4-yl]oxy]-5-fluoro- | Inhibitor |
| 143 | 439575-02-7 | N-(5-((5-(4-Acetylpiperazine-1-carbonyl)-4-methoxy-2-methylphenyl)thio)thiazol-2-yl)-4-(((3,3-dimethylbutan-2-yl)amino)methyl)benzamide | BMS 509744 BMS-509744 (BMS 509744 N-(5-((5-(4-Acetylpiperazine-1-carbonyl)-4-methoxy-2-methylphenyl)thio)thiazol-2-yl)-4-(((3,3-dimethylbutan-2-yl)amino)methyl)benzamide N-[5-[[5-[(4-Acetyl-1-piperazinyl)carbonyl]-4-methoxy-2-methylphenyl]thio]-2-thiazolyl]-4-[[(1,2,2-trimethylpropyl)amino]methyl]benzamide Benzamide, N-[5-[[5-[(4-acetyl-1-piperazinyl)carbonyl]-4-methoxy-2-methylphenyl]thio]-2-thiazolyl]-4-[[(1,2,2-trimethylpropyl)amino]methyl]- | |
| 144 | 146368-14-1 | cy5-NHS ester | CY6-SE CY 5-NHS Sulfo-Cy5-SE CY5 NHS ESTER cy5-NHS ester CY5 NHS ESTER,Cy5-SE Cyanine 5 monosuccinimidyl ester [equivalent to Cy5 NHS ester] 2-(5-(1-(6-((2,5-Dioxopyrrolidin-1-yl)oxy)-6-oxohexyl)-3,3-dimethyl-5-sulfoindolin-2-ylidene)penta-1,3-dien-1-yl)-1-ethyl-3,3-dimethyl-3H-indol-1-ium-5-sulfonate | Cy;fluorescent dye;chemical reagent;Keywords Qing dye;chemiluminescence;biochemical reagent;biochemical industry;fluorescent labeled dye |
| 145 | 89483-06-7 | (2S)-2-[[(tert-butoxy)carbonyl]amino]-3-cyclopropylpropanoic acid | BOC-L-CPA.DCHA Boc-L-CPA.DCHA BOC-ALA(CPRO)-OH DCHA BOC-ALA(CYCLOPROPYL)-OH DCHA BOC-L-CYCLOPROPYLALANINE-DCHA BOC-BETA-CYCLOPROPYL-ALA-OH DCHA BOC-BETA-CYCLOPROPYL-ALANINE DCHA BOC-BETA-CYCLOPROPYL-L-ALA-OH DCHA BOC-BETA-CYCLOPROPYL-L-ALANINE DCHA BOC-ALA(BETA-CYCLOPROPYL)-OH DICYCLOHEXYLAMMONIUM SALT (2S)-2-[[(tert-butoxy)carbonyl]amino]-3-cyclopropylpropanoic acid N-ALPHA-T-BUTOXYCARBONYL-3-CYCLOPROPYL-L-ALANINE DICYCLOHEXYLAMMONIUM SALT | |
| 146 | 960404-48-2 | Dapagliflozin propanediol | CS-1307 Dapagliflozin propanediol Dag column net a water glycol BMS 512148 (2S)-1,2-propanediol Dapagliflozin propanediol hydrate Dapagliflozin propanediol monohydrate Dapagliflozin (S)-Propylene Glycol Hydrate DAPAGLIFLOZIN Dapagliflozin propylene glycolate hydrate Forxiga Dapagliflozin (S)-Propylene Glycol Hydrate Dag column net a water glycol | API;Raw materials;Chemical raw mat;Medical raw materials;Dapaglifloe impurity c;Pharmaceutical hypoglycemic drugs;Pharmaceutical raw materials-scientific research raw materials |
| 147 | 307297-39-8 | Epitalon | Epitalon Epithalon Epithalamin Epithalamine EpithalonAcetate Epithalon, Epithalon Tetra Peptide L-Alanyl-L-α-glutamyl-L-α-aspartylglycine Glycine, L-alanyl-L-a-glutamyl-L-a-aspartyl- L-alanyl-L-alpha-glutamyl-L-alpha-aspartylglycine | Spot;Raw materials;Chemical reagents;Biofunctional peptides;Pharmaceutical peptides;Organic chemical raw materials;Shaanxi Linnaeus's main products |
| 148 | 1401708-83-5 | Dihexa | amide Dihexa PNB-0408 aminohexanoic Dihexa (PNB-0408) N-hexanoic-Tyr-Ile-(6) Hexanoyl-Tyr-Ile-Ahx-NH2 TIANFUCHEM--1401708-83-5---Dihexa N-hexanoic-Try-Ile-(6)-amino hexanoic amide N-(1-OXOHEXYL)-L-TYROSYL-N-(6-AMINO-6-OXOHEXYL)-L-ISOLEUCINAMIDE L-Isoleucinamide, N-(1-oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)- | spot;Wuhan Belka main;Peptide intermediates;Shaanxi Linnaeus main products |
| 149 | 1165910-22-4 | LGD-4033 | LGD4033 LGD-4033 LIGANDROL POWDER LGD-4033 LIGANDROL LIGANDROL (LGD-4033, VK-5211) lgd 4033 sarms powder lgd-4033 ligandrol 4-((R)-2-((R)-2,2,2-Trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoroMethyl)benzonitrile 4-[(2R)-2-[(1R)-2,2,2-Trifluoro-1-hydroxyethyl]-1-pyrrolidinyl]-2-(trifluoromethyl)benzonitrile 4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile 4-((R)-2-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoroMethyl)benzonitrile(LGD-4033) | Export;SARMs(S;1165910-22-4;Heterocycles;LGD-4033 whatsapp;Aromatic derivatives;Health care additives;SARM series for export;Pharmaceutical intermediates;Pharmaceutical raw materials |
| 150 | 913611-97-9 | Brexpiprazole | CS-1678 OPC34712 OPC 34712 OPC34712 OPC-34712 OPC-34712 Brexpiprazole Brexpiprazoleimpuritya Brexpiprazole(OPC34712) Brexpiprazole impurity a 7-{4-[4-(1-Benzothiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2(1H)-one 7-(4-(4-(Benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one | API;Eipiz;Inhibitors;Drug Substance;Drug substance (API);Raw material new drug;Small molecule inhibitor;Pharmaceutical raw material;Pharmaceutical Intermediate;Dopamine D2 receptor partial agonist |
| 151 | 102212-26-0 | ARN-2966 | 2-PMAP ARN-2966 ARN 2966 102212-26-0 ARN2966(2-PMAP) 2-((pyridin-2-ylmethyl)amino)phenol Phenol, 2-[(2-pyridinylmethyl)amino]- | |
| 152 | 24587-41-5 | H-PHE-TRP-OH | Phe-Trp Phe-Trp-OH H-PHE-TRP-OH L-Phe-L-Trp-OH phenylalanyltryptophan L-PHENYLALANYL-L-TRYPTOPHAN n-l-phenylalanyl-l-tryptopha Nα-(L-Phenylalanyl)-L-tryptophan | |
| 153 | 1151516-14-1 | RDEA-594 sodiuM | CS-651 RDEA-594 sodiuM LESINURAD SODIUM Lesinurad sodiuM Pentanedioicacid,5-oxo-,diethylester sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetate Sodium 2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3- yl)sulfanyl)acetate Acetic acid, 2-((5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl)thio)-, sodium salt | Drug Substance |
| 154 | 71420-92-3 | 4-BOC-AMINOMETHYLPHENYLACETIC ACID | 4-BOC-AMINOMETHYLPHENYLACETIC ACID BOC-4-AMINOMETHYL-PHENYLACETIC ACID [4-(TERT-BUTOXYCARBONYLAMINO-METHYL)-PHENYL]-ACETIC ACID 2-(4-(((tert-Butoxycarbonyl)aMino)Methyl)phenyl)acetic acid Benzeneacetic acid, 4-[[[(1,1-diMethylethoxy)carbonyl]aMino]Methyl]- 4-(tert-Butoxycarbonylamino-methyl)-phenyl-acetic acid Boc-(4-aminomethylphenyl)acetic acid 4-(tert-Butoxycarbonylamino-methyl)-phenyl-acetic acid Boc-(4-aminomethylphenyl)acetic acid | pharmacetical;Amino acid-derived compounds |
| 155 | 75937-12-1 | TERT-BUTYL N-(6-HYDROXYHEXYL)CARBAMATE | BOC-ACP(6)-OL BOC-AHX(6)-OL BOC-NH-(CH2)6-OH BOC-6-AMINOHEXANOL 6-(BOC-AMINO)-1-HEXANOL N-T-BUTOXYCARBONYL-6-AMINO-1-HEXANOL TERT-BUTYL N-(6-HYDROXYHEXYL)CARBAMATE 6-(TERT-BUTOXYCARBONYLAMINO)-1-HEXANOL N-T-BUTOXYCARBONYL-6-AMINO-AMINO-1-HEXANOL CARBAMIC ACID,N-(6-HYDROXYHEXYL)-, 1,1-DIMETHYLETHYL ESTER | Synthesis;Aliphatics;Miscellular Reagents;Miscellaneous Reagents;Chemical raw materials |
| 156 | 82321-04-8 | N-SUCCINIMIDYL 6-(2,4-DINITROANILINO)HEXANOATE | DNP-X, SE DNP-X ACID, SE Succinimidyldinitroanilinohexanoate N-SUCCINIMIDYL 6-(2,4-DINITROANILINO)HEXANOATE 6-(2,4-DINITROPHENYL)AMINOHEXANOIC ACID, SUCCINIMIDYL ESTER N-(2,4-Dinitrophenyl)-6-aminocaproic acid N-succinimidyl ester N-(2,4-DINITROPHENYL)-6-AMINOHEXANOIC ACID N-SUCCINIMIDYL ESTER N-(2,4-Dinitrophenyl)-6-aminocaproic acid N-succinimidyl ester Hexanoic acid,6-[(2,4-dinitrophenyl)amino]-, 2,5-dioxo-1-pyrrolidinyl ester | Fluorescent labeling dyes;N-Substituted Succinimides;Fluorescent Probes, labels, particles and stains;N-Substituted Maleimides, sucinimides & phtalimides;N-Substituted Maleimides, Succinimides & Phtha |
| 157 | 81-93-6 | Phenosafranin | nsc9855 CI 50200 CI NO 50200 Phenosafranin phenosafranine,chloride 3,7-diamino-5-phenyl-phenaziniuchloride 3,7-DIAMINO-5-PHENYLPHENAZINIUM CHLORIDE 2,8-DiaMino-10-phenyl-phenaziniuM Chloride Phenazinium,3,7-diamino-5-phenyl-,chloride | Amines;Aromatics;Mutagenesis Research Chemicals |
| 158 | 4569-86-2 | CI 50206 | CI 50206 N,N-DIETHYLPHENOSAFRANINE Methylene violet 3rax, pure Phenazinium,3-amino-7-(diethylamino)-5-phenyl-,chloride 3-AMINO-7-DIETHYLAMINO-5-PHENYL-PHENAZIN-5-IUM CHLORIDE PhenaziniuM,3-aMino-7-(diethylaMino)-5-phenyl-, chloride 2-Amino-8-(diethylamino)-10-phenylphenazine-10-ium·chloride 3-Amino-7-(diethylamino)-5-phenyl phenazinium chloride, 3-Amino-7-(diethylamino)-5-phenylphenazinium chloride, N,N-Diethylphenosafranine 3-Amino-7-(diethylamino)-5-phenyl phenazinium chloride, 3-Amino-7-(diethylamino)-5-phenylphenazinium chloride, N,N-Diethylphenosafranine | Stains and dyes;Biochemical reagents;Hematology and histology |
| 159 | 467-62-9 | CI 42500 | CI 42500 4,4,4-triaminotritol pararosanilinebase[qr] PARAROSANILINE C.I. 42500 Tris(p-aminophenyl)methanol tris(4-aminophenyl)carbinol[qr] pararosaniline base (C.I. 42500) methanol,tris(4-aminophenyl)-[qr] PARAROSANILINE BASE, FOR MICROBIOLOGY | Stains and dyes;Biological stains;Biochemical reagents;Hematology and Histology;Other biochemical reagents |
| 160 | 596-03-2 | 4,5-DIBROMOFLUORESCEIN | 4,5-Dibromof SOLVENT RED 72 4,5dibromo-fluorescei 4,5-DIBROMOFLUORESCEIN 4,5-dibromofluororescein 4,5-Dibromofluorescein,Solvent Red72 Dibromofluorescein (contains Mono-, Tri- and Tetra-) 4,5-dibromo-3,6-dihydroxyspiro[2-benzofuran-3,9-xanthene]-1-one | Synthesis;Halogenated compounds;Organic chemical raw materials |
| 161 | 62758-12-7 | ETHYL ORANGE | ETHYL ORANGE EthylOrangeSodium RESAZURINE REDOX INDICATOR Ethyl Orange sodium salt,4-(4-Diethylaminophenylazo)benzenesulfonic acid sodium salt | Azo;Organics;pH Indicators;Indicator (pH);Analytical Chemistry |
| 162 | 4569-88-4 | INDOINE BLUE | CI 12210 JANUS BLUE CI NO 12210 INDOINE BLUE BASIC BLUE 16 LABOTEST-BB LT00451857 SAFRANIN BLUE C.I. NO. 12210 3-AMINO-2,8-DIMETHYL-7-(2-HYDROXY-1-NAPHTHYLAZO)-5-PHENYLPHENAZINIUM CHLORIDE | Biochemical reagents |
| 163 | 12627-53-1 | LEISHMAN'S STAIN | LEISHMAN'S STAIN LeishmanSStainSolution LeishmanSStainForMicroscopy LEISHMANS EOSINE METHYLENE BLUE LEISHMANS EOSINE METHYLENE BLUE SOLUTION | Biochemistry;Stains and dyes;Biochemical reagents;Hematology and Histology;Other biochemical reagents |
| 164 | 547-57-9 | CI 13015 | CI 13015 TROPAEOLIN 0 AcidOrange6(C.I.14270) FAST YELLOW C.I. NO. 13080 TROPAEOLIN O C.I. NO. 14270 TROPAEOLIN OO C.I. NO. 13080 TROPAEOLIN O FOR C.I. No 14270 4-((2,4-dihydroxyphenyl)azo)-benzenesulfonicacimonosodiumsalt 4-[(2,4-dihydroxyphenyl)azo]-benzenesulfonicacimonosodiumsalt | Azo;Organics;pH Indicators;Indicator (pH);Analytical Chemistry |
| 165 | 1481677-78-4 | UNC-0642 | UNC0642 UNC 0642 UNC-0642 2-(4,4-difluoropiperidin-1-yl)-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine 2-(4,4-Difluoropiperidin-1-yl)-6-methoxy-N-[1-(propan-2-yl)piperidin-4-yl]-7-[3-(pyrrolidin-1-yl)propoxy]quinazolin-4-amine 2-(4,4-Difluoro-1-piperidinyl)-6-methoxy-N-[1-(1-methylethyl)-4-piperidinyl]-7-[3-(1-pyrrolidinyl)propoxy]-4-quinazolinamine UNC0642, 2-(4,4-Difluoro-1-piperidinyl)-6-Methoxy-N-[1-(1-Methylethyl)-4-piperidinyl]-7-[3-(1-pyrrolidinyl)propoxy]-4-quinazolinaMine UNC0642, 2-(4,4-Difluoro-1-piperidinyl)-6-Methoxy-N-[1-(1-Methylethyl)-4-piperidinyl]-7-[3-(1-pyrrolidinyl)propoxy]-4-quinazolinaMine | Inhibitors;Reagents for Cell Biology |
| 166 | 89889-52-1 | BIOTIN-XX-NHS | BIOTIN-XX-NHS Biotin-AC5-AC5-OSU N-SUCCINIMIDYL N-6-(BIOTINYLAMINO)CAP 6-(BIOTINAMIDOCAPROYLAMIDO)CAPROIC ACID N-HYDROXYSU Biotinamidohexanoyl-6-aminohexanoic acid N-hydroxysuccinimide ester 6-[6-(Biotinylamino)hexanoylamino]hexanoicacidN-hydroxysuccinimideester 6-((+)-Biotinamidohexanoylamino)hexanoic acid N-hydroxysuccinimide ester 5-[5-(N-SUCCINIMIDYLOXYCARBONYL)PENTYLAMIDO]HEXYL D-BIOTINAMIDE (BIOTIN-(AC5)2-OSU) interMediate of 6-((+)-BiotinaMidohexanoylaMino)hexanoic acid N-hydroxysucciniMide ester Biotin-X-X-NHS, N-Succinimidyl N-[6-(biotinylamino)caproyl]-6-aminocaproate, 6-(Biotinamidocaproylamido)caproic acid N-hydroxysuccinimide ester | Biotin Derivatives;Cross Linking Reagents |
| 167 | 1208313-97-6 | Ketone Ester | R-BHB BD-AcAc 2 Ketone Ester (R)-3-hydroxybutyl (R)-3-hydroxybutyrate (R)-(R)-3-hydroxybutyl 3-hydroxybutanoate [(3R)-3-hydroxybutyl] (3R)-3-hydroxybutanoate (3R)-3-Hydroxybutanoic acid (3R)-3-hydroxybutyl ester Butanoic acid, 3-hydroxy-, (3R)-3-hydroxybutyl ester, (3R)- | Chemical raw materials |
| 168 | 1343-78-8 | Cochineal | Cochineal NATURAL RED 4 cochenilledye cochineal(dye) Cochineal acid FD AND C CARMINE 7-beta-D-Glucopyranosyl-3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxoanthracene-2-carboxylic acid 3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracene-2-carboxylic acid 3,5,6,8-tetrahydroxy-9,10-diketo-1-methyl-7-(3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl)anthracene-2-carboxylic acid | Anthraquinones;Hydroxyanthraquinones |
| 169 | 4452-06-6 | ZM 449829 | ZM 449829 JAK3 INHIBITOR V 2-Acrylonaphthone 2-NAPHTHYLVINYL KETONE 1-Naphthalen-2-yl-propenone 1-(2-Naphthyl)-2-propen-1-one 1-(2-NAPHTHALENYL)-2-PROPEN-1-ONE 2-Propen-1-one, 1-(2-naphthalenyl)- | Intracellular Signaling |
| 170 | 76-12-0 | 1,2-DIFLUOROTETRACHLOROETHANE | 1,2-DIFLUOROTETRACHLOROETHANE SYM-DIFLUOROTETRACHLOROETHANE TETRACHLORO-1,2-DIFLUOROETHANE 1,1,2,2-Tetrachlorodifluoroethane 1,1,2,2-Tetrachlor-1,2-difluorethan 1,2-difluoro-1,1,2,2-tetrachloro-ethan 1,1,2,2-tetrachloro-1,2-difluoro-ethan 1,1,2,2-TETRACHLORO-1,2-DIFLUOROETHANE | CFC;refrigerants;Industrial/Fine Chemicals |
| 171 | 1081-71-6 | 4-HYDROXY-3-METHOXYPHENYLPYRUVIC ACID | Vanylpyruvic acid vanilpyruvic acid Hydroxymethoxyphenylpyruvicacid 3-Methoxy-4-hydroxyphenylpyruvic acid 4-HYDROXY-3-METHOXYPHENYLPYRUVIC ACID 3-(4-hydroxy-3-methoxy-phenyl)-2-keto-propionic acid | Phenol |
| 172 | 1297537-33-7 | (S)-5-acetyl-N-(1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-1H-pyrazole-3-carboxamide | ORM-15341 Ketodarolutamide ORM-15341(Ketodarolutamide) 5-Acetyl-N-[(1S)-2-[3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-... (S)-5-acetyl-N-(1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-1H-pyrazole-3-carboxamide (S)-3-acetyl-N-(1-(3-(3-chloro-4-cyano-phenyl)-1H-pyrazol-1-yl)propan-2-yl)-1H-pyrazole-5-carboxamide 5-Acetyl-N-[(1S)-2-[3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl]-1-methylethyl]-1H-Pyrazole-3-carboxamide 1H-Pyrazole-3-carboxamide, 5-acetyl-N-[(1S)-2-[3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl]-1-methylethyl]- | SARM series;Pharmaceutical original drug series |
| 173 | 144875-48-9 | Resiquimod | resquimod RESIQUIMOD Resiquimod R848,Resiquimod 4-Amino-2-(ethoxymethyl)-alpha alpha-dimethyl-1H-imidazo(4,5-c)quinoline-1-ethanol 1-[4-Amino-2-(ethoxymethyl)-1H-imidazo[4,5-C]quinolin-1-yl]-2-methylpropan-2-ol 4-Amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-1H-imidazo[4,5-c]quinoline-1-ethanol | Aromatics;Heterocycles |
| 174 | 1146-99-2 | 2-(4-CHLOROPHENYL)INDANE-1,3-DIONE | chlophenadione chlor-athrombon 2-(p-chlorophenyl)-3-indandione 2-(4-chlorofenil)-1,3-indandione 2-(p-chlorophenyl)-1,3-indandione 2-(p-chlorophenyl)indan-1,3-dione 2-(4-chlorophenyl)indene-1,3-dione 2-(4-CHLOROPHENYL)INDANE-1,3-DIONE 2-(4-chlorophenyl)-1h-indene-1,3(2h)-dione | Inhibitors |
| 175 | 1446321-46-5 | Voxelotor | GBT 440 OXBRYTA Voxelotor Hemoglobin Modulators-1 Voxelotor(GBT440, GTX011) Voxelotor, GBT-440, GBT 440, GBT440, GTx-011, GTx011, GTx 011 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde 2-Hydroxy-6-{[2-(1-isopropyl-1H-pyrazol-5-yl)-3-pyridinyl]methoxy}benzaldehyde 2-hydroxy-6-([2-[1-(propan-2-yl)-1H-pyrazol-5-yl]pyridin-3-yl]methoxy)benzaldehyde | API |
| 176 | 1297538-32-9 | ODM-201 | 0DM021 CS-1565 ODM-021 ODM-201 BAY-1841788 ODM-201(Darolutamide) N-{(2S)-1-[3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl]propan-2-yl}-5-[(1RS)-1-hydroxyethyl]-1H-pyrazole-3-carboxamide | API |
| 177 | 1223405-08-0 | Larotrectinib sulfate | ARRY 470) sulfate LOXO-101 (sulfate) Larotrectinib sulfate Larotrectinib(LOXO 101 Larotrectinib (LOXO-101) sulfate (3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide sulfate | API;LOXO-101;Intermediates-Pharmaceutical Intermediates |
| 178 | 1420477-60-6 | Acalabrutinib | ACP-196 Acalabrutinib acalabrutinib 4-[8-Amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide Benzamide, 4-[8-amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinyl- | Intermediates-Pharmaceutical Intermediates |
| 179 | 159857-79-1 | Val-cit-PAB-OH | EOS-61316 VAL-CIT-PAB Val-cit-PAB-OH NH2-Val-Cit-PAB (D)-VAL-CIT-PAB L-Valyl-N5-(aminocarbonyl)-N-[4-(hydroxymethyl)phenyl]-L-ornithinamide L-Ornithinamide, L-valyl-N5-(aminocarbonyl)-N-[4-(hydroxymethyl)phenyl]- (S)-2-((R)-2-amino-3-methylbutanamido)-N-(4-(hydroxymethyl)phenyl)-5-ureidopentanamide (S)-2-((S)-2-amino-3-methylbutanamido)-N-(4-(hydroxymethyl)phenyl)-5-ureidopentanamide | ADCs;Linker;ADC LINKER |
| 180 | 1942114-09-1 | EAI-045 | EA1045 EAI045 EAI-045 CS-2350 EAI 045 2-(5-fluoro-2-hydroxyphenyl)-2-(1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide N-(3-((5-fluoroethoxy)phenyl)amino)pyrimidin-4-yl)amino)phenyl)acrylamide (EAI-045) α-(5-fluoro-2-hydroxyphenyl)-1,3-dihydro-1-oxo-N-2-thiazolyl-2H-Isoindole-2-acetamide N-(3-((5-fluoroethoxy)phenyl)amino)pyrimidin-4-yl)amino)phenyl)acrylamide (EAI-045) | API;Intermediates-Pharmaceutical Intermediates |
| 181 | 1421372-66-8 | Mutated EGFR-IN-1 | HY-78869 AZD9291 3 AZD9291 int-5 Mutated EGFR-IN-1 AZD9291DA HCl salt N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]benzene-1,2,4-triamine N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine 1,2,4-Benzenetriamine, N1-[2-(dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]- | AZD9291;Pharmaceutical intermediate |
| 182 | 857036-77-2 | Cediranib Maleate | AZD-2171 MALEATE AZD 2171 MALEATE AZD 2171 Maleate Cediranib Maleate West to Ni BuMa Maleate Cediranib Maleate(AZD-2171) Cediranib maleate (AZD-2171 maleate 4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline maleate (Z)-but-2-enedioic acid,4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline | API;Intermediates-Pharmaceutical Intermediates |
| 183 | 1312445-63-8 | NVP-BKM120 (Hydrochloride) | BKM 120AAA BKM 120 hydrochloride Buparlisib hydrochloride NVP-BKM120 (Hydrochloride) 5-(2,6-DiMorpholinopyriMidin-4-yl)-4-(trifluoroMethyl)pyridin-2-aMine hydrochloride | Intermediates-Pharmaceutical Intermediates |
| 184 | 1256589-74-8 | 9-ethyl-6,6-diMethyl-8-(4-Morpholinopiperidin-1-yl)-11-oxo-5a,6,11,11a-tetrahydro-5H-benzo[b]carbazole-3-carbonitrile hydrochloride | CH-5428402 AF-802 Hydrochloride RG-7853 Hydrochloride Alectinib Hydrochloride 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5H-benzo[b]carbazole-3-carbonitrile,hydrochloride 9-ethyl-6,6-diMethyl-8-(4-Morpholinopiperidin-1-yl)-11-oxo-5a,6,11,11a-tetrahydro-5H-benzo[b]carbazole-3-carbonitrile hydrochloride | Intermediates-Pharmaceutical Intermediates |
| 185 | 2577-40-4 | H-PHE-PHE-OH | PHE-PHE L-PHE-PHE H-PHE-PHE-OH DI-L-PHENYLALANINE L-PHENYLALANYL-L-PHENYLALANINE L-Phenylalanine,L-phenylalanyl- (2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanoic acid | Amino Acid Derivatives |
| 186 | 760981-83-7 | Solithromycin | OP 1068 Solithromycin 2H-Oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(1H,7H,9H)-tetrone, 1-[4-[4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl]butyl]-4-ethyl-7-fluorooctahydro-11-methoxy-3a,7,9,11,13,15-hexamethyl-10-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, (3aS,4R,7S,9R,10R,11R,13R,15R,15aR)- | Inhibitors |
| 187 | 756525-91-4 | BOC-15-AMINO-4,7,10,13-TETRAOXAPENTADECANOIC ACID | Boc-NH-PEG4-CH2CH2COOH BOC-15-AMINO-4,7,10,13-TETRAOXAPENTADECANOIC ACID 15-(Boc-aMino)-4,7,10,13-tetraoxapentadecanoic acid N-(tert-Butyloxycarbonyl)-15-amino-4,7,10,13-tetraoxapentanedecanoic acid 5,8,11,14-Tetraoxa-2-azaheptadecanedioic acid 1-(1,1-dimethylethyl) ester 3-[2-[2-[2-[2-(tert-Butoxycarbonylamino)ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid 3-[2-[2-[2-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid | PEG;ADCs Linkers |
| 188 | 119768-44-4 | N-BOC-(R)-1-AMINO-2-PROPANOL | BOC-(R)-1-AMINO-2-PROPANOL N-BOC-(R)-1-AMINO-2-PROPANOL N-Boc-(R)-2-hydroxypropanamine BOC-(R)-(-)-1-AMINO-2-PROPANOL (R)-tert-Butyl 2-hydroxypropylcarbaMate Carbamic acid, [(2R)-2-hydroxypropyl]-, 1,1-dimethylethyl ester (9CI) | N-BOC |
| 189 | 1204669-58-8 | Epacadostat | INCN024360 Epacadostat INCB-24360(INCB-024360) Epacadostat(INCB024360) Epacadostat(INCN024360) Epacadostat (INCB24360, INCB024360) N-(3-Bromo-4-fluoro-phenyl)-N'-hydroxy-4-[2-(sulfamoylamino)ethylamino]-1,2,5-oxadiazole-3-carboxamidine (Z)-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-4-[2-(sulfamoylamino)ethylamino]-1,2,5-oxadiazole-3-carboxamidine (Z)-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-4-((2-(sulfamoylamino)ethyl)amino)-1,2,5-oxadiazole-3-carboximidamide | Scientific research raw materials |
| 190 | 1047645-82-8 | GSK2110183B | GSK2110183B Afuresertib HCl GSK-2110183 hydrochloride Afuresertib (hydrochloride) N-((S)-1-Amino-3-(3-fluorophenyl)propan-2-yl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)thiophene-2-carboxamide hydrochloride | Intermediates-Pharmaceutical Intermediates |
| 191 | 1801747-42-1 | SHP099 | SHP099 SHP-099 (free base) 6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amine 6-(4-Amino-4-methyl-1-piperidinyl)-3-(2,3-dichlorophenyl)-2-pyrazinamine 2-Pyrazinamine, 6-(4-amino-4-methyl-1-piperidinyl)-3-(2,3-dichlorophenyl)- 6-(4-Azanyl-4-Methyl-Piperidin-1-Yl)-3-[2,3-Bis(Chloranyl)phenyl]pyrazin-2-Amine | Intermediates-Pharmaceutical Intermediates |
| 192 | 1849590-01-7 | EFT-508 | EFT-508 CS-2450 eFT-508 eFT508 -MNK Tomivosertib eFT-508 (eFT508) Tomivosertib eFT508 6'-[(6-Amino-4-pyrimidinyl)amino]-8'-methylspiro[cyclohexane-1,3'(2'H)-imidazo[1,5-a]pyridine]-1',5'-dione 6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-1'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'(2'H)-dione | Intermediates-Pharmaceutical Intermediates |
| 193 | 1310726-60-3 | Upadacitinib | ABT-494 Upadacitinib Upadacitinib (Rinvoq) Upadacitinib (ABT-494) ABT-494(Upadacitinib) free base | Intermediates-Pharmaceutical Intermediates |
| 194 | 920509-32-6 | MGL-3196 | CS-2429 MGL-3196 Resmetirom 2-[3,5-Dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-2,3,4,5-tetrahydro-3,5-dioxo-1,2,4-triazine-6-carbonitrile 1,2,4-Triazine-6-carbonitrile, 2-[3,5-dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-2,3,4,5-tetrahydro-3,5-dioxo- | Intermediates-Pharmaceutical Intermediates |
| 195 | 1219810-16-8 | RSL3 | RSL3 CS-2409 methyl (1S,3R)-2-(2-chloroacetyl)-1-(4-methoxycarbonylphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-3-carboxylate (1S,3R)-Methyl 2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1-[4-(methoxycarbonyl)phenyl]-1H-pyrido[3,4-b]indole-3-carboxylate | Intermediates-Pharmaceutical Intermediates |
| 196 | 444606-18-2 | SB-681323 | GW 681323 SB-681323 DilMapiMod Dilmapimod (SB-681323) 8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-2-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-Pyrido[2,3-d]pyrimidin-7(8H)-one Pyrido[2,3-d]pyrimidin-7(8H)-one, 8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-2-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]- | API |
| 197 | 1346242-81-6 | ERDAFITINIB | Erdafitinib ERDAFITINIB JNJ-42756493 Suftalan Zine Erdafitinib(JNJ-42756493) N-(3,5-dimethoxyphenyl)-N'-(1-methylethyl)-N-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine | Intermediates-Pharmaceutical Intermediates |
| 198 | 1346547-00-9 | 6-[(1,1-Dimethylethyl)sulfonyl]-N-(5-fluoro-1H-indazol-3-yl)-4-quinolinamine | GSK583 RIP2 kinase inhibitor 583 6-[(1,1-Dimethylethyl)sulfonyl]-N-(5-fluoro-1H-indazol-3-yl)-4-quinolinamine 4-Quinolinamine, 6-[(1,1-dimethylethyl)sulfonyl]-N-(5-fluoro-1H-indazol-3-yl)- | Intermediates-Pharmaceutical Intermediates |
| 199 | 1123837-84-2 | Sitravatinib | MG516 CS-2638 Sitravatinib N-(3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 1,1-Cyclopropanedicarboxamide, N-[3-fluoro-4-[[2-[5-[[(2-methoxyethyl)amino]methyl]-2-pyridinyl]thieno[3,2-b]pyridin-7-yl]oxy]phenyl]-N'-(4-fluorophenyl)- | Intermediates-Pharmaceutical Intermediates |
| 200 | 1123837-84-2 | Sitravatinib | MG516 CS-2638 Sitravatinib N-(3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 1,1-Cyclopropanedicarboxamide, N-[3-fluoro-4-[[2-[5-[[(2-methoxyethyl)amino]methyl]-2-pyridinyl]thieno[3,2-b]pyridin-7-yl]oxy]phenyl]-N'-(4-fluorophenyl)- | Intermediates-Pharmaceutical Intermediates |
| 201 | 193884-53-6 | Disodium [(4-chlorophenyl)sulfanyl](10-methyl-9(10H)-acridinylidene)methyl phosphate | APS-5 Lumigen APS 5 9-(4-Chlorophenylthiophosphoryloxymethylidene)-10-methylacridan,disodium salt Disodium [(4-chlorophenyl)sulfanyl](10-methyl-9(10H)-acridinylidene)methyl phosphate | Intermediates-Pharmaceutical Intermediates |
| 202 | 202592-23-26 | 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-2,3,9-triMethyl-, (6S)- | (+)-JQ1 (free acid) JQ-1 (carboxylic acid) (+)-JQ-1 CARBOXYLIC ACID 2-Methyl-5-trifluoroMethyl-2H-pyrazol-3-ylaMine 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-2,3,9-triMethyl-, (6S)- | Intermediates-Pharmaceutical Intermediates |
| 203 | 1802220-02-5 | TPX-0005 | TPX-0005 Ropotrectinib 1,15-Etheno-1H-pyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one,11-fluoro-6,7,13,14-tetrahydro-7,13-dimethyl-, (7S,13R)- | Intermediates-Pharmaceutical Intermediates |
| 204 | 24730-31-2 | surfactin | C12043 abs9122 surfactin surfactin C Surfactin C1 Surfactin peptide Biosurfactants Surfactin surfactin from bacillus subtilis Cyclo(L-α-aspartyl-D-leucyl-L-leucyl-3-hydroxy-13-methyltetradecanoyl-L-α-glutamyl-L-leucyl-D-leucyl-L-valyl) | Antibiotics;Antibiotics A to;Antibiotics N-SAntibiotics |
| 205 | 733030-01-8 | Tipiracil hydrochloride-trifluridine mixt | TAS102 TAS-102 Trifluridine-tipiracil hydrochloride mixt Tipiracil hydrochloride-trifluridine mixt TRIFLURIDINE-TIPIRACIL HYDROCHLORIDE MIXTURE | Intermediates-Pharmaceutical Intermediates |
| 206 | 1228585-88-3 | GS9620 | GS9620 CS-925 GS9620 GS 9620 Vesatolimod 4-Amino-2-butoxy-8-[3-(1-pyrrolidinylmethyl)benzyl]-7,8-dihydro-6(5H)-pteridinone 4-amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5H)-one 4-amino-2-butoxy-8-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-5,7-dihydropteridin-6-one | API;Small molecule inhibitors;Pharmaceutical intermediates |
| 207 | 846557-71-9 | ML385 | ML385 N-[4-[2,3-Dihydro-1-(2-methylbenzoyl)-1H-indol-5-yl]-5-methyl-2-thiazolyl]-1,3-benzodioxole-5-acetamide 1,3-Benzodioxole-5-acetamide, N-[4-[2,3-dihydro-1-(2-methylbenzoyl)-1H-indol-5-yl]-5-methyl-2-thiazolyl]- 2-(1,3-benzodioxol-5-yl)-N-[5-methyl-4-[1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide | Intermediates-Pharmaceutical Intermediates |
| 208 | 112093-28-4 | Endoxifen | Endoxifen (Z)-Endoxifen (Z)-4-Hydroxy-N-desmethyl Tamoxifen (Z)-4-Hydroxy-N-DesMethyl TaMoxifen (Endoxifen) Phenol, 4-[(1Z)-1-[4-[2-(MethylaMino)ethoxy]phenyl]-2-phenyl-1-butenyl]- 4-[(1Z)-1-[4-[2-(Methylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]phenol | Aromatics;Inhibitors;Pharmaceutica;Metabolites & Impurities;Intermediates & Fine Chemicals;Aromatics, Metabolites & Impurities;Aromatics, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fin |
| 209 | 249921-19-5 | Anamorelin | Rc 1291 ONO-7643 anamorelin Anamorelin Unii-dd5rba1nkf Anamorelin (RC-1291) 3-Piperidinecarboxylic acid, 1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-, trimethylhydrazide, (3R)- (3R)-1-(2-Methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide (R)-1-((S)-2-((1H-indol-3-yl)methyl)-5-amino-5-methyl-4-oxohexanoyl)-3-benzyl-N,N',N'-trimethylpiperidine-3-carbohydrazide 2-amino-N-[(2R)-1-[(3R)-3-benzyl-3-[dimethylamino(methyl)carbamoyl]piperidin-1-yl]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-methylpropanamide | Inhibitors;Bioactive molecules |
| 210 | 1118567-05-7 | EGT1442 | EGT1442 CS-2165 EGT0001442 EGT 0001442 Bexagliflozin Bexagliflozin,EGT1442 EGT1442(Bexagliflozin,THR1442) (1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[2-(cyclopropyloxy)ethoxy]phenyl]methyl]phenyl]-D-glucitol | inhibitors;Cell biology reagents |
| 211 | 1192500-31-4 | AvibactaM | AvibactaM Avibactam free acid Avibactam Impurity 37 (E)-7-fluoro-3-methylhept-4-en-2-one AVIBACTAM FREE ACID (NXL-104 FREE ACID) (2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-ylhydrogensulfate Avibactam,(2S,5R)-7-Oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carbox amide Sulfuric acid mono[(1R,2S,5R)-2-(aminocarbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl] ester | Impurity reference substance;Pharmaceutical active molecule |
| 212 | 75178-90-4 | 5-(BOC-AMINO)-1-PENTANOL | N-BOC-5-AMINOPENTANOL 5-(BOC-AMINO)-1-PENTANOL 5-(Boc-amino)pentan-1-ol TERT-BUTYL (5-HYDROXYPENTYL)CARBAMATE N-T-BUTOXYCARBONYL-5-AMINO-1-PENTANOL N-TU-BUTOXYCARBONYL-5-AMINO-1-PENTANOL TERT-BUTYL N-(5-HYDROXYPENTYL)CARBAMATE 1-(tert-Butoxycarbonylamino)-5-pentanol N-(5-HYDROXYPENTYL)CARBAMIC ACID TERT-BUTYL ESTER | Aliphatics;All Aliphatics |
| 213 | 159858-22-7 | FMoc-Val-Cit-PAB | Fmoc-Val-Cit-PAB FMoc-Val-Cit-PAB Fmoc-Val-Cit-PAB-OH Fmoc-val-citrulline-para-aminobenzyl-OH L-Ornithinamide, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-valyl-N5-(aminocarbonyl)-N-[4-(hydroxymethyl)phenyl]- (9H-fluoren-9-yl)methyl ((2S)-1-((1-((4-(hydroxymethyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamate (9H-fluoren-9-yl)methyl((S)-1-((())-1-((4-(hydroxymethyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamate (9H-fluoren-9-yl)methyl N-[(1S)-1-{[(1S)-4-(carbamoylamino)-1-{[4-(hydroxymethyl)phenyl]carbamoyl}butyl]carbamoyl}-2-methylpropyl]carbamate (9H-fluoren-9-yl)methyl ((S)-1-(((S)-1-((4-(hydroxymethyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamate | ADCs;ADC Linker |
| 214 | 351184-42-4 | N-FMOC-4-PIPERIDINOL | N-FMOC-4-PIPERIDINOL FMOC-4-HYDROXYPIPERIDINE 1-Fmoc-4-hydroxypiperidine (9H-fluoren-9-yl)methyl 4-hydroxypiperidine-1-carboxylate 4-Hydroxy-1-piperidinecarboxylic acid 9H-fluoren-9-ylmethyl ester 1-Piperidinecarboxylic acid, 4-hydroxy-, 9H-fluoren-9-ylmethyl ester | pharmacetical |
| 215 | Cross-linked dextran gel G-75 | Dextran gel G75 Sephadex G-75 medium Cross-linked dextran gel G-75 | Electrophoresis and separation materials;Biochemical Reagents-Separation Materials and Consumables | |
| 216 | 1445993-26-9 | ABBV-075 | 5100 ABBV-075 Mivebresib Mivebresib (ABBV-075 ) N-(4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide | Cell biology reagents;Active small molecular library |
| 217 | 728865-23-4 | CHIR-090 | CHIR-090 CHIR 090 N-[(1S,2R)-2-Hydroxy-1-[(hydroxyamino)carbonyl]propyl]-4-[[4-(4-morpholinylmethyl)phenyl]ethynyl]benzamide N-[(2S,3R)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-[2-[4-(morpholin-4-ylmethyl)phenyl]ethynyl]benzamide | Biochemical Industry |
| 218 | 863971-53-3 | FMoc-Val-Cit-PAB-PNP | Moc-Val-Cit-PAB-PNP FMoc-Val-Cit-PAB-PNP FMOC-VAL-CIT-PAB-PNP (9-FLUORENYLMETHYLOXYCARBONYL-VALYL-CITRULLYL-(4-AMINOBENZYL)-(4-NITROPHENYL)CARBONATE) L-Ornithinamide, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-valyl-N5-(aminocarbonyl)-N-[4-[[[(4-nitrophenoxy)carbonyl]oxy]methyl]phenyl]- {4-[(2S)-5-(carbamoylamino)-2-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-methylbutanamido]pentanamido]phenyl}methyl 4-nitrophenyl carbonate 4-[[(2S)-1-amino-5-(carbamoylamino)-1-oxopentan-2-yl]-[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methylbutanoyl]amino]phenyl]methyl (4-nitrophenyl) carbonate (9H-fluoren-9-yl)methyl ((S)-3-methyl-1-(((S)-1-((4-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-1-oxobutan-2-yl)carbamate | ADCs;Pharmaceutical |
| 219 | 1446486-33-4 | 9-Propenyladenine | 9-Propenyladenine Tenofovir Impurity B Tenofovir impurity 23 Tenofovir disoproxil-10 9-(1E)-1-Propen-1-yl-9H-purin-6-amine 9-Propenyladenine (Tenofovir Impurity) (E)-9-(prop-1-en-1-yl)-9H-purin-6-amine (R)-2-(6-amino-9H-purin-9-yl)propan-1-ol Tenofovir Disoproxil Fumarate impurity B Mutagenic Impurity of Tenofovir Disoproxil | Impurity reference substance |
| 220 | 253449-04-6 | 1-(3,6-DIBROMO-9H-CARBAZOL-9-YL)-3-(DIMETHYLAMINO)PROPAN-2-OL | WISKOSTATIN 1-(3,6-dibromocarbazol-9-yl)-3-(dimethylamino)propan-2-ol 3,6-Dibromo-α-[(dimethylamino)methyl]-9H-cabazole-9-ethanol 1-(3,6-DIBROMO-9H-CARBAZOL-9-YL)-3-(DIMETHYLAMINO)PROPAN-2-OL 3,6-Dibromo-9-[3-(dimethylamino)-2-hydroxyprop-1-yl]-9H-carbazole 9H-Carbazole-9-ethanol, 3,6-dibroMo-alpha-[(diMethylaMino)Methyl]- 3-(3,6-Dibromo-9H-carbazol-9-yl)-N,N-dimethyl-2-hydroxypropylamine | Small molecule inhibitor |
| 221 | 57333-96-7 | Tacalcitol | C12919 Tacalcitol 1α,24R-Dihydroxyvitamin D3 lα,24R-Dihy-droxyvitamin D3 1α,24(R)-Dihydroxyvitamin D3 lα,24-Dihydroxycholecalciferol (1α,3β-5Z,7E,24R)-9,10-Secoholesta-5,7,10(19)-triene-1,3,24-triol [5Z,7E,24R,(+)]-9,10-Secocholesta-5,7,10(19)-triene-1α,3β,24-triol (1a,3b,5Z,7E,24R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,24-triol | API;Vitamin D3 analogs;Chemical raw materials |
| 222 | 956-48-9 | 2,6-dichlorophenolindophenol | DCPIP Indochlorophenol Dichloroindophenol Dichlorophenolindphenol 2,6-dichlorophenolindophenol PHENOLINDO-2,6-DICHLOROPHENOL 4-(3,5-dichloro-4-hydroxy-phenyl)iminocyclohexa-2,5-dien-1-one | Biochemical Reagents-Other Chemical Reagents |
| 223 | 148504-34-1 | CALCEIN-AM | CAL-AM CALCEIN-AM NSC 689290 CALCEIN, AM Calcein, AM Calcein AM solution Calcein AM solution Calcein AcetoxyMethyl Ester 4',5'-Bis(N,N-bis(carboxymethyl)aminomethyl)fluorescein acetoxymethyl ester 3',6'-Di(O-acetyl)-2',7'-bis[N,N-bis(carboxymethyl)aminomethyl]fluoresceintetraacetoxymethylester,DMSOsolution Glycine, N,N'-((3',6'-bis(acetyloxy)-3-oxospiro(isobenzofuran-1(3H),9'-(9H)xanthene)-2',7'-diyl)bis(methylene))bis(N-(2-((acetyloxy)methoxy)-2-oxoethyl)-, bis((acetyloxy)methyl) ester N,N'-[[3',6'-Bis(acetyloxy)-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-2',7'-diyl]bis(Methylene)]bis[N-[2-[(acetyloxy)Methoxy]-2-oxoethyl]glycine 1,1'-Bis[(acetyloxy) Methyl] Ester | Int;Amines;Aromatics;Fluorescent;Heterocycles;Calcium Probes;Stains and Dyes;Stains&Dyes, A to;biochemical reagent;Fluorescent Labels & Indicators |
| 224 | 11016-15-2 | C-PHYCOCYANIN | C-PC PHYCOCYANIN C C-PHYCOCYANIN C-Phycocyanin from Spirulina C-phycocyanin from spirulina sp. C-phycocyanin from porphyra tenera C-phycocyanin partially purified from*spirulina S | Biochemical Industry |
| 225 | 150347-59-4 | 5(6)-(N-SUCCINIMIDYLOXYCARBONYL)-3',6',O,O'-DIACETYLFLUORESCEIN | CFSE 5-CARBOXYFLUORESCEIN-NHS DIACETATE CARBOXYFLUORESCEIN DIACETATE, NHS ESTER 5-CARBOXY-DI-O-ACETYLFLUORESCEIN N-SUCCINIMIDYL ESTER 5(6)-CARBOXYFLUORESCEIN DIACETATE N-SUCCINIMIDYL ESTER 5(6)-Carboxyfluorescein diacetate, succinimidyl ester(CFDA) 5(6)-CARBOXYFLUORESCEIN DIACETATE-N-HYDROXY-SUCCINIMIDE ESTER 5(6)-(N-SUCCINIMIDYLOXYCARBONYL)-3',6',O,O'-DIACETYLFLUORESCEIN | Chemical reagent |
| 226 | 113558-14-8 | Ikarisoside F | Ikarisoside F IKARISOSIDE F Icarisoside F Ikarisoside F (Ikarisoside-F 4H-1-Benzopyran-4-one, 3-[(6-deoxy-2-O-β-D-xylopyranosyl-α-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methyl-2-buten-1-yl)- 3-[(6-Deoxy-2-O-beta-D-xylopyranosyl-alpha-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one | Plant extract;Standard substance;Reference substance;Standard substance-traditional Chinese medi;Traditional Chinese medicine reference substance;Reference substance and active ingredient monomer |
| 227 | 107390-08-9 | garcinone D | GARCINONE D garcinone D 1,3,6-trihydroxy-8-(3-hydroxy-3-methylbutyl)-7-methoxy-2-(3-methylbut-2-enyl)xanthen-9-one 1,3,6-Trihydroxy-8-(3-hydroxy-3-methylbutyl)-7-methoxy-2-(3-methyl-2-buten-1-yl)-9H-xanthen-9-one 9H-Xanthen-9-one,1,3,6-trihydroxy-8-(3-hydroxy-3-methylbutyl)-7-methoxy-2-(3-methyl-2-buten-1-yl)- | phytochemical;Plant extract;chemical reagent;Standard substance;Standard substance, ref;pharmaceutical intermediate;standardized herbal extract;reference standards from Chinese medicinal herbs (TCM).; |
| 228 | 53185-12-9 | Fagomine | Fagomine D-FagoMine 1,2,5-Trideoxy-1,5-epimino-D-xylo-hexitol (2R)-3β,4α-Dihydroxypiperidine-2α-methanol (2R)-2-(Hydroxymethyl)piperidine-3β,4α-diol (2R)-2α-(Hydroxymethyl)piperidine-3β,4α-diol (2R,3R,4R)-3,4-Dihydroxy-2-piperidinemethanol (2R,3R,4R)-2-(Hydroxymethyl)piperidine-3,4-diol | Plant extract |
| 229 | 174022-42-5 | Bevirimat | BVM PA-457 PA-457 CS-1322 MPC-4326 FH11327 MPC-4326 Bevirimat YK FH312 Bevirimat 174022-42-5 Bevirimat, PA 457, FH 312 | Plant extract;Main products;Standard products;Pharmaceutical raw materials;Standard substance-traditional Chinese medicine sta;Reference substance-traditional Chinese medicine reference substance |
| 230 | 68027-15-6 | Pulsatillasaponin D | Pulsatillasaponin D Pulsatilla saponin D, BR Pulsatilla saponin D (SB365) Pulsatilla saponin D 68027-15-6 Hederagenin 3-O-α-L-rhaMnopyranosyl(1→2)-(β-D-glucopyranosyl(1→4))-α-L-arabinopyranoside Hederagenin 3-O-α-L-rhamnopyranosyl(1→2)-(β-D-glucopyranosyl(1→4))-α-L-arabinopyranoside Olean-12-en-28-oic acid,3-[[O-6-deoxy-a-L-mannopyranosyl-(12)-O-[b-D-glucopyranosyl-(14)]-a-L-arabinopyranosyl]oxy]-23-hydroxy-, (3b,4a)- Olean-12-en-28-oic acid, 3-[[O-6-deoxy-α-L-mannopyranosyl-(1→2)-O-[β-D-glucopyranosyl-(1→4)]-α-L-arabinopyranosyl]oxy]-23-hydroxy-, (3β,4α)- | che;reagent;standard s;phytochemical;Main products;Plant extract;chemical reagent;Standard substance;Reference substance;Plant extraction standard |
| 231 | 640-79-9 | Glycochenodeoxycholic Acid | GCDC Glycochenodeoxycholate Chenodeoxycholylglycine Glycochenodeoxycholic Acid N-[(3a,5b,7a)-3,7-dihydroxy-24-oxocholan-24-yl]-Glycine 2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid | Reference substance |
| 232 | 113973-31-2 | (Z)-Akuammidine | (19Z)-Rhazine (Z)-Akuammidine Sarpagan-16-carboxylicacid, 17-hydroxy-, methyl ester, (19Z)- | Alkal;Alkaloid;Alkaloids;Plant extract;Standard substance;Reference substance;Standard substance, reference substance;Standard substance-control medicinal material |
| 233 | 89590-98-7 | Mogroside VI | Mogroside VI mogroside VI | phytochemical;Plant extract;chemical reagent;Standard substance;standardized herbal ext;pharmaceutical intermediate;Standard substance of analytical reagent;Standard substance-standard substance of tr |
| 234 | 183321-86-0 | OSI-420, Free Base (Desmethyl Erlotinib) | OSI-420 Erlotinib-10 OSI-420Free Base OSI-420 impurity 6-O-Desmethyl Erlotinib Erlotinib 6-O-Desmethyl Metabolite Erlotinib Hydrochloride iMpurity 9 Erlotinib O-Desmethyl Metabolite Isomer OSI-420, Free Base (Desmethyl Erlotinib) 2-((4-((3-ethynylphenyl)amino)-7-(2-methoxyethoxy) 2-((4-((3-ethynylphenyl)amino)-7-(2-methoxyethoxy)quizolin-6-yl)oxy)ethan-1-ol | Inhibitors;Heterocycles;Metabolites &;Pharmaceuticals;Cell biology reagent;Metabolites & Impurities;Impurity reference substance;Intermediates & Fine Chemicals;Small molecule inhibitor, natural produc |
| 235 | 58471-53-7 | H-ASP-ASP-OH | ASP-ASP H-ASP-ASP-OH diaspartic acid L-ASPARTYL-L-ASPARTIC ACID Ornithine aspartate impurity C L-Aspartic acid, L-a-aspartyl- L-Ornithine L-Aspartate Impurity 5 (S)-2-((S)-2-Amino-3-carboxypropanamido)succinic acid | Peptides;Dipeptides;Polypeptide;Amino Acid Derivatives;Dipeptides and Tripeptides;Dipeptides and Tripeptides;Impurity reference substance;Reference substance-impurity reference substance |
| 236 | 949095-98-1 | (RS)-4-(3-MethylaMino-1-thiophen-2-yl-propyl)-naphthalen-1-ol | Duloxetine EP IMpurity C Duloxetine Phenolic IMpurity (PHL) Duloxetine hydrochloride impurity F Duloxetine metabolite Para-Naphthol Duloxetine 4-[3-(Methylamino)-1-(2-thienyl)propyl]-1-naphthalenol 4-(3-(Methylamino)-1-(thiophen-2-yl)propyl)naphthalen-1-ol (RS)-4-(3-MethylaMino-1-thiophen-2-yl-propyl)-phthalen-1-ol (RS)-4-(3-MethylaMino-1-thiophen-2-yl-propyl)-naphthalen-1-ol | 072-duloxetine;Duloxetine impurity;Pharmaceutical intermediate;Impurity reference substance;Reference substance-impurity reference substance |
| 237 | 15483-27-9 | H-ARG-ARG-OH ACETATE SALT | Arg-Arg H-ARG-ARG-OH H-Arg-Arg-OH arginylarginine H-ARG-ARG-OH ACOH L-Arginyl-L-arginine L-Arginine, L-arginyl- H-ARG-ARG-OH ACETATE SALT L-ARGINYL-L-ARGININE ACETATE | Standard |
| 238 | 1258296-60-4 | RO495 | RO495 CS-2667 RO495 (CS-2667) RO495 (TYK Tool 1) N-(2-((2-amino-6-methylpyrimidin-4-yl)amino)pyridin-4-yl)-2,6-dichlorobenzamide Benzamide, N-[2-[(2-amino-6-methyl-4-pyrimidinyl)amino]-4-pyridinyl]-2,6-dichloro- | |
| 239 | 344940-63-2 | Diphenylterazine | DTZ Diphenylterazine diphenylterazine Diphenylterazine (DTZ) 2-Benzyl-6,8-diphenylimidazo[1,2-a]pyrazin-3(7H)-one Imidazo[1,2-a]pyrazin-3(7H)-one, 6,8-diphenyl-2-(phenylmethyl)- | |
| 240 | 327156-95-6 | 顺式-[4-(Boc-氨基)环己基]乙酸 | BOC-1,4-CIS-ACHA-OH FMOC-1,4-CIS-ACHA-OH BOC-CIS-4-AMINOCYCLOHEXANE ACETIC ACID FMOC-CIS-4-AMINOCYCLOHEXANE ACETIC ACID BOC-CIS-1,4-AMINOCYCLOHEXYL ACETIC ACID BOC-CIS-4-AMINOCYCLOHEXANE-1-ACETIC ACID FMOC-CIS-1,4-AMINOCYCLOHEXYL ACETIC ACID FMOC-CIS-4-AMINOCYCLOHEXANE-1-ACETIC ACID | N-BOC;Amino acids |
| 241 | 139262-20-7 | Fmoc-trans-4-Hydroxy-D-proline | FMOC-D-HYP-OH Fmoc-D-trans-Hyp-OH Fmoc-trans-4-Hydroxy-D-proline N-Fmoc-(4S)-4-hydroxy-D-proline (9H-Fluoren-9-yl)MethOxy]Carbonyl D-trans-Hyp-OH N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-D-HYDROXYPROLINE N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-TRANS-4-HYDROXY-D-PROLINE (2R,4S)-N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-4-HYDROXYPYRROLIDINE-2-CARBOXYLIC ACID | |
| 242 | 865231-46-5 | (S)-3-(4-((4'-(Trifluoromethyl)-[1,1'-biphenyl]-3-yl)methoxy)phenyl)hex-4-ynoic acid | AMG-837 AMG837 CS-1283 AMG 837 (S)-3-(4-((4'-(Trifluoromethyl)-[1,1'-biphenyl]-3-yl)methoxy)phenyl)hex-4-ynoic acid Benzenepropanoic acid, β-1-propyn-1-yl-4-[[4'-(trifluoromethyl)[1,1'-biphenyl]-3-yl]methoxy]-, (βS)- (betaS)-beta-1-Propyn-1-yl-4-[[4'-(trifluoromethyl)[1,1'-biphenyl]-3-yl]methoxy]benzenepropanoic acid (S)-3-(4-((4'-(Trifluoromethyl)-[1,1'-biphenyl]-3-yl)methoxy)phenyl)hex-4-ynoic acid (AMG-837 free acid) 1259389-38-2 (calium salt hydrate) | |
| 243 | 343770-23-0 | Fmoc-(Nd-4-methyltrityl)-L-ornithine | FMOC-ORN(MTT)-OH FMOC-L-ORN(MTT)-OH FMOC-ORN[TRT(4-CH3)]-OH Fmoc-(Nd-4-methyltrityl)-L-ornithine FMOC-(N-D-4-METHYLTRITYL)-L-ORNITHINE N-ALPHA-FMOC-N-DELTA-4-METHYLTRITYL-L-ORNITHINE N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N-GAMMA-METHYLTRITYL-L-ORNITHINE N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N-DELTA-METHYLTRITYL-L-ORNITHINE N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-N-DELTA-4-METHYLTRITYL-L-ORNITHINE | amino acids;Amino acid intermediates;Non-natural amino acids and derivatives |
| 244 | 1217644-25-1 | 3-Amino-5-methoxy-1H-indole-2-carboxylic acidethyl ester | Fmoc-L-α-methylserine FMOC-ALPHA-METHYL-D-SER FMOC-D-ALPHA-METHYLSERINE FMOC-(R)-2-AMINO-2-METHYL-3-HYDROXYPROPANOIC ACID D-Serine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methyl- 3-Amino-5-methoxy-1H-indole-2-carboxylic acidethyl ester (2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-hydroxy-2-methylpropanoic acid | unnatural amino acids |
| 245 | 212688-51-2 | Fmoc-D-Ser(trt)-OH | Fmoc-D-Ser(trt)-OH FMOC-D-SER(TRT)-OH FMOC-O-TRITYL-D-SERINE N-ALPHA-FMOC-O-TRITYL-D-SERINE (9H-Fluoren-9-yl)MethOxy]Carbonyl D-Ser(Trt)-OH N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-O-TRITYL-D-SERINE N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-O-TRITYL-D-SERINE N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-O-(triphenylmethyl)-D-serine | Amino acid;Amino Acids;Chemical raw materials;Fmoc-protective amino acid |
| 246 | 359766-58-8 | Fmoc-beta-t-butyl-D-alanine | FMOC-D-LEU(ME)-OH FMOC-D-ALA(TBU)-OH Fmoc-β-tBu-D-Ala-OH Fmoc-beta-tBu-D-Ala-OH FMOC-T-BUTYL-D-ALANINE FMOC-D-(NEOPENTYL)GLY-OH Fmoc-beta-t-butyl-D-alanine N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-D-T-BUTYL-ALANINE N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-D-GAMMA-METHYL-LEUCINE | |
| 247 | 212651-52-0 | Fmoc-beta-chloro-L-alanine | FMOC-ALA(3-CL)-OH Fmoc-L-Ala(3-Cl)-OH FMOC-ALA(BETA-CL)-OH Fmoc-b-Chloro-Ala-OH FMOC-B-CHLORO-ALA-OH FMOC-BETA-CHLORO-ALA-OH FMOC-(3-CHLORO)-L-ALANINE Fmoc-beta-chloro-L-alanine FMOC-BETA-CHLORO-L-ALANINE N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-3-CHLORO-L-ALANINE | Amino acid derived compound |
| 248 | 57407-08-6 | DEAE-Sepharose | DEAE-Sepharose DEAE-Sepharose(R) DEAE SEPHAROSE CL-6B DEAE-SEPHAROSE(R) CL-6B DEAE-Sepharose Fast Flow DIETHYLAMINOETHYL SEPHAROSE Diethylaminoethyl-Sepharose(R) agarose,2-(diethylamino)ethylether DIETHYLAMINOETHYL-SEPHAROSE(R) CL-6B | Biochemical Reagents-Separation Materials and Consumables |
| 249 | 3625-57-8 | Nile Blue A | CI 51180 Nile Blue A CI NO 51180 BASIC BLUE 12 nileblueasulphate BASIC BLUE 12 SULFATE SALT | marker;Phenoxazine;Chemical reagent |
| 250 | 7423-31-6 | Stains-All | DBTC Stains-All CARBOCYANIN DBTC 3,3'-DIETHYL-9-METHYL-4,5,4',5'-DIBENZOTHIACARBOCYANINE 3,3'-DIETHYL-9-METHYL-4,5,4',5'-DIBENZOTHIACARBOCYANINE BROMIDE 1-ETHYL-2-[3-(1-ETHYLNAPHTHO[1,2-D]THIAZOLIN-2-YLIDENE)-2-METHYLPROPENYL]NAPHTHO[1,2-D]THIAZOLIUM BROMIDE | Naphthothiazole |
| 251 | 74515-25-6 | LAURDAN | LAURDAN 6-DODECANOYL-2-DIMETHYLAMINONAPHTHALENE N,N-DIMETHYL-6-DODECANOYL-2-NAPHTHYLAMINE 6-Dodecanoyl-N,N-dimethyl-2-naphthylamine 2-(DIMETHYLAMINO)-6-DODECANOYLNAPHTHALENE 6-Dodecanoyl-2-dimethylaminonaphthalene laurdan 1-[6-(dimethylamino)naphthalen-2-yl]dodecan-1-one laurdan [6-Dodecanoyl-2-diMethylaMinonaphthalene] | Biochemical reagents |
| 252 | 199745-67-0 | Texas Red-X,SE | texas red-X Texas Red-X,SE TEXAS RED-X NHS Texas Red-x, acid Texas Red-X, succinimidyl ester *Single isomer* | |
| 253 | 153587-01-0 | NS 1619 | NS 161 NS1619 NS-1619 NS 1619 NS 1619 (1,3-DIHYDRO-1-(2-HYDROXY-5-(TRI FLUOROMETHYL)PHEN 1-(2-hydroxy-5-(trifluoroMethyl)phenyl)-5-(trifluoroMethyl)-1H-b 1-(2-hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-1H-benzo[d]imidazol-2(3H)-one 5-(TRIFLUOROMETHYL)-1-(5-(TRIFLUOROMETHYL)-2-HYDROXYPHENYL)-1H-BENZO[D]IMIDAZOL-2(4H)-ONE 1,3-DIHYDRO-1-[2-HYDROXY-5-(TRIFLUOROMETHYL)PHENYL]-5-(TRIFLUOROMETHYL)-2H-BENZIMIDAZOL-2-ONE 2H-Benzimidazol-2-one, 1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)- | API;Synthesis |
| 254 | 6268-05-9 | 4-Benzamido-2,5-Dimethoxyaniline | CI 37155 FAST BLUE RR FAST BLUE SALT RR FAST BLUE RR BASE AZOIC DIAZO NO 24 LABOTEST-BB LT00133744 Azoic Diazo Component 24 (37155) 4-Benzamido-2,5-Dimethoxyaniline | Reagents and supplements |
| 255 | 80883-54-1 | 7-DIMETHYLAMINOCOUMARIN-4-ACETIC ACID | DMACA COUMARIN D 126 DMACA Coumarin D 126 7-DIMETHYLAMINOCOUMARIN-4-ACETIC ACID 7-(Dimethylamino)coumarine-4-Acetic Acid 7-(Dimethylamino)coumarin-4-acetic acid(DMACA) 2-[7-(dimethylamino)-2-oxochromen-4-yl]acetic acid 2-(7-(DiMethylaMino)-2-oxo-2H-chroMen-4-yl)acetic acid | Coumarines |
| 256 | 13636-18-5 | FENDILINE HYDROCHLORIDE | hk137 difmecor FENDILINE HYDROCHLORIDE N-(3,3-Diphenylpropyl)-α-methylbenzylamine hydrochloride 3,3-diphenyl-N-(1-phenylethyl)-1-propanamine hydrochloride N-[3,3-DIPHENYLPROPYL]-ALPHA-METHYLBENZYLAMINE HYDROCHLORIDE gamma-phenyl-n-(1-phenylethyl)-benzenepropanaminhydrochloride gamma-phenyl-n-(1-phenylethyl)benzenepropanaminehydrochloride | Small molecule inhibitor |
| 257 | 62851-42-7 | JENNER'S STAIN | JENNER STAIN JENNERS STAIN JENNER'S STAIN Jenner'sStain (9CI) METHYLENE BLUE EOSIN EOSIN-METHYLENE BLUE METHYLENE BLUE-EOSIN JENNER EOSIN-METHYLENE BLUE JENNER | Stains and dyes;Biochemical reagents;Hematology and histology;Other biochemical reagents |
| 258 | 119171-73-2 | [10-Acetyl-3,7-dihydroxyphenoxazine] | ADHP AMPLEX RED Ampliflu Red AMPLEX(R) RED REAGENT 10-ACETYL-3,7-DIHYDROXYPHENOXAZINE [10-Acetyl-3,7-dihydroxyphenoxazine] 10-ACETYL-3,7-DIHYDROXYPHENOXAZINE [ADHP] | Synthetic material intermediates |
| 259 | 68683-34-1 | Bilirubin conjugate | Bilirubin conjugate Ditaurobilirubin disodium salt Bilirubin Conjugate (sodium salt) disodium 2,2'-[(1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-2,17-divinyl-21H-biline-8,12-diyl)bis[(1-oxopropane-3,1-diyl)imino]]bis[ethane-1-sulphonate] 2,2'-[(2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-diyl)bis[(1-oxo-3,1-propanediyl)imino]]bis(ethanesulfonic acid sodium) salt 2,2'-[[(2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline)-8,12-diyl]bis[(1-oxo-3,1-propanediyl)imino]]bis(ethanesulfonic acid sodium) salt 2,2'-[[(2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline)-8,12-diyl]bis[(1-oxo-3,1-propanediyl)imino]]bis[ethanesulfonic acid sodium] salt | Biochemical reagents |
| 260 | 186689-07-6 | 2-[N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glucose | 2-NBDG 2-NBD-Glucose 2-Deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose 2-(N-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)AMINO)-2-DEOXYGLUCOSE 2-[N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glucose 2-NBDG,2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose 2-NBDG [2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose] | Stable isotope |
| 261 | 1448346-63-1 | AG-120 Racemate | AG-120 AG-120 racemic AG-120 Racemate AG-120 Ivosidenib Ivosidenib (RG-120) Ivosidenib (RG-120 racemic) 1-(4-Cyano-2-pyridinyl)-5-oxo-L-prolyl-2-(2-chlorophenyl)-N-(3,3-difluorocyclobutyl)-N2-(5-fluoro-3-pyridinyl)glycinamide (2S)-N-(1 -(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide | Small molecule inhibitor |
| 262 | 1392116-14-1 | (S)-2-(((E)-((S)-3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl)((4-chlorophenyl)sulfonamido)methylene)amino)-3-methylbutanamide | JD 5037 JD-5037 CS-2558 (S)-2-((Z)-(((S)-3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl)(4-chlorophenylsulfonamido)methylene)amino)-3-methylbutanamide (S)-2-(((E)-((S)-3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl)((4-chlorophenyl)sulfonamido)methylene)amino)-3-methylbutanamide Butanamide, 2-[[[(4S)-3-(4-chlorophenyl)-4,5-dihydro-4-phenyl-1H-pyrazol-1-yl][[(4-chlorophenyl)sulfonyl]amino]methylene]amino]-3-methyl-, (2S)- | |
| 263 | 519187-97-4 | Edonerpic maleate | T-817 T817 T 817 Edonerpic T-817MA)) EDONERPIC T-817 maleate Edonerpic maleate EDONERPIC MALEATE Edonerpic maleate (T-817 maleate | |
| 264 | 819-83-0 | Disodium β-glycerophosphate | BGP β-sodium glycerophosphate Disodium β-glycerophosphate 2-(Dihydrogen phosphate)-1,2,3-propanetriol Disodium Salt | Organic chemical raw materials;General biochemical reagents-lipids |
| 265 | 124387-19-5 | 5(6)-Carboxy-di-O-acetylfluorescein | 5(6)-CFDA 5(6)-FAM DA 5(6)-FAM DIACETATE 5(6)-Carboxyfluorescein diacetate 5(6)-Carboxy-di-O-acetylfluorescein 5-(AND-6)-CARBOXYFLUORESCEIN DIACETATE 5(6)-CFDA [5(6)-Carboxyfluorescein diacetate] Spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-ar-carboxylicacid, 3',6'-bis(acetyloxy)-3-oxo- | Pigments;Biochemical reagents |
| 266 | 866405-64-3 | Dorsomorphin | CS-1075 COMPOUND C Dorsomorphin AMPK INHIBITOR AMPK Inhibitor, Compound C, Dorsomorphin AMPK Inhibitor, Compound C, Dorsomorphin 6-[4-(2-PIPERIDIN-1-YLETHOXY)PHENYL]-3-PYRIDIN-4-YLPYRAZOLO[1,5-A]PYRIMIDINE | Inhibitor;Inhibitors;Chemical linkage;High purity reagent;Cell biology reagent;Small molecule inhibitor;Small molecule inhibitor, natural product |
| 267 | 130497-33-5 | 2-(3,4-Dichlorophenyl)-1-(2-(pyrrolidin-1-ylmethyl)piperidin-1-yl)ethanone hydrochloride | BRL-52537 BRL-52537A BRL 52537 HYDROCHLORIDE (2S)-1-[(3,4-Dichlorophenyl)acetyl]-2-(1-pyrrolidinylmethyl)piperidine 1-[(2S)-2α-(Pyrrolizinomethyl)piperidino]-2-(3,4-dichlorophenyl)ethanone 2-(3,4-Dichlorophenyl)-1-(2-(pyrrolidin-1-ylMethyl)piperidin-1-yl)ethanone 2-(3,4-Dichlorophenyl)-1-(2-(pyrrolidin-1-ylmethyl)piperidin-1-yl)ethanone hydrochloride 2-(3,4-Dichlorophenyl)-1-(2-(pyrrolidin-1-ylmethyl)-piperidin-1-yl)ethanone hydrochloride | Opioid receptor and opioid-like receptor |
| 268 | 135944-05-7 | Fmoc-Alpha-Methyl-L-Phe | Fmoc-á-Me-Phe-OH FMOC-ALPHA-ME-PHE-OH FMoc-alphaMe-L-Phe-OH FMOC-ALPHA-METHYL-L-PHE Fmoc-Alpha-Methyl-L-Phe FMOC-ALPHA-BENZYL-L-ALA FMOC-ALPHA-METHYL-L-PHENYLALANINE FMOC-(S)-2-AMINO-2-METHYL-3-PHENYLPROPANOIC ACID | Unusual amino acids;α-Methyl Amino Acids;unnatural amino acids;Non-natural amino acids;Phenylalanine derivatives;Phe derivatives, Fmoc-protective amino acids |
| 269 | 5786-68-5 | Quipazine Maleate | ma1291 quipazinemeleate Quipazine Maleate 1-(2-quinolyl)piperazinemaleate 2-(1-PIPERAZINYL)QUINOLINE DIMALEATE 2-[1-PIPERAZINYL]QUINOLINE MALEATE SALT | Aromatics;Synthesis;Heterocycles;Pharmaceuticals;Intermediates & Fine Chemicals |
| 270 | 199113-98-9 | Balaglitazone | Nn2344 Drf-2593 Drf 2593 Balaglitazone Unii-4m1609828o Balaglitazone [inn] 2,4-Thiazolidinedione,5-[[4-[(3,4-dihydro-3-methyl-4-oxo-2-quinazolinyl) methoxy]phenyl]methyl]- | API;APIs;Cell cycle |
| 271 | 20300-59-8 | 7-Methoxycoumarin-3-carboxylic acid | 7-Methoxycoumarin-3-carbonic acid 7-METHOXYCOUMARIN-3-CARBOXYLIC ACID 7-Methoxycoumarin-3-carboxylic acid 7-Methoxy-2-oxochromene-3-carboxylic acid 7-METHOXY-2-OXO-2H-CHROMENE-3-CARBOXYLIC ACID 7-METHOXYCOUMARIN-3-CARBOXYLIC ACID, FOR FLUORESCENCE | Fluoresce;Nitrogen heterocycles;Biochemicals and Reagents;Biochemicals and Reagents;Pharmaceutical intermediates;Functional Group Reactive La;Fluorescent probes, labeling, particles and staining; |
| 272 | 26993-30-6 | D-erythro-sphingosine-1-phosphate | SPA SPHINGOSINE-1-PHOSPHATE D-ERYTHRO-SPHINGOSINE-1-PHOSPHATE D-erythro-sphingosine-1-phosphate SPHINGOSINE-1-PHOSPHATE, D-ERYTHRO D-ERYTHRO-DIHYDROSPHINGOSINE-1-PHOSPHATE (E)-D-ERYTHRO-2-AMINO-1-(DIHYDROGENPHOSPHATE)-4-OCTADECENE-1,3-DIOL | proteins;Activators;Chemical Activators |
| 273 | 3061-90-3 | Ala-Phe | Ala-Phe L-ALA-PHE NSC 89630 H-ALA-PHE-OH alanylphenylalanine L-alanyl-phenylalanine (S)-2-((S)-2-AMinopropanaMido)-3-phenylpropanoic acid (2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanoic acid (S)-2-[[(S)-2-Aminopropionyl]amino]-3-phenylpropionic acid | Peptides;Dipeptides;Chemical biology;Peptide synthesis;Dipeptides and Tripeptides;Dipeptides and Tripeptides |
| 274 | 3061-91-4 | Val-Tyr | VY Val-Tyr VAL-TYR H-VAL-TYR-OH L-Tyrosine, L-valyl- (S)-2-((S)-2-Amino-3-methylbutanamido)-3-(4-hydroxyphenyl)propanoic acid | Peptides;Dipeptides;Polypeptides;Biochemical reagents;Dipeptides and Tripeptides;Dipeptides and Tripeptides |
| 275 | 3918-90-9 | Phe-Val | FV Phe-Val PHE-VAL H-PHE-VAL-OH L-PHENYLALANYL-L-VALINE L-Valine, L-phenylalanyl- (S)-2-((S)-2-Amino-3-phenylpropanamido)-3-methylbutanoic acid | Peptides;Dipeptides;Biochemical reagents;Dipeptides and Tripeptides;Dipeptides and Tripeptides |
| 276 | 53213-94-8 | 3,3'-Dipropylthiadicarbocyanine iodide | DISC3(5) 3,3'-Dipropylthiadicarbocyanine iodide 3,3'-DIPROPYL-2,2'-THIADICARBOCYANINE IODIDE 3,3'-DIPROPYLTHIADICARBOCYANINE IODIDE, FOR FLUORESCENCE 3-PROPYL-2-[5-[3-PROPYL-2(3H)BENZOTHIAZOLYLIDENE]-1,3-PENTADIENYL]BENZOTHIAZOLIUM IODIDE 3-PROPYL-2-(5-[3-PROPYL-1,3-BENZOTHIAZOL-2(3H)-YLIDENE]-1,3-PENTADIENYL)-1,3-BENZOTHIAZOL-3-IUM IODIDE BENZOTHIAZOL-3-IUM, 3-PROPYL-2-[(1E,3E)-5-[3-PROPYL-2(3H)-BENZOTHIAZOLYLIDENE]-1,3-PENTADIENYL]-, IODIDE | Cyanine |
| 277 | 60311-02-6 | Sulforhodamine 101 | SR101 CI 45100 SULFORHODAMINE Sulforhodamine 101 SULFORHODAMINE 640 SULFORHODAMINE 101 SULFORHODAMINE 101 ACID Sulforhodamine 101 (free acid) | S;Stains and Dyes;Stains & Dyes, A;Stains and Dyes;Stains&Dyes, A to;Fluorescent labeling dyes;Analytical reagents-developer;Synthetic material intermediates;Fluorescent probes, labeling, particle |
| 278 | 65646-68-6 | Fenretinide | 4HPR FENRETINIDE Fenretinide Fenretinimide Fenretinide(4-HPR) 4-HYDROXYPHENYLRETINAMIDE p-Hydroxyphenylretinamide 4-HPR, Fenretinide, N-(4-Hydroxyphenyl)retinamide (2E,4E,6E,8E)-N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenamide | Retinoids;Inhibitors;Drug Analogues;Pharmaceuticals;Reference substance;Intracellular receptor;Protein tyrosine kinase;Small molecule inhibitors;Pharmaceutical bulk drugs;Traditional Chinese medic |
| 279 | 7763-65-7 | His-Leu | HIS-LEU His-Leu H-HIS-LEU-OH N-Histidylleucine L-HISTIDYL-L-LEUCINE L-Leucine, L-histidyl- -2-Amino-3-(1H-imidazol-4-yl) (S)-2-((S)-2-aMino-3-(1H-iMidazol-4-yl)propanaMido)-4-Methylpentanoic acid | Peptides;Standards;Dipeptides;Chemical biology;Dipeptides and Tripeptides;Dipeptides and Tripeptides |
| 280 | 1242933-88-5 | Fmoc-Lys(5-FAM)-OH | FMOC-Lys(5-FAM) FMOC-LYS(5-FAM)-OH Fmoc-Lys(5-FAM)-OH FMOC -LYS(5-FAM)-OH N-ALPHA-FMOC-N-EPSILON-(5-CARBOXYFLUORESCEIN)-L-LYSINE N6-[(3',6'-Dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5-yl)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-lysine L-Lysine, N6-[(3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5-yl)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]- (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-(3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthen]-5-ylcarboxamido)hexanoic acid | amino acids;Amino acids;Non-natural amino acids |
| 281 | 300815-41-2 | RS 102895 | RS 102895 RS 102895 HYDROCHLORIDE 1'-(4-(trifluoromethyl)phenethyl)spiro[benzo[d][1,3]oxazine-4,4'-piperidin]-2(1H)-one 1'-[2-[4-(trifluoromethyl)phenyl]ethyl]-spiro[4h-3,1-benzoxazine-4,4'-peperidin]-2(1h)-one Spiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one, 1'-[2-[4-(trifluoromethyl)phenyl]ethyl]- 1'-(4-(TrifluoroMethyl)phenethyl)spiro[benzo[d][1,3]oxazine-4,4'-piperidin]-2(1H)-one hydrochloride 1'-[2-[4-(trifluoromethyl)phenyl]ethyl]spiro[1H-3,1-benzoxazine-4,4'-piperidine]-2-one,hydrochloride 1'-[2-[4-(TRIFLUOROMETHYL)PHENYL]ETHYL]-SPIRO[4H-3,1-BENZOXAZINE-4,4'-PIPERIDIN]-2(1H)-ONE HYDROCHLORIDE | Custom chemicals;Cytokine signaling;RS 102895 CCR2-selective chemokine receptor antagonist.;RS 102895 CCR2-selective chemokine receptor antagonist. Cytokine signaling |
| 282 | 123622-48-0 | FMOC-5-AMINOPENTANOIC ACID | FMOC-5-AVA-OH FMOC-APE(5)-OH FMOC-NH-(CH2)4-COOH RARECHEM EM WB 0074 FMOC-5-AMINOVALERIC ACID FMOC-5-AMINOPENTANOIC ACID 5-(FMOC-AMINO)PENTANOIC ACID N-(9-FLUORENYLMETHYLOXYCARBONYL)-5-AMINO-PENTANOIC ACID | Reagents;Synthesis;Amino Acids;Amino acids;Chemical reagents;Amino intermediates;Non-natural amino acids and derivatives |
| 283 | 649749-10-0 | Bis(choline)tetrathioMolybdate | WTX-101 CHOLINE TETRATHIOMOLYBDATE Choline tetrathiomolybdate Bis(choline)tetrathioMolybdate ATN-224 (Choline tetrathiomolybdateWTX-101) bis(sulfanylidene)molybdenum,2-hydroxyethyl(trimethyl)azanium,sulfanide | Cell biology reagent |
| 284 | 654670-89-0 | FMOC-DAP(MTT)-OH | FMOC-DPR(MTT)-OH FMOC-DAP(MTT)-OH FMOC-L-DAP(MTT)-OH FMoc-Nβ-4-Methyltrityl-L-2,3-diaMinopropionic acid N-ALPHA-FMOC-N-BETA-4-METHYLTRITYL-L-DIAMINOPROPIONIC ACID N-ALPHA-FMOC-N-BETA-4-METHYLTRITYL-L-ALPHA,BETA-DIAMINOPROPIONIC ACID N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-N-BETA(4-METHYL-TRITYL)-L-2,3-DIAMINOPROPIONIC ACID N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N-BETA-(P-METHYLTRITYL)-L-2,3-DIAMINOPROPIONIC ACID | amino acid;Amino acid;amino acids;Amino acids;Unusual Amino Acids;Amino acid intermediates;Amino acid derivative compounds;Non-natural amino acids and extremely derivatives |
| 285 | 7360-09-0 | H-TRP-GLY-OH | WG TRP-GLY Trp-Gly-OH L-Trp-Gly-OH H-TRP-GLY-OH tryptophylglycine TRP-GLY CRYSTALLINE N-L-Tryptophylglycine | Peptide;Short peptide;Standard substance;Amino Acid Derivatives |
| 286 | 756526-02-0 | 5,8,11,14,17,20,23,26-Octaoxa-2-azanonacosanedioic acid 1-(9H-fluoren-9-ylmethyl) ester | Fmoc-PEG8-CH2CH2COOH Fmoc-N-amido-PEG8-acid FMoc-NH-PEG8-CH2CH2COOH Fmoc-PEG8-propionic acid Fmoc-NH-(PEG)8-CH2CH2COOH 5,8,11,14,17,20,23,26-Octaoxa-2-azanonacosanedioic acid 5,8,11,14,17,20,23,26-Octaoxa-2-azanonacosanedioic acid,1-(9-fluren-9-ylmethyl)ester 5,8,11,14,17,20,23,26-Octaoxa-2-azanonacosanedioic acid 1-(9H-fluoren-9-ylmethyl) ester 5,8,11,14,17,20,23,26-Octaoxa-2-azanonacosanedioic acid, 1-(9H-fluoren-9-ylMethyl) ester | Polyethylene glycol modifier |
| 287 | 882847-32-7 | Fmoc-18-amino-4,7,10,13,16-pentaoxaoctadecanoic acid | Fmoc-NH-PEG5-COOH Fmoc-PEG5-CH2CH2COOH Fmoc-N-amido-PEG5-acid FMoc-NH-PEG5-CH2CH2COOH Fmoc-PEG5-propionic acid Fmoc-18-amino-4,7,10,13,16-pentaoxaoctadecanoic acid FMOC-18-AMINO-4,7,10,13,16-PENTAOXAOCTADECANOIC ACID 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19-hexaoxa-4-azadocosan-22-oic acid 5,8,11,14,17-Pentaoxa-2-azaeicosanedioic acid 1-(9H-fluoren-9-ylmethyl) ester | Others;Additives;amino acid;PEG products-Fmoc-PEG;Polyethylene glycol modifier |
| 288 | 884880-39-1 | FMOC-(R)-2-AMINO-3-HYDROXY-3-METHYLBUTANOIC ACID | (R)-Fmoc-b,b-dimethyl-serine FMOC-(R)-2-AMINO-3-HYDROXY-3-METHYLBUTANOIC ACID (R)-N-Fmoc-2-amino-3-hydroxy-3-methylbutanoic acid N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-3-hydroxy-D-valine D-Valine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-3-hydroxy- (2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-hydroxy-3-methylbutanoic acid | Amino acids;unnatural amino acids |
| 289 | 944797-51-7 | FMoc-N-Me-Cys(Trt)-OH | FMoc-N-Me-Cys(Trt)-OH FMOC-N-ME-CYS(TRT)-OH Fmoc-N-Me-L-Cys(Trt)-OH FMOC-N-METHYL-L-CYSTEINE(TRT) (9H-Fluoren-9-yl)MethOxy]Carbonyl N-Me-Cys(Trt)-OH N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-methyl-S-trityl-L-cysteine N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-S-(triphenylmethyl)-L-cysteine (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(tritylthio)propanoic acid (2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}(methyl)amino)-3-[(triphenylmethyl)sulfanyl]propanoic acid | amino acids;Protection of amino acids |
| 290 | 1005264-47-0 | MX69 | MX69 MX-69 CS-2402 MX69 (MX 69 Benzoic acid, 4-[8-[[(3,4-dimethylphenyl)amino]sulfonyl]-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-4-yl]- | inhibitors;Cell biology reagents |
| 291 | 1009820-21-6 | CX-4945 (Silmitasertib) | CX-4945 Silmitasertib CX-4945, CX4945 Silmitasertib(CX-4945) CX-4945 Silmitasertib CX-4945 (Silmitasertib) 5-[(3-chlorophenyl)amino]-Benzo[c]-2,6-naphthyridine-8-carboxylic acid 5-[(3-Chlorophenyl)amino]benzo[c]-2,6-naphthyridine-8-carboxylic acid CX-4945 (Silmitasertib) | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors |
| 292 | 1015474-32-4 | CC122 | CC122 CC 122 CC-122 AVADOMIDE Avadomide CC122 (Avadomide) Avadomide(CC-122) 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)piperidine-2,6-dione | API;Inhibitor |
| 293 | 1047634-65-0 | GSK2141795 | CS-1304 UPROSERTIB Uprosertib GSK2141795 GSK 2141795C GSK-2141795,UPROSERTIB Uprosertib(GSK2141795) Uprosertib , GSK2141795C N-[(1S)-2-Amino-1-[(3,4-difluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-furancarboxamide | API;Inhibitors;Cell biology reagents;Small molecule inhibitors |
| 294 | 1137359-47-7 | BRD7552 | CS-1560 BRD7552 BRD-7552 BRD 7552 Methyl [2,3-O-bis(Benzo[1,3]dioxol-5-yl-carbamoyl)]-4-O-(4-ethoxycarbonyl-phenylcarbamoyl)-α-D-glucopyranoside α-D-Glucopyranoside, methyl, 2,3-bis(N-1,3-benzodioxol-5-ylcarbamate) 4-[N-[4-(ethoxycarbonyl)phenyl]carbamate] ethyl 4-(((2R,3R,4S,5R,6S)-4,5-bis(benzo[d][1,3]dioxol-5-ylcarbamoyloxy)-2-(hydroxymethyl)-6-methoxy-tetrahydro-2H-pyran-3-yloxy)carbonyl)benzoate | Active molecule |
| 295 | 1164470-53-4 | (E)-1-(4-chlorophenyl)-3-(1,1,1-trichloro-4-oxo-6-phenylhex-5-en-2-yl)thiourea | 2 Sal003 SAL003 CS-1897 Sal 003 SAL 003 SAL-003 (2E)-3-Phenyl-N-(2 (2E)-3-PHENYL-N-(2 eIF-2α Inhibitor II, Sal003 2-TRICHLORO-1-{[(4-CHLOROPHENYL)CARBAMOTHIOYL]AMINO}ETHYL)ACRYLAMIDE 2-trichloro-1-{[(4-chlorophenyl)carbamothioyl]amino}ethyl)acrylamide (E)-1-(4-chlorophenyl)-3-(1,1,1-trichloro-4-oxo-6-phenylhex-5-en-2-yl)thiourea 3--Phenyl-N-(2,2,2-trichloro-1-((((4-chlorophenyl)amino)carbonothioyl)amino)ethyl)acrylamide | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 296 | 1173699-31-4 | AMG-337 | CS-1559 AMG 337 AMG-337 (R)-6-(1-(8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one 6-[(1R)-1-[8-Fluoro-6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-a]pyridin-3-yl]ethyl]-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one 1,6-Naphthyridin-5(6H)-one, 6-[(1R)-1-[8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-a]pyridin-3-yl]ethyl]-3-(2-methoxyethoxy)- | Cell biology reagents;Organic chemical raw materials |
| 297 | 118414-82-7 | MK-886 | MK-886 CS-1988 L-663,536 3-[3-tert-Butylthio-1-(4-chlorobenzyl)-5-isopropyl-1H-indol-2-yl]-2,2-dimethylpropionic acid 3-[1-(4-Chlorobenzyl)-3-(tert-butylthio)-5-isopropyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid 3-[1-(4-Chlorobenzyl)-3-(tert-butylthio)-5-isopropyl-1H-indol-2-yl]-2,2-dimethylpropionic acid 3-[tert-Butylthio-1-(4-chlorobenzyl)-5-isopropyl-1H-indol-2-yl]-2,2-dimethylpropionic Acid, Sodium Salt 1-[(4-CHLOROPHENYL)METHYL]-3-[(1,1-DIMETHYLETHYL)THIO]-ALPHA,ALPHA-DIMETHYL-5-(1-METHYLETHYL)-1H-INDOLE-2-PROPANOIC ACID | Inhibitor;Inhibitors;All Inhibitors;Prostanoid receptor and related |
| 298 | 1203494-49-8 | DASA-58 | DASA58 DASA-58 CS-1563 DASA 58 3-[[4-[(2,3-Dihydro-1,4-benzodioxin-6-yl)sulfonyl]hexahydro-1H-1,4-diazepin-1-yl]sulfonyl]benzenamine Benzenamine, 3-[[4-[(2,3-dihydro-1,4-benzodioxin-6-yl)sulfonyl]hexahydro-1H-1,4-diazepin-1-yl]sulfonyl]- | Cell biology reagent |
| 299 | 1228013-15-7 | CC-115 | CC115 CC 115 CC-115 CS-2038 CC-115(free base) 1-Ethyl-7-(2-methyl-6-(4h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-5-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one Pyrazino[2,3-b]pyrazin-2(1H)-one, 1-ethyl-3,4-dihydro-7-[2-methyl-6-(1H-1,2,4-triazol-5-yl)-3-pyridinyl]- | Cell biology reagent |
| 300 | 1232030-35-1 | FRAX486 | FRAX486 CS-1943 FRAX 486 FRAX-486 6-(2,4-Dichlorophenyl)-8-ethyl-2-[[3-fluoro-4-(1-piperazinyl)phenyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one 6-(2,4-dichlorophenyl)-8-ethyl-2-((3-fluoro-4-(piperazin-1-yl)phenyl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one Pyrido[2,3-d]pyriMidin-7(8H)-one, 6-(2,4-dichlorophenyl)-8-ethyl-2-[[3-fluoro-4-(1-piperazinyl)phenyl]aMino]- 6-(2,4-dichlorophenyl)-8-ethyl-2-{[3-fluoro-4-(1-piperazinyl)phen Yl]amino}pyrido[2,3-d]pyrimidin-7(8h)-one FRAX597 | inhibitors;Cell biology reagents |
| 301 | 1234480-46-6 | XMD8-87 | XMD8 87 CS-2588 XMD8-87 XMD-8-87 XMD 8 87 ACK1-B19 XMD8-87 (ACK1-B19) 2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)-11-methyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one 5,11-Dihydro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-11-methyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one 6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one, 5,11-dihydro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-11-methyl- | Cell biology reagent |
| 302 | 1238697-26-1 | TAK-063 | TAK063 CS-1534 TAK-063 TAK 063 Balipodect TAK-063(Balipodect) TAK063, TAK 063, TAK-063, BALIPODECT 1-[2-Fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one Pyridone 6[1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one] | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 303 | 1265965-22-7 | S49076 | S49076 CS-2684 S4 9076 S4-9076 2,4-Thiazolidinedione, 3-[[2,3-dihydro-3-[[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene]-2-oxo-1H-indol-5-yl]methyl]- | Cell biology reagent |
| 304 | 1286770-55-5 | Verubecestat | MK8931 MK8931 MK-8931 MK 8931 SCH900931 SCH-900931 SCH 900931 SCH900931 SCH-900931 SCH 900931 MK-8931-009 Verubecestat MK-8931-009 Verubecestat free base MK-8931 Trifluoroacetat VERUBECESTAT FREE BASE, | |
| 305 | 130495-35-1 | 1-(2-(4-methoxyphenyl)-2-(3-(4-methoxyphenyl)propoxy)ethyl)-1H-imidazole hydrochloride | SKF 96365 SKF-96365, HCl SK AND F 96365 SKF 96365 HYDROCHLORIDE SKF-96365 (hydrochloride) 1-[BETA-[3-(4-METHOXYPHENYL)PROPOXY]-4-METHOXYPHENETHYL]-1H-IMIDAZOLE HCL 1-[β-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenethyl]-1h-imidazole hydrochloride 1-(BETA-[3-(4-METHOXYPHENYL)PROPOXY]-4-METHOXYPHENETHYL)-1H-IMIDAZOLE HYDROCHLORIDE 1-(2-(4-methoxyphenyl)-2-(3-(4-methoxyphenyl)propoxy)ethyl)-1H-imidazole hydrochloride 1-[2-(4-METHOXYPHENYL)-2-[3-(4-METHOXYPHENYL)PROPOXY]ETHYL]-1H-IMIDAZOLE HYDROCHLORIDE | Signalling;Inhibitors;Calcium channel;Cell biology reagents |
| 306 | 1313363-54-0 | (S)-1-(4-chlorophenyl)-7-isopropoxy-6-methoxy-2-(4-(methyl(((1r,4S)-4-(4-methyl-3-oxopiperazin-1-yl)cyclohexyl)methyl)amino)phenyl)-1,2-dihydroisoquinolin-3(4H)-one | CGM097 CS-1248 CS-2423 CGM 097 CGM-097 NVP-CGM097 NVPCGM097 NVPCGM 097 NVPCGM-097 NVP-CGM097 (CGM097) (S)-1-(4-Chlorophenyl)-7-isopropoxy-6-methoxy-2-(4-[methyl[4-(4-methyl-3-oxopiperazin-1-yl)-trans-cyclohexylmethyl]amino]phenyl)-1,4-dihydro-2H-isoquinolin-3-one (S)-1-(4-Chlorophenyl)-7-isopropoxy-6-methoxy-2-(4-(methyl(((1r,4S)-4-(4-methyl-3-oxopiperazin-1-yl)cyclohexyl)methyl)amino)phenyl)-1,2-dihydroisoquinolin-3(4H)-one (S)-1-(4-chlorophenyl)-7-isopropoxy-6-methoxy-2-(4-(methyl(((1r,4S)-4-(4-methyl-3-oxopiperazin-1-yl)cyclohexyl)methyl)amino)phenyl)-1,2-dihydroisoquinolin-3(4H)-one | Cell biology reagents;Synthetic material intermediates |
| 307 | 1338545-07-5 | OTS-964 | OTS964 OTS-964 CS-2531 OTS 964 OTS964 HCl OTS964+OTS964 HCL OTS964+OTS964 HCl OTS964 HYDROCHLORIDE (R)-9-(4-(1-(dimethylamino)propan-2-yl)phenyl)-8-hydroxy-6-methylthieno[2,3-c]quinolin-4(5H)-one (R)-9-[4-[1-(Dimethylamino)propan-2-yl]phenyl]-8-hydroxy-6-methylthieno[2,3-c]quinolin-4(5H)-one Hydrochloride | API;Cell biology reagent |
| 308 | 134381-21-8 | Epoxomicin | BU-4061T Aids010837 EPOXOMICIN Epoxomicin Aids-010837 EPOXOMICIN, SYNTHETIC (2R)-2-[ACETYL-(N-METHYL-L-ISOLEUCYL)-L-ISOLEUCYL-L-THREONYL-L-LEUCYL]-2-METHYLOXIRANE n-acetyl-n-methyl-l-isoleucyl-l-isoleucyl-n-[(1s)-3-methyl-1-[[(2r)-2-methyloxiranyl]carbonyl]butyl]-l-threoninamide L-Threoninamide, N-acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]- | peptides;Inhibitors;ProteasomeInhibitors;Cell biology reagents;Antibody-secondary antibody;Pharmaceutical intermediates |
| 309 | 1345098-78-3 | XMD16-5 | CS-2587 XMD16-5 XMD 16 5 XMD-16-5 XMD 16-5 5,11-Dihydro-2-[[4-(4-hydroxy-1-piperidinyl)phenyl]amino]-11-methyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one 6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one, 5,11-dihydro-2-[[4-(4-hydroxy-1-piperidinyl)phenyl]amino]-11-methyl- | Cell biology reagent |
| 310 | 136553-81-6 | BQ-123 SODIUM SALT | BQ-123 BQ-123 SODIUM SALT ETA-RECEPTOR ANTAGONIST C(DTRP-DASP-PRO-DVAL-LEU) cyclo(Trp-Asp-Pro-Val-Leu) CYCLO(D-ASP-PRO-D-VAL-LEU-D-TRP) CYCLO (D-ALPHA-ASPARTYL-L-PROLYL-D-VALYL-L-LEUCYL-D-TRYPTOPHYL) | Antagonists;Endothelins;Custom polypeptide;Endothelin receptor;Reference substance;Peptides for Cell Biology;Peptides for Cell Biology |
| 311 | 141400-58-0 | PX-12 | PX-12 PX 12 IV-2) CS-2384 PX-12 (PX12 2-(sec-Butyldisulfanyl)-1H-iMidazole 2-[(1-Methylpropyl)dithio]-1H-imidazole 1H-Imidazole, 2-[(1-methylpropyl)dithio]- | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 312 | 1415560-69-8 | Crizotinib (hydrochloride) | PF-2341066 HYDROCHLORIDE PF-02341066 hydrochloride PF-2341066 hydrochloride) PF 02341066 hydrochloride PF-02341066 HYDROCHLORIDE Crizotinib (hydrochloride) Crizotinib HCl,PF-02341066 HCl Crizotinib hydrochloride (PF-02341066 hydrochloride 3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamine hydrochloride | MET;Inhibitors;Reference substance;Cell biology reagents;Anti-tumor and immunosuppressive agents |
| 313 | 1419949-20-4 | NVP-TNKS656 | TNKS656 CS-1333 TNKS 656 TNKS-656 NVP-TNKS656 NVP-TNKS656 - TNKS 656 1-Piperidineacetamide, N-(cyclopropylmethyl)-4-(4-methoxybenzoyl)-N-[(3,5,7,8-tetrahydro-4-oxo-4H-pyrano[4,3-d]pyrimidin-2-yl)methyl]- N-(cyclopropylmethyl)-2-(4-(4-methoxybenzoyl)piperidin-1-yl)-N-((4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrimidin-2-yl)methyl)acetamide N-(cyclopropylmethyl)-2-(4-(4-methoxybenzoyl)piperidin-1-yl)-N-((4-oxo-4,5,7,8-tetrahydro-3H-pyrano[4,3-d]pyrimidin-2-yl)methyl)acetamide | Cell biology reagent |
| 314 | 1429639-50-8 | CZ415 | CZ415 CZ 415 CZ-415 CS-2392 CZ415 (Free base) (S)-1-(4-(7,7-dimethyl-4-(3-methylmorpholino)-6,6-dioxido-5,7-dihydrothieno[3,4-d]pyrimidin-2-yl)phenyl)-3-ethylurea Urea, N-[4-[5,7-dihydro-7,7-dimethyl-4-[(3S)-3-methyl-4-morpholinyl]-6,6-dioxidothieno[3,4-d]pyrimidin-2-yl]phenyl]-N'-ethyl- | inhibitors;Cell biology reagents |
| 315 | 1439399-58-2 | CB-839 | CB839 CB-839 CB 839 CPD1593 CB-839,TELAGLENASTAT N-[5-[4-[6-[[2-[3-(trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-2-pyridineacetamide 2-(pyridin-2-yl)-N-(5-(4-(6-(2-(3-(trifluoromethoxy)phenyl)acetamido)pyridazin-3-yl)butyl)-1,3,4-thiadiazol-2-yl)acetamide 2-(pyridin-2-yl)-N-(5-(4-(6-(2-(3-(trifluoromethoxy)phenyl)acetamido)pyridazin-3-yl)butyl)-1,3,4-thiadiazol-2-yl)acetamide CB-839 | Raw drug;Biochemical reagent;Cell biology reagent;Medical reference substance |
| 316 | 1453848-26-4 | GDC-0994 | CS-1841 GDC0994 GDC-0994 GDC 0994 EOS-60648 Ravoxertinib (S)-1-(1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one 1-[(1S)-1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl]-4-[2-[(1-methyl-1H-pyrazol-5-yl)amino]-4-pyrimidinyl]-2(1H)-pyridinone (S)-1-(1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one GDC-0994 | Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 317 | 1469924-27-3 | Atglistatin | CS-1024 ATGLISTATIN Atglistatin 3-(4'-(DIMETHYLAMINO)BIPHENYL-3-YL)-1,1-DIMETHYLUREA N'-[4'-(Dimethylamino)[1,1'-biphenyl]-3-yl]-N,N-dimethylurea 3-(4'-(dimethylamino)-[1,1'-biphenyl]-3-yl)-1,1-dimethylurea Atglistatin N'-[4'-(Dimethylamino)[1,1'-biphenyl]-3-yl]-N,N-dimethylurea N'-[4'-(Dimethylamino)[1,1'-biphenyl]-3-yl]-N,N-dimethylurea Atglistatin N'-[4'-(Dimethylamino)[1,1'-biphenyl]-3-yl]-N,N-dimethylurea Atglistatin Atglistatin N'-[4'-(Dimethylamino)[1,1'-biphenyl]-3-yl]-N,N-dimethylurea | Inhibitors |
| 318 | 1515856-92-4 | XEN445 | XEN445 CS-1251 XEN 445 XEN-445 (S)-2-(3-(pyridin-2-ylmethoxy)pyrrolidin-1-yl)-5-(trifluoromethyl)benzoic acid 2-[(3S)-3-(pyridin-2-ylmethoxy)pyrrolidin-1-yl]-5-(trifluoromethyl)benzoic acid (S)-2-(3-(PYRIDIN-2-YLMETHOXY)PYRROLIDIN-1-YL)-5-(TRIFLUOROMETHYL)BENZOIC ACID. HCL 2-[(3S)-3-(2-Pyridinylmethoxy)-1-pyrrolidinyl]-5-(trifluoromethyl)benzoic acid XEN445 XEN445 2-[(3S)-3-(2-Pyridinylmethoxy)-1-pyrrolidinyl]-5-(trifluoromethyl)benzoic acid | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 319 | 157654-67-6 | NSC 632839 | NSC-632839 NSC 632839 NSC632839 HCl NSC632839hydrochloride Ubiquitin Isopeptidase Inhibitor II Ubiquitin Isopeptidase Inhibitor II, F6 3,5-Bis[(4-methylphenyl)methylene]-4-piperidonehydrochloride 4-Piperidione,3,5-bis[(4-methylphenyl)methylene] hydrochloride | Cell biology reagent;Traditional Chinese medicine reference substance |
| 320 | 159182-43-1 | 4-[[(HEXYLAMINO)CARBONYL]AMINO]-N-[4-[2-[[(2S)-2-HYDROXY-3-(4-HYDROXYPHENOXY)PROPYL]AMINO]ETHYL]PHENYL]-BENZENESULFONAMIDE | 507 L755 L 755 CS-2258 L755,507 L-755507 L-755,507 (S)-4-(3-Hexylureido)-N-(4-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)phenyl)benzenesulfonamide 4-[[(HEXYLAMINO)CARBONYL]AMINO]-N-[4-[2-[[(2S)-2-HYDROXY-3-(4-HYDROXYPHENOXY)PROPYL]AMINO]ETHYL]PHENYL]-BENZENESULFONAMIDE | Adrenoceptor;Cell biology reagent |
| 321 | 1604810-83-4 | THZ1 | THZ1 THZ-1 THZ 1 CDK7 INHIBITOR THZ1 HY-80013 GTPL8052 SCHEMBL14979765 (E)-N-(3-((5-Chloro-4-(1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)-4-(4-(dimethylamino)but-2-en (E)-N-(3-((5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)-4-(4-(dimethylamino)but-2-enamido)benzamide (E)-N-(3-((5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)-4-(4-(dimethylamino)but-2-enamido)benzamide THZ1 N-[3-[[5-Chloro-4-(1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]benzamide Benzamide, N-[3-[[5-chloro-4-(1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]- | API;Inhibitor;Cell biology reagent |
| 322 | 1609960-30-6 | TH287 | TH287 TH-287 CS-1671 TH287 hydrochloride 6-(2,3-dichlorophenyl)-N4-methylpyrimidine-2,4-diamine 6-(2,3-Dichlorophenyl)-N4-methyl-2,4-pyrimidinediamine 6-(2,3-Dichlorophenyl)-N4-methylpyrimidine-2,4-diamine hydrochloride | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 323 | 1609960-31-7 | TH588 | TH588 TH 588 TH-588 CS-1701 TH588(TH-588) 6-(2,3-dichlorophenyl)-N4-cyclopropylpyrimidine-2,4-diamine N4-Cyclopropyl-6-(2,3-dichlorophenyl)-2,4-pyrimidinediamine N4-cyclopropyl-6-(2,3-dichlorophenyl)pyrimidine-2,4-diamine | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 324 | 1624602-30-7 | VR23 | VR23 CS-1579 VR23(VR-23) 7-Chloro-4-[4-[(2,4-dinitrophenyl)sulfonyl]-1-piperazinyl]quinoline 7-chloro-4-(4-((2,4-dinitrophenyl)sulfonyl)piperazin-1-yl)quinoline Quinoline, 7-chloro-4-[4-[(2,4-dinitrophenyl)sulfonyl]-1-piperazinyl]- | |
| 325 | 1627494-13-6 | AZD8186 | AZD8186 CS-1576 AZD-8186 AZD 8186 8-(1-((3,5-difluorophenyl)amino)ethyl)-N,N-dimethyl-2-morpholino-4-oxo-4H-chromene-6-carboxamide (R)-8-(1-(3,5-difluorophenylamino)ethyl)-N,N-dimethyl-2-morpholino-4-oxo-4H-chromene-6-carboxamide 8-[(1R)-1-[(3,5-Difluorophenyl)amino]ethyl]-N,N-dimethyl-2-(4-morpholinyl)-4-oxo-4H-1-benzopyran-6-carboxamide | cell biology reagents;Small molecule inhibitors |
| 326 | 1627709-94-7 | LJI308 | LJI308 CS-2181 LJI 308 LJI-308 2,6-Difluoro-4-[4-[4-(4-morpholinyl)phenyl]-3-pyridinyl]phenol Phenol, 2,6-difluoro-4-[4-[4-(4-morpholinyl)phenyl]-3-pyridinyl]- | inhibitors;Cell biology reagents |
| 327 | 1639042-08-2 | AZD9496 | AZD9496 CS-2107 AZD 9496 AZD-9496 (E)-3-[3,5-Difluoro-4-[(1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl]phenyl]acrylic acid 3-[3,5-Difluoro-4-[(1r,3r)-2-(2-fluoro-2-methylpropyl)-2,3,4,9-tetrahydro-3-methyl-1h-pyrido[3,4-b]indol-1-yl]phenyl]-2-propenoic acid 2-Propenoic acid, 3-[3,5-difluoro-4-[(1R,3R)-2-(2-fluoro-2-methylpropyl)-2,3,4,9-tetrahydro-3-methyl-1H-pyrido[3,4-b]indol-1-yl]phenyl]-, (2E)- | API;Inhibitors;Small molecule inhibitors |
| 328 | 1668553-26-1 | Abbvie Mcl-1 Inhibitor | CS-2151 CS-2202 A1210477 A-1210477 A 1210477 Abbvie Mcl-1 Inhibitor BIIB-024, TAK580, AMG-2112819, BSK1369, DAY-101 7-(5-((4-(4-(N,N-dimethylsulfamoyl)piperazin-1-yl)phenoxy)methyl)-1,3-dimethyl-1H-pyrazol-4-yl)-1-(2-morpholinoethyl)-3-(3-(naphthalen-1-yloxy)propyl)-1H-indole-2-carboxylic acid 7-[5-[[4-[4-[(Dimethylamino)sulfonyl]-1-piperazinyl]phenoxy]methyl]-1,3-dimethyl-1H-pyrazol-4-yl]-1-[2-(4-morpholinyl)ethyl]-3-[3-(1-naphthalenyloxy)propyl]-1H-indole-2-carboxylic acid 1H-Indole-2-carboxylic acid, 7-[5-[[4-[4-[(dimethylamino)sulfonyl]-1-piperazinyl]phenoxy]methyl]-1,3-dimethyl-1H-pyrazol-4-yl]-1-[2-(4-morpholinyl)ethyl]-3-[3-(1-naphthalenyloxy)propyl]- | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 329 | 1675201-83-8 | PD1-PDL1 inhibitor 1 | PD-L1 T3655 avelumab PD-1PD-L1 inhibitor PD1-PDL1 inhibitor 1 (2S)-1-{2,6-Dimethoxy-4-[(2-methyl-3-biphenylyl)methoxy]benzyl}-2-piperidinecarboxylic acid (2S)-1-[[2,6-Dimethoxy-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-2-piperidinecarboxylic acid 2-Piperidinecarboxylic acid, 1-[[2,6-dimethoxy-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-, (2S)- | Inhibitors;APIs and intermediates |
| 330 | 1675203-84-5 | BMS-202 | BMS-202 BMS-203 PD1 inhibitor 2 PD 1 inhibitor 2 PD-1 inhibitor 2 PD-L1 inhibitor 1 PD1-PDL1 inhibitor 2 N-[2-[[[2-Methoxy-6-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]-3-pyridinyl]methyl]amino]ethyl]acetamide Acetamide, N-[2-[[[2-methoxy-6-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]-3-pyridinyl]methyl]amino]ethyl]- | Biochemical reagents;Chemical raw materials |
| 331 | 170787-99-2 | Efaproxiral sodium | RSR-13 Rsr 13 sodium Unii-3L83qp52xi Efaproxiral sodium EFAPROXIRAL SODIUM 2-[4-[2-(3,5-Dimethylphenylamino)-2-oxoethyl]phenoxy]-2-methylpropionic acid Sodium 2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxoethyl]phenoxy]-2-methylpropanoate 2-(4-(2-((3,5-Dimethylphenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoic acid monosodium salt Propanoic acid, 2-(4-(2-((3,5-dimethylphenyl)amino)-2-oxoethyl)phenoxy)-2-methyl-, monosodium salt | Inhibitors;Small molecule inhibitors, natural products |
| 332 | 176957-55-4 | CCT007093 | CCTOO7093 CCT007093 2,5-Bis(2-thienylmethylene)-cyclopentanone (2E,5E)-2,5-Bis(2-thienylmethylene)cyclopentanone 2,5-bis(2-thienylMethylene)-, (E,E)-Cyclopentanone Cyclopentanone, 2,5-bis(2-thienylMethylene)-, (E,E)- (2E,5E)-2,5-Bis(thiophen-2-ylmethylene)cyclopentanone (2E,5E)-2,5-Bis(2-thienylmethylene)cyclopentanone CCT007093 | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 333 | 1799753-84-6 | BAY-876 | CS-2442 BAY-876 N4-(1-(4-cyanobenzyl)-5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)-7-fluoroquinoline-2,4-dicarboxamide N4-[1-[(4-cyanophenyl)methyl]-5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-fluoro-2,4-Quinolinedicarboxamide 2,4-Quinolinedicarboxamide, N4-[1-[(4-cyanophenyl)methyl]-5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-fluoro- | Cell biology reagent |
| 334 | 1802088-50-1 | NCT-501 | NCT-501 CS-2069 1H-Purine-2,6-dione, 8-[[4-(cyclopropylcarbonyl)-1-piperazinyl]methyl]-3,7-dihydro-1,3-dimethyl-7-(3-methylbutyl)- | Cell biology reagent |
| 335 | 187235-37-6 | (S)-PA 824 | PA 824 EOS-60675 (S)-PA 824 (S)-PA 824 (PRETOMANID) (S)-6-(4-(trifluoromethoxy)benzyloxy)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (S)-6,7-Dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-5H-imidazo[2,1-b][1,3]oxazine (6S)-6,7-Dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-5H-imidazo[2,1-b][1,3]oxazine 5H-IMidazo[2,1-b][1,3]oxazine, 6,7-dihydro-2-nitro-6-[[4-(trifluoroMethoxy)phenyl]Methoxy]-, (6S)- (6S)-6,7-Dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-5H-imidazo[2,1-b][1,3]oxazine PA-824 | Heteroc;Aromatics;Inhibitors;Heterocycles;Raw materials;Pharmaceuticals;Medical raw materials;Pharmaceutical bulk drugs;Pharmaceutical raw materials;Intermediates & Fine Chemicals |
| 336 | 1884220-36-3 | SBI-0206965 | CS-1581 SBI0206965 SBI-0206965 SBI 0206965 SBI-0206965 SBI 0206965. 2-((5-Bromo-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)oxy)-N-methylbenzamide Benzamide, 2-[[5-bromo-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]oxy]-N-methyl- | Standards;Inhibitors;Bioactive molecules;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 337 | 1956356-56-1 | KYA1797K | CS-2581 KYA1797K (5Z)-5-[[5-(4-Nitrophenyl)-2-furanyl]methylene]-4-oxo-2-thioxo-3-thiazolidinepropanoic acid potassium salt | Reference substance |
| 338 | 200626-61-5 | Benzotriazol-1-yl-(2,4-Dichloro-Phenyl)-Methanone | ITSA-1 CS-2249 ITSA-1(ITSA1) IFLAB-BB F0451-3184 1-(2,4-Dichlorobenzoyl)-1H-benzotriazole 1-(2,4-DICHLOROBENZOYL)-1H-BENZOTRIAZOLE Benzotriazol-1-yl-(2,4-Dichloro-Phenyl)-Methanone BENZOTRIAZOL-1-YL-(2,4-DICHLORO-PHENYL)-METHANONE Methanone, 1H-benzotriazol-1-yl(2,4-dichlorophenyl)- (1H-Benzo[d][1,2,3]triazol-1-yl)(2,4-dichlorophenyl)methanone | Standard;Active small sub-library |
| 339 | 215543-92-3 | SU 5402 | SU5402 SU 5402 PF-02969207 2-[(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)Methyl]-4-Methyl- 3-[3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-METHYLIDENYL]-2-INDOLINONE 3-[4-METHYL-2-[(2-OXO-1H-INDOL-3-YLIDENE)METHYL]-1H-PYRROL-3-YL]PROPANOIC ACID 3-[4-Methyl-2-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-yl]-propionic acid 2-[(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-4-methyl-1H-pyrrole-3-propanoic acid 3-[3-(2-Carboxyethyl)-4-methylpyrrol-2-methylidenyl]-2-indolinone | Inhibitors;Heterocycles;Pharmaceuticals;Cell biology reagents;Angiogenesis and Metastasis;Intermediates & Fine Chemicals |
| 340 | 218156-96-8 | SRPIN340 | SRPIN340 SRPIN-340 SRPIN 340 SRPKINHIBITOR SRPK inhibitor N-(2-(piperidin-1-yl)-5-(trifluoroMethyl)phenyl)isonicotinaMide 4-Pyridinecarboxamide, N-[2-(1-piperidinyl)-5-(trifluoromethyl)phenyl]- N-[2-(1-Piperidinyl)-5-(trifluoromethyl)phenyl]-4-pyridinecarboxamide SRPIN 340 SRPK inhibitor N-[2-(1-Piperidinyl)-5-(trifluoromethyl)phenyl]-4-pyridinecarboxamide | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 341 | 218924-25-5 | KNK437 | KNK437 KNK423 HEAT SHOCK PROTEIN INHIBITOR I HEAT SHOCK PROTEIN INHIBITOR II 3,4-METHYLENEDIOXY-BENZYLIDINE-GAMMA-BUTYROLACTAM N-FORMYL-3,4-METHYLENEDIOXY-BENZYLIDINE-GAMMA-BUTYROLACTAM 3-(1,3-Benzodioxol-5-ylmethylene)-2-oxo-1-pyrrolidinecarboxaldehyde | API;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 342 | 222638-67-7 | S-(2-boronoethyl)-L-cysteine hydrochloride | BEC HCl BEC hydrochloride S-(2-BORONOETHYL)-L-CYSTEINE HYDROCHLORIDE S-(2-boronoethyl)-L-cysteine hydrochloride BEC hydrochloride - S-(2-Boronoethyl)-L-cysteine hydrochloride (R)-2-amino-3-((2-boronoethyl)thio)propanoic acid hydrochloride | |
| 343 | 223104-29-8 | SEA0400 | CS-1043 SEA0400 SEA 0400 SEA-0400 SEA-0400 2-(4-((2,5-DIFLUOROBENZYL)OXY)PHENOXY)-5-ETHOXYANILINE 2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline 2-[4-[(2,5-Difluorophenyl)methoxy]phenoxy]-5-ethoxybenzenamine BenzenaMine, 2-[4-[(2,5-difluorophenyl)Methoxy]phenoxy]-5-ethoxy- | Inhibitor;Cell biology reagent;Membrane transport/ion channel |
| 344 | 293754-55-9 | T0901317 | T 1317 T0901317 T 0901317 TO-901317 T-0901317 S 055746,BCL201 N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl] N-(2,2,2-TRIFLUOROETHYL)-N-[4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL]BENZENESULFONAMIDE BenzenesulfonaMide, N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoroMethyl)ethyl]phenyl]- | Standards;Inhibitors;Biochemical reagents;Cell biology reagents;PPAR and RXR Regulators;PPAR and RXR Regulators;Gene Regulation and Expression;Cell Signaling and Neuroscience;Gene Regulation and |
| 345 | 300586-90-7 | OAC1 | OAC1 OAC-1 OAC 1 BAS 00287861 iPSC Induction Enhancer II, OAC1 N-1H-Pyrrolo[2,3-c]pyridin-5-ylbenzamide N-(1H-pyrrolo[3,2-d]pyridin-5-yl)benzamide BenzaMide, N-1H-pyrrolo[2,3-c]pyridin-5-yl- | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 346 | 301353-96-8 | 1-(3,6-Dibromo-carbazol-9-yl)-3-phenylamino-propan-2-ol | P7C3 CS-1463 301353-96-8 1-(3,6-Dibromo-carbazol-9-yl)-3-phenylamino-propan-2-ol 6-Dibromo-α-[(phenylamino)methyl]-9H-carbazole-9-ethanol 3,6-Dibromo-a-[(phenylamino)methyl]-9H-carbazole-9-ethanol 1-(3,6-DIBROMO-9H-CARBAZOL-9-YL)-3-(PHENYLAMINO)PROPAN-2-OL | API;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 347 | 305834-79-1 | 2-Amino-6-chloro-α-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic Acid Ethyl Ester | SC79 SC97 SC 79 Akt Activator II AKT ACTIVATOR II Akt Activator II, SC79 2-AMino-6-chloro-α-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic Acid Ethyl Ester 2-Amino-6-chloro-α-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic Acid Ethyl Ester 4H-1-Benzopyran-4-acetic acid, 2-amino-6-chloro-α-cyano-3-(ethoxycarbonyl)-, ethyl ester 2-Amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 348 | 315704-66-6 | PTC-209 | PTC-209 PTC-209 (PTC209 PTC-209 free base N-(2,6-Dibromo-4-methoxyphenyl)-4-(2-methylimidazo[1,2-a]pyrimidin-3-yl)-2-thiazolamine N-(2,6-dibroMo-4-Methoxyphenyl)-4-(2-MethyliMidazo[1,2-a]pyriMidin-3-yl)thiazol-2-aMine 2-THIAZOLAMINE, N-(2,6-DIBROMO-4-METHOXYPHENYL)-4-(2-METHYLIMIDAZO[1,2-A]PYRIMIDIN-3-YL)- N-(2,6-Dibromo-4-methoxyphenyl)-4-(2-methylimidazo[1,2-a]pyrimidin-3-yl)-2-thiazolamine PTC-209 | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 349 | 315706-13-9 | 4EGI-1 | 4EGI-1 α-[2-[4-(3,4-Dichlorophenyl)-2-thiazolyl]hydrazinylidene]-2-nitro-benzenepropanoic acid 2-((4-(3,4-Dichlorophenyl)thiazol-2(3H)-ylidene)hydrazono)-3-(2-nitrophenyl)propanoic acid alpha-[2-[4-(3,4-Dichlorophenyl)-2-thiazolyl]hydrazinylidene]-2-nitrobenzenepropanoic acid 2-[[4-(3,4-dichlorophenyl)-4,5-dihydro-1,3-thiazol-2-yl]hydrazinylidene]-3-[2-(dihydroxyamino)phenyl]propanoic acid | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 350 | 328541-79-3 | N-2-Naphthalenyl-glycine 2-[(3,5-Dibromo-2,4-dihydroxyphenyl)methylene]hydrazide | GLYH 101 GLYH-101 GlyH-101 CFTR Inhibitor II, GlyH-101 N-2-Naphthalenylglycine [(3,5-dibromo-2,4-dihydroxyphenyl)methylene]hydrazide N-2-Naphthalenyl-glycine 2-[(3,5-Dibromo-2,4-dihydroxyphenyl)methylene]hydrazide N-2-Naphthalenyl-glycine 2-[(3,5-dibromo-2,4-dihydroxyphenyl)methylene]hydrazide Glycine, N-2-naphthalenyl-, [(3,5-dibroMo-2,4-dihydroxyphenyl)Methylene]hydrazide (NAPHTHALEN-2-YLAMINO)-ACETIC ACID (3,5-DIBROMO-2,4-DIHYDROXY-BENZYLIDENE)-HYDRAZIDE GlyH 101 N-2-Naphthalenylglycine [(3,5-dibromo-2,4-dihydroxyphenyl)methylene]hydrazide N-2-Naphthalenylglycine [(3,5-dibromo-2,4-dihydroxyphenyl)methylene]hydrazide CFTR Inhibitor II | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products;CFTR Inhibitor II, GlyH-101 is a cell-permeable glycinyl hydrazone compound.;CFTR Inhibitor II, GlyH-101 is a cell-perm |
| 351 | 328998-25-0 | (E)-4-(3-((5-(4-Nitrophenyl)furan-2-yl)methylene)-2-oxo-5-phenyl-2,3-dihydro-1H-pyrrol-1-yl)benzoic | CS-1228 4E1RCat 4E1RCAT 4-[(3E)-3-[[5-(4-nitrophenyl)furan-2-yl]methylidene]-2-oxo-5-phenylpyrrol-1-yl]benzoic acid (E)-4-(3-((5-(4-Nitrophenyl)furan-2-yl)methylene)-2-oxo-5-phenyl-2,3-dihydro-1H-pyrrol-1-yl)benzoic 4-[2,3-Dihydro-3-[[5-(4-nitrophenyl)-2-furanyl]methylene]-2-oxo-5-phenyl-1H-pyrrol-1-yl]benzoic acid Benzoic acid, 4-[2,3-dihydro-3-[[5-(4-nitrophenyl)-2-furanyl]Methylene]-2-oxo-5-phenyl-1H-pyrrol-1-yl]- 4-[(3E)-3-[[5-(4-Nitrophenyl)furan-2-yl]methylidene]-2-oxo-5-phenyl-2,3-dihydro-1H-pyrrol-1-yl]benzoic acid | Medicine;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 352 | 342639-96-7 | KRIBB11 | CS-2403 KRIBB11 KRIBB-11 KRIBB 11 N2-1H-Indazol-5-yl-N6-methyl-3-nitro-2,6-pyridinediamine 2,6-Pyridinediamine, N2-1H-indazol-5-yl-N6-methyl-3-nitro- N2-(1H-Indazol-5-yl)-N6-methyl-3-nitropyridine-2,6-diamine | Standard;Inhibitors;Cell biology reagents |
| 353 | 345630-40-2 | SF1670 | SF1670 SF-1670 SF 1670 PTP CD45 Inhibitor SF1670(PTENINHIBITOR) SF1670(PTENinhibitor) 6-PHENYL-2-(2-PYRAZINYL)-4(1H)-PYRIMIDINONE N-(9,10-Dioxo-9,10-dihydro-2-phenanthrenyl)-2,2-diMethylpropanaMide N-(9,10-dihydro-9,10-dioxo-2-phenanthrenyl)-2,2-dimethyl-propanamide | Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 354 | 348086-71-5 | BAY 57-1293 | AIC316 Pritelivir PRITELIVIR BAY 57-1293 BAY-57-1293 BAY571293(Pritelivir) 2-METHYL-2-PROPANYL [4-(CHLOROSULFONYL)PHENYL]CARBAMATE Benzeneacetamide, N-[5-(aminosulfonyl)-4-methyl-2-thiazolyl]-N-methyl-4-(2-pyridinyl)- N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide BAY57-1293 Pritelivir | Inhibitors;Small molecule inhibitors;Scientific research active molecules;Small molecule inhibitors, natural products |
| 355 | 349085-38-7 | HC-030031 | HC030031 HC-030031 HC 030031 2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide 2-(1,3-dimethyl-2,6-dioxo-2,3-dihydro-1H-purin-7(6H)-yl)-N-(4-isopropylphenyl)acetamide 2-(1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL)-N-(4-ISOPROPYLPHENYL)ACETAMIDE 1,2,3,6-Tetrahydro-1,3-diMethyl-N-[4-(1-Methylethyl)phenyl]-2,6-dioxo-7H-purine-7-acetaMide 7H-Purine-7-acetamide, 1,2,3,6-tetrahydro-1,3-dimethyl-N-[4-(1-methylethyl)phenyl]-2,6-dioxo- | Amines;Aromatics;Inhibitors;Heterocycles;Pharmaceuticals;Intermediates & Fine Chemicals;Small molecule inhibitors, natural products |
| 356 | 431898-65-6 | N-(6-CHLORO-9H-PYRIDO[3,4-B]INDOL-8-YL)-3-PYRIDINECARBOXAMIDE DIHYDROCHLORIDE | PS1145 PS-1145 CS-2600 PS 1145 IKK Inhibitor X PS-1145 DIHYDROCHLORIDE N-(6-chloro-9H-pyrido[3,4-b]indol-8-yl)pyridine-3-carboxamide 3-Pyridinecarboxamide, N-(6-chloro-9H-pyrido[3,4-b]indol-8-yl)- N-(6-CHLORO-9H-PYRIDO[3,4-B]INDOL-8-YL)-3-PYRIDINECARBOXAMIDE DIHYDROCHLORIDE | Cell biology reagents;A cell-permeable β-carboline compound that displays anti-inflammatory properties.;A cell-permeable beta-carbon compound that displays anti-inflammatory properties. |
| 357 | 459147-39-8 | SW033291 | CS-1608 SW033291 SW033291(SW-033291) 2-butylsulfinyl-4-phenyl-6-thiophen-2-ylthieno[5,4-b]pyridin-3-amine 2-(Butylsulfinyl)-4-phenyl-6-(2-thienyl)thieno[2,3-b]pyridin-3-amine Thieno[2,3-b]pyridin-3-amine, 2-(butylsulfinyl)-4-phenyl-6-(2-thienyl)- 4-phenyl-6-(thiophen-2-yl)-2-thioxo-1,2- dihydropyridine-3-carbonitrile 2-(butylsulfinyl)-4-phenyl-6-(thiophen-2-yl)thieno[2,3-b]pyridin-3-amine | API;Inhibitors;Dominant products-d;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 358 | 472981-92-3 | (E)-3-(4-chlorophenyl)-N-(3-methoxyphenyl)acrylamide | SB366791 SB 366791 4'-CHLORO-3-METHOXYCINNAMANILIDE N-(3-METHOXYPHENYL)-4-CHLOROCINNAMIDE N-(4-Methoxyphenyl)-4-chlorocinnamamide (E)-3-(4-CHLOROPHENYL)-N-(3-METHOXYPHENYL)ACRYLAMIDE 3-(4-Chlorophenyl)-N-(3-methoxyphenyl)-2-propenamide (E)-3-(4-chlorophenyl)-N-(3-methoxyphenyl)acrylamide 2-Propenamide,3-(4-chlorophenyl)-N-(3-methoxyphenyl)- | API;Cell biology reagents;Vanilloid/TRPV channel;Other biochemical reagents |
| 359 | 49671-76-3 | ZLN005 | ZLN005 ZLN-005 2-(4-tert-Butylphenyl)benzimidazole 2-(4-tert-Butylphenyl)-1H-benzimidazole 2-(4-TERT-BUTYLPHENYL)-1H-BENZO[D]IMIDAZOLE 2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazole 2-(4-tert-Butylphenyl)benzimidazole ZLN005 ZLN005 2-(4-tert-Butylphenyl)benzimidazole | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 360 | 52029-86-4 | 7-Oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic Acid | STO609 STO-609 STO 609 STO-609 ACETATE STO-609 free base STO-609 ACETIC ACID 7-Oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic Acid 7-OXO-7H-BENZIMIDAZO[2,1-A]BENZ[DE]ISOQUINOLINE-3-CARBOXYLIC ACID ACETATE 7-Oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic acid - acetic acid | Protein Kinase |
| 361 | 521937-07-5 | 3-Hydroxy-5,6,7,8-tetrahydro-10-oxa-8-aza-benzo[a]azulen-9-one | CID755673 CID 755673 PKD Inhibitor, CID755673 7-hydroxy-2,3,4,5-tetrahydro-[1]benzofuro[2,3-c]azepin-1-one 2,3,4,5-Tetrahydro-7-hydroxy-1H-benzofuro[2,3-c]azepin-1-one 7-Hydroxy-2,3,4,5-tetrahydro-1H-benzofuro[2,3-c]azepin-1-one 3-Hydroxy-5,6,7,8-tetrahydro-10-oxa-8-aza-benzo[a]azulen-9-one CID 755673 2,3,4,5-Tetrahydro-7-hydroxy-1H-benzofuro[2,3-c]azepin-1-one | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products;Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals |
| 362 | 75350-46-8 | Fluorescein-5-Maleimide | Fluorescein-5-Maleimide 5-Maleimido-fluorescein N-(5-Fluoresceinyl)maleimide 5-MF [Fluorescein-5-MaleiMide] 1-(3',6'-Dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthen]-5-yl)-1H-pyrrole-2,5-dione 1-(3',6'-Dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5-yl)-1H-pyrrole-2,5-dione | Biochemical reagents |
| 363 | 803647-40-7 | NSC59984 | CS-2317 NCI59984 NSC59984 NSC 59984 NSC-59984 NSC59984,NCI59984 1-(4-Methyl-1-piperazinyl)-3-(5-nitro-2-furanyl)-2-propen-1-one | Inhibitor |
| 364 | 81624-55-7 | NSC348884 | CS-2168 NSC348884 NSC 348884 NSC-348884 N1,N1,N2,N2-Tetrakis[(6-methyl-1H-benzimidazol-2-yl)methyl]-1,2-ethanediamine 1,2-Ethanediamine, N1,N1,N2,N2-tetrakis[(6-methyl-1H-benzimidazol-2-yl)methyl]- 1,2-EthanediaMine, N,N,N',N'-tetrakis[(5-Methyl-1H-benziMidazol-2-yl)Methyl]- (9CI) | Inhibitors;Cell biology reagents;Raw materials and intermediates |
| 365 | 839706-07-9 | BenzaMide, N-[3-[1,4-dihydro-1-Methyl-7-[(6-Methyl-3-pyridinyl)aMino]-2-oxopyriMido[4,5-d]pyriMidin-3(2H)-yl]-4-Methylphenyl]-3-(trifluoroMethyl)- | GNF-7 CS-1945 BenzaMide, N-[3-[1,4-dihy... N-[4-methyl-3-[1-methyl-7-[(6-methylpyridin-3-yl)amino]-2-oxo-4H-pyrimido[4,5-d]pyrimidin-3-yl]phenyl]-3-(trifluoromethyl)benzamide N-[3-[1,4-Dihydro-1-methyl-7-[(6-methyl-3-pyridinyl)amino]-2-oxopyrimido[4,5-d]pyrimidin-3(2H)-yl]-4-methylphenyl]-3-(trifluoromethyl)benzamide N-(4-Methyl-3-(1-methyl-7-((6-methylpyridin-3-yl)amino)-2-oxo-1,2-dihydropyrimido[4,5-d]pyrimidin-3(4H)-yl)phenyl)-3-(trifluoromethyl)benzamide BenzaMide, N-[3-[1,4-dihydro-1-Methyl-7-[(6-Methyl-3-pyridinyl)aMino]-2-oxopyriMido[4,5-d]pyriMidin-3(2H)-yl]-4-Methylphenyl]-3-(trifluoroMethyl)- | Standard;Inhibitors;Biochemical reagents;Cell biology reagents;Small molecule inhibitors |
| 366 | 853220-52-7 | BML-284 | AMBMP BML-284 Wnt Agonist Wnt agonist 1 Wnt agonist 1 (BML-284) CID 11210285 hydrochloride N4-(1,3-benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)-2,4-pyrimidinediamine hydrochloride 2-Amino-4-(3,4-(methylenedioxy)benzylamino)-6-(3-methoxyphenyl)pyrimidine hydrochloride | Cell biology reagent |
| 367 | 854107-55-4 | (2Z,5Z)-5-(3-chloro-4-((R)-2,3-dihydroxypropoxy)benzylidene)-2-(propyliMino)-3-(o-tolyl)thiazolidin-4-one | CS-2110 PONESIMOD PonesiMod ACT 128800 PONESIMOD,ACT-128800 Ponesimod ( ACT-128800) (2Z,5Z)-5-(3-chloro-4-((R)-2,3-dihydroxypropoxy)benzylidene)-2-(propyliMino)-3-(o-tolyl)thiazolidin-4-one 5-[3-Chloro-4-[((2R)-2,3-dihydroxypropyl)oxy]benz-(Z)-ylidene]-2-((Z)-propylimino)-3-(o-tolyl)thiazolidin-4-one (5Z)-5-[[3-chloro-4-[(2R)-2,3-dihydroxypropoxy]phenyl]methylidene]-3-(2-methylphenyl)-2-propylimino-1,3-thiazolidin-4-one 4-Thiazolidinone, 5-[[3-chloro-4-[(2R)-2,3-dihydroxypropoxy]phenyl]Methylene]-3-(2-Methylphenyl)-2-(propyliMino)-, (2Z,5Z)- | Inhibitor |
| 368 | 875787-07-8 | 2H-Indazole, 2-[(2-chloro-4-fluorophenyl)Methyl]-3-(4-fluorophenyl)-7-(trifluoroMethyl)- | LXR623 WAY-252623 WAY 252623 LXR-623 (WAY-252623) LXR-623 ( WAY 252623) 2-[(2-chloro-4-fluorophenyl)Methyl]-3-(4-fluorophenyl)-7-(trifluoroMethyl)- 2-[(2-Chloro-4-fluorophenyl)methyl]-3-(4-fluorophenyl)-7-(trifluoromethyl)-2H-indazole 2H-Indazole, 2-[(2-chloro-4-fluorophenyl)Methyl]-3-(4-fluorophenyl)-7-(trifluoroMethyl)- 2-[(2-Chloro-4-fluorophenyl)methyl]-3-(4-fluorophenyl)-7-(trifluoromethyl)-2H-indazole WAY 252623 | API;Inhibitor;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors |
| 369 | 890128-81-1 | BFH772 | BFH772 BFH-772 Bfh-722 CS-2412 BFH 772 6-((6-(Hydroxymethyl)pyrimidin-4-yl)oxy)-N-(3-(trifluoromethyl)phenyl)-1-naphthamide 1-Naphthalenecarboxamide, 6-[[6-(hydroxymethyl)-4-pyrimidinyl]oxy]-N-[3-(trifluoromethyl)phenyl]- | Cell biology reagent |
| 370 | 896720-20-0 | VX-11e | VX11E VX 11E VX-11e VX 11e VX-11E TCS ERK 11e VX-11e(TCS ERK 11e) TCS ERK 11e (VX-11e) 4-[2-[(2-Chloro-4-fluorophenyl)amino]-5-methyl-4-pyrimidinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide 1H-Pyrrole-2-carboxaMide, 4-[2-[(2-chloro-4-fluorophenyl)aMino]-5-Methyl-4-pyriMidinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]- | MAPK;Anti-tumor;Standard substance;Anti-cancer&immunity;Cell biology reagent;Anti-cancer & immunity |
| 371 | 911417-87-3 | SLx-2119 | KD-025 SLx2119 SLx 2119 SLX-2119 SLx-2119 ROCK INHIBITOR ROCK inhibitor 2 KD025 (SLx-2119) 2-[3-[4-[(1H-Indazol-5-yl)amino]quinazolin-2-yl]phenoxy]-N-isopropylacetamide | API;Cell cycle;Cell biology reagents |
| 372 | 912545-86-9 | SAG | SAG CS-1655 SAG (Smo agonist) SAG (cyclopamine antagonist) Smoothened Agonist (SAG) free base 3-Chloro-N-[trans-4-(MethylaMino)cyclohexyl]-N-[[3-(4-pyridinyl)phenyl]Methyl]- 3-chloro-N-((1r,4r)-4-(methylamino)cyclohexyl)-N-(3-(pyridin-4-yl)benzyl)benzo[b]thiophene-2-carboxamide 3-Chloro-N-[trans-4-(methylamino)cyclohexyl]-N-[[3-(4-pyridinyl)phenyl]methyl]- benzo[b]thiophene-2-carboxamide | Inhibitors;Heterocycles;Kit-Elisa kit;Pharmaceuticals;Heterocyclic Compoun;Cell biology reagents;Heterocyclic Compounds;Small molecule inhibitors;Sulfur & Selenium Compounds;Intermediates & Fine Chemi |
| 373 | 918633-87-1 | TH-302 | TH-302 TH 302 EOS-61724 EvofosfaMide Evofosfamide(TH 302) TH-302 (Evofosfamide) (1-methyl-2-nitro-1H-imidazol-5-yl)methylN,N'-bis(2-bromoethyl)diamidophosphate N,N'-Bis(2-bromoethyl)phosphorodiamidic acid (1-methyl-2-nitro-1H-imidazol-5-yl)methyl ester | API;APIs;TH-302;Metabolism |
| 374 | 939981-39-2 | RG7112 | RG7112 RG 7112 CS-2164 p53 inhibitor RO5045337 (RG7112) p53 and MDM2 proteins-interaction-inhibitor [(4R,5S)-4,5-Bis(4-chlorophenyl)-2-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydro-4,5-dimethyl-1H-imidazol-1-yl][4-[3-(methylsulfonyl)propyl]-1-piperazinyl]methanone Methanone, [(4S,5R)-4,5-bis(4-chlorophenyl)-2-[4-(1,1-diMethylethyl)-2-ethoxyphenyl]-4,5-dihydro-4,5-diMethyl-1H-iMidazol-1-yl][4-[3-(Methylsulfonyl)propyl]-1-piperazinyl]- | Inhibitor;Apoptosis;Cell biology reagent |
| 375 | 1047953-91-2 | 2-chloro-N-(4-(5-(3,4-dichlorophenyl)-3-(2-methoxyethoxy)-1H-1,2,4-triazol-1-yl)phenyl)acetamide | MI-2 CHD-4 MALT1 inhibitor MI-2 MI 2 (MALT1 inhibitor) TELOMERASE INHIBITOR II, SODIUM SALT 5'-D(ATGAAAATCAGGGTTAGG)-3', SODIUM SALT 2-chloro-N-(4-(5-(3,4-dichlorophenyl)-3-(2-methoxyethoxy)-1H-1,2,4-triazol-1-yl)phenyl)acetamide 2-Chloro-N-[4-[5-(3,4-dichlorophenyl)-3-(2-methoxyethoxy)-1H-1,2,4-triazol-1-yl]phenyl]-Acetamide | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 376 | 1096708-71-2 | MLN2480 | MLN2480 CS-2188 MLN 2480 MLN2480 BIIB-024 MLN-2480 MLN2480 (BIIB-024) (R)-2-(1-(6-amino-5-chloropyrimidine-4-carboxamido)ethyl)-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide 6-Amino-5-chloro-N-[(1R)-1-[5-[[[5-chloro-4-(trifluoromethyl)-2-pyridinyl]amino]carbonyl]-2-thiazolyl]ethyl]-4-pyrimidinecarboxamide 2-[(1r)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-n-[5-chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide | Inhibitor;Cell biology reagent |
| 377 | 1140964-99-3 | E7449 | E7449 E 7449 E-7449 1140964-99-3 UNII-9X5A2QIA7C Stenoparib (E7449) 8-(1,3-dihydro-isoindol-2-ylmethyl)-2,9-dihydro-1,2,7,9-tetraaza-phenalen-3-one 3H-Pyridazino[3,4,5-de]quinazolin-3-one, 8-[(1,3-dihydro-2H-isoindol-2-yl)methyl]-1,2-dihydro- | Cell biology reagent |
| 378 | 1163719-56-9 | CCT196969 | CS-2447 CCT196969 CB93134226 CCT-196969 CCT 196969 1-(3-(tert-Butyl)-1-phenyl-1H-pyrazol-5-yl)-3-(2-fluoro-4-((3-oxo-3,4-dihydropyrido[2,3-b]pyra Urea, N-[4-[(3,4-dihydro-3-oxopyrido[2,3-b]pyrazin-8-yl)oxy]-2-fluorophenyl]-N'-[3-(1,1-dimethylethyl)-1-phenyl-1H-pyrazol-5-yl]- | Standard;Cell biology reagent |
| 379 | 1190378-57-4 | MRT67307 | MRT67307 MRT68921 MRT67307 HCl MRT67307 (free base) MRT67307 hydrochloride N-[3-[[5-Cyclopropyl-2-[[3-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino]propyl]cyclobutanecarboxamide N-[3-[[5-Cyclopropyl-2-[[3-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino]propyl]-cyclobutanecarboxamide hydrochloride | API;NF-kB |
| 380 | 1194961-19-7 | PRT-060318 | PRT 318 CS-1688 P 142-76 PRT-060318 PRT-060318(PRT318) 2-(((1R,2S)-2-aminocyclohexyl)amino)-4-(m-tolylamino)pyrimidine-5-carboxamide 2-[[(1R,2S)-2-Aminocyclohexyl]amino]-4-[(3-methylphenyl)amino]-5-pyrimidinecarboxamide | Cell biology reagent |
| 381 | 1206799-15-6 | LY2801653 | CS-685 LY2801653 LY2801653 Merestinib MERESTINIB LY-2801653 LY 2801653 MET INHIBITOR MET inhibitor LY2801653(Merestinib) N-(3-fluoro-4-((1-Methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl)oxy)phenyl)-1-(4-fluorophenyl)-6-Methyl-2-oxo-1,2-dihydropyridine-3-carboxaMide N-[3-Fluoro-4-[[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-3-pyridinecarboxamide | API;Inhibitors;Cell biology reagents;Small molecule inhibitors;Only for scientific research |
| 382 | 1207293-36-4 | BI-847325 | BI847325 BI-847325 BI 847325 3-[3-[[4-(dimethylaminomethyl)anilino]-phenylmethylidene]-2-oxo-1H-indol-6-yl]-N-ethylprop-2-ynamide (Z)-3-(3-(((4-((Dimethylamino)methyl)phenyl)amino)(phenyl)methylene)-2-oxoindolin-6-yl)-N-ethylpropiolamide 3-[3-[[[4-[(Dimethylamino)methyl]phenyl]amino]phenylmethylene]-2,3-dihydro-2-oxo-1H-indol-6-yl]-N-ethyl-2-propynamide 2-Propynamide, 3-[3-[[[4-[(dimethylamino)methyl]phenyl]amino]phenylmethylene]-2,3-dihydro-2-oxo-1H-indol-6-yl]-N-ethyl- | APIs;Cell biology reagents |
| 383 | 1218942-37-0 | GKT137831 | CS-1795 GKT137831 GKT-137831 GKT 137831 Setanaxib GKT137831 2-(2-Chlorophenyl)-4-(3-(diMethylaMino)phenyl)-5-Methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione 2-(2-chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1,2-dihydro-5H-pyrazolo[4,3-c]pyridine-3,6-dione 2-(2-Chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione GKT137831 | API;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 384 | 1221713-92-3 | N-(3-fluoro-4-((3-phenyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy)phenyl)-2-(4-fluorophenyl)-1,5-dimethyl-3-oxo-2,3-dihydro-1H-pyrazole-4-carboxamide. | NPS-1034 2-(4-Fluorophenyl)-N-[3-fluoro-4-[(3-phenyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl]-2,3-dihydro-1,5-dimethyl-3-oxo-1H-pyrazole-4-carboxamide N-(3-fluoro-4-((3-phenyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy)phenyl)-2-(4-fluorophenyl)-1,5-dimethyl-3-oxo-2,3-dihydro-1H-pyrazole-4-carboxamide. 1H-Pyrazole-4-carboxamide, 2-(4-fluorophenyl)-N-[3-fluoro-4-[(3-phenyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl]-2,3-dihydro-1,5-dimethyl-3-oxo- | |
| 385 | 1224887-10-8 | GSK2256098 | CS-2424 GTPL7939 GSK2256098 GSK-2256098 GSK 2256098 FAK inhibitor GS2256098 2-(5-chloro-2-(1-isopropyl-3-methyl-1H-pyrazol-5-ylamino)pyridin-4-ylamino)-N-methoxybenzamide Benzamide, 2-[[5-chloro-2-[[3-methyl-1-(1-methylethyl)-1H-pyrazol-5-yl]amino]-4-pyridinyl]amino]-N-methoxy- 2-[(5-chloro-2-{[3-methyl-1-(1-methylethyl)-1H-pyrazol-5-yl]amino}-4-pyridinyl)amino]-N(methyloxy)benzamide | APIs;Inhibitors;Cell biology reagents;Bioactive molecules-API;Small molecule inhibitors;Pharmaceutical raw materials;Small molecule inhibitors, natural products |
| 386 | 1229582-33-5 | URMC-099 | RMC099 CS-1776 URMC 099 URMC-099 PEPOSERTIB, MSC2490484A 3-(1H-indol-5-yl)-5-[4-[(4-methyl-1-piperazinyl)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridine 1H-?Pyrrolo[2,?3-?b]?pyridine, 3-?(1H-?indol-?5-?yl)?-?5-?[4-?[(4-?methyl-?1-?piperazinyl)?methyl]?phenyl]?- 3-(1H-indol-5-yl)-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridine URMC-099 | api;Standards;Inhibitors;Small molecule inhibitors, natural products |
| 387 | 1234015-54-3 | LY2606368 (dihydrochloride) | LY-2606368 (Prexasertib) LY2606368 dihydrochloride LY-2606368 dihydrochloride Prexasertib dihydrochloride Prexasertib HCl (LY2606368) LY2606368 (dihydrochloride) Prexasertib (LY2606368) 2HCl 5-(5-(2-(3-aMinopropoxy)-6-Methoxyphenyl)-1H-pyrazol-3-ylaMino)pyrazine-2-carbonitrile hydrochloride 5-(5-(2-(3-aMinopropoxy)-6-Methoxyphenyl)-1H-pyrazol-3-ylaMino)pyrazine-2-carbonitrile dihydrochloride | Cell biology reagent |
| 388 | 125314-13-8 | CP21R7 | CP21R7 CS-2352 CP21R7(CP21) CP21 (CP21R7) 3-(3-Aminophenyl)-4-(1-methyl-1H-indol-3-yl)pyrrole-2,5-dione 3-(3-aminophenyl)-4-(1-methyl-3-indolyl)-1H-pyrrole-2,5-dione 3-(3-aminophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione 1H-Pyrrole-2,5-dione, 3-(3-aminophenyl)-4-(1-methyl-1H-indol-3-yl)- | inhibitors;Cell biology reagents |
| 389 | 1253952-02-1 | Netarsudil (AR-13324) 2HCl | Netarsudil RHOPRESSA NETARSUDIL AR13324 HCl AR-13324 HCl AR13324 HCL AR-13324 HCL AR-13324 (hydrochloride) Netarsudil hydrochloride NETARSUDIL HYDROCHLORIDE Netarsudil dihydrochloride Netarsudil (AR-13324) 2HCl | Inhibitors;Intermediates;Reference substance;Pharmaceutical bulk drugs;Pharmaceutical raw materials |
| 390 | 1290541-46-6 | RAD51 Inhibitor B02 | B02 BO2 CS-2461 RAD51 INHIBITOR B02 RAD51 Inhibitor B02 (E)-3-benzyl-2-(2-(pyridin-3-yl)vinyl)quinazolin-4(3H)-one 3-(Phenylmethyl)-2-[(1E)-2-(3-pyridinyl)ethenyl]-4(3H)-quinazolinone 4(3H)-Quinazolinone, 3-(phenylmethyl)-2-[(1E)-2-(3-pyridinyl)ethenyl]- | Standard;Cell biology reagent |
| 391 | 1290543-63-3 | PF-3084014 | CS-2699 PF-3084014 PF03084014 PF-03084014 PF 03084014 Nirogacestat PF-03084014 (PF-3084014) PF-03084014 (Nirogacestat) (2S)-2-[[(2S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl]amino]-N-[1-[1-(2,2-dimethylpropylamino)-2-methylpropan-2-yl]imidazol-4-yl]pentanamide | api;Nerve signal |
| 392 | 1334493-07-0 | BP-1-102 | BP1-102 BP1-102 BP 1-102 BP-1-102 BP 1-102. STAT3 Inhibitor XVIII STAT3 INHIBITOR XVIII STAT3 Inhibitor XVIII, BP-1-102 4-(N-(4-Cyclohexylbenzyl)-2-(2,3,4,5,6-pentafluoro-N-methylphenylsulfonamido)acetamido)-2-hydr 4-(N-(4-cyclohexylbenzyl)-2-(2,3,4,5,6-pentafluoro-N-methylphenylsulfonamido)acetamido)-2-hydroxybenzoic acid Benzoic acid, 4-[[(4-cyclohexylphenyl)methyl][2-[methyl[(2,3,4,5,6-pentafluorophenyl)sulfonyl]amino]acetyl]amino]-2-hydroxy- | API;Cell biology reagent |
| 393 | 1338806-73-7 | CFI-400945 (free base) | CFI-400945 ocifisertib 1338806-73-7 CFI-400945 (free base) CFI-400945 (CFI400945 Spiro[cyclopropane-1,3'-[3H]indol]-2'(1'H)-one, 2-[3-[(1E)-2-[4-[[(2R,6S)-2,6-dimethyl-4-morpholinyl]methyl]phenyl]ethenyl]-1H-indazol-6-yl]-5'-methoxy-, (1R,2S)- | API |
| 394 | 1351635-67-0 | ONO-4059 (analog) | CS-1629 GS-4059 ONO-4059 ON 0459 ANALOG ON-0459 analog ON 0459 analog ON-0459 ANALOG ONO-4059 (analog) ONO-4059 (ONO-WG-307) 6-AMINO-7-(4-PHENOXYPHENYL)-9-[(3S)-1-(PROP-2-ENOYL)PIPERIDIN-3-YL]PURIN-8-ONE | inhibitors;Cell biology reagents |
| 395 | 1357470-29-1 | ON123300 | 123300 CS-2199 ON123300 ON 123300 ON-123300 ON-123300 8-cyclopentyl-2-((4-(4-methylpiperazin-1-yl)phenyl)amino)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitrile 8-Cyclopentyl-7,8-dihydro-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-7-oxo-pyrido[2,3-d]pyrimidine-6-carbonitrile Pyrido[2,3-d]pyrimidine-6-carbonitrile, 8-cyclopentyl-7,8-dihydro-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-7-oxo- | inhibitors;Cell biology reagents |
| 396 | 1360614-48-7 | Necrosulfonamide | 100318 CS-2351 Necrosulfonamide (E)-NECROSULFONAMIDE Necrosulfonamide (NSA) (E)-N-(4-(N-(3-Methoxypyrazin-2-yl)sulfaMoyl)phenyl)-3-(5-nitrothiophen-2-yl)acrylaMide (2E)-N-[4-[[(3-Methoxy-2-pyrazinyl)amino]sulfonyl]phenyl]-3-(5-nitro-2-thienyl)-2-propenamide 2-Propenamide, N-[4-[[(3-methoxy-2-pyrazinyl)amino]sulfonyl]phenyl]-3-(5-nitro-2-thienyl)-, (2E)- | Chemical reagents |
| 397 | 1373422-53-7 | GSK-J1 | GSK J1 GSK-J1 GCK J1 Histone Lysine Demethylase Inhibitor VII, GSK-J1 N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-beta-alanine 3-((6-(4,5-Dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoic acid | API;Inhibitors;Active molecules;Chemical industry;Cell biology reagents |
| 398 | 1420071-30-2 | Bioymifi | BioyMifi Bioymifi Bioymifi, 1420071-30-2 (E)-5-(5-((3-(4-bromophenyl)-2-imino-4-oxothiazolidin-5-ylidene)methyl)furan-2-yl)isoindoline-1,3-dione (Z)-5-(5-[(3-[4-Bromophenyl]-2-imino-4-oxothiazolidin-5-ylidene)methyl]furan-2-yl)isoindoline-1,3-dione 1H-Isoindole-1,3(2H)-dione, 5-[5-[[3-(4-broMophenyl)-2-iMino-4-oxo-5-thiazolidinylidene]Methyl]-2-furanyl]- 5-[5-[[(5Z)-3-(4-Bromophenyl)-2-imino-4-oxo-5-thiazolidinylidene]methyl]-2-furanyl]-1H-isoindole-1,3(2H)-dione (Z)-5-(5-((3-(4-bromophenyl)-2-imino-4-oxothiazolidin-5-ylidene)methyl)furan-2-yl)isoindoline-1,3-dione (Bioymifi) Bioymifi 1H-Isoindole-1,3(2H)-dione, 5-[5-[[3-(4-broMophenyl)-2-iMino-4-oxo-5-thiazolidinylidene]Methyl]-2-furanyl]- | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 399 | 1429749-41-6 | Thiomyristoyl | 1429749-41-6 Thiomyristoyl Carbamic acid, N-[(1S)-1-[(phenylamino)carbonyl]-5-[(1-thioxotetradecyl)amino]pentyl]-, phenylmethyl ester N-?[(1S)?-?1-?[(Phenylamino)?carbonyl]?-?5-?[(1-?thioxotetradecyl)?amino]?pentyl]?-carbamic Acid Phenylmethyl Ester | Cell biology reagent |
| 400 | 1429881-91-3 | UNC2025 | CS-2109 UNC2025 UNC2025 UNC-2025 UNC 2025 UNC 2025. BEMPEDOIC ACID, ESP-55016 (1r,4r)-4-(2-(Butylamino)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-7H-pyrrolo[2,3-d]pyrimi (1r,4r)-4-(2-(butylamino)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexanol Cyclohexanol, 4-[2-(butylamino)-5-[4-[(4-methyl-1-piperazinyl)methyl]phenyl]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-,trans- (1R,4R)-4-(2-(butylamino)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexanol UNC-2025 | Standard;Inhibitors;Cell biology reagents |
| 401 | 1430844-80-6 | A-1331852 | CS-2498 A1331852 A-1331852 A 1331852 6-(8-(benzo[d]thiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl)-3-(1-(adamantylmethyl)-5-methyl-1H-pyrazol-4-yl)picolinic acid 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl]-3-[5-methyl-1-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-1H-pyrazol-4-yl]pyridine-2-carboxylic acid 2-Pyridinecarboxylic acid, 6-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-3-[5-methyl-1-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-1H-pyrazol-4-yl]- | Standard;Cell biology reagent |
| 402 | 1431697-89-0 | OTSSP167 | CS-1832 OTSSP167 OTSSP 167 OTSSP-167 MELK inhibitor OTSSP 167 hydrochloride OTSSP-167 hydrochloride OTSSP167 (hydrochloride) | API;Medicine;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 403 | 1454682-72-4 | LY3009120 | DP 4978 CS-1616 DP4978 DP 4978 DP-4978 LY3009120 LY-3009120 LY03009120 LY 3009120 LY-3009120 N-(3,3-dimethylbutyl)-N'-[2-fluoro-4-methyl-5-[7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl]phenyl]- N-(3,3-Dimethylbutyl)-N'-[2-fluoro-4-methyl-5-[7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl]phenyl]urea Urea, N-(3,3-dimethylbutyl)-N'-[2-fluoro-4-methyl-5-[7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl]phenyl]- | Cell biology reagent |
| 404 | 1474034-05-3 | RTA-408 | RTA408 RTA-408 CS-1306 RTA 408 Omaveloxolone NRF1-ACTIVATOR-1 Nrf1-activator-1 Omaveloxolone (RTA-408) N-(2-Cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2,2-difluoropropanamide Propanamide, N-(2-cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2,2-difluoro- | APIs;Inhibitors;Omaveloxolone |
| 405 | 1527473-33-1 | PF-06447475 | CS-1734 PF06447475 PF-06447475 PF 06447475 3-(4-morpholino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)benzonitrile 3-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)benzonitrile 3-[4-(4-Morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-benzonitrile Benzonitrile, 3-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]- | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 406 | 1532533-67-7 | TGR-1202 | TGR1205 RP-5264 TGR-1202 Umbralisib RP-5264 TGR-1202 Umbralisib (TGR-1202) (S)-2-(1-(4-AMINO-3-(3-FLUORO-4-ISOPROPOXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1-YL)ETHYL)-6-FLUORO-3-(3-FLUOROPHENYL)-4H-CHROMEN-4-ONE 4H-1-Benzopyran-4-one, 2-[(1S)-1-[4-amino-3-[3-fluoro-4-(1-methylethoxy)phenyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)- | Cell biology reagent |
| 407 | 1550008-55-3 | ML264 | ML264 ML264 ML-264 ML 264 CS-2175 CID-51003603 CID-51003603 (E)-3-(3-chlorophenyl)-N-(2-((1,1-dioxidotetrahydro-2H-thiopyran-4-yl)(methyl)amino)-2-oxoethyl)acrylamide (2E)-3-(3-Chlorophenyl)-N-[2-[methyl(tetrahydro-1,1-dioxido-2H-thiopyran-4-yl)amino]-2-oxoethyl]-2-propenamide 2-Propenamide, 3-(3-chlorophenyl)-N-[2-[methyl(tetrahydro-1,1-dioxido-2H-thiopyran-4-yl)amino]-2-oxoethyl]-, (2E)- | Medicine;Standard;Inhibitors;Cell biology reagents |
| 408 | 1594092-37-1 | AZ191 | AZ191 AZ 191 AZ-191 CS-1824 N-[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]-4-(1-methyl-1h-pyrrolo[2,3-c]pyridin-3-yl)-2-pyrimidinamine 2-Pyrimidinamine, N-[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]-4-(1-methyl-1H-pyrrolo[2,3-c]pyridin-3-yl)- [2-Methoxy-4-(4-methyl-piperazin-1-yl)-phenyl]-[4-(1-methyl-1H-pyrrolo[2,3-c]pyridin-3-yl)-pyrimidin-2-yl]-amine N-[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]-4-(1-methyl-1h-pyrrolo[2,3-c]pyridin-3-yl)-2-pyrimidinamine, AZ191 | Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 409 | 1608125-21-8 | AMG319 | ACP319 AMG319 AMG-319 CS-1593 AMG 319 ACP 319 (S)-N-(1-(7-Fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (αS)--Fluoro-α-methyl-N-9H-purin-6-yl-2-(2-pyridinyl)-3-quinolinemethanamine (alphaS)-7-Fluoro-alpha-methyl-N-9H-purin-6-yl-2-(2-pyridinyl)-3-quinolinemethanamine | Cell biology reagent |
| 410 | 1609402-14-3 | N-(4-(3-((5-(dimethylamino)naphthalene)-1-sulfonamido)phenyl)thiazol-2-yl)acetamide | HA15 HA 15 HA-15 CS-2893 N-(4-(3-((5-(dimethylamino)naphthalene)-1-sulfonamido)phenyl)thiazol-2-yl)acetamide Acetamide, N-[4-[3-[[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]amino]phenyl]-2-thiazolyl]- | medicine;Cell biology reagents |
| 411 | 1613724-42-7 | HTH-01-015 | CS-2296 HTH-01-015 CHSDJDLAKKAWCI-UHFFFAOYSA-N 5,13-Dihydro-4,5,13-trimethyl-2-[[1-(4-piperidinyl)-1H-pyrazol-4-yl]amino]-6H-naphtho[2,3-e]pyrimido[5,4-b][1,4]diazepin-6-one 6H-Naphtho[2,3-e]pyrimido[5,4-b][1,4]diazepin-6-one, 5,13-dihydro-4,5,13-trimethyl-2-[[1-(4-piperidinyl)-1H-pyrazol-4-yl]amino]- | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 412 | 1619994-68-1 | GSK2801 | GSK2801 GSK 2801 GSK-2801 GSK2801 GSK-2801 1-[1-[2-(Methylsulfonyl)phenyl]-7-propoxy-3-indolizinyl]ethanone 1-(1-(2-(methylsulfonyl)phenyl)-7-propoxyindolizin-3-yl)ethanone 1-[1-(2-Methanesulfonyl-phenyl)-7-propoxy-indolizin-3-yl]-ethanone 1-(7-(2-Methylsulfonyl-phenyl)-4-propoxy-1-aza-bicyclo[4.3.0]nona-2,4,6,8-tetraen-9-yl)-ethanone | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 413 | 1622849-58-4 | 5-(phenylmethyl)-N-[(3S)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]-3-isoxazolecarboxamide | GSK481 CS-2186 GSK481 - GSK'481 5-(phenylmethyl)-N-[(3S)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]-3-isoxazolecarboxamide 3-Isoxazolecarboxamide, 5-(phenylmethyl)-N-[(3S)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]- | inhibitors;Cell biology reagents |
| 414 | 1628208-23-0 | CPI-455； 6-isopropyl-7-oxo-5-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile | CPI455 CPI-455 CPI 455 CPI-455(free base) 6-Isopropyl-7-oxo-5-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile Pyrazolo[1,5-a]pyrimidine-3-carbonitrile, 4,7-dihydro-6-(1-methylethyl)-7-oxo-5-phenyl- CPI-455； 6-isopropyl-7-oxo-5-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile | Cell biology reagent |
| 415 | 1628316-74-4 | 5-((4-((6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1H-indole-2-carbonitrile | MI136 MI 136 MI-136 MI136) CS-2162 HY-19319 (MI 136 HY-19319 (MI 136 MI-136 HY-19319 (MI 136 MI136) 5-((4-((6-(2,2,2-Trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1H-in 5-((4-((6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1H-indole-2-carbonitrile 5-[[4-[[6-(2,2,2-Trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-1H-indole-2-carbonitrile 1H-Indole-2-carbonitrile, 5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]- | inhibitors;Cell biology reagents |
| 416 | 1629268-00-3 | ARS-853 | ARS-853 CS-2646 ARS-853 (ARS853) 1-(3-(4-((4-chloro-2-hydroxy-5-(1-methylcyclopropyl)phenyl)glycyl)piperazin-1-yl)azetidin-1-yl)prop-2-en-1-one 2-Propen-1-one, 1-[3-[4-[2-[[4-chloro-2-hydroxy-5-(1-methylcyclopropyl)phenyl]amino]acetyl]-1-piperazinyl]-1-azetidinyl]- | Cell biology reagent |
| 417 | 1637739-82-2 | BQU57 | BQU57 CS-2300 6-amino-1,3-dimethyl-4-(4-(trifluoromethyl)phenyl)-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile Pyrano[2,3-c]pyrazole-5-carbonitrile, 6-amino-1,4-dihydro-1,3-dimethyl-4-[4-(trifluoromethyl)phenyl]- | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 418 | 1642300-52-4 | KPT-8602 | CS-2388 ATG-016 KPT-8602 Eltanexor KPT-8602 (KPT 8602 Eltanexor (KPT-8602 (E)-3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-2-(pyrimidin-5-yl)acrylamide 5-Pyrimidineacetamide, α-[[3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]methylene]-, (αE)- | Cell biology reagent |
| 419 | 1687736-54-4 | SGC707 | SGC707 SGC 707 CS-2192 N-6-Isoquinolinyl-N'-[2-oxo-2-(1-pyrrolidinyl)ethyl]urea Urea, N-6-isoquinolinyl-N'-[2-oxo-2-(1-pyrrolidinyl)ethyl]- | API;Inhibitors;Chemical industry;Cell biology reagents |
| 420 | 1714146-59-4 | I-BRD9 | GSK602 I-BRD9 I-BRD-9 CS-2328 I-brd9 GSK602 N-(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)-5-ethyl-4-oxo-7-(3-(trifluoromethyl)phenyl)-4,5-di 5-Ethyl-4,5-dihydro-4-oxo-N-(tetrahydro-1,1-dioxido-2H-thiopyran-4-yl)-7-[3-(trifluoromethyl)phenyl]thieno[3,2-c]pyridine-2-carboximidamide Thieno[3,2-c]pyridine-2-carboximidamide, 5-ethyl-4,5-dihydro-4-oxo-N-(tetrahydro-1,1-dioxido-2H-thiopyran-4-yl)-7-[3-(trifluoromethyl)phenyl]- | API;Inhibitor;Active small sub-library |
| 421 | 181223-80-3 | DEL-22379 | CS-2171 DEL22379 DEL 22379 DEL-22379 N-(3-((5-methoxy-1H-indol-3-yl)methylene)-2-oxoindolin-5-yl)-3-(piperidin-1-yl)propanamide (E)-N-(3-((5-methoxy-1H-indol-3-yl)methylene)-2-oxoindolin-5-yl)-3-(piperidin-1-yl)propanamide N-{3-[(5-methoxyindol-3-yl)methylene]-2-oxo(1H-benzo[3,4-d]azolidin-5-yl)}-3-piperidylpropanamide N-[2,3-Dihydro-3-[(5-methoxy-1H-indol-3-yl)methylene]-2-oxo-1H-indol-5-yl]-1-piperidinepropanamide | Inhibitor |
| 422 | 1857417-13-0 | 4-Methyl-1-(1H-pyrazol-4-ylmethyl)-5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-1H-indole-2-carbonitrile | mi503 MI503 mi-503 MI 503 MI-503 CS-1946 1-((1H-Pyrazol-4-yl)methyl)-4-methyl-5-((4-((6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4- 4-Methyl-1-(1H-pyrazol-4-ylmethyl)-5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-1H-indole-2-carbonitrile 1H-Indole-2-carbonitrile, 4-methyl-1-(1H-pyrazol-4-ylmethyl)-5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]- | Inhibitors;Spot Products |
| 423 | 1910124-24-1 | GSK6853 | GSK6853 CS-2243 GSK-6853 GSK 6853 FQWDVNSBYDXPIO-CQSZACIVSA-N BRPF1 bromodomain inhibitor GS6853 N-[2,3-dihydro-1,3-dimethyl-6-[(2R)-2-methyl-1-piperazinyl]-2-oxo-1H-benzimidazol-5-yl]-2-methoxybenzamide Benzamide, N-[2,3-dihydro-1,3-dimethyl-6-[(2R)-2-methyl-1-piperazinyl]-2-oxo-1H-benzimidazol-5-yl]-2-methoxy- | API;Customized classes;Cell biology reagents;Active small molecular library |
| 424 | 193551-21-2 | SB 239063 | CS-402 SB 239063 TRANS-1-(4-HYDROXYCYCLOHEXYL)-4-(FLUOROPHENYL)-5-(2-METHOXYPYRIMIDIN-4-YL) IMIDAZOLE TRANS-4-[4-(4-FLUOROPHENYL)-5-(2-METHOXY-4-PYRIMIDINYL)-1H-IMIDAZOL-1-YL]CYCLOHEXANOL TRANS-1-(4-HYDROXYCYCLOHEXYL)-4-(4-FLUOROPHENYL)-5-(2-METHOXYPYRIMIDIN-4-YL) IMIDAZOLE TRANS-1-(4-HYDROXYCYCLOHEXYL)-4-(4-FLUOROPHENYL)-5-(2-METHOXYPYRIDIMIDIN-4-YL)IMIDAZOLE Cyclohexanol, 4-[4-(4-fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl]-, trans- | Aromatics;Heterocycles;Protein Kinase Inhibitors and Activators |
| 425 | 2002381-31-7 | APS-2-79 (hydrochloride) | APS279 APS-279 CS-2444 APS-2-79 APS 2 79 APS-2-79 (hydrochloride) 6,7-dimethoxy-N-(2-methyl-4-phenoxyphenyl)quinazolin-4-amine hydrochloride | |
| 426 | 252017-04-2 | AZD7545 | AZD7545 AZD4575 AZD7547 CS-1842 AZD 7547 AZD-7547 4-[[3-Chloro-4-[[(2R)-3,3,3-trifluoro-2-hydroxy-2-methyl-1-oxopropyl]amino]phenyl]sulfonyl]-N,N-dimethylbenzamide | API;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 427 | 263707-16-0 | ESI-09 | ESI09 ESI-09 ESI 09 (E)-3-(5-tert-butylisoxazol-3-yl)-2-(2-(3-chlorophenyl)hydrazono)-3-oxopropanenitrile alpha-[(3-Chlorophenyl)hydrazono]-5-(1,1-dimethylethyl)-beta-oxo-3-isoxazolepropanenitrile α-[2-(3-Chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-b-oxo-3-isoxazolepropanenitrile α-[(2-(3-Chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-β-oxo-3-isoxazolepropanenitrile 3-Isoxazolepropanenitrile, α-[2-(3-chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-β-oxo- | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 428 | 288250-47-5 | 1-(4-Chlorophenyl)-N-(3-cyano-4-(4-morpholinopiperidin-1-yl)phenyl)-5-methyl-1H-pyrazole-4-carboxami | Y320 Y-320 1-(4-Chlorophenyl)-N-(3-cyano-4-(4-morpholinopiperidin-1-yl)phenyl)-5-methyl-1H-pyrazole-4-car 1-(4-Chlorophenyl)-N-(3-cyano-4-(4-morpholinopiperidin-1-yl)phenyl)-5-methyl-1H-pyrazole-4-carboxami 1-(4-CHLOROPHENYL)-N-(3-CYANO-4-(4-MORPHOLINOPIPERIDIN-1-YL)PHENYL)-5-METHYL-1H-PYRAZOLE-4-CARBOXAMIDE 1-(4-Chlorophenyl)-N-[3-cyano-4-[4-(4-morpholinyl)-1-piperidinyl]phenyl]-5-methyl-1H-pyrazole-4-carboxamide 1-(4-Chlorophenyl)-N-[3-cyano-4-[4-(4-morpholinyl)-1-piperidinyl]phenyl]-5-methyl-1H-pyrazole-4-carboxamide Y320 Y320 1-(4-Chlorophenyl)-N-[3-cyano-4-[4-(4-morpholinyl)-1-piperidinyl]phenyl]-5-methyl-1H-pyrazole-4-carboxamide | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 429 | 307543-71-1 | STF 083010 | CS-2901 CS-2595 STF083010 STF 083010 STF-083010 N-[(2-Hydroxy-1-naphthalenyl)methylene]-2-thiophenesulfonamide 2-Thiophenesulfonamide, N-[(2-hydroxy-1-naphthalenyl)methylene]- (E)-N-((2-hydroxynaphthalen-1-yl)methylene)thiophene-2-sulfonamide | Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 430 | 312756-74-4 | 4-Bromo-N-(4-bromophenyl)-3-[[(phenylmethyl)amino]sulfonyl]benzamide | RS1 RS 1 RS-1 CS-2312 RAD51-stimulatory compound 1 RAD51-Stimulatory Compound-1, RS-1 RS-1 - RAD51-Stimulatory Compound-1 3-benzylsulfamoyl-4-bromo-N-(4-bromophenyl)benzamide 4-BroMo-N-(4-broMophenyl)-3-[[(phenylMethyl)aMino]sulfonyl]benzaMide 4-Bromo-N-(4-bromophenyl)-3-[[(phenylmethyl)amino]sulfonyl]benzamide | API;Amines, Aromatics, Pharmaceuticals;Amines, Aromatics, Pharmaceuticals, Intermediates & Fine Chemicals |
| 431 | 346640-08-2 | CCF642 | CCF642 CCF 642 CCF-642 AC1LYELL 3-(4-Methoxyphenyl)-5-[(5-nitro-2-thienyl)methylene]-2-thioxo-4-thiazolidinone 4-Thiazolidinone, 3-(4-methoxyphenyl)-5-[(5-nitro-2-thienyl)methylene]-2-thioxo- | Cell biology reagent |
| 432 | 413611-93-5 | N-2-Biphenylyl-7-nitro-2,1,3-benzoxadiazol-4-aMine | 10074G5 10074-g 10074-G5 10074 G5 c-Myc Inhibitor II N-2-Biphenylyl-7-nitro-2,1,3-benzoxadiazol-4-aMine Biphenyl-2-yl-(7-nitrobenzo[1,2,5]oxadiazol-4-yl)amine N-[1,1′-Biphenyl-2-yl]-7-nitro-2,1,3-Benzoxadiazol-4-amine | Cell biology reagent |
| 433 | 436133-68-5 | N-(3-Chloro-4-methylphenyl)-2-[2,6-dinitro-4-(trifluoromethyl)phenyl]-hydrazinecarbothioamide | Kobe0065 Kobe 0065 Kobe-0065 Kobe0065, 436133-68-5 N-(3-CHLORO-4-METHYLPHENYL)-2-(2,6-DINITRO-4-(TRIFLUOROMETHYL)PHENYL)HYDRAZINECARBOTHIOAMIDE N-(3-Chloro-4-Methylphenyl)-2-[2,6-dinitro-4-(trifluoroMethyl)phenyl]-hydrazinecarbothioaMide N-(3-Chloro-4-methylphenyl)-2-[2,6-dinitro-4-(trifluoromethyl)phenyl]-hydrazinecarbothioamide Kobe-0065 N-(3-Chloro-4-methylphenyl)-2-[2,6-dinitro-4-(trifluoromethyl)phenyl]hydrazinecarbothioamide N-(3-Chloro-4-methylphenyl)-2-[2,6-dinitro-4-(trifluoromethyl)phenyl]hydrazinecarbothioamide KOBE0065 | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products;Aromatics, Miscellaneous Reagents, Pharmaceuticals, Intermediates & Fine Chemicals |
| 434 | 476310-60-8 | (OC-6-45) Aqua (3-hydroxy-2-pyridinecarboxylato-kapaN1,kapaO2)[3-(hydroxy-kapaO)-2-pyridinecarboxylato(2-)-kapaO2]oxo-vanadate(1-), hydrogen, trihydrate | VO Ohpic VO-Ohpic VO-OHpic (hydrate) VO-Ohpic trihydrate VO-OHpic trihydrate VO-OHpic (PTEN Inhibitor) (OC-6-45) Aqua (3-hydroxy-2-pyridinecarboxylato-kapaN1,kapaO2)[3-(hydroxy-kapaO)-2-pyridinecarboxylato(2-)-kapaO2]oxo-vanadate(1-), hydrogen, trihydrate (OC-6-45)-aqua(3-Hydroxy-2-pyridinecarboxylato-kappaN1,kappaO2)[3-(hydroxy-kappaO)-2-pyridinecarboxylato(2-)-kappaO2]oxovanadate(1-) hydrogen trihydrate (OC-6-45) Aqua (3-hydroxy-2-pyridinecarboxylato-kapaN1,kapaO2)[3-(hydroxy-kapaO)-2-pyridinecarboxylato(2-)-kapaO2]oxo-vanadate(1-), hydrogen, trihydrate | |
| 435 | 491833-29-5 | Eliglustat | GENZ99067 GENZ99067 Eliglustat GENZ 99067 GENZ-99067 Genz 99067 GENZ 99067 GENZ-112638 ELIGLUSTAT TARTRATE Eliglustat(Genz-99067) Eliglustat(GENZ 112638) N-[(1R,2R)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]-octanamide N-[(1R,2R)-1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-(1- pyrrolidinyl)-2-propanyl]octanamide | Inhibitor |
| 436 | 522629-08-9 | CGP 57380 | P 57380 CS-1420 CGP57380 CGP 57380 CGP-57380 MNK1 Inhibitor N3-(4-Fluorophenyl)-1H-pyrazolo[3,4-d]pyrimidine-3,4-diamine CGP57380, N3-(4-fluorophenyl)-1h-pyrazolo[3,4-d]pyrimidine-3,4-diamine | Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 437 | 629664-81-9 | 3-(3,4-Difluorobenzoyl)-1,2,3,6-tetrahydro-1,1-dimethylazepino[4,5-b]indole-5-carboxylic acid 1-methylethyl ester | XL335 CS-899 Fxr 450 WAY-362450 WAY 362450 Turofexorate isopropyl TUROFEXORATE ISOPROPYL TUROFEXORATE ISOPROPYL Turofexorate isopropyl [usan] isopropyl 3-(3,4-difluorobenzoyl)-1,1-dimethyl-1,2,3,4,5,5a,6,10b-octahydroazepino[4,5-b]indole-5-carboxylate 3-(3,4-Difluorobenzoyl)-1,2,3,6-tetrahydro-1,1-dimethylazepino[4,5-b]indole-5-carboxylic acid 1-methylethyl ester | Inhibitors;A farnesoid X receptor (FXR) agonist.;A farnesoid X receptor (FXR) agonist .;Small molecule inhibitors, natural products |
| 438 | 6501-72-0 | 2-(3-Phenyl-4,5-dihydroisoxazol-5-yl)acetic Acid | GIT27 GIT27 GIT 27 GIT-27 CS-1488 VGX1027 VGX-1027 VGX 1027 VGX-1027(GIT 27) VGX-1027 ( GIT 27) 4,5-Dihydro-3-phenyl-5-isoxazoleaceticacid 4,5-DIHYDRO-3-PHENYL-5-ISOXAZOLEACETICACID 2-(3-Phenyl-4,5-dihydroisoxazol-5-yl)acetic Acid 2-(3-PHENYL-4,5-DIHYDROISOXAZOL-5-YL)ACETIC ACID 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 439 | 659730-32-2 | Amg 517 | AMG517 CS-691 Amg 517 AMG-517 N-[4-[[6-[4-(Trifluoromethyl)phenyl]-4-pyrimidinyl]oxy]-2-benzothiazolyl]acetamide N-(4-((6-(4-(Trifluoromethyl)phenyl)pyrimidin-4-yl)oxy)benzo[d]thiazol-2-yl)acetamide AcetaMide, N-[4-[[6-[4-(trifluoroMethyl)phenyl]-4-pyriMidinyl]oxy]-2-benzothiazolyl]- N-[4-[[6-[4-(Trifluoromethyl)phenyl]-4-pyrimidinyl]oxy]-2-benzothiazolyl]acetamide AMG517 | API;Inhibitors;Small molecule inhibitors, natural products |
| 440 | 817194-38-0 | GSK180736A | CS-2541 GSK180736 GSK180736A GSK180736A (GSK180736) GRK2 inhibitor GS180736A 5-Pyrimidinecarboxamide, 4-(4-fluorophenyl)-1,2,3,4-tetrahydro-N-1H-indazol-5-yl-6-methyl-2-oxo- 4-(4-fluorophenyl)-N-(1H-indazol-5-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide | API;Cell biology reagent |
| 441 | 836620-48-5 | AS1842856 | CS-2538 AS1842856 AS 1842856 AS-1842856 5-Amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid 5-Amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 3-Quinolinecarboxylic acid, 5-amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo- | biochemical reagent |
| 442 | 895158-95-9 | SC144 | SC144 SC144 SC-144 SC 144 CS-805 2-(7-fluoropyrrolo[1,2-a]quinoxalin-4-yl)hydrazide Pyrazinecarboxylic acid 2-(7-fluoropyrrolo[1,2-a]quinoxalin-4-yl)hydrazide 2-Pyrazinecarboxylic acid, 2-(7-fluoropyrrolo[1,2-a]quinoxalin-4-yl)hydrazide | Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 443 | 899805-25-5 | CC-930 | CC930 MCC930 CC 930 CC-930 TANZISERTIB Tanzisertib TANZISERTIB (CC-930) 4-[[9-[(3s)-oxolan-3-yl]-8-(2,4,6-trifluoroanilino)purin-2-yl]amino]cyclohexan-1-ol trans-4-[[9-[(3S)-Tetrahydro-3-furanyl]-8-[(2,4,6-trifluorophenyl)amino]-9H-purin-2-yl]amino]cyclohexanol | MAPK |
| 444 | 924416-43-3 | AdipoRon | ADIPORON AdipiRon AdipoRon SC-396658 AdipoR agonist 2-(4-benzoylphenoxy)-N-(1-benzylpiperidin-4-yl)acetaMide 2-(4-Benzoylphenoxy)-N-[1-(phenylmethyl)-4-piperidinyl]acetamide ACETAMIDE, 2-(4-BENZOYLPHENOXY)-N-[1-(PHENYLMETHYL)-4-PIPERIDINYL]- 2-(4-Benzoylphenoxy)-N-[1-(phenylmethyl)-4-piperidinyl]acetamide AdipoRon | Inhibitors;Chemical raw materials;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 445 | 926259-99-6 | BG45 | BG45 BG 45 CS-2040 45, HDAC3 Inhibitor BG45, HDAC3 Inhibitor N-(2-Aminophenyl)pyrazine-2-carboxamide PYRAZINE-2-CARBOXYLIC ACID-(2-AMINO-ANILIDE) | Standards;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 446 | 926927-61-9 | Motolimod | VTX2337 VTX-378 VTX 378 VTX 2337 VTX-2337 MOTOLIMOD Motolimod Obicetrapib Motolimod(VTX-2337) 2-amino-n,n-dipropyl-8-[4-(pyrrolidine-1-carbonyl)phenyl]-3h-1-benzazepine-4-carboxamide 2-amino-N,N-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3H-benzo[b]azepine-4-carboxamide | Inhibitor;Pharmaceutical raw materials |
| 447 | 927822-86-4 | KC7F2 | KC7F2 HIF-1α Translation Inhibitor, KC7F2 N,N'-(Dithiodi-2,1-ethanediyl)bis[2,5-dichloro-benzenesulfonaMide N,N'-(Disulfanediylbis(ethane-2,1-diyl))bis(2,5-dichlorobenzenesulfonamide) N,N'-(2,2'-disulfanediylbis(ethane-2,1-diyl))bis(2,5-dichlorobenzenesulfonamide) 2,5-dichloro-N-[2-[2-[(2,5-dichlorophenyl)sulfonylamino]ethyldisulfanyl]ethyl]benzenesulfonamide | Inhibitors;Cell biology reagents;Aromatics, Inhibitors, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds |
| 448 | 934493-76-2 | SAR245409 | CS-1242 SAR245409 Voxtalisib VOXTALISIB Voxtalisib (XL-765) Voxtalisib (SAR245409) Voxtalisib (XL765, SAR245409) SAR245409 (XL765, Voxtalisib) Voxtalisib (SAR245409, XL765) Analogue 2-Amino-8-ethyl-4-methyl-6-(1H-pyrazol-5-yl)pyrido[2,3-d]pyrimidin-7(8H)-one | |
| 449 | 942206-85-1 | GSK1016790A | GSK101 CS-2774 GSK1016790A GSK 1016790A GSK-1016790A GSK1016790A (GSK101) N-((S)-1-(4-((S)-2-(2,4-dichlorophenylsulfonaMido)-3-hydroxypropanoyl)piperazin-1-yl)-4-Methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxaMide (N-((1S)-1-{[4-((2S)-2-{[(2,4-Dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide Benzo[b]thiophene-2-carboxamide, N-[(1S)-1-[[4-[(2S)-2-[[(2,4-dichlorophenyl)sulfonyl]amino]-3-hydroxy-1-oxopropyl]-1-piperazinyl]carbonyl]-3-methylbutyl]- | Cell biology reagent |
| 450 | 946128-88-7 | Ro 5126766 | CS-1469 CH5126766 Ro 5126766 RO5126766(CH5126766) 3-{2-(methylaminosulfonyl)amino-3-fluoropyridin-4-ylmethyl}-4-methyl-7-(pyrimidin-2-yloxy)-2-oxo-2H-1-benzopyran Sulfamide, N-[3-fluoro-4-[[4-methyl-2-oxo-7-(2-pyrimidinyloxy)-2H-1-benzopyran-3-yl]methyl]-2-pyridinyl]-N'-methyl- 3-[[2-[(Methylaminosulfonyl)amino]-3-fluoropyridin-4-yl]methyl]-4-methyl-7-[(pyrimidin-2-yl)oxy]-2H-1-benzopyran-2-one RO5126766(CH5126766) 3-[[2-[(Methylaminosulfonyl)amino]-3-fluoropyridin-4-yl]methyl]-4-methyl-7-[(pyrimidin-2-yl)oxy]-2H-1-benzopyran-2-one | |
| 451 | 1000787-75-6 | Tegobuvir | GS9190 GS 9190 GS 9190 GS333126 GS 333126 Tegobuvir GS 333126 GS-333126 Tegobuvir (GS-9190) 5-[[6-[2,4-Bis(trifluoromethyl)phenyl]-3-pyridazinyl]methyl]-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine 5-((6-(2,4-bis(TrifluoroMethyl)phenyl)pyridazin-3-yl)Methyl)-2-(2-fluorophenyl)-5H-iMidazo[4,5-c]pyridine | Metabolism |
| 452 | 1001288-58-9 | FT011 | FT011 SHP-627 (E)-2-[[3-(3-Methoxy-4-propargyloxyphenyl)-1-oxo-2-propenyl]amino]benzoic Acid Benzoic acid, 2-[[(2E)-3-[3-methoxy-4-(2-propyn-1-yloxy)phenyl]-1-oxo-2-propen-1-yl]amino]- | Inhibitor |
| 453 | 1005491-05-3 | Tirasemtiv | CK 2017357 TiraseMtiv Tirasemtiv TIRASEMTIV(CK-2017357) Tirasemtiv(CK-2017357) tiraseMtiv (CK-2017357) 6-ethynyl-1-(pentan-3-yl)-1H-iMidazo[4,5-b]pyrazin-2-ol 6-ETHYNYL-1-(PENTAN-3-YL)-1H-IMIDAZO[4,5-B]PYRAZIN-2(3H)-ONE 1-(1-Ethylpropyl)-6-ethynyl-1,3-dihydro-2H-imidazo[4,5-b]pyrazin-2-one Tirasemtiv 1-(1-Ethylpropyl)-6-ethynyl-1,3-dihydro-2H-imidazo[4,5-b]pyrazin-2-one Tirasemtiv 1-(1-Ethylpropyl)-6-ethynyl-1,3-dihydro-2H-imidazo[4,5-b]pyrazin-2-one | Chemical reagent |
| 454 | 1005780-62-0 | TAK-593 | TAK-593 1005780-62-0 1H-Pyrazole-5-carboxamide, N-[5-[[2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl]oxy]-2-methylphenyl]-1,3-dimethyl- | Cell biology reagent |
| 455 | 1006036-87-8 | MK-2894 | MK2894 MK 2894 MK-2894 4-{1-[({2,5-Dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic acid 4-[1-[[[2,5-Dimethyl-4-[[4-(trifluoromethyl)phenyl]methyl]-3-thienyl]carbonyl]amino]cyclopropyl]benzoic acid Benzoic acid, 4-[1-[[[2,5-dimethyl-4-[[4-(trifluoromethyl)phenyl]methyl]-3-thienyl]carbonyl]amino]cyclopropyl]- | G protein coupled receptor & G protein |
| 456 | 1011301-27-1 | Tenovin-3 | CS-1154 TENOVIN3 Tenovin-3 TENOVIN 3 TENOVIN-3 N-(4-aMinophenylcarbaMothioyl)-4-tert-butylbenzaMide 1-(4-AMino-phenyl)-3-(4-tert-butyl-benzoyl)-thiourea N-[[(4-Aminophenyl)amino]thioxomethyl]-4-(1,1-dimethylethyl)benzamide TENOVIN-3 1-(4-AMino-phenyl)-3-(4-tert-butyl-benzoyl)-thiourea | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 457 | 1019331-10-2 | S0859 | S0859 100852 S 0859 CS-1766 S 0859 S-0859 (4S)-4-HYDROXY-4-[(3R)-3-HYDROXYBUTYL]-3,5,5-TRIMETHYL-2-CYCLOHEXEN-1-ONE 2-Chloro-N-((2'-(N-cyanosulfamoyl)-[1,1'-biphenyl]-4-yl)methyl)-N-(4-methylbenzyl)benzamide 2-Chloro-N-[[2′-[(cyanoamino)sulfonyl][1,1′-biphenyl]-4-yl]methyl]-N-[(4-methylphenyl)methyl]-benzamide 2-chloro-N-[[2'-[(cyanoamino)sulfonyl][1,1'-biphenyl]-4-yl]methyl]-N-[(4-methylphenyl)methyl]- S0859 | APIs;Inhibitors;Ion channels;Membrane transport;Cell biology reagents;Small molecule inhibitors;Membrane transport/ion channels;Small molecule inhibitors, natural products |
| 458 | 1020315-31-4 | PF-04457845 | CS-1549 PF04457845 PF-04457845 N-Pyridazin-3-yl-4-(3-{[5-(trifluoroMethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxaMide N-3-Pyridazinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methylene]-1-piperidinecarboxamide N-pyridazin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methylidene]piperidine-1-carboxamide 1-Piperidinecarboxamide, n-3-pyridazinyl-4-[[3-[[5-(trifluoromethyl)-2- pyridinyl]oxy]phenyl]methylene]- | Nerve signal |
| 459 | 102121-60-8 | 4-[(5,6,7,8-Tetrahydro-5,5,8,8-Tetramethyl-2-Naphthalenyl)Carboxamido]Benzoic Acid | AM580 AM 580 AM580 AM580 4-(1,1,4,4-Tetramethyltetralin-6-ylcarbonylamino)benzoic acid 4-((5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbonyl)aminobenz 2-Naphthalenecarboxamide,5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-N-3-quinolinyl- 4-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalene-2-carboxamido)benzoic acid 4-[(5,6,7,8-Tetrahydro-5,5,8,8-Tetramethyl-2-Naphthalenyl)Carboxamido]Benzoic Acid 4-[(5,6,7,8-TETRAHYDRO-5,5,8,8-TETRAMETHYL-2-NAPHTHALENYL)CARBOXAMIDO]BENZOIC ACID 4-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalene-2-ylcarbonylamino)benzoic acid Benzoic acid,4-[[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbonyl]amino]- | Cell biology reagent;Intracellular receptor;Signal transduction pathway kinase inhibitor |
| 460 | 1032229-33-6 | A939572 | A939572 A-939572 A 939572 SCD inhibitor stearoyl-CoA desaturase (SCD) inhibitor 4-(2-Chlorophenoxy)-N-[3-[(methylamino)carbonyl]phenyl]-1-Piperidinecarboxamide 4-(2-Chlorophenoxy)-N-(3-(methylcarbamoyl)-phenyl)piperidine-1-carboxamide (A939572) | Cell biology reagent |
| 461 | 1033836-12-2 | HPGDS inhibitor 1 | CS-1438 MDK36122 HPGDS inhibitor 1 Prostaglandin D Synthase (hematopoietic-type) Inhibitor I 6-(3-fluorophenyl)-N-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)nicotinaMide 6-(3-Fluorophenyl)-N-[1-(2,2,2-trifluoroethyl)-4-piperidinyl]-3-pyridinecarboxamide 3-PYRIDINECARBOXAMIDE, 6-(3-FLUOROPHENYL)-N-[1-(2,2,2-TRIFLUOROETHYL)-4-PIPERIDINYL]- | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 462 | 1037792-44-1 | MBX-2982 | MBX2982 MBX-2982 SAR-260093 2-[1-(5-ethylpyrimidin-2-yl)-4-piperidyl]-4-[[4-(tetrazol-1-yl)phenoxy]methyl]thiazole pyrimidine, 5-ethyl-2-[4-[4-[[4-(1h-tetrazol-1-yl)phenoxy]methyl]-2-thiazolyl]-1-piperidinyl]- 5-Ethyl-2-[4-[4-[[[4-(1H-tetrazol-1-yl)phenyl]oxy]methyl]thiazol-2-yl]piperidin-1-yl]pyrimidine 5-Ethyl-2-[4-[4-[[[4-(1H-tetrazol-1-yl)phenyl]oxy]methyl]thiazol-2-yl]piperidin-1-yl]pyrimidine MBX-2982 | Inhibitors;Small molecule inhibitors;G protein coupled receptors & G proteins;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors |
| 463 | 1042672-97-8 | IRAK inhibitor 6 | CS-647 CS-2482 IRAK-IN-6 IRAK inhibitor 6 N-[2-methoxy-4-(4-morpholinyl)phenyl]-2-(3-pyridinyl)- N-(2-Methoxy-4-Morpholinophenyl)-2-(pyridin-3-yl)thiazole-4-carboxaMide N-[2-Methoxy-4-(4-morpholinyl)phenyl]-2-(3-pyridinyl)-4-thiazolecarboxamide 4-ThiazolecarboxaMide, N-[2-Methoxy-4-(4-Morpholinyl)phenyl]-2-(3-pyridinyl)- | azole |
| 464 | 107257-28-3 | PK14105 | PK14105 PK 14105 1-(2-Fluoro-5-nitrophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide 3-Isoquinolinecarboxamide, 1-(2-fluoro-5-nitrophenyl)-N-methyl-N-(1-methylpropyl)- | |
| 465 | 1088991-73-4 | MK-6096 | MK6096 MK 6096 CS-1825 MK-6096 Filorexant FILOREXANT MK-6096(Filorexant) ((2R,5R)-5-(((5-Fluoropyridin-2-yl)oxy)methyl)-2-methylpiperidin-1-yl)(5-methyl-2-(pyrimidin-2-yl)phenyl)methanone MK6096 | |
| 466 | 1093070-14-4 | PLpro inhibitor | BENZAMIDE PLpro inhibitor 5-acetamido-2-methyl-n-(2-naphthalen-1-ylethyl)benzamide 5-acetamido-2-methyl-N-[2-(1-naphthalenyl)ethyl]benzamide 5-(acetylamino)-2-methyl-N-[(1R)-1-(1-naphthalenyl)ethyl]- 5-(ACETYLAMINO)-2-METHYL-N-[(1R)-1-(1-NAPHTHALENYL)ETHYL]- 5-acetylamino-2-methyl-N-[(R)-1-(1-naphthyl)ethyl]benzamide 5-Acetylamino-2-methyl-N-(1R-naphthalen-1-yl-ethyl)benzamide 5-(Acetylamino)-2-methyl-N-[(1R)-1-(1-naphthalenyl)ethyl]benzamide | |
| 467 | 1093222-27-5 | Pim1/AKK1-IN-1 | CS-2864 3-B]PYRIDIN-3-YL]- 3-b]pyridin-3-yl]- AAK1 DUAL INHIBITOR 3-PYRIDINECARBOXAMIDE LKB1(AAK1 dual inhibitor) N-[5-(4-cyanophenyl)-1H-pyrrolo[2 N-[5-(4-CYANOPHENYL)-1H-PYRROLO[2 N-[5-(4-Cyanophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-3-pyridinecarboxamide | reference substance;Cell biology reagent |
| 468 | 1096687-52-3 | SPK-601 | SPK601 SPK-601 LMV-601 SPK 601 SPK-0601 Carbonodithioic acid rel-(-)-O-[(3aR,4R,5S,7R,7aR)-octahydro-4,7-methano-1H-inden-5-yl] ester potassium salt | Apoptosis |
| 469 | 1099644-42-4 | ITD-1 | ITD1 ITD 1 ITD-1 AOB6123 CS-1731 SCHEMBL3239096 ETHYL 4-{[1,1'-BIPHENYL]-4-YL}-2,7,7-TRIMETHYL-5-OXO-1,4,6,8-TETRAHYDROQUINOLINE-3-CARBOXYLATE 4-[1,1'-Biphenyl]-4-yl-1,4,5,6,7,8-hexahydro-2,7,7-trimethyl-5-oxo-3-quinolinecarboxylic acid ethyl ester 3-Quinolinecarboxylic acid, 4-[1,1'-biphenyl]-4-yl-1,4,5,6,7,8-hexahydro-2,7,7-trimethyl-5-oxo-, ethyl ester | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 470 | 1103522-45-7 | N-Despropyl-macitentan | ACT132577 ACT-132577 ACT 132577 ACT-132577 Aprocitentan APROCITENTAN Despropyl Macitentan DESPROPYL MACITENTAN N-Despropyl Macitentan N-Despropyl-macitentan Macitentan N-Despropyl Impurity 5-(4-BROMOPHENYL)-4-[2-(5-BROMOPYRIMIDIN-2-YL)OXYETHOXY]-6-(SULFAMOYLAMINO)PYRIMIDINE N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]sulfamide | APIS;176-marcetane |
| 471 | 1110766-97-6 | Lusutrombopag | S888711 S 888711 Lusutrombopag Lusutrombopag S-888711 (E)-3-[2,6-dichloro-4-[4-[3-[(S)-1-hexyloxyethyl]-2-methoxyphenyl]thiazol-2-ylcarbamoyl]phenyl]-2-methylacrylic acid 2-Propenoic acid, 3-[2,6-dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-, (2E)- | API |
| 472 | 1123231-07-1 | WAY-262611 | DKK1 MAY-262611 WAY-262611 1-[4-(2-Naphthalenyl)-2-pyrimidinyl]-4-piperidinemethanamine 1-{1-[4-(2-Naphthyl)-2-pyrimidinyl]-4-piperidinyl}methanamine 4-PiperidineMethanaMine, 1-[4-(2-naphthalenyl)-2-pyriMidinyl]- 1-[4-(2-Naphthalenyl)-2-pyrimidinyl]-4-piperidinemethanamine MAY-262611 | Inhibitors;Kit-Elisa kit;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 473 | 1123838-51-6 | Glesatinib (hydrochloride) | CS-2642 Glesatinib HCl MGCD-265 HYDROCHLORIDE Glesatinib (hydrochloride) | Cell biology reagent |
| 474 | 1125758-85-1 | A-804598 | CS-2234 A 804598 A-804598 1-cyano-2-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine 1-CYANO-2-[(1S)-1-PHENYLETHYL]-3-QUINOLIN-5-YLGUANIDINE 2-Cyano-1-[(1S)-1-phenylethyl]-3-(5-quinolinyl)guanidine N-Cyano-N′′-[(1S)-1-phenylethyl]-N′-5-quinolinyl-guanidine Guanidine, N-cyano-N''-[(1S)-1-phenylethyl]-N'-5-quinolinyl- | |
| 475 | 1126084-37-4 | ASP-9521 | ASP9521 ASP-9521 ASP 9521 ASP-9521 17HSD5 inhibitor AKR1C3 inhibitor AKR1C3 INHIBITOR 17HSD5 INHIBITOR 17??HSD5 INHIBITOR ASP 9521. AKR1C3 inhibitor ASP 9521. AKR1C3 INHIBITOR 1-[1-[(5-Methoxy-1H-indol-2-yl)carbonyl]piperidin-4-yl]-2-methylpropan-2-ol [4-(2-Hydroxy-2-methylpropyl)-1-piperidinyl](5-methoxy-1H-indol-2-yl)methanone | |
| 476 | 1132935-63-7 | ABT-333 | ABT333 CS-2000 ABT-333 ABT 333 Dasabuvir Dasabuvir (ABT-333) N-{6-[5-(2,4-Dioxo-3,4-dihydro-1(2H)-pyrimidinyl)-2-methoxy-3-(2-methyl-2-propanyl)phenyl]-2-naphthyl}methanesulfonamide N-[6-[3-tert-Butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl]naphthalen-2-yl]methanesulfonamide Dasabuvir (ABT-333) | Pharmaceutical raw materials |
| 477 | 1133432-46-8 | GDC-0834 (Racemate) | CS-1264 GDC0834 GDC 0834 GDC-0834 (Racemate) GDC-0834 (RaceMate) N-[3-[6-[[4-(1,4-Dimethyl-3-oxo-2-piperazinyl)phenyl]amino]-4,5-dihydro-4-methyl-5-oxo-2-pyrazinyl]-2-methylphenyl]-4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxamide Benzo[b]thiophene-2-carboxamide, N-[3-[6-[[4-(1,4-dimethyl-3-oxo-2-piperazinyl)phenyl]amino]-4,5-dihydro-4-methyl-5-oxo-2-pyrazinyl]-2-methylphenyl]-4,5,6,7-tetrahydro- | |
| 478 | 1137868-52-0 | TAK-960 | CS-554 TAK960 TAK-960 TAK 960 CS-1725 4-((9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino)-2-fluoro-5-methoxy-N-(1-methylpiperidin-4-yl)benzamide 4-[(9-Cyclopentyl-7,7-difluoro-6,7,8,9-tetrahydro-5-methyl-6-oxo-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2-fluoro-5-methoxy-N-(1-methyl-4-piperidinyl)benzamide Benzamide, 4-[(9-cyclopentyl-7,7-difluoro-6,7,8,9-tetrahydro-5-methyl-6-oxo-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2-fluoro-5-methoxy-N-(1-methyl-4-piperidinyl)- | Inhibitor;Cell biology reagent |
| 479 | 1138245-13-2 | Mirogabalin | DS5565 A200-0700 Asapiprant Mirogabalin [(1R,5S,6S)-6-(Aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl]acetic acid 2-((1R,5S,6S)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic acid 2-[(1R,5S,6S)-6-(aminomethyl)-3-ethyl-6-bicyclo[3.2.0]hept-3-enyl]acetic acid | API;Chemical reagents;API and intermediates |
| 480 | 115066-14-3 | 6-Cyano-7-Nitroquinoxaline-2,3-Dione | CNQX FG-9065 CNQX 2NA CNQX DISODIUM CNQX DISODIUM SALT 6-Cyano-7-Nitroquinoxaline-2,3-Dione 6-CYANO-7-NITROQUINOXALINE-2,3 (1H,4H)-DIONE 7-Nitro-2,3-dioxo-2,3-dihydroquinoxaline-6-carbonitrile | Glutamate;Aromatics;Synthesis;Heterocycles;Neurochemicals;Glutamate receptor;Heterocyclic Compounds |
| 481 | 1161233-85-7 | BTZ043 | BTZ043 CS-2310 PBTZ 169 BTZ 10526043 BTZ043 raceMate BTZ043 (BTZ-043 2-[(3S)-3-methyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl]-8-nitro-6-(trifluoromethyl)-1,3-benzothiazin-4-one 2-[(2S)-2-Methyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl]-8-nitro-6-trifluoromethyl-4H-1,3-benzothiazin-4-one | Inhibitor;Cell biology reagent |
| 482 | 1166827-44-6 | AZD7687 | AZD7687 AZD 7687 AZD-7687 [trans-4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl]acetic acid Cyclohexaneacetic acid, 4-[4-[6-(aminocarbonyl)-3,5-dimethyl-2-pyrazinyl]phenyl]-, trans- | Metabolism |
| 483 | 116686-15-8 | FK 3311 | FK-3311 FK3311 FK 3311 CS-1073 COX-2 Inhibitor V COX-2 Inhibitor V, FK3311 N-[4-Acetyl-2-(2,4-difluorophenoxy)phenyl]methanesulfonamide Methanesulfonamide, N-[4-acetyl-2-(2,4-difluorophenoxy)phenyl]- N-[4-Acetyl-2-(2,4-difluorophenoxy)phenyl]-methanesulfonamide FK3311 | Inhibitor |
| 484 | 1170856-93-5 | Calcein (tetraethyl ester) | Calcein tetraethyl ester Fluorexon tetraethyl ester Calcein (tetraethyl ester) TETRAETHYL FLUORESCEIN BIS(METHYLENE)BIS(AZANETRIYL)TETRAACETATE Tetraethyl Fluorescein Bis(methylene)bis(azanetriyl)tetraacetate Tetraethyl 2,2',2'',2'''-(((3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-4',5'-diyl)bis(methylene))bis(azanetriyl))tetraacetate N,N'-[(3',6'-Dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-4',5'-diyl)bis(methylene)]bis[N-(2-ethoxy-2-oxoethyl)-glycine] 1,1'-diethyl ester Glycine, N,N'-[(3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-4',5'-diyl)bis(methylene)]bis[N-(2-ethoxy-2-oxoethyl)-, 1,1'-diethyl ester | Fluorescent labeling dye |
| 485 | 1181770-72-8 | EMD638683 | EMD638683 ]-2-ethyL EMD-638683 EMD 638683 N'-[2-(3,5-DifL )-2-hydroxyacetyL N'-(2-(3,5-difluorophenyl)-2-hydroxyacetyl)-2-ethyl-4-hydroxy-3-methylbenzohydrazide Benzeneacetic acid, 3,5-difluoro-α-hydroxy-, 2-(2-ethyl-4-hydroxy-3-methylbenzoyl)hydrazide 3,5-Difluoro-alpha-hydroxybenzeneacetic acid 2-(2-ethyl-4-hydroxy-3-methylbenzoyl)hydrazide | |
| 486 | 1184136-10-4 | UNC-926 Hydrochloride | UNC926 UNC 926 UNC-926 UNC-926 Hydochloride UNC-926 Hydrochloride (3-bromophenyl)-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone (3-Bromophenyl)[4-(1-pyrrolidinyl)-1-piperidinyl]-methanone Methanone, (3-bromophenyl)[4-(1-pyrrolidinyl)-1-piperidinyl]- (3-Bromophenyl)[4-(1-prrolidinyl)-1-piperidinyl]methanone hydrochloride | Amines;Aromatics;Heterocycles;Pharmaceuticals;Intermediates & Fine Chemicals |
| 487 | 1190308-01-0 | PSI-7976 | PSI-7976 Y008005-A Sofosbuvir (R)-Phosphate N-[[P(R),2'R]-2'-Deoxy-2'-fluoro-2'-methyl-P-phenyl-5'-uridylyl]-L-alanine 1-methylethyl ester L-Alanine, N-[[P(R),2'R]-2'-deoxy-2'-fluoro-2'-methyl-P-phenyl-5'-uridylyl]-, 1-methylethyl ester isopropyl ((R)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanite isopropyl ((R)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-Lalaninate (S)-isopropyl 2-((R)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphorylamino)propanoate | Sofosbuvir impurity;Reference substance-impurity reference substance |
| 488 | 1190932-38-7 | COH29 | COH29 COH-29 181687 COH 29 CS-2737 RNR Inhibitor COH29 N-(4-(3,4-dihydroxyphenyl)-5-phenylthiazol-2-yl)-3,4-dihydroxybenzamide Benzamide, N-[4-(3,4-dihydroxyphenyl)-5-phenyl-2-thiazolyl]-3,4-dihydroxy- | Standard;Cell biology reagent |
| 489 | 1191911-26-8 | CZC-25146 | CZC25146 CZC 25146 CZC-25146 CHEMBL2397014 LRRK2 INHIBITOR II LRRK2 Inhibitor II N-(2-(2-(2-Methoxy-4-MorpholinophenylaMino)-5-fluoropyriMidin-4-ylaMino)phenyl)MethanesulfonaMide N-(2-((5-fluoro-2-((2-methoxy-4- morpholinophenyl)amino)pyrimidin- 4- yl)amino)phenyl)methanesulfonamide N-[2-[[5-Fluoro-2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]phenyl]methanesulfonamide Methanesulfonamide, N-[2-[[5-fluoro-2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]phenyl]- | API;Amines, Aromatics, Heterocycles, Inhibitors, Pharmaceuticals, Intermediates & Fine Chemicals |
| 490 | 1191911-27-9 | CZC-54252 | CS-1730 CZC54252 CZC 54252 CZC-54252 CZC 54252 hydrochloride N-(2-(5-chloro-2-(2-methoxy-4-morpholinophenylamino)pyrimidin-4-ylamino)phenyl)methanesulfonamide Methanesulfonamide, N-[2-[[5-chloro-2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]phenyl]- N-[2-[[5-Chloro-2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]phenyl]methanesulfonamide hydrochloride | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 491 | 1197300-24-5 | TGR5 Receptor Agonist | TGR5 TGR5 Receptor Agonist 3-(2-CHLOROPHENYL)-N-(4-CHLOROPHENYL)-N,5-DIMETHYLISOXAZOLE-4-CARBOXAMIDE 3-(2-chlorophenyl)-N-(4-chlorophenyl)-N,5-diMethyl-4-IsoxazolecarboxaMide 4-IsoxazolecarboxaMide, 3-(2-chlorophenyl)-N-(4-chlorophenyl)-N,5-diMethyl- 3-(2-Chlorophenyl)-N-(4-chlorophenyl)-N,5-dimethyl-4-isoxazolecarboxamide TGR5 TGR5 4-IsoxazolecarboxaMide, 3-(2-chlorophenyl)-N-(4-chlorophenyl)-N,5-diMethyl- | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 492 | 1198300-79-6 | Cerdulatinib | CS-1823 PRT2070 PRT 2070 PRT062070 PRT-2070 PRT-062070 PRT 062070 PRT-062070 Cerdulatinib Cerdulatinib(PRT-062070 PRT 062070 (Cerdulatinib) 4-(Cyclopropylamino)-2-[[4-[4-(ethylsulfonyl)-1-piperazinyl]phenyl]amino]-5-pyrimidinecarboxamide 4-(cyclopropylamino)-2-(4-(4-(ethylsulfonyl)piperazin-1-yl)phenylamino)pyrimidine-5-carboxamide PRT062070 | Standards;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 493 | 1199796-29-6 | INT-777 | S-EMCA INT-777 CS-1212 INT-777, S-EMCA 6α-Ethyl-23(S)-Methylcholic acid 6a-Ethyl-23(S)-methylcholic acid 6alpha-Ethyl-23(S)-methylcholic acid Cholane-23-carboxylic acid, 6-ethyl-3,7,12-trihydroxy-, (3α,5β,6α,7α,12α,23S)- | biochemical reagent |
| 494 | 1202916-90-2 | CX-6258 | CX6258 CX-6258 CX 6258 (Z)-5-CHLORO-3-((5-(3-(4-METHYL-1,4-DIAZEPANE-1-CARBONYL)PHENYL)FURAN-2-YL)METHYLENE)INDOLIN-2-ONE.HCL (3E)-5-Chloro-3-[[5-[3-[(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)carbonyl]phenyl]-2-furanyl]methylene]-1,3-dihydro-2H-indol-2-one (3E)-5-Chloro-3-[[5-[3-[(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)carbonyl]phenyl]-2-furanyl]methylene]-1,3-dihydro-2H-indol-2-one CX-6258 CX6258 (3E)-5-Chloro-3-[[5-[3-[(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)carbonyl]phenyl]-2-furanyl]methylene]-1,3-dihydro-2H-indol-2-one | JAK;STAT;JAK/STAT;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 495 | 1206123-37-6 | Etrasimod | APD334 CS-2445 APD-334 APD 334 APD-334 APD 334 Etrasimod ETRASIMOD Neflamapimod Etrasimod(APD334) (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid | APIS;Inhibitors;APIs and intermediates |
| 496 | 1206801-37-7 | LY2801653 (dihydrochloride) | CS-1046 LY2801653 LY2801653 2HCl LY-2801653 DIHYDROCHLORIDE LY-2801653 dihydrochloride LY 2801653 dihydrochloride LY2801653 (dihydrochloride) LY 2801653 DIHYDROCHLORIDE Merestinib(LY2801653 dihydrochloride) | reference substance;Cell biology reagent |
| 497 | 1210004-12-8 | 4-nitrophenyl 4-(3-phenoxybenzyl)piperazine-1-carboxylate | JZL195 JZL-195 CS-1586 JZL 195 4-nitrophenyl 4-(3-phenoxybenzyl)piperazine-1-carboxylate 4-[(3-Phenoxyphenyl)methyl]-1-piperazinecarboxylic acid 4-nitrophenyl ester 1-Piperazinecarboxylic acid, 4-[(3-phenoxyphenyl)methyl]-, 4-nitrophenyl ester | API;Medicine;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 498 | 1211443-80-9 | LEE011 (hydrochloride) | LEE011 HCl Ribociclib HCl LEE011 (hydrochloride) Ribociclib (Hydrochloride) LEE-011 HCl salt, Ribociclib HCl salt RIBOCICLIB HYDROCHLORIDE (LEE011 HYDROCHLORIDE) 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide hydrochloride | Cell biology reagent |
| 499 | 1225037-39-7 | PQR309 | PQR309 PQR 309 PQR-309 CS-2024 PI3K-IN-2 Bimiralisib PQR309 Bimiralisib Bimiralisib (PQR309)(free base) 5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine | APIs;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 500 | 1229652-21-4 | HA 130 | HA130 HA 150 HA-130 HA 130 CS-1606 HA130 (HA-130) HA130 (Autotaxin Inhibitor) (Z)-3-((4-((3-(4-fluorobenzyl)-2,4-dioxothiazolidin-5-ylidene)methyl)phenoxy)methyl)phenylboronic acid B-[3-[[4-[[3-[(4-Fluorophenyl)Methyl]-2,4-dioxo-5-thiazolidinylidene]Methyl]phenoxy]Methyl]phenyl]boronic Acid | A;Aromatics;Inhibitors;Heterocycles;Boron Derivatives;Intermediates & F;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products;Aromatics, Boron Derivatives, Hetero |
| 501 | 123066-64-8 | 4-(3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl)-phenylamine | CRAC 2 CRAC intermediate 2 4-[3,5-bis(trifluoromethyl)pyrazol-1-yl]aniline 4-(3,5-Bis(trifluoroMethyl)-1H-pyrazol-1-yl)aniline 4-(3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl)-phenylamine Benzenamine, 4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]- | |
| 502 | 1232221-74-7 | APY0201 | APY0201 APY 0201 APY-0201 N-(3-methylbenzylidene)-N'-(7-morpholin-2-pyridin-4-yl-pyrazolo[1,5-a]pyrimidin-5-yl)hydrazine Benzaldehyde, 3-methyl-, 2-[7-(4-morpholinyl)-2-(4-pyridinyl)pyrazolo[1,5-a]pyrimidin-5-yl]hydrazone (E)-4-(5-(2-(3-methylbenzylidene)hydrazinyl)-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl)morpholine N-(3-Methylbenzylidene)-N'-[7-(morpholin-4-yl)-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-5-yl]hydrazine 4-{5-[(E)-2-[(3-methylphenyl)methylidene]hydrazin-1-yl]-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl}morpholine | Inhibitors;Customized;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 503 | 1233706-88-1 | CAY10650 | CS-1520 CAY10650 CAY 10650 CAY-10650 3-isobutanoyl-1-[2-oxo-3-(4-phenoxyphenoxy)propyl]indole-5-carboxylic acid 3-(2-Methyl-1-oxopropyl)-1-[2-oxo-3-(4-phenoxyphenoxy)propyl]-1H-indole-5-carboxylic acid 1H-Indole-5-carboxylic acid, 3-(2-Methyl-1-oxopropyl)-1-[2-oxo-3-(4-phenoxyphenoxy)propyl]- | |
| 504 | 1233948-35-0 | ELR510444 | CS-1765 LR-510444 ELR510444 ELR-510444 N-[5-(5-Cyano-2-thienyl)-2-methylphenyl]-4-methylbenzenesulfonamide N-(5-(5-cyanothiophen-2-yl)-2-Methylphenyl)-4-MethylbenzenesulfonaMide N-(5-(5-cyanothiophen-2-yl)-2-methylphenyl)-4-methylbenzenesulfonamide ELR-510444 | API;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 505 | 1234479-76-5 | ERK5-IN-1 | CS-2049 XMD 8-85 ERK5-IN-1 ERK5 inhibitor 1 ERK5-IN-1 XMD 8-85 6H-PyriMido[4,5-b][1,4]benzodiazepin-6-one, 5,11-dihydro-2-[[2-Methoxy-4-(4-Methyl-1-piperazinyl)phenyl]aMino]-5,11-diMethyl- | |
| 506 | 1234563-16-6 | Epetraborole (hydrochloride) | AN3365 AN 3365 AN-3365 AN3365HCL GSK2251052 GSK-2251052 GSK 2251052 Epetraborole HCl AN3365 (hydrochloride) Epetraborole (hydrochloride) (S)-3-(aMinoMethyl)-7-(3-hydroxypropoxy)benzo[c][1,2]oxaborol-1(3H)-ol | |
| 507 | 1235403-62-9 | PF 05089771 | CS-2129 PF5089771 PF05089771 PF 05089771 PF-05089771 Nav1.7-IN-1 4-(2-(3-amino-1H-pyrazol-4-yl)-4-chlorophenoxy)-5-chloro-2-fluoro-N-(thiazol-4-yl)benzenesulfonamide 4-(2-(3-AMINO-1H-PYRAZOL-4-YL)-4-CHLOROPHENOXY)-5-CHLORO-2-FLUORO-N-(THIAZOL-4-YL)BENZENESULFONAMIDE 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide | API |
| 508 | 1235481-90-9 | P7C3-A20 | CS-2365 P7C3-A20 N-(3-(3,6-DIBROMO-9H-CARBAZOL-9-YL)-2-FLUOROPROPYL)-3-METHOXYANILINE 9H-Carbazole-9-propanamine, 3,6-dibromo-β-fluoro-N-(3-methoxyphenyl)- 3,6-Dibromo-beta-fluoro-N-(3-methoxyphenyl)-9H-carbazole-9-propanamine P7C3-A20 3,6-Dibromo-beta-fluoro-N-(3-methoxyphenyl)-9H-carbazole-9-propanamine | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 509 | 1235560-28-7 | ABT-639 | ABT-693 CS-2286 ABT-639 ABT-639 (ABT639 ABT-639, CID 46851313 (R)-4-chloro-2-fluoro-N-(2-fluorophenyl)-5-(octahydropyrrolo[1,2-a]pyrazine-2-carbonyl)benzenesulfonamide 4-CHLORO-2-FLURO-N-(2-FLUOROPHENYL)-5-[(8AR)-HEXAHYDROPYRROLO[1,2-A]PYRAZIN-2(1H)-YLCARBONYL]BENZENESULFONAMIDE 4-Chloro-2-fluoro-N-(2-fluorophenyl)-5-[[(8aR)-hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]carbonyl]benzenesulfonamide | |
| 510 | 1237744-13-6 | 4-[6-Methoxy-2-[(1E)-2-(3-nitrophenyl)ethenyl]-4-oxo-3(4H)-quinazolinyl]-benzoic Acid | QNZ46 QNZ-46 QNZ 46 CS-2059 4-[6-Methoxy-2-[(1E)-2-(3-nitrophenyl)ethenyl]-4-oxo-3(4H)-quinazolinyl]-benzoic Acid | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 511 | 1252594-99-2 | ETP-46321 | CS-2500 ETP46321 ETP-46321 ETP 46321 5-(2-((4-methylsulfonylpiperazin-1-yl)methyl)-8-morpholinoimidazo[1,2-a]pyrazin-6-yl)pyrimidin-2-amine 2-Pyrimidinamine, 5-[2-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-8-(4-morpholinyl)imidazo[1,2-a]pyrazin-6-yl]- | Cell biology reagent |
| 512 | 1253452-78-6 | KS176 | KS176 KS-176 KS 176 CS-2318 N-(4-(2-hydroxyethyl)phenyl)-2-(4-nitrobenzamido)benzamide N-[4-(2-Hydroxyethyl)phenyl]-2-[(4-nitrobenzoyl)amino]-benzamide Benzamide, N-[4-(2-hydroxyethyl)phenyl]-2-[(4-nitrobenzoyl)amino]- | inhibitors;Cell biology reagents |
| 513 | 1257213-50-5 | BMS-986020 | AM152 CS-2492 BMS986020 BMS 986020 BMS-986020 1-{4'-[3-methyl-4-((R)-1-phenyl-ethoxycarbonylamino)-isoxazol-5-yl]-biphenyl-4-yl}-cyclopropanecarboxylic acid Cyclopropanecarboxylic acid, 1-[4'-[3-methyl-4-[[[(1R)-1-phenylethoxy]carbonyl]amino]-5-isoxazolyl][1,1'-biphenyl]-4-yl]- (R)-1-(4'-(3-methyl-4-(((1-phenylethoxy)carbonyl)amino)isoxazol-5-yl)-[1,1'-biphenyl]-4-yl)cyclopropane-1-carboxylic acid | Inhibitor |
| 514 | 1257426-19-9 | TBA-354 | TBA354 TBA-354 TBA 354 EOS-60528 (S)-2-Nitro-6-((6-(4-(trifluoromethoxy)phenyl)pyridin-3-yl)methoxy)-6,7-dihydro-5H-imidazo[2,1 (S)-2-nitro-6-((6-(4-(trifluoroMethoxy)phenyl)pyridin-3-yl)Methoxy)-6,7-dihydro-5H-iMidazo[2,1-b][1,3]oxazine (6S)-6,7-Dihydro-2-nitro-6-[[6-[4-(trifluoromethoxy)phenyl]-3-pyridinyl]methoxy]-5H-imidazo[2,1-b][1,3]oxazine (6S)-2-nitro-6-({6-[4-(trifluoromethoxy)phenyl]-3-pyridinyl}methoxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine BX471(6S)-2-nitro-6-({6-[4-(trifluoromethoxy)phenyl]-3-pyridinyl}methoxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine | Inhibitor |
| 515 | 1258226-87-7 | Ombitasvir | ABT-267 Ombitasvir ombitasvir Viekira Pak) Ombitasvir(ABT-267) 2,2'-[[(2S,5S)-1-[4-(1,1-Dimethylethyl)phenyl]-2,5-pyrrolidinediyl]di-4,1-phenylene]bis[N-(methoxycarbonyl)-L-valyl-L-prolinamide L-Prolinamide, 2,2'-[[(2S,5S)-1-[4-(1,1-dimethylethyl)phenyl]-2,5-pyrrolidinediyl]di-4,1-phenylene]bis[N-(methoxycarbonyl)-L-valyl- | Chemical reagents;Pharmaceutical raw materials |
| 516 | 1262618-39-2 | GS967 | GS967 GS-967 GS 967 GS458967 GS 458967 GS458967 GS-458967 GS 458967 GS967(GS-458967) 6-(4-(trifluoroMethoxy)phenyl)-3-(trifluoroMethyl)-[1,2,4]triazolo[4,3-a]pyridine | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 517 | 129198-88-5 | Autocamtide 2 trifluoroacetate salt | AUTOCAMTIDE-2 Autocamtide II AUTOCAMTIDE-2 [KKALRRQETVDAL] CAM KINASE II SELECTIVE SUBSTRATE Autocamtide 2 trifluoroacetate salt LYS-LYS-ALA-LEU-ARG-ARG-GLN-GLU-THR-VAL-ASP-ALA-LEU L-Leucine,L-lysyl-L-lysyl-L-alanyl-L-leucyl-L-arginyl-L-arginyl-L-glutaminyl-L-a-glutamyl-L-threonyl-L-valyl-L-a-aspartyl-L-alanyl- | Peptide;Standards;Polypeptides;Biochemical reagents;Other biochemical reagents;Calmodulin-dependent protein kinase II;Calmodulin-dependent protein kinase IIEnzyme Subs;Calmodulin-dependent protein |
| 518 | 1292310-49-6 | IKK epsilon-IN-1 | CS-1801 IKKε-IN-1 IKKE-IN-1 IKK epsilon-IN-1 IKK(epsilon)-IN-1 (IKKE-IN-1) 5-[2-(4-Morpholin-4-ylanilino)pyrimidin-4-yl]-2-(oxan-4-yloxy)benzonitrile 5-(2-((4-morpholinophenyl)amino)pyrimidin-4-yl)-2-((tetrahydro-2H-pyran-4-yl)oxy)benzonitrile IKKε-IN-1 | API |
| 519 | 1309357-15-0 | CX-4945 (sodium salt) | 1309357-15-0 CX-4945 Sodium Silmitasertib sodium CX-4945 (sodium salt) CX-4945 (sodiuM salt) Silmitasertib sodium salt Silmitasertib (CX-4945) Sodium CX-4945 sodium salt(Silmitasertib) Silmitasertib sodium salt,CX-4945 sodium salt CX-4945 sodium salt (Silmitasertib sodium salt) | Standard substance;Reference substance;Cell biology reagent |
| 520 | 1309684-94-3 | RO8994 | RO8994 CS-2264 RO 8994 RO-8994 (2'S,3R,4'S,5'R)-N-[4-(Aminocarbonyl)-2-methoxyphenyl]-6-chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-1,2-dihydro-2-oxo-spiro[3H-indole-3,3'-pyrrolidine]-5'-carboxamide Spiro[3H-indole-3,3'-pyrrolidine]-5'-carboxamide, N-[4-(aminocarbonyl)-2-methoxyphenyl]-6-chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-1,2-dihydro-2-oxo-, (2'S,3R,4'S,5'R)- | API;Cell biology reagent |
| 521 | 1311367-27-7 | BIX 02565 | CS-2569 BIX02565 BIX-02565 BIX 02565 (5R)-N-[1-[3-(Dimethylamino)propyl]-1H-benzimidazol-2-yl]-2,3,4,5-tetrahydro-5-methyl-1-oxo-1H-[1,4]diazepino[1,2-a]indole-8-carboxamide | Cell biology reagent |
| 522 | 1313881-70-7 | ARQ-092 | ARQ092 CS-2349 ARQ-092 ARQ 092 Miransertib MIRANSERTIB AKT inhibitor 2 ARQ 092 Free Base 3-[3-[4-(1-aminocyclobutyl)phenyl]-5-phenylimidazo[4,5-b]pyridin-2-yl]pyridin-2-amine 2-Pyridinamine, 3-[3-[4-(1-aminocyclobutyl)phenyl]-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl]- | inhibitors;Cell biology reagents |
| 523 | 1314118-94-9 | MK2-IN-1 (hydrochloride) | MK 25 1314118-94-9 MK2 Inhibitor IV MK 25 (hydrochloride) MK2-IN-1 (hydrochloride) MK2 inhibitor 1 hydrochloride 5-(4-Chlorophenyl)-N-(4-(piperazin-1-yl)phenyl)-N-(pyridin-2-ylmethyl)furan-2-carboxamide hydrochloride[MK2 Inhibitor Hydrochloride] | |
| 524 | 1314891-22-9 | TMP195 | TMP195 TFMO 2 TMP 195 CS-2651 TMP-195 TMP-195 TMP 195 - TFMO 2 N-[2-Methyl-2-(2-phenyloxazol-4-yl)propyl]-3-[5-(trifluoroMethyl)-1,2,4-oxadiazol-3-yl]benzaMide | API;Standard |
| 525 | 1316755-16-4 | EMA401 | EMA401 CS-2652 EMA-401 EMA 401 Olodanrigan OLODANRIGAN PD-126055 free acid Olodanrigan(EMA401) (S)-5-(benzyloxy)-2-(2,2-diphenylacetyl)-6-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (3S)-2-(2,2-Diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinolinecarboxylic acid | API |
| 526 | 132836-42-1 | YS-49 | YS49 YS 49 YS-49 CS-884 1,2,3,4-Tetrahydro-1-(1-naphthalenylmethyl)-6,7-isoquinolinediol hydrobromide 1,2,3,4-Tetrahydro-1-(1-naphthalenylmethyl)-6,7-Isoquinolinediol hydrobromide monohydrate | Akt;mTOR;PI3K;PI3K/Akt/mTOR |
| 527 | 1333377-65-3 | CHR-6494 | CHR-6494 CHR 6494 trifluoroacetate salt CHR-6494 trifluoroacetate salt Haspin Kinase Inhibitor, CHR-6494 3-(1H-indazol-5-yl)-N-propyliMidazo[1,2-b]pyridazin-6-aMine 3-(1H-Indazol-5-yl)-N-propylimidazo[1,2-b]pyridazin-6-amine trifluoroacetate salt 3-(1H-Indazol-5-yl)-N-propyl-imidazo[1,2-b]pyridazin-6-amine trifluoroacetate salt CHR-6494 3-(1H-indazol-5-yl)-N-propyliMidazo[1,2-b]pyridazin-6-aMine | cell cycle;Cell biology reagents |
| 528 | 133413-70-4 | PF 1022A | PF1022A PF 1022A PF-1022A 133413-70-4 Cyclo(D-2-hydroxypropanoyl-N-methyl-L-leucyl-3-phenyl-D-2-hydroxypropanoyl-N-methyl-L-leucyl-D-2-hydroxypropanoyl-N-methyl-L-leucyl-3-phenyl-D-2-hydroxypropanoyl-N-methyl-L-leucyl) Cyclo[(αR)-α-hydroxybenzenepropanoyl-N-methyl-L-leucyl-(2R)-2-hydroxypropanoyl-N-methyl-L-leucyl-(αR)-α-hydroxybenzenepropanoyl-N-methyl-L-leucyl-(2R)-2-hydroxypropanoyl-N-methyl-L-leucyl] | |
| 529 | 1334179-85-9 | (4-{[Bis-(1-tert-butyl-1H-[1,2,3]triazol-4-ylmethyl)-amino]-methyl}-[1,2,3]triazol-1-yl)-acetic acid | BTTAA (4-{[Bis-(1-tert-butyl-1H-[1,2,3]triazol-4-ylmethyl)-amino]-methyl}-[1,2,3]triazol-1-yl)-acetic acid 2-(4-((Bis(2,2-dimethyl-1-(1H-1,2,3-triazol-4-yl)propyl)amino)methyl)-1H-1,2,3-triazol-1-yl)aceticacid 2-(4-((bis((1-(tert-butyl)-1H-1,2,3-triazol-4-yl)methyl)amino)methyl)-1H-1,2,3-triazol-1-yl)acetic acid 1H-1,2,3-Triazole-1-acetic acid, 4-[[bis[[1-(1,1-diMethylethyl)-1H-1,2,3-triazol-4-yl]Methyl]aMino]Methyl]- {4-[(Bis{[1-(2-methyl-2-propanyl)-1H-1,2,3-triazol-4-yl]methyl}amino)methyl]-1H-1,2,3-triazol-1-yl}acetic acid | Chemical reagent |
| 530 | 1337883-32-5 | DiZPK | DIZPK DiZPK N-DIZPK CS-4117 DiZPK.HCl N6-((3-(3-Methyl-3H-diazirin-3-yl)propyl)carbamoyl)-L-lysine L-Lysine, N6-[[[3-(3-methyl-3H-diazirin-3-yl)propyl]amino]carbonyl]- (S)-2-aMino-6-(3-(3-(3-Methyl-3H-diazirin-3-yl)propyl)ureido)hexanoic acid | Inhibitor |
| 531 | 1345847-93-9 | Altiratinib | DP 5164 DCC-2701 ALTIRATINIB Altiratinib Altiratinib(DCC2701) DCC2701 (Altiratinib) Altiratinib(DCC-22701) Altiratinib(DCC2701,DP5164) N-(4-(2-(cyclopropanecarboxamido)pyridin-4-yloxy)-2,5-difluorophenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide | Inhibitors;Cell biology reagents;Small molecule inhibitors;New drugs under development;Small molecule inhibitors, natural products |
| 532 | 1345982-69-5 | GSK2330672 | CS-2639 GSK2330672 linerixibat GSK 2330672 Iinerixibat GSK-2330672 Iinerixibat (GSK2330672) 3-[[(3R,5R)-3-butyl-3-ethyl-7-methoxy-1,1-dioxo-5-phenyl-4,5-dihydro-2H-1λ6,4-benzothiazepin-8-yl]methylamino]pentanedioic acid Pentanedioic acid, 3-((((3R,5R)-3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-methoxy-1,1-dioxido-5-phenyl-1,4-benzothiazepin-8-yl)methyl)amino)- | Reagent |
| 533 | 1350462-55-3 | MK-5172 (hydrate) | MK5172 hydrate MK5172 HYDRATE MK 5172 HYDRATE MK 5172 hydrate MK-5172 (hydrate) Grazoprevir hydrate GRAZOPREVIR HYDRATE Grazoprevir hydrate (MK-5172 hydrate) (33R,35S,91R,92R,5S)-5-(tert-butyl)-N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-17-methoxy-4,7-dioxo-2,8-dioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopropanacyclotetradecaphane-35-carboxamide Hydrate | |
| 534 | 1350622-33-1 | kb-NB77-78 | CS-1291 kb-NB77-78 kb-NB77-78, 1350622-33-1 9-[(tert-Butyldimethylsilyl)oxy]-1H,2H,3H,4H-chromeno[3,4-b]pyridin-5-one 9-(TERT-BUTYLDIMETHYLSILYLOXY)-3,4-DIHYDRO-1H-CHROMENO[3,4-B]PYRIDIN-5(2H)-ONE 9-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-1,2,3,4-tetrahydro-5H-[1]benzopyrano[3,4-b]pyridin-5-one kb-NB77-78 9-(TERT-BUTYLDIMETHYLSILYLOXY)-3,4-DIHYDRO-1H-CHROMENO[3,4-B]PYRIDIN-5(2H)-ONE | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 535 | 1351522-04-7 | AC710 | AC710 AC 710 CS-2269 AC-710 AC 710 N-(4-(3-(5-tert-butylisoxazol-3-yl)ureido)phenyl)-5-(1-ethyl-2,2,6,6-tetramethylpiperidin-4-yloxy)picolinamide 5-[(1-Ethyl-2,2,6,6-tetramethyl-4-piperidinyl)oxy]-N-[4-({[5-(2-methyl-2-propanyl)-1,2-oxazol-3-yl]carbamoyl}amino)phenyl]-2-pyridinecarboxamide N-[4-[[[[5-(1,1-Dimethylethyl)-3-isoxazolyl]amino]carbonyl]amino]phenyl]-5-[(1-ethyl-2,2,6,6-tetramethyl-4-piperidinyl)oxy]-2-pyridinecarboxamide N-[4-[[[[5-(1,1-Dimethethylethyl)-3-isoxazolyl]amino]carbonyl]amino]phenyl]-5-[(1-ethyl-2,2,6,6-tetramethyl-4-piperidinyl)oxy]-2-pyridinecarboxamide | Standard;Inhibitors;Reference compounds;Cell biology reagents |
| 536 | 1352066-68-2 | AMG 232 | AMG-232 CS-1300 AMG 232 AMG 232 2-((3R,5R,6S)-5-(3-Chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid 2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-[(2S)-3-methyl-1-propan-2-ylsulfonylbutan-2-yl]-2-oxopiperidin-3-yl]acetic acid(AMG232) 3-Piperidineacetic acid, 5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-[(1S)-2-methyl-1-[[(1-methylethyl)sulfonyl]methyl]propyl]-2-oxo-, (3R,5R,6S)- | |
| 537 | 1353625-73-6 | Presatovir | CS-2075 GS-5806 Presatovir Presatovir (GS-5806) N-(2-((S)-2-(5-((S)-3-aminopyrrolidin-1-yl)-6-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl)-4-chlorophenyl)methanesulfonamide N-(2-{[(2S)-2-{5-[(3S)-3-Amino-1-pyrrolidinyl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl}-1-piperidinyl]carbonyl}-4-chlorophenyl)methanesulfonamide Methanesulfonamide, N-[2-[[(2S)-2-[5-[(3S)-3-amino-1-pyrrolidinyl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]-1-piperidinyl]carbonyl]-4-chlorophenyl]- | |
| 538 | 1355326-21-4 | Mutant IDH1-IN-1 | CS-1779 IDH1-IN-1 MUTANT IDH1-IN-1 Mutant IDH1-IN-1 Mutant IDH1 inhibitor 1 N-[2-(Cyclohexylamino)-1-(2-methylphenyl)-2-oxoethyl]-N-(3-fluorophenyl)-1H-benzimidazole-1-acetamide 1H-Benzimidazole-1-acetamide, N-[2-(cyclohexylamino)-1-(2-methylphenyl)-2-oxoethyl]-N-(3-fluorophenyl)- | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 539 | 1356962-34-9 | HG-14-10-04 | CS-1175 CS-2526 HG-14-10-04 5-chloro-4-(1H-indol-3-yl)-N-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidin-2-amine 2-Pyrimidinamine, 5-chloro-4-(1H-indol-3-yl)-N-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]- | |
| 540 | 1357171-62-0 | ML228 | ML228 L-228 KC7F2 ML-228 ML 228 CID-46742353 N-([1,1'Biphenyl]-4-ylmethyl)-6-phenyl-3-(2-pyridinyl)-1,2,4-triazin-5-amine N-([1,1-Biphenyl]-4-ylmethyl)-6-phenyl-3-(pyridin-2-yl)-1,2,4-triazin-5-amine 1,2,4-Triazin-5-amine, N-([1,1'-biphenyl]-4-ylmethyl)-6-phenyl-3-(2-pyridinyl)- | |
| 541 | 1357389-11-7 | RGFP966 | CS-871 RGFP966 RGFP 966 RGFP-966 RGFP-966 (2E)-N-(2-Amino-4-fluorophenyl)-3-[1-(3-phenyl-2-propen-1-yl)-1H-pyrazol-4-yl]-2-propenamide | Standards;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 542 | 1357920-84-3 | Belizatinib | TSR011 TSR011 TSR-011 CS-2493 TSR 011 Belizatinib BELIZATINIB Belizatinib (TSR011) Benzamide, 4-fluoro-N-[6-[[4-(1-hydroxy-1-methylethyl)-1-piperidinyl]methyl]-1-[cis-4-[[(1-methylethyl)amino]carbonyl]cyclohexyl]-1H-benzimidazol-2-yl]- | Cell biology reagent |
| 543 | 1361224-53-4 | AMG-3969 | CS-2503 AMG3969 AMG-3969 AMG 3969 Benzenemethanol, 4-[(2S)-4-[(6-amino-3-pyridinyl)sulfonyl]-2-(1-propyn-1-yl)-1-piperazinyl]-α,α-bis(trifluoromethyl)- (S)-2-(4-(4-((6-Aminopyridin-3-yl)sulfonyl)-2-(prop-1-yn-1-yl)piperazin-1-yl)phenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol | Organic chemistry |
| 544 | 1361951-15-6 | TP-3654 | TP3654 TP3654 CS-2702 TP 3654 TP-3654 Cyclohexanemethanol, α,α-dimethyl-4-[[3-[3-(trifluoromethyl)phenyl]imidazo[1,2-b]pyridazin-6-yl]amino]-, trans- | API;Cell biology reagent |
| 545 | 1365888-06-7 | GDC-0810 | CS-2080 ARN-810 GDC-0810 BRILANESTRANT GDC-0810(ARN-810) GDC-0810 (Brilanestrant) (E)-3-(4-((E)-2-(2-CHLORO-4-FLUOROPHENYL)-1-(1H-INDAZOL-5-YL)BUT-1-EN-1-YL)PHENYL)ACRYLIC ACID (E)-3-[4-[(E)-2-(2-Chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl]phenyl]-2-propenoic acid | |
| 546 | 1374516-07-0 | TUG-891 | TUG-891 CS-2448 TUG 891 3-(4-{[5-fluoro-2-(4-methylphenyl)phenyl]methoxy}phenyl)propanoic acid 4-[(4-Fluoro-4'-methyl[1,1'-biphenyl]-2-yl)methoxy]-benzenepropanoic acid Benzenepropanoic acid, 4-[(4-fluoro-4'-methyl[1,1'-biphenyl]-2-yl)methoxy]- | Inhibitor |
| 547 | 1375465-91-0 | ACY-738 | ACY738 ACY738 ACY-738 ACY 738 CS-2244 R-1503,RO4402257 2-(1-phenylcyclopropylamino)-N-hydroxypyrimidine-5-carboxamide N-Hydroxy-2-[(1-phenylcyclopropyl)amino]-5-pyrimidinecarboxamide 5-Pyrimidinecarboxamide, N-hydroxy-2-[(1-phenylcyclopropyl)amino]- 2-(1-Phenyl-cyclopropylamino)-pyrimidine-5-carboxylic acid hydroxyamide | Standard;Cell biology reagent |
| 548 | 1380424-42-9 | KML-29 | KML29 KML-29 KML 29 CS-2396 KML29 (KML-29) 1,1,1,3,3,3-hexafluoropropan-2-yl 4-(bis(benzo[d][1,3]dioxol-5-yl)(hydroxy)methyl)piperidine-1-carboxylate 4-[Bis(1,3-benzodioxol-5-yl)hydroxymethyl]-1-piperidinecarboxylic acid 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ester 1-Piperidinecarboxylic acid, 4-[bis(1,3-benzodioxol-5-yl)hydroxymethyl]-, 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ester | Inhibitor;Inhibitors;Heterocycles;Pharmaceuticals;Intermediates & Fine Chemicals;Heterocycles, Inhibitors, Pharmaceuticals, Intermediates & Fine Chemicals |
| 549 | 1391712-60-9 | CEP-37440 | CS-1603 CEP37440 CEP 37440 CEP-37440 2-(5-chloro-2-{(S)-6-[4-(2-hydroxyethyl)piperazin-1-yl]-1-methoxy-6,7,8,9-tetrahydro-5H-benzocyclohepten-2-ylamino}pyrimidin-4-ylamino)-N-methylbenzamide (S)-2-((5-chloro-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-1-methoxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide 2-[[5-Chloro-2-[[(6S)-6,7,8,9-tetrahydro-6-[4-(2-hydroxyethyl)-1-piperazinyl]-1-methoxy-5H-benzocyclohepten-2-yl]amino]-4-pyrimidinyl]amino]-N-methylbenzamide Benzamide, 2-[[5-chloro-2-[[(6S)-6,7,8,9-tetrahydro-6-[4-(2-hydroxyethyl)-1-piperazinyl]-1-methoxy-5H-benzocyclohepten-2-yl]amino]-4-pyrimidinyl]amino]-N-methyl- | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 550 | 1394854-52-4 | GSK-J2 | SK-J2 GSK J2 GSK-J2 CS-1294 β-Alanine, N-[2-(3-pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]- N-[2-(3-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-beta-alanine 3-((2-(pyridin-3-yl)-6-(1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)pyrimidin-4-yl)amino)propanoic acid | Cell biology reagent |
| 551 | 1401090-53-6 | Ibiglustat | GZ-452 GZ402671 SAR402671 GZ-402671 VENGLUSTAT Ibiglustat GZ402671 IBIGLUSTAT GZ 402671 SAR402671 GENZ-682452 genz-682452 VENGLUSTAT SAR-402671 SAR 402671 IBIGLUSTAT GENZ-682452 Genz-682452-AA GENZ-682452-AA Ibiglustat(Genz-682452) Ansofaxine Hydrochloride (S)-QUINUCLIDIN-3-YL (2-(2-(4-FLUOROPHENYL)THIAZOL-4-YL)PROPAN-2-YL)CARBAMATE | API |
| 552 | 1401242-74-7 | ML277 | ML277 ML 277 ML-277 ML-277 CID-53347902 VU0458298-2, VU0458298-3 (R)-N-(4-(4-Methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide (2R)-N-[4-(4-Methoxyphenyl)-2-thiazolyl]-1-[(4-methylphenyl)sulfonyl]-2-piperidinecarboxamide (2R)-N-[4-(4-Methoxyphenyl)-1,3-thiazol-2-yl]-1-(4-methylphenyl)sulfonylpiperidine-2-carboxamide (2R)-N-[4-(4-Methoxyphenyl)-1,3-thiazol-2-yl]-1-[(4-methylphenyl) sulfonyl]-2-piperidinecarboxamide | API |
| 553 | 1402821-41-3 | GV-58 | GV-58 (2R)-2-[[6-[[(5-Methylthiophen-2-yl)methyl]amino]-9-propyl-9H-purin-2-yl]amino]butan-1-ol 1-Butanol, 2-[[6-[[(5-methyl-2-thienyl)methyl]amino]-9-propyl-9H-purin-2-yl]amino]-, (2R)- | |
| 554 | 1408064-71-0 | JNK-IN-7 | CS-2418 JNK-IN-7 JNK inhibitor JNK inhibitor 7 (E)-3-(4-(dimethylamino)but-2-enamido)-N-(4-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide 3-[[4-(Dimethylamino)-1-oxo-2-buten-1-yl]amino]-N-[4-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide Benzamide, 3-[[4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-N-[4-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]- | MAPK;Cell biology reagent |
| 555 | 140926-75-6 | NSC5844 | RE640 RE 640 RE640 RE-640 NSC5844 RE-640 RE 640 NSC 5844 NSC-5844 NSC5844 (RE640) N,N'-bis(7-chloroquinolin-4-yl)ethane-1,2-diamine 1,2-Ethanediamine, N1,N2-bis(7-chloro-4-quinolinyl)- | Cell biology reagent |
| 556 | 1418741-86-2 | UNC1079 | 104511 CS-2180 UNC1079 UNC 1079 CHEMBL2426474 1,4-phenylenebis(1,4'-bipiperidin-1'-ylMethanone) 1,1'-(1,4-Phenylene)bis[1-[1,4'-bipiperidin]-1'-ylmethanone] Methanone, 1,1'-(1,4-phenylene)bis[1-[1,4'-bipiperidin]-1'-yl- | Inhibitor |
| 557 | 1430213-30-1 | ML216 | ML216 ML 216 ML-216 CS-1561 CID49852229 CID 49852229 CID49852229 CID-49852229 CID-49852229 CID 49852229 ML216(CID-49852229) 1-(4-Fluoro-3-(trifluoromethyl)phenyl)-3-(5-(pyridin-4-yl)-1,3,4-thiadiazol-2-yl)urea | Cell biology reagent |
| 558 | 1431698-10-0 | OTSSP167 (hydrochloride) | OTSSP 167 OTSSP-167 OTSSP167HCL MELK INHIBITOR OTS-167 hydrochloride OTSSP167 HCl (OTS167) OTSSP167 (hydrochloride) OTSSP167 HCl (OTS167 HCl) 1-[6-(3,5-Dichloro-4-hydroxyphenyl)-4-[[trans-4-[(dimethylamino)methyl]cyclohexyl]amino]-1,5-naphthyridin-3-yl]-ethanone hydrochloride | Medicine |
| 559 | 1442684-77-6 | AM-2394 | AM2394 AM 2394 AM-2394 CS-2242 N-[6'-(2-Hydroxy-2-methylpropoxy)-4-[(5-methyl-3-pyridinyl)oxy][3,3'-bipyridin]-6-yl]-N'-methylurea 1-(6'-(2-hydroxy-2-methylpropoxy)-4-((5-methylpyridin-3-yl)oxy)-[3,3'-bipyridin]-6-yl)-3-methylurea Urea, N-[6'-(2-hydroxy-2-methylpropoxy)-4-[(5-methyl-3-pyridinyl)oxy][3,3'-bipyridin]-6-yl]-N'-methyl- | API;Inhibitor |
| 560 | 1445605-23-1 | Lu AF21934 | CS-2215 LU-AF21934 Lu AF21934 LU AF 21934 LU-AF 21934 LU-AF-21934 LU AF-21934 (1S,2R)-N1-(3,4-Dichlorophenyl)-1,2-cyclohexanedicarboxamide 1,2-Cyclohexanedicarboxamide, N1-(3,4-dichlorophenyl)-, (1S,2R)- | |
| 561 | 1446182-94-0 | CUDC-427 | GDC0917 GDC-0917 GDC 0917 CUDC-427 1446182-94-0 GDC-0917 (CUDC-427) CUDC-427 (GDC-0917) L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-[2-(2-oxazolyl)-4-phenyl-5-thiazolyl]- | Cell biology reagent |
| 562 | 1448895-09-7 | ML314 | ML314 ML 314 ML-314 ML-314 2-Cyclopropyl-6,7-dimethoxy-4-(4-(2-methoxyphenyl)piperazin-1-yl)quinazoline Quinazoline, 2-cyclopropyl-6,7-dimethoxy-4-[4-(2-methoxyphenyl)-1-piperazinyl]- | |
| 563 | 1449240-68-9 | K145 (hydrochloride) | K145(HCl) SPHK2 INHIBITOR SphK2 inhibitor K-145 HYDROCHLORIDE K14 (hydrochloride) K 145 HYDROCHLORIDE K145 (hydrochloride) 3-(2-Amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione hydrochloride | API;Cell biology reagent |
| 564 | 1453097-13-6 | HUHS015 | HUHS015 HUHS-015 HUHS 015 4-Benzyl-3-methyl-1-(6-methyl-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-5-ol 1H-Pyrazol-5-ol, 3-methyl-1-(6-methyl-1H-benzimidazol-2-yl)-4-(phenylmethyl)- | Cell biology reagent |
| 565 | 1454619-14-7 | PU-WS13 | PUWS13 PU-WS13 CS-2047 CS-1689 PU WS13 8-((3,5-dichlorophenyl)thio)-9-(3-(isopropylamino)propyl)-9H-purin-6-amine 8-(3,5-dichlorophenyl)sulfanyl-9-[3-(propan-2-ylamino)propyl]purin-6-amine 6-Amino-8-[(3,5-dichlorophenyl)thio]-N-(1-methylethyl)-9H-purine-9-propanamine 9H-Purine-9-propanamine, 6-amino-8-[(3,5-dichlorophenyl)thio]-N-(1-methylethyl)- | Cell biology reagent |
| 566 | 1456858-58-4 | HG-9-91-01 | HG-9-91-01 SIK INHIBITOR 1 1-(2,4-dimethoxyphenyl)-3-(2,6-dimethylphenyl)-1-[6-[4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]urea 1-(2,4-dimethoxyphenyl)-3-(2,6-dimethylphenyl)-1-(6-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)urea N-(2,4-Dimethoxyphenyl)-N'-(2,6-dimethylphenyl)-N-[6-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]urea Urea, N-(2,4-dimethoxyphenyl)-N'-(2,6-dimethylphenyl)-N-[6-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]- | API |
| 567 | 146204-42-4 | BM212 | BM212 BM 212 BM-212 1-((1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl)methyl)-4-methylpiperazine Piperazine, 1-[[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl]methyl]-4-methyl- | |
| 568 | 1462249-75-7 | PFK-158 | PFK 158 PFK-158 PFK-158 free base PFK-158, ACT-PFK-158 (2E)-1-(4-Pyridinyl)-3-[7-(trifluoromethyl)-2-quinolinyl]-2-propen-1-one 2-Propen-1-one, 1-(4-pyridinyl)-3-[7-(trifluoromethyl)-2-quinolinyl]-, (2E)- | Active molecules;Cell biology reagents |
| 569 | 146368-16-3 | CY3-SE | CY3-SE Cy3-SE Cyanine 3 Sulfo-Cy3-SE CY3 NHS ESTER Cyanine3 NHS ester Cy3-SECy3 NHS Ester Cy3-NHS ester(C35H41N3O10S2) 2-[3-[1-[6-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-6-oxohexyl]-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1-propen-1-yl]-1-ethyl-3,3-dimethyl-5-sulfo-3H-indolium inner salt | Qing dyes;Fluorescent dyes;Chemical reagents;Biochemical reagents;Fluorescent labeling dyes;Synthetic material intermediates |
| 570 | 1472624-85-3 | 7ACC2 | 7ACC2 7ACC-2 7ACC 2 7ACC 2 7ACC-2 7-[benzyl(methyl)amino]-2-oxochromene-3-carboxylic acid 7-[Benzyl(methyl)amino]-2-oxo-2H-chromene-3-carboxylic acid 2H-1-Benzopyran-3-carboxylic acid, 7-[methyl(phenylmethyl)amino]-2-oxo- | Medicine;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 571 | 150725-87-4 | Ro 46-2005 | RO462005 RO 462005 RO-462005 Ro 46-2005 Benzenesulfonamide,4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(3-methoxyphenoxy)-4-pyrimidinyl]- | |
| 572 | 1516896-09-5 | PDE10-IN-1 | PDE10-IN-1 PDE10 inhibitor 1 PDE10-IN-1 is a potent PDE10-IN-1 inhibitor 3-Methyl-2-((1S,2S)-2-(quinolin-2-yl)cyclopropyl)-3H-iMidazo[4,5-f]quinoline 5,8-dimethyl-2-[(1S,2S)-2-{3-methylimidazo[2,1-f]1,6-naphthyridin-2-yl}cyclopropyl]-[1,2,4]triazolo[1,5-a]pyrazine 2-((1R,2R)-2-(5,8-Dimethyl-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)cyclopropyl)-3-methylimidazo[2,1-f][1,6]naphthyridine Imidazo[2,1-f][1,6]naphthyridine, 2-[(1R,2R)-2-(5,8-dimethyl[1,2,4]triazolo[1,5-a]pyrazin-2-yl)cyclopropyl]-3-methyl- | |
| 573 | 1531634-31-7 | AF38469 | AF38469 CS-2561 AF38469 (AF-38469) Benzoic acid, 2-[[(6-methyl-2-pyridinyl)amino]carbonyl]-5-(trifluoromethyl)- | |
| 574 | 1532593-30-8 | ML355 | ML355 ML 355 ML-355 N-(benzo[d]thiazol-2-yl)-4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide N-2-Benzothiazolyl-4-[[(2-hydroxy-3-methoxyphenyl)methyl]amino]benzenesulfonamide Benzenesulfonamide, N-2-benzothiazolyl-4-[[(2-hydroxy-3-methoxyphenyl)methyl]amino]- | API |
| 575 | 1557268-88-8 | Avitinib (maleate) | AC0010 AC-0010 AC0010 AC-0010 AC 0010. AC0010MA AC 0010. AC-0010MA AC 0010MA Avitinib (maleate) Avitinib (AC0010) maleate N-(3-((2-((3-Fluoro-4-(4-methylpiperazin-1-yl)phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenyl)acrylamide maleate | Reagents;Inhibitors;Cell biology reagents |
| 576 | 156223-05-1 | 3-(2,4-dimethoxybenzylidene)anabaseine | DMBX-anabaseine GTS-21 (DMXB-A) 3-(2,4-dimethoxybenzylidene)anabaseine 3-(2,4)-DiMethoxybenzylidineanabaseine 3-(2,4-Dimethoxy-benzyl)-3,4,5,6-tetrahydro-[2,3']bipyridinyl 3-(2,4-DiMethoxy-benzyl)-3,4,5,6-tetrahydro-[2,3']bipyridinyl Dihydrochloride (3E)-3-[(2,4-Dimethoxyphenyl)methylene]-3,4,5,6-tetrahydro-2,3'-Bipyridine dihydrochloride 3-[(3E)-3-[(2,4-dimethoxyphenyl)methylidene]-5,6-dihydro-4H-pyridin-2-yl]pyridine dihydrochloride | Inhibitors;Raw materials;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 577 | 156722-18-8 | (3β,5β,14β)-21,23-Epoxy-24-Norchola-20,22-diene-3,14,17-triol | PST2238 ROSTAFUROXIN Rostafuroxin Rostafuroxin PST2284 Rostafuroxin (PST-2238) (3β,5β,14β)-21,23-Epoxy-24-Norchola-20,22-diene-3,14,17-triol (3beta,5beta,14beta)-21,23-Epoxy-24-norchola-20,22-diene-3,14,17-triol (3beta,5beta,14beta)-21,23-Epoxy-24-norchola-20,22-diene-3,14,17-triol Rostafuroxin (PST 2238) (3S,5R,8R,9S,10S,13R,14S,17R)-17-(3-furyl)-10,13-dimethyl-2,3,4,5,6,7, 8,9,11,12,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,14,17-triol | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 578 | 1599432-08-2 | NIBR189 | CS-1583 NIBR189 NIBR-189 NIBR 189 (E)-3-(4-bromophenyl)-1-(4-(4-methoxybenzoyl)piperazin-1-yl)prop-2-en-1-one (2E)-3-(4-Bromophenyl)-1-[4-(4-methoxybenzoyl)-1-piperazinyl]-2-propen-1-one (2E)-3-(4-Bromophenyl)-1-[4-4-methoxybenzoyl)-1-piperazinyl]-2-propene-1-one 2-Propen-1-one, 3-(4-bromophenyl)-1-[4-(4-methoxybenzoyl)-1-piperazinyl]-, (2E)- | api |
| 579 | 1604810-84-5 | THZ2 | THZ2 THZ 2 THZ-2 CS-1182 CDK7-IN-1 THZ2,CDK7-IN-1 (E)-N-(3-((5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)-3-(4-(dimethylamino)but-2-enamido)benzamide Benzamide, N-[3-[[5-chloro-4-(1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-3-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]- | Cell biology reagent |
| 580 | 1621175-65-2 | TC-G-1008 | GPR39C3 CS-2374 GPR39 C3 GPR39-C3 TC-G-1008 16211175-65-2 TC-G-1008 (GPR39-C3) N-[3-Chloro-4-[[[2-(methylamino)-6-(2-pyridinyl)-4-pyrimidinyl]amino]methyl]phenyl]methanesulfonamide N-(3-Chloro-4-(((2-(methylamino)-6-(pyridin-2-yl)pyrimidin-4-yl)amino)methyl)phenyl)methanesulfonamide Methanesulfonamide, N-[3-chloro-4-[[[2-(methylamino)-6-(2-pyridinyl)-4-pyrimidinyl]amino]methyl]phenyl]- | |
| 581 | 1627696-51-8 | LY3177833 | CS-2783 LY3177833 LY-3177833 LY 3177833 (R)-3-(5-fluoropyrimidin-4-yl)-3-methyl-6-(1H-pyrazol-4-yl)isoindolin-1-one 1H-Isoindol-1-one, 3-(5-fluoro-4-pyrimidinyl)-2,3-dihydro-3-methyl-6-(1H-pyrazol-4-yl)-, (3R)- | Cell biology reagent |
| 582 | 1628838-42-5 | RAF709 | RAF709 CS-2505 RAF 709 RAF-709 N-[2-Methyl-5'-(4-morpholinyl)-6'-[(tetrahydro-2H-pyran-4-yl)oxy][3,3'-bipyridin]-5-yl]-3-(trifluoromethyl)benzamide Benzamide, N-[2-methyl-5'-(4-morpholinyl)-6'-[(tetrahydro-2H-pyran-4-yl)oxy][3,3'-bipyridin]-5-yl]-3-(trifluoromethyl)- | Cell biology reagent |
| 583 | 1629869-44-8 | Pimodivir | VX-787 CS-2483 Pimodivir VRT-0928787 (2S,3S)-3-[[5-Fluoro-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)-4-pyrimidinyl]amino]bicyclo[2.2.2]octane-2-carboxylic acid | Chemical reagents |
| 584 | 163769-88-8 | 5,6-DIHYDRO-2,3-DIMETHOXY-6,6-DIMETHYLBENZ[7,8]INDOLIZINO[2,3-B]QUINOXALINE | YM90709 YM-90709 YM 90709 5,6-DIHYDRO-2,3-DIMETHOXY-6,6-DIMETHYLBENZ[7,8]INDOLIZINO[2,3-B]QUINOXALINE 2,3-Dimethoxy-6,6-dimethyl-5,6-dihydrobenzo[7,8]indolizino[2,3-b]quinoxaline Benz[7,8]indolizino[2,3-b]quinoxaline,5,6-dihydro-2,3-dimethoxy-6,6-dimethyl- | API |
| 585 | 1637735-84-2 | FIIN-3 | FIIN3 FIN-3 FIIN-3 FIIN 3 FIIN-3 CS-2331 2-Propenamide, N-[4-[[[[(2,6-dichloro-3,5-dimethoxyphenyl)amino]carbonyl][6-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]amino]methyl]phenyl]- | inhibitors;Cell biology reagents |
| 586 | 1640282-31-0 | I-CBP 112 | CS-2420 I-CBP112 I-CBP 112 I-CBP-112 I-CBP 112 I-CBP112, 1640282-31-0 I-CBP112 hydrochloride 1-Propanone, 1-[7-(3,4-dimethoxyphenyl)-2,3-dihydro-9-[[(3S)-1-methyl-3-piperidinyl]methoxy]-1,4-benzoxazepin-4(5H)-yl]- 1-[7-(3,4-Dimethoxyphenyl)-9-[[(3S)-1-methylpiperidin-3-yl]methoxy]-2,3,4,5-tetrahydro-1,4-benzoxazepin-4-yl]propan-1-one | |
| 587 | 164178-33-0 | AM 630 | AM630 AM 630 AM-630 SC-200365(AM-630) Iodopravadoline (AM630) 1-[2-(Morpholin-4-yl)ethyl]-2-Methyl-3-(4-Methoxybenzoyl)-6-iodoindole (6-iodo-2-Methyl-1-(2-Morpholinoethyl)-1H-indol-3-yl)(4-Methoxyphenyl)Methanone 6-IODO-2-METHYL-1-[[2-(4-MORPHOLINYL)ETHYL]-1H-INDOL-3-YL](4-METHOXYPHENYL)METHANONE Methanone, [6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl)- | Cannabinoid receptor;Antibody-secondary antibody;G protein coupled receptor & G protein |
| 588 | 1642303-38-5 | ITI214 | ITI214 ITI214 ITI-214 ITI 214 1642303-38-5 ITI-214 phosphate PDE1-IN-1 (phosphate) ITI-214 phosphate salt ITI-214 PHOSPHATE SALT. | |
| 589 | 164658-13-3 | CGP60474 | CS-506 CGP60474 CGP-60474 CGP 60474 3-[[4-[2-(3-chloroanilino)pyrimidin-4-yl]pyridin-2-yl]amino]propan-1-ol 3-[[4-[2-[(3-Chlorophenyl)amino]-4-pyrimidinyl]-2-pyridinyl]amino]-1-propanol 1-Propanol, 3-[[4-[2-[(3-chlorophenyl)amino]-4-pyrimidinyl]-2-pyridinyl]amino]- | cell cycle;Cell biology reagents |
| 590 | 165538-40-9 | Terutroban | S18886 S 18886 Triplion Terutroban (R)-6-[[(4-Chlorophenyl)sulfonyl]amino]-5,6,7,8-tetrahydro-2-methyl-1-naphthalenepropanoic acid (6R)-6-[[(4-chlorophenyl)sulfonyl]amino]-5,6,7,8-tetrahydro-2-methyl-1-naphthalenepropanoic acid 3-[(6R)-6-[(4-CHLOROPHENYL)SULFONYLAMINO]-2-METHYL-5,6,7,8-TETRAHYDROPHTHALEN-1-YL]PROPANOIC ACID 3-[(6R)-6-[(4-CHLOROPHENYL)SULFONYLAMINO]-2-METHYL-5,6,7,8-TETRAHYDRONAPHTHALEN-1-YL]PROPANOIC ACID | Kit-Cell Analysis Kit |
| 591 | 168682-53-9 | (S)-ethyl 2-amino-5-(((R)-3-(benzylthio)-1-(((S)-2-ethoxy-2-oxo-1-phenylethyl)amino)-1-oxopropan-2-yl)amino)-5-oxopentanoate | CS-1110 TER 199 TLK-199 TELINTRA Ezatiostat Terrapin 199 (2R)-L-gamma-Glutamyl-S-(phenylmethyl)-L-cysteinyl-2-phenylglycine 1,3-diethyl ester Glycine, L-g-glutaMyl-S-(phenylMethyl)-L-cysteinyl-2-phenyl-,1,3-diethyl ester, (2R)- (S)-ETHYL 2-AMINO-5-((R)-3-(BENZYLTHIO)-1-((R)-2-ETHOXY-2-OXO-1-PHENYLETHYLAMINO)-1-OXOPROPAN-2-YLAMINO)-5-OXOPENTANOATE (S)-ethyl 2-amino-5-(((R)-3-(benzylthio)-1-(((S)-2-ethoxy-2-oxo-1-phenylethyl)amino)-1-oxopropan-2-yl)amino)-5-oxopentanoate | Inhibitors;Cell biology reagents;Scientific research reagents |
| 592 | 173039-10-6 | 2-(Phosphonomethyl)pentanedioic acid | 2-PMPA CS-2454 NAALADASEINHIBITOR PMPA(NAALADaseinhibitor) 2-PMPA(NAALADaseinhibitor) 2-(Phosphonomethyl)pentanedioic acid 2-(PHOSPHONOMETHYL)PENTANEDIOIC ACID Pentanedioic acid, 2-(phosphonomethyl)- 2-(Phosphonomethyl)pentane-1,5-dioicacid 2-(PHOSPHONOMETHYL)PENTANEDIOIC ACID (PMPA) | |
| 593 | 173529-10-7 | HMN-176 | HMN-176 HMN 176 HMN176 CS-2239 Benzenesulfonamide, 4-methoxy-N-[2-[(1E)-2-(1-oxido-4-pyridinyl)ethenyl]phenyl]- (NE)-N-[(6E)-6-[2-(1-hydroxypyridin-4-ylidene)ethylidene]cyclohexa-2,4-dien-1-ylidene]-4-methoxybenzenesulfonamide | API;Cell biology reagent |
| 594 | 173865-33-3 | CDD3505 | 136091 CDD3505 CDD-3505 CDD 3505 4-NITRO-1-TRITYL-1H-IMIDAZOLE 4-nitro-1-trityl-1H-imidazole 1H-Imidazole, 4-nitro-1-(triphenylmethyl)- | |
| 595 | 173952-44-8 | (+/-)-4-(4-AMINOPHENYL)-1,2-DIHYDRO-1-METHYL-2-PROPYLCARBAMOYL-6,7-METHYLENEDIOXYPHTHALAZINE | SYM2206 CS-2046 SYM 2206 SYM-2206 8-(4-Aminophenyl)-5-methyl-N-propyl-1,3-dioxolo[4,5-g]phthalazine-6(5H)-carboxamide 1,3-Dioxolo[4,5-g]phthalazine-6(5H)-carboxamide, 8-(4-aminophenyl)-5-methyl-N-propyl- (S)-8-(4-aminophenyl)-5-methyl-N-propyl-[1,3]dioxolo[4,5-g]phthalazine-6(5H)-carboxamide SYM 2206,(±)-4-(4-Aminophenyl)-1,2-dihydro-1-methyl-2-propylcarbamoyl-6,7-methylenedioxyphthalazine | |
| 596 | 174634-09-4 | TAS-103 (dihydrochloride) | TAS 103 TAS-103(2HCl) BMS-247615-2HCl TAS-103(BMS-247615) BMS247615 dihydrochloride TAS-103 (dihydrochloride) TAS-103 (dihydrochloride) BMS 247615 dihydrochloride BMS-247615 dihydrochloride 6-[[2-(Dimethylamino)ethyl]amino]-3-hydroxy-7H-indeno[2,1-c]quinolin-7-one dihydrochloride | Cell biology reagent |
| 597 | 175013-84-0 | Tonabersat | SB220453 SB 22045 SB 220453 Tonabersat TONABERSAT Tonabersat [ban, inn] N-((3S,4S)-6-Acetyl-3-hydroxy-2,2-diMethylchroMan-4-yl)-3-chloro-4-fluorobenzaMide 2H-Benzo(B)pyran-3-ol, 6-acetyl-4-(3-chloro-4-fluorobenzoylamino)-3,4-dihydro-2,2-dimethyl- N-[(3S,4S)-6-Acetyl-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl]-3-chloro-4-fluoro-benzamide | Aromatics;Inhibitors;Heterocycles;Aromatics Compounds |
| 598 | 176161-24-3 | BENZIMIDAVIR | Maribavi Maribavir BENZIMIDAVIR 5,6-DICHLORO-2-ISOPROPYLAMINO-1-(-L-RIBOFURANOSYL)-LH-BENZIMIDAZOLE 5,6-DICHLORO-2-(ISOPROPYLAMINO)-1-(BETA-L-RIBOFURANOSYL)-1H-BENZIMIDAZOLE (2S,3S,4R,5S)-2-(5,6-Dichloro-2-(isopropylamino)-1H-benzo[d]-imidazol-1-yl)-5-(hydroxymethyl)tetr | Inhibitors;Mature technology;Chemical raw materials;Small molecule inhibitors;Pharmaceutical raw materials;Small molecule inhibitors, natural products |
| 599 | 17780-75-5 | CLORGYLINE HYDROCHLORIDE | CLORGYLINE HYDROCHLORIDE N-methyl-N-propargyl-3-(2,4-*dichlorophenoxy)prop N-METHYL-N-PROPARGYL-3-(2,4-*DICHLOROPHE NOXY)PROPYL 3-(2,4-dichlorophenoxy)-n-methyl-n-propargyl-propylaminhydrochloride N-METHYL-N-PROPARGYL-3-(2,4-DICHLOROPHENOXY)-PROPYLAMINE HYDROCHLORIDE n-(3-(2,4-dichlorophenoxy)propyl)-n-methyl-2-propynylaminhydrochloride n-(3-(2,4-dichlorophenoxy)propyl)-n-methyl-2-propyn-1-aminhydrochloride N-[3-(2,4-dichlorophenoxy)propyl]-N-methyl-2-propynylamine hydrochloride | Small molecule inhibitor |
| 600 | 1808011-22-4 | EPZ031686 | CS-2707 EPZ031686 EPZ 031686 EPZ-031686 6-chloro-2-oxo-N-((1R,3r,5S)-8-(((1-(4,4,4-trifluorobutyl)piperidin-4-yl)methyl)sulfonyl)-8-azabicyclo[3.2.1]octan-3-yl)indoline-5-carboxamide | Cell biology reagent |
| 601 | 1817626-54-2 | PF06650833 | CS-2457 PF6650833 PF06650883 PF06650833 PF-06650833 PF 06650833 1-[[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxo-2-pyrrolidinyl]methoxy]-7-methoxy-6-isoquinolinecarboxamide 1-(((2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carboxamide 6-Isoquinolinecarboxamide,1-(((2S,3S,4S)-3-ethyl-4-fluoro-5-oxo-2-pyrrolidinyl)methoxy)-7-methoxy- | API |
| 602 | 1818885-28-7 | ARV-825 | ARV825 ARV-825 AVR-825 CS-2252 ARV 825 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-N-[4-[2-[2-[2-[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethoxy]phenyl]-2,3,9-trimethyl-, (6S)- | Cell biology reagent |
| 603 | 1820565-69-2 | PIM-447 (dihydrochloride) | EOS-62253 PIM-447 2HCl PIM447 DIHYDROCHLORIDE LGH-447 dihydrochloride PIM-447 (dihydrochloride) N-(4-((1R,3S,5S)-3-amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide | Cell biology reagent |
| 604 | 186953-56-0 | Pafuramidine | DB289 Pafuramidine PAFURAMIDINE Unii-H1vg379J2x 4,4'-(2,5-Furandiyl)bis[N-methoxybenzenecarboximidamide] BenzenecarboxiMidaMide,4,4'-(2,5-furandiyl)bis[N-Methoxy- | Microbiology |
| 605 | 191089-60-8 | K-7174 (dihydrochloride) | K7174 K-7174 K-7174 K 7174 K-7174 2HCl K-7174-2HCL K-7174 dihydrochloride K-7174 (dihydrochloride) K-7174 DIHYDROCHLORIDE. 1,4-Bis((E)-5-(3,4,5-trimethoxyphenyl)pent-4-en-1-yl)-1,4-diazepane 1,4-Bis[5-(3,4,5-triMethoxyphenyl)-4(E)-pentenyl]hexahydro-1H-1,4-diazepine K-7174, 1,4-Bis[5-(3,4,5-triMethoxyphenyl)-4(E)-pentenyl]hexahydro-1H-1,4-diazepine | Catalyst |
| 606 | 193746-75-7 | SB 242235 | CS-668 SB242235 SB242235 SB-242235 SB 242235 4-[4-(4-Fluorophenyl)-1-(4-piperidinyl)-1H-imidazol-5-yl]-2-methoxypyrimidine 4-(4-(4-Fluorophenyl)-1-(piperidin-4-yl)-1H-iMidazol-5-yl)-2-MethoxypyriMidine Pyrimidine, 4-[4-(4-fluorophenyl)-1-(4-piperidinyl)-1H-imidazol-5-yl]-2-methoxy- | Cell biology reagent |
| 607 | 195371-52-9 | NSC 42834 | NSC 42834 1-Butanone JAK2 Inhibitor V, Z3 2-methyl-1-phenyl-4-(2-pyridinyl)-2-[2-(2-pyridinyl)ethyl]- 2-Methyl-1-phenyl-4-(2-pyridinyl)-2-[2-(2-pyridinyl)ethyl]-1-butanone 2-METHYL-1-PHENYL-4-(PYRIDIN-2-YL)-2-(2-(PYRIDIN-2-YL)ETHYL)BUTAN-1-ONE 1-Butanone, 2-Methyl-1-phenyl-4-(2-pyridinyl)-2-[2-(2-pyridinyl)ethyl]- NSC 42834 2-Methyl-1-phenyl-4-(2-pyridinyl)-2-[2-(2-pyridinyl)ethyl]-1-butanone | Standards;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 608 | 195514-80-8 | AP20187 | AP20187 AP-20187 AP 20187 AP20187 (AP-20187 (1S,1'S)-(((2,2'-((2-((dimethylamino)methyl)propane-1,3-diyl)bis(azanediyl))bis(acetyl))bis(oxy))bis(3, (1R,1'R)-(((((2-((dimethylamino)methyl)propane-1,3-diyl)bis(azanediyl))bis(2-oxoethane-2,1-diyl))bis(oxy))bis(3,1-phenylene))bis(3-(3,4-dimethoxyphenyl)propane-1,1-diyl) (2S,2'S)-bis(1-((S)-2-(3,4,5-trimethoxyphenyl)butanoyl)piperidine-2-carboxylate) (S,2S,2'S)-(1R,1'R)-(((((2-((dimethylamino)methyl)propane-1,3-diyl)bis(azanediyl))bis(2-oxoethane-2,1-diyl))bis(oxy))bis(3,1-phenylene))bis(3-(3,4-dimethoxyphenyl)propane-1,1-diyl) bis(1-((S)-2-(3,4,5-trimethoxyphenyl)butanoyl)piperidine-2-carboxylate) (1R)-3-(3,4-dimethoxyphenyl)-1-[3-[2-[[2-[[[2-[3-[(1R)-3-(3,4-dimethoxyphenyl)-1-[(2S)-1-[(2S)-2-(3,4,5-trimethoxyphenyl)butanoyl]piperidine-2-carbonyl]oxypropyl]phenoxy]acetyl]amino]methyl]-3-(dimethylamino)propyl]amino]-2-oxoethoxy]phenyl]propyl] (2S)-1-[(2S)-2-(3,4,5-trimethoxyphenyl)butanoyl]piperidine-2-carboxylate | Inhibitor |
| 609 | 195733-43-8 | (2R,3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid hydrochloride | ABT-627 ABT627 ABT 627 A 147627.1 Abbott 147627 Atrasentan HCl ABBOTT 147627 Atrasentan hydrochloride Atrasentan hydrochloride (ABT-627 Atrasentan hydrochloride, CID 159595 Atrasentan hydrochloride (ABT-627 hydrochloride) (2R,3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid hydrochloride 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-, monohydrochloride, (2R,3R,4S)- | Amines;Aromatics;Heterocycles;Chiral Reagents;Pharmaceuticals;Intermediates & Fine Chemicals |
| 610 | 196808-24-9 | GW1929 | GW1929 GW1929 HYDRATE GW 1929 hydrochloride N-(2-BENZOYLPHENYL)-O-[2-(METHYL-2-PYRIDINYLAMINO)ETHYL]-L-TYROSINE N-(2-Benzoylphenyl)-O-[2-(methyl-2-pyridinylamino)ethyl]-L-tyrosine hydrate N-(2-Benzoylphenyl)-O-[2-(methyl-2-pyridinylamino)ethyl]-L-tyrosinehydrochloride (2S)-2-(2-benzoylanilino)-3-[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]propanoic acid (S)-2-(2-Benzoylphenylamino)-3-(4-(2-(methyl(pyridin-2-yl)amino)ethoxy)phenyl)propanoic acid | Cell cycle;Small molecules;Intracellular receptor |
| 611 | 199986-75-9 | CVT-313 | BAT5 D6S82E CVT-313 CVT 313 CVT-313(NG-26) CDK2 INHIBITOR III Anti-ABHD16A antibody produced in rabbit 2(BIS-(HYDROXYETHYL)AMINO)-6-(4-METHOXYBENZYLAMINO)-9-ISOPROPYL-PURINE 2,2'-(9-isopropyl-6-(4-methoxybenzylamino)-9H-purin-2-ylazanediyl)diethanol | Cell biology reagent |
| 612 | 202350-68-3 | PNU-159682 | PNU159682 PNU-159682 | Cytotoxin;Daily chemicals;Chemical reagents;Cell biology reagents;Pharmaceutical raw materials;Research original drug series;API [for scientific research only] |
| 613 | 204697-65-4 | Olcegepant | BIBN-4096 Olcegepant BIBN 4096BS BIBN 4096BS API Olcegepant 1-[3,5-Dibromo-N-[[4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl)-1-piperidinyl]carbonyl]-D-tyrosyl-L-lysyl]-4-(4-pyridinyl)-piperazine Piperazine, 1-[3,5-dibromo-N-[[4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl)-1-piperidinyl]carbonyl]-D-tyrosyl-L-lysyl]-4-(4-pyridinyl)- N-[2-[5-Amino-1(S)-[4-(4-pyridinyl)piperazin-1-ylcarbonyl]pentylamino]-1(R)-(3,5-dibromo-4-hydroxybenzyl)-2-oxoethyl]-4-(2-oxo-1,2,3,4-tetrahydroquinazolin-3-yl)piperidine-1-carboxamide | Nerve signal |
| 614 | 2061980-01-4 | XMU-MP-1 | CS-2590 XMU-MP-1 4-[(6,10-Dihydro-5,10-dimethyl-6-oxo-5H-pyrimido[5,4-b]thieno[3,2-e][1,4]diazepin-2-yl)amino]benzenesulfonamide 4-((5,10-dimethyl-6-oxo-6,10-dihydro-5H-pyrimido[5,4-b]thieno[3,2-e][1,4]diazepin-2-yl)amino)benzenesulfonamide Benzenesulfonamide, 4-[(6,10-dihydro-5,10-dimethyl-6-oxo-5H-pyrimido[5,4-b]thieno[3,2-e][1,4]diazepin-2-yl)amino]- | API;Cell biology reagent |
| 615 | 2076-91-7 | TPT-260 (Dihydrochloride) | NSC 55712 TPT-260 2HCl TPT-260 , NSC55712 TPT-260 (Dihydrochloride) TPT-260 (Dihydrochloride), NSC55712 THIOPHENE-2,5-DIYLBIS(METHYLENE) DICARBAMIMIDOTHIOATE.2HCL Carbamimidothioic acid 2,5-thiophenediylbis(methylene) ester dihydrochloride | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 616 | 210110-90-0 | N-Butyldeoxynojirimycin Hydrochloride | NB-DNJ, HCL N-BUTYL-DNJ, HCL Miglustat, Hydrochloride N-BUTYLDEOXYNOJIRIMYCIN HCL N-Butyldeoxynojirimycin Hydrochloride N-BUTYLDEOXYNOJIRIMYCIN, HYDROCHLORIDE N-(N-BUTYL)DEOXYNOJIRIMYCIN, HYDROCHLORIDE (2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochloride (2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)-,3,4,5-Piperidinetriol Hydrochloride | All Inhibitors;Pharmaceuticals;Sugar-sugar block;Glycosidase Inhibitors;Intermediates & Fine Chemicals |
| 617 | 210829-30-4 | Gemcitabine (elaidate) | CO-101 CO101 CO 101 CP 4126 CS-1569 CP4126 CP 4126 CP-4126 GeMcitabine elaidate GEMCITABINE ELAIDATE Gemcitabine (elaidate) GeMcitabine 5'-elaidate Gemcitabine elaidate(CP-4126 CP-4126 (LVT derivative of Gemcitabine) | Signal transduction pathway kinase inhibitor |
| 618 | 212779-48-1 | NG 52 | NG 52 NG-52 COMPOUND 52 NG 52 (Compound 52 ) 2-(2-HYDROXYETHYLAMINO)-6-(3-CHLORANILINO)-9-ISOPROPYLPURINE 2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE 2-(2-Hydroxyethylamino)-6-(3-chloroanilino)-9-isopropylpurine, NG-52 2-((6-((3-chlorophenyl)aMino)-9-isopropyl-9H-purin-2-yl)aMino)ethanol 2-[[6-[(3-Chlorophenyl)amino]-9-(1-methylethyl)-9H-purin-2-yl]amino]ethanol | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 619 | 212844-54-7 | (2R)-2-[[6-[(3-CHLORO-4-CARBOXYPHENYL)AMINO]-9-(1-METHYLETHYL)-9H-PURIN-2-YL]AMINO]-3-METHYL-1-BUTANOL | NG 95 PURVALANOL B Purvalanol B(NG 95) Purvalanol B ( NG 95) (R)-2-Chloro-4-((2-((1-hydroxy-3-methylbutan-2-yl)amino)-9-isopropyl-9H-purin-6-yl)amino)benzo (2R)-2-((6-((3-Chloro-4-carboxyphenyl)amino)-9-(1-methylethyl)-9H-purin-2-yl)amino)-3-methyl-1-butanol (2R)-2-[[6-[(3-CHLORO-4-CARBOXYPHENYL)AMINO]-9-(1-METHYLETHYL)-9H-PURIN-2-YL]AMINO]-3-METHYL-1-BUTANOL NG 95, (2R)-2-[[6-[(3-Chloro-4-carboxyphenyl)amino]-9-(1-methylethyl)-9H-purin-2-yl]amino]-3-methyl-1-butanol | Signalling;Cell biology reagent |
| 620 | 217645-70-0 | BX471 | BX471 ZK811752 (BX471) BX471(ZK-811752) (5-Chloro-2-{2-[4-(4-fluoro-benzyl)-2-Methyl-piperazin-1-yl]-2-oxo-ethoxy}-phenyl)-urea (2R)-1-[[[4-Chloro-2-(ureido)phenoxy]methyl]carbonyl]-2-methyl-4-(4-fluorobenzyl)piperazine N-[5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)methyl]-2-methyl-1-piperazinyl]-2-oxoethoxy]phenyl]-urea Urea, N-[5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)Methyl]-2-Methyl-1-piperazinyl]-2-oxoethoxy]phenyl]- Piperazine,1-[[2-[(aminocarbonyl)amino]-4-chlorophenoxy]acetyl]-4-[(4-fluorophenyl)methyl]-2-methyl-, (2R)- (2R)-1-[[2-[(Aminocarbonyl)amino]-4-chlorophenoxy]acetyl]-4-[(4-fluorophenyl)methyl]-2-methylpiperazine ZK811752 (BX471) | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 621 | 221243-82-9 | 4-Amino-1-tert-butyl-3-(1'-naphthyl)pyrazolo[3,4-d]pyrimidine | CS-2001 1-NA-PP1 1-Naphthyl PP1 1-NAPHTHYL PP1(1-NA-PP 1) 4-Amino-1-tert-butyl-3-(1'-naphthyl)pyrazolo[3,4-d]pyrimidine 4-AMINO-1-TERT-BUTYL-3-(1'-NAPHTHYL)PYRAZOLO[3,4-D]PYRIMIDINE 1-tert-butyl-3-(naphthalen-1-yl)-1H-pyrazolo[3,4-d]pyriMidin-4-aMine 1-(1,1-Dimethylethyl)-3-(1-naphthalenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 1H-Pyrazolo[3,4-d]pyrimidin-4-amine,1-(1,1-dimethylethyl)-3-(1-naphthalenyl)- | Other APIs;Nucleotides;Pharmaceuticals;Cell biology reagents;Intracellular Signaling;Bases & Related Reagents;Tyrosine Kinase Inhibitors;Intermediates & Fine Chemicals |
| 622 | 224177-60-0 | Siramesine (hydrochloride) | SIRAMESINE SiraMesine, Lu-28-179 SiraMesine (hydrochloride) Siramesine (hydrochloride) Siramesine (HCl salt), Lu-28-179 SiramesineLu-28-179 hydrochloride 1'-[4-[1-(4-Fluorophenyl)-1H-indol-3-yl]butyl]spiro[isobenzofuran-1(3H),4'-piperidine] monohydrochloride Siramesine hydrochloride 1'-[4-[1-(4-Fluorophenyl)-1H-indol-3-yl]butyl]spiro[isobenzofuran-1(3H),4'-piperidine] monohydrochloride SiraMesine, Lu-28-179 1'-[4-[1-(4-Fluorophenyl)-1H-indol-3-yl]butyl]spiro[isobenzofuran-1(3H),4'-piperidine] monohydrochloride | Inhibitors;Small molecule inhibitors;Other biochemical reagents;Small molecule inhibitors, natural products |
| 623 | 226954-04-7 | AC-5216 | XBD-173 AC-5216 Emapunil EMapunil Emapunil(AC-5216) AC 5216 (Emapunil) N-Benzyl-N-ethyl-2-(7-Methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetaMide N-Ethyl-7,8-dihydro-7-methyl-8-oxo-2-phenyl-N-(phenylmethyl)-9H-purine-9-acetamide 9H-Purine-9-acetaMide,N-ethyl-7,8-dihydro-7-Methyl-8-oxo-2-phenyl-N-(phenylMethyl)- | Inhibitors;Active molecules;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 624 | 23146-22-7 | IQ-1S (free acid) | IQ1S IQ-1S IQ 1S IQ-1S CS-2230 IQ-1 sodium IQ-1S (free acid) 11H-Indeno[1,2-b]quinoxalin-11-one oxime Sodium | |
| 625 | 232271-19-1 | (S)-2-(2,6-Dichlorobenzamido)-3-(2',6'-dimethoxy-[1,1'-biphenyl]-4-yl)propanoic acid | TR14035 MDK1191 TR 14035 TR-14035 MDK-1191 N-(2,6-Dichlorobenzoyl)-4-(2,6-diMethoxyphenyl)-L-phenylalanine (S)-2-(2,6-Dichlorobenzamido)-3-(2',6'-dimethoxy-[1,1'-biphenyl]-4-yl)propanoic acid (S)-2-(2,6-DichlorobenzaMido)-3-(2',6'-diMethoxy-[1,1'-biphenyl]-4-yl)propanoic acid (alphaS)-alpha-[(2,6-Dichlorobenzoyl)amino]-2',6'-dimethoxy-[1,1'-biphenyl]-4-propanoic acid | |
| 626 | 249537-73-3 | H-MET-ALA-GLY-PRO-HIS-PRO-VAL-ILE-VAL-ILE-THR-GLY-PRO-HIS-GLU-GLU-OH | VIVIT NFAT INHIBITOR MAGPHPVIVITGPHEE NFAT Inhibitor (VIVIT peptide) MET-ALA-GLY-PRO-HIS-PRO-VAL-ILE-VAL-ILE-THR-GLY-PRO-HIS-GLU-GLU H-MET-ALA-GLY-PRO-HIS-PRO-VAL-ILE-VAL-ILE-THR-GLY-PRO-HIS-GLU-GLU-OH | Polypeptides;Gene Regulation;Gene Regulation;Directory peptides;Gene Regulation and Expression;Cell Signaling and Neuroscience;Gene Regulation and Expression;Cell Signaling and Neuroscience |
| 627 | 256477-09-5 | UK-371804 | UK-371804 Urokinase inhibitor 1 Urokinase inhitibor 1 UK-371804 (Urokinase inhitibor 1) N-[[1-[(Aminoiminomethyl)amino]-4-chloro-7-isoquinolinyl]sulfonyl]-2-methylalanine Alanine, N-[[1-[(aminoiminomethyl)amino]-4-chloro-7-isoquinolinyl]sulfonyl]-2-methyl- | |
| 628 | 256925-03-8 | AL 082D06 | D 06 D06 D-06 AL082D06 AL-082D06 AL 082D06 AL 082D06(D-06) 4,4'-[(2-Chloro-5-nitrophenyl)methylene]bis[N,N-dimethylbenzenamine] 4-[(2-Chloro-5-nitrophenyl)-[4-(dimethylamino)phenyl]methyl]-N,N-dimethylaniline | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 629 | 266359-93-7 | Reparixin (L-lysine salt) | Reparixin L-lysine REPERTAXIN L-LYSINE SALT Reparixin (L-lysine salt) Reparixin L-lysine salt (Repertaxin L-lysine salt) R-(-)-2-(4-ISOBUTYLPHENYL)PROPIONYL METHANSULPHONAMIDE, LYSINE SALT | |
| 630 | 271576-80-8 | SD-06 | SD06 SD-06 SD 06 CS-2591 ATG-010 SD 0006 SD-06-1 SD 0006(SD-06) 3-[N-(2-Hydroxyacetyl)-4-piperidyl]-4-(4-pyrimidinyl)-5-(4-chlorophenyl)pyrazole 1-(4-(5-(4-Chlorophenyl)-4-(pyrimidin-4-yl)-1H-pyrazol-3-yl)piperidin-1-yl)-2-hydroxyethanone | MAPK |
| 631 | 275371-94-3 | Taspoglutide | R-1583 ITM-077 BIM-51077 Taspoglutide taspoglutide Taspoglutide Acetate 7-36-Glucagon-like peptide I (human), 8-(2-methylalanine)-35-(2-methylalanine)-36-L-argininamide- | Spot;Peptides;Catalog polypeptides |
| 632 | 290815-26-8 | Avosentan | SPP-301 Avosentan avosentan Ro 67-0565 avosentan,CID 9912992 N-(6-Methoxy-5-(2-methoxyphenoxy)-2-(pyridin-4-yl)-pyrimidin-4-yl)-5-methylpyridine-2-sulfonam N-[6-Methoxy-5-(2-methoxyphenoxy)-2-(4-pyridinyl)-4-pyrimidinyl]-5-methyl-2-pyridinesulfonamide 2-Pyridinesulfonamide,N-[6-methoxy-5-(2-methoxyphenoxy)-2-(4-pyridinyl)-4-pyrimidinyl]-5-methyl- N-(6-Methoxy-5-(2-methoxyphenoxy)-2-(pyridin-4-yl)-pyrimidin-4-yl)-5-methylpyridine-2-sulfonamide | Standard sample of bulk drug;Pharmaceutical intermediates;G protein coupled receptor & G protein |
| 633 | 306974-70-9 | GW-1100 | GW1100 GW-1100 GW 1100 1-(4-Ethoxycarbonylphenyl)-2-(4-fluorobenzylthio)-5-(2-ethoxy-5-pyrimidinylmethyl)-4-pyrimidinone Benzoic acid, 4-[5-[(2-ethoxy-5-pyrimidinyl)methyl]-2-[[(4-fluorophenyl)methyl]thio]-4-oxo-1(4H)-pyrimidinyl]-, ethyl ester | Aromatics;Inhibitors;Heterocycles;Pharmaceuticals;Intermediates & Fine Chemicals;G protein coupled receptor & G protein |
| 634 | 309271-94-1 | Inauhzin | INAUHZIN Inauhzin Inauhzin(INZ) 10-[1-Oxo-2-(2H-1,2,4-triazino[5,6-b]indol-3-ylthio)butyl]-10H-phenothiazine 2-(9H-[1,2,4]TRIAZINO[6,5-B]INDOL-3-YLTHIO)-1-(10H-PHENOTHIAZIN-10-YL)BUTAN-1-ONE 2-((5H-[1,2,4]Triazino[5,6-b]indol-3-yl)thio)-1-(10H-phenothiazin-10-yl)butan-1-one 1-Phenothiazin-10-yl-2-(9H-1,3,4,9-tetraaza-fluoren-2-ylsufanyl)-butan-1-one (Inauhzin) 10-[1-Oxo-2-(2H-1,2,4-triazino[5,6-b]indol-3-ylthio)butyl]-10H-phenothiazine Inauhzin(INZ) | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 635 | 3131-03-1 | mikamycin B | PA 114B NSC 92554 mikamycin B VirginiaMycin B Pristinamycin IA PristinaMycin P 1 Ostreogrycin B, PristinaMycin IA, StreptograMin B, Syncothrecin B1, Synergistin B, VernaMycin Balpha, VirginiaMycin 1A, NSC 125176, 14725-1, PA 114B, RP 12535 N-[(3-Hydroxy-2-pyridinyl)carbonyl]-L-threonyl-(2R)-2-aMinobutanoyl-L-prolyl-4-(diMethylaMino)-N-Methyl-L-phenylalanyl-(2S)-4-oxo-2-piperidinecarbonyl-(2S)-2-phenylglycine (6-13)-lactone | Inhibitors;Heterocycles;Chiral Reagents;Pharmaceuticals;Microbial metabolites;Intermediates & Fine Chemicals |
| 636 | 315694-89-4 | TC-DAPK 6 | CS-1003 TCDAPK6 TC-DAPK 6 DAPK inhibitor DAPK INHIBITOR 2-(2-Phenylethenyl)-4-(3-pyridinylmethylene)-5(4H)-oxazolone 5(4H)-Oxazolone, 2-(2-phenylethenyl)-4-(3-pyridinylmethylene)- (4E)-2-[(E)-2-phenylethenyl]-4-(pyridin-3-ylmethylidene)-1,3-oxazol-5-one 2-(2-Phenylethenyl)-4-(3-pyridinylmethylene)-5(4H)-oxazolone TC-DAPK 6 | Cell biology reagent;Protein kinase 1 inhibitor |
| 637 | 321688-88-4 | Poloxin | Poloxin Polo-like Kinase Inhibitor V, Poloxin (Z)-2-Isopropyl-5-methyl-4-(((2-methylbenzoyl)oxy)imino)cyclohexa-2,5-dienone 2-Methyl-5-(1-methylethyl)-1-[O-(2-methylbenzoyl)oxime]-2,5-Cyclohexadiene-1,4-dione 2-Methyl-5-(1-methylethyl)-2,5-cyclohexadiene-1,4-dione 1-[O-(2-methylbenzoyl)oxime] 2,5-Cyclohexadiene-1,4-dione, 2-methyl-5-(1-methylethyl)-, 1-[O-(2-methylbenzoyl)oxime] | cell cycle;Cell biology reagents |
| 638 | 329907-28-0 | TTP 22 | CS-886 TTP 22 3-(5-P-TOLYLTHIENO[2,3-D]PYRIMIDIN-4-YLTHIO)PROPANOIC ACID 3-[[5-(4-Methylphenyl)thieno[2,3-d]pyriMidin-4-yl]thio]propanoic acid Propanoic acid, 3-[[5-(4-Methylphenyl)thieno[2,3-d]pyriMidin-4-yl]thio]- 3-[2-(3-HYDROXY-5-METHOXYPHENYL)ETHYL]-6-METHOXY-2-(3-METHYL-2-BUTEN-1-YL)PHENOL TTP 22 3-[[5-(4-Methylphenyl)thieno[2,3-d]pyrimidin-4-yl]thio]propanoic acid | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 639 | 330786-25-9 | PCI 29732 | CS-2698 PCI29732 PCI-29732 PCI 29732 PCI 29732 (This product is only available in Japan.) 1-Cyclopentyl-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 4-Amino-1-cyclopentyl-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine 1H-Pyrazolo[3,4-d]pyrimidin-4-amine, 1-cyclopentyl-3-(4-phenoxyphenyl)- | |
| 640 | 332117-28-9 | Chembridge-5861528 | CS-1651 TCS5861528 TCS 5861528 TCS-5861528 Chembridge-5861528 CHEMBRIDGE-5861528 CheMbridge 5861528 7H-Purine-7-acetamide, 1,2,3,6-tetrahydro-1,3-dimethyl-N-[4-(1-methylpropyl)phenyl]-2,6-dioxo- 2-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-[4-(1-methylpropyl)phenyl]acetamide | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 641 | 349085-82-1 | GSK137647A | CS-2460 GSK137647 GSK 137647 GSK-137647 GSK137647A GSK-137647A GSK 137647A FFA4 (GPR120) agonist GS137647A | API |
| 642 | 353262-04-1 | NS6180 | NS6180 NS-6180 CS-1648 NS 6180 4-[[3-(Trifluoromethyl)phenyl]methyl]-2H-1,4-benzothiazin-3(4H)-one 2H-1,4-Benzothiazin-3(4H)-one, 4-[[3-(trifluoromethyl)phenyl]methyl]- | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 643 | 354813-19-7 | Balicatib | AAE581 AAE-581 AAE 581 AAE-581 BALICATIB Balicatib Balicatib, AAE-581 N-(1-(CYANOMETHYLCARBAMOYL)CYCLOHEXYL)-4-(4-PROPYLPIPERAZIN-1-YL)BENZAMIDE N-[1-(Cyanomethylcarbamoyl)cyclohexyl]-4-(4-propylpiperazin-1-yl)benzamide Balicatib(AAE-581) Balicatib N-[1-(Cyanomethylcarbamoyl)cyclohexyl]-4-(4-propylpiperazin-1-yl)benzamide | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 644 | 36341-25-0 | 2-(4-HYDROXY-3-METHOXYPHENYL)BENZOTHIAZOLE | Y109 Y-109 YL-109 4-(benzo[d]thiazol-2-yl)-2-Methoxyphenol 4-(1,3-Benzothiazol-2-yl)-2-methoxyphenol 2-(4-HYDROXY-3-METHOXYPHENYL)BENZOTHIAZOLE 4-(3H-1,3-benzothiazol-2-ylidene)-2-methoxycyclohexa-2,5-dien-1-one | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 645 | 370586-05-3 | CID-797718 | CS-1341 CID797718 CID-797718 CID 797718 CID 797718, 370586-05-3 9-Hydroxy-1H,2H,3H,4H-chromeno[3,4-b]pyridin-5-one 9-HYDROXY-1,2,3,4-TETRAHYDROCHROMENO[3,4-B]PYRIDIN-5-ONE 9-HYDROXY-3,4-DIHYDRO-1H-CHROMENO[3,4-B]PYRIDIN-5(2H)-ONE | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 646 | 377727-87-2 | Preladenant | SCH-420814 Preladenant Unii-950o97nupo Sch 420814 Preladenant 2-(Furan-2-yl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)piperazin-1-yl)-ethyl)-7H-pyrazolo[4,3-e][1,2,4 2-(2-Furanyl)-7-[2-[4-[4-(2-Methoxyethoxy)phenyl]-1-piperazinyl]ethyl]-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyriMidin-5-aMine 7H-Pyrazolo(4,3-E)(1,2,4)triazolo(1,5-C)pyrimidin-5-amine, 2-(2-furanyl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)-1-piperazinyl)ethyl)- 2-Furan-2-yl-7-(2-{4-[4-(2-Methoxy-ethoxy)-phenyl]-piperazin-1-yl}-ethyl)-7,9a-dihydro-5H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyriMidin-5-ylaMine | Spot;Amines;Aromatics;Inhibitors;Heterocycles;Pharmaceuticals;Intermediates & Fine Chemicals |
| 647 | 3918-92-1 | H-VAL-PHE-OH | VAL-PHE H-VAL-PHE-OH Valylphenylalanine L-VALYL-L-PHENYLALANINE L-Phenylalanine, L-valyl- | |
| 648 | 40013-87-4 | 24, 25-Dihydroxy VD3 | 24, 25-Dihydroxy VD3 Vitamin D15 Injection 24,25-dihydroxyvitamind3 24,25-dihydroxyvitamined3 24(R), 25-DIHYDROXYVITAMIN D3 7,10(19)-triene-3,24,25-triol,(3-beta,5z,7e)-10-secocholesta-5 (3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,24,25-triol (6R)-2-Methyl-6-[(1R,3aS,4E,7aR)-octahydro-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylenecyclohexylidene]ethylidene]-7a-methyl-1H-inden-1-yl]-2,3-heptanediol (6R)-6-[(1R,3aR,4E,7aS)-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylidene-cyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methyl-heptane-2,3-diol | |
| 649 | 406205-74-1 | Bay 59-3074 | CS-2278 BAY59-3074 Bay 59-3074 BAY 59-3074 BAY-59-3074 BAY 59-3074 3-[2-Cyano-3-(trifluoromethyl)phenoxy]phenyl4,4,4-trifluoro-1-butanesulfonicacidester 1-Butanesulfonic acid, 4,4,4-trifluoro-, 3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl ester | Inhibitors;Cell biology reagents;Pharmaceutical intermediate |
| 650 | 406209-26-5 | ACHP (Hydrochloride ) | IKK-beta inhibitor IKK-2 inhibitor VIII ACHP (Hydrochloride ) ACHP (Hydrochloride ) Bayer IKK-beta inhibitor 2-Amino-6-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-4-(4-piperidinyl)-3-pyridinecarbonitrile hydrochloride 2-amino-6-[2-(cyclopropylmethoxy)-6-oxocyclohexa-2,4-dien-1-ylidene]-4-piperidin-4-yl-1H-pyridine-3-carbonitrile (6Z)-2-amino-6-[2-(cyclopropylmethoxy)-6-oxocyclohexa-2,4-dien-1-ylidene]-4-piperidin-4-yl-1H-pyridine-3-carbonitrile | |
| 651 | 41332-24-5 | NP118809 | Z160 39-1B4 NP118809 NP 118809 NP-118809 1-(DiphenylMethyl)-4-(1-oxo-3,3-diphenylpropyl)piperazine Piperazine, 1-(diphenylmethyl)-4-(1-oxo-3,3-diphenylpropyl)- 1-[4-(DiphenylMethyl)-1-piperazinyl]-3,3-diphenyl-1-propanone | Aromatics;Heterocycles;Ion channels;Pharmaceuticals;Membrane transport;Intermediates & Fine Chemicals |
| 652 | 415713-60-9 | RI-1 | RI1 RI-1 RAD51 inhibitor 1 RAD51 inhibitor RI-1 3-Chloro-1-(3,4-dichlorophenyl)-4-Morpholino-1H-pyrrole-2,5-dione 3-Chloro-1-(3,4-dichlorophenyl)-4-(4-morpholinyl)-1H-pyrrole-2,5-dione 1H-Pyrrole-2,5-dione, 3-chloro-1-(3,4-dichlorophenyl)-4-(4-morpholinyl)- | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 653 | 432001-69-9 | Skp2 Inhibitor C1 | CS-1230 MDK-1699 SKPin C1 Skp2-IN-C1 kp2 Inhibitor C1 Skp2 Inhibitor C1 Skp2 inhibitor C1 (SKPin C1) 2-[4-Bromo-2-[[4-oxo-3-(3-pyridinylmethyl)-2-thioxo-5-thiazolidinylidene]methyl]phenoxy]acetic acid | Cell biology reagent |
| 654 | 439083-90-6 | Bay 60-7550 | BAY 607550 BAY 60-7550 Bay 60-7550 2-(3,4-Dimethoxybenzyl)-7-((2R,3R)-2-hydroxy-6-phenylhexan-3-yl)-5-methylimidazo[5,1-f][1,2,4] 2-[(3,4-Dimethoxyphenyl)methyl]-7-[(1R)-1-[(1R)-1-hydroxyethyl]-4-phenylbutyl]-5-methyl-imidazo[5,1-f][1,2,4]triazin-4(1H)-one Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[(3,4-dimethoxyphenyl)methyl]-7-[(1R)-1-[(1R)-1-hydroxyethyl]-4-phenylbutyl]-5-methyl- | Inhibitors;Nucleotides;Pharmaceuticals;Bases & Related Reagents;Cyclic Nucleotide related;Intermediates & Fine Chemicals |
| 655 | 439288-66-1 | GW627368 | CS-1654 GW627368 GW627368X GW 627368 GW-627368 GW 627368X GW-627368X GW627368(GW627368X) N-(benzenesulfonyl)-2-[4-(4,9-diethoxy-3-oxo-1H-benzo[f]isoindol-2-yl)phenyl]acetamide 4-(4,9-Diethoxy-1,3-dihydro-1-oxo-2H-benz[f]isoindol-2-yl)-N-(phenylsulfonyl)benzeneacetamide 2-[4-(4,9-Diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]-N-(phenylsulfonyl)acetamide | Inhibitors;Small molecule inhibitors;Synthetic material intermediates;Small molecule inhibitors, natural products |
| 656 | 448906-42-1 | methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate | ITE ARYL HYDROCARBON RECEPTOR LIGAND methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate Methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate 2-(1'H-INDOLE-3'-CARBONYL)-THIAZOLE-4-CARBOXYLIC ACID methyl 2-(1H-indole-3-carbonyl)-1,3-thiazole-4-carboxylate 2-(1H-INDOL-3-YLCARBONYL)-4-THIAZOLECARBOXYLIC ACID METHYL ESTER 2-(1'H-indole-37-carbonyl)-thiasole-4-carboxylic acid methyl ester 4-Thiazolecarboxylic acid, 2-(1H-indol-3-ylcarbonyl)-, methyl ester | Cell biology reagents;Chemical raw materials |
| 657 | 448947-81-7 | GlyT2-IN-1 | Yoda 1 CS-2063 GlyT2-IN-1 GlyT2-IN-1(YODA 1) Yoda 1 (GlyT2-IN-1) 2-[5-[[(2,6-Dichlorophenyl)methyl]thio]-1,3,4-thiadiazol-2-yl]pyrazine Pyrazine, 2-[5-[[(2,6-dichlorophenyl)methyl]thio]-1,3,4-thiadiazol-2-yl]- | |
| 658 | 454453-49-7 | 2-[2,6-Dinitro-4-(trifluoromethyl)phenyl]-N-(4-fluorophenyl)hydrazinecarbothioamide | CS-1280 kobe2602 kobe-2602 KOBE-2602 kobe 2602 2-[2,6-Dinitro-4-(trifluoromethyl)phenyl]-N-(4-fluorophenyl)hydrazinecarbothioamide 2-[2,6-Dinitro-4-(trifluoroMethyl)phenyl]-N-(4-fluorophenyl)hydrazinecarbothioaMide kobe-2602 2-[2,6-Dinitro-4-(trifluoromethyl)phenyl]-N-(4-fluorophenyl)hydrazinecarbothioamide | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products;Aromatics, Miscellaneous Reagents, Pharmaceuticals, Intermediates & Fine Chemicals |
| 659 | 457081-03-7 | Pyridone 6 | MERCK5 MERk-5 CS-665 MERCK 5 Merck-5 Pyridone 6 JAK INHIBITOR I JAK Inhibitor I(Merck 5) 2-(tert-butyl)-9-fluoro-3H-benzo[h]iMidazo[4,5-f]isoquinolin-7(6H)-one | Standards;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 660 | 477908-53-5 | 2-((1E,3E,5E)-7-((E)-1-(6-((2,5-dioxopyrrolidin-1-yl)oxy)-6-oxohexyl)-3,3-dimethyl-5-sulfoindolin-2-ylidene)hepta-1,3,5-trien-1-yl)-1-ethyl-3,3-dimethyl-3H-indol-1-ium-5-sulfonate | CY7-SE Cy7-SE Cy7 dye Sulfo-Cy7-SE Cy3 NHS Ester sulfo-cyanine7,Cy7-SE diSulfo-Cy7 NHS ester(Ethyl) Sulfo-Cyanine7 Succinimidyl Ester 2-((1E,3E,5E)-7-((E)-1-(6-((2,5-dioxopyrrolidin-1-yl)oxy)-6-oxohexyl)-3,3-dimethyl-5-sulfoindolin-2-ylidene)hepta-1,3,5-trien-1-yl)-1-ethyl-3,3-dimethyl-3H-indol-1-ium-5-sulfonate 2-[7-[1-[6-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-6-oxohexyl]-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1,3,5-heptatrien-1-yl]-1-ethyl-3,3-dimethyl-5-sulfo-3H-indolium, inner salt | Fluorescent dyes;Chemical reagents;Fluorescent labeling dyes |
| 661 | 483313-22-0 | SB-674042 | SB674042 SB 674042 SB-674042 SB-674042, CID10204153 [5-(2-Fluorophenyl)-2-methyl-4-thiazolyl][2(S)-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)methyl-1-pyrrolidinyl]methanone Methanone, [5-(2-fluorophenyl)-2-methyl-4-thiazolyl][(2S)-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]-1-pyrrolidinyl]- (S)-1-[5-[2-Fluorophenyl]-2-methylthiazol-4-yl]-1-[2-[[5-phenyl-[1,3,4]oxadiazol-2-yl]methyl]pyrrolidin-1-yl]methanone [5-(2-FLUOROPHENYL)-2-METHYL-1,3-THIAZOL-4-YL]-[(2S)-2-[(5-PHENYL-1,3,4-OXADIAZOL-2-YL)METHYL]PYRROLIDIN-1-YL]METHANONE (2S)- 1-[[5-(2-Fluorophenyl)-2-methyl-4-thiazolyl]carbonyl]-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]-pyrrolidine (9CI) | G protein coupled receptor & G protein |
| 662 | 486427-17-2 | CIQ | CIQ CS-2044 (3-Chlorophenyl)[3,4-dihydro-6,7-dimethoxy-1-[(4-methoxyphenoxy)methyl]-2(1H)-isoquinolinyl]methanone (3-chlorophenyl)(6,7-dimethoxy-1-((4-methoxyphenoxy)methyl)-3,4-dihydroisoquinolin-2(1H)-yl)methanone (3-Chlorophenyl)-[6,7-dimethoxy-1-[(4-methoxyphenoxy)methyl]-3,4-dihydro-1H-isoquinolin-2-yl]methanone (3-Chlorophenyl){6,7-dimethoxy-1-[(4-methoxyphenoxy)methyl]-3,4-d ihydro-2(1H)-isoquinolinyl}methanone Methanone, (3-chlorophenyl)[3,4-dihydro-6,7-dimethoxy-1-[(4-methoxyphenoxy)methyl]-2(1H)-isoquinolinyl]- | |
| 663 | 491871-58-0 | TCS PIM-1 1 | CS-1482 TCS PIM-1 SC 204330 TCS PIM-1 1 TCS PIM 1-1 3-Cyano-4-phenyl-6-(3-bromo-6-hydroxy)phenyl-2(1H)-pyridone 6-(5-Bromo-2-hydroxyphenyl)-1,2-dihydro-2-oxo-4-phenyl-3-pyridinecarbonitrile | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 664 | 496791-37-8 | AR-C155858 | AR C15585 AR C155858 AR-C155858 AR-C 155858 (S)-6-((3,5-dimethyl-1H-pyrazol-4-yl)methyl)-5-(4-hydroxyisoxazolidine-2-carbonyl)-1-isobutyl-3-methylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione (S)-6-[(3,5-Dimethyl-1H-pyrazol-4-yl)methyl]-5-[(4-hydroxyisoxazolidin-2-yl)carbonyl]-1-isobutyl-3-methylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione 6-[(3,5-Dimethyl-1H-pyrazol-4-yl)methyl]-5-[[(4S)-4-hydroxy-2-isoxazolidinyl]carbonyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione, 6-[(3,5-dimethyl-1H-pyrazol-4-yl)methyl]-5-[[(4S)-4-hydroxy-2-isoxazolidinyl]carbonyl]-3-methyl-1-(2-methylpropyl)- | Ion channels;Membrane transport |
| 665 | 496794-70-8 | HhAntag | HhAntag GLI1-Mediated transcription inhibitor N-[4-chloro-3-[6-(dimethylamino)-1H-benzimidazol-2-yl]phenyl]-3 N-[4-Chloro-3-[5-(dimethylamino)-1H-benzimidazol-2-yl]phenyl]-3,5-dimethoxybenzamide BenzaMide, N-[4-chloro-3-[6-(diMethylaMino)-1H-benziMidazol-2-yl]phenyl]-3,5-diMethoxy- N-(4-chloro-3-(5-(diMethylaMino)-1H-benzo[d]iMidazol-2-yl)phenyl)-3,5-diMethoxybenzaMide N-(4-Chloro-3-(6-(dimethylamino)-1H-benzo[d]imidazol-2-yl)phenyl)-3,5-dimethoxybenzamide | Cell biology reagent |
| 666 | 516480-79-8 | BML-277 | C 3742 BML277 BML-277 CS-1761 BML 277 BML-277 (C 3742) CHK2 INHIBITOR II BML-277,CHK2 INHIBITOR II 2-(4-(4-CHLOROPHENOXY)PHENYL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXAMIDE | API;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 667 | 518058-84-9 | KX1-004 | CS-1235 KX1-004 KX1-004, 518058-84-9 5-fluoro-N-(3-hydroxybenzyl)-1H-indole-2-carboxaMide 5-Fluoro-N-[(3-hydroxyphenyl)methyl]-1H-indole-2-carboxamide 5-Fluoro-N-[(3-hydroxyphenyl)methyl]-1H-indole-2-carboxamide KX1-004 KX1-004 5-Fluoro-N-[(3-hydroxyphenyl)methyl]-1H-indole-2-carboxamide | Standards;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 668 | 529488-28-6 | 2,3-dimethoxy-12-(2-(methylamino)ethyl)-[1,3]dioxolo[4',5':4,5]benzo[1,2-h]benzo[c][1,6]naphthyridin-13(12H)-one | GENZ644282 GNZ-644282 Genz644282 GENZ 644282 Genz-644282 GENZ-644282 GENZ 644282 8,9-dimethoxy-2,3-methylenedioxy-5-[2-(N-methylamino)ethyl]-5H-dibenzo[c,h]1,6-naphthyridin-6-one 2,3-Dimethoxy-12-[2-(methylamino)ethyl]benzo[c][1,3]benzodioxolo[5,6-h][1,6]naphthyridin-13(12H)-one 2,3-Dimethoxy-12-[2-(methylamino)ethyl]benzo[c][1,3]benzodioxolo[5,6-h][1,6]naphthyridin-13(12H)-one GENZ-644282 | inhibitor;cell cycle;biological reagent;cell biology reagent;drug active molecule |
| 669 | 530141-72-1 | T-5224 | T5224 T-5225 T-5224 CS-1217 T 5224. 3-(5-(4-(Cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxybenzo-[d]isoxazol-6-yl)methoxy)phenyl) 3-(5-(4-(Cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-oxo-2,3-dihydrobenzo[d]isoxazol-6-yl)methoxy) 3-[5-[4-(cyclopentoxy)-2-hydroxy-benzoyl]-2-[(3-hydroxy-1,2-benzo xazol-6-yl)methoxy]phenyl]propanoic acid Benzenepropanoic acid, 5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(2,3-dihydro-3-oxo-1,2-benzisoxazol-6-yl)Methoxy]- | API;Inhibitor |
| 670 | 537034-17-6 | BML-210 | CS-2301 BML-210 CAY10433 BML-210, (BML210 BML-210(CAY10433) N-(2-AMINOPHENYL)-N'-PHENYL-OCTANEDIAMIDE N1-(2-aminophenyl)-N8-phenyl-octanediamide N-PHENYL-N'-(2-AMINOPHENYL)HEXAMETHYLENEDIAMIDE | Standard;Inhibitors;Cell biology reagents |
| 671 | 5465-86-1 | 4-Methyl-2-(1-piperidinyl)-quinoline | ML204 ML 204 ML-204 NSC 25850 4-methyl-2-(piperidin-1-yl)quinoline 4-METHYL-2-(1-PIPERIDINYL)-QUINOLINE 4-Methyl-2-(1-piperidinyl)-quinoline Quinoline, 4-methyl-2-(1-piperidinyl)- | Inhibitors;Small molecule inhibitors;Aromatics, Heterocycles, Inhibitors;Small molecule inhibitors, natural products |
| 672 | 547757-23-3 | BMS-345541 hydrochloride | CS-1009 BMS-345541 BMS-345541 HCl BMS345541 (HCl Salt) BMS 345541 (HCl Salt) BMS345541 HYDROCHLORIDE BMS-345541 hydrochloride BMS 345541 hydrochloride BMS 345541 HYDROCHLORIDE BMS-345541 HYDROCHLORIDE N1-(1,8-Dimethylimidazo[1,2-a]quinoxalin-4-yl)-1,2-ethanediamine hydrochloride N-(1,8-Dimethylimidazo[1,2-a]quinoxalin-4-yl)-1,2-ethanediamine hydrochloride | NF-kB |
| 673 | 54-91-1 | Pipobroman | A-8103 Amedel Vercyte NSC-25154 Pipobroman 1,4-Bis(3-bromo-1-oxopropyl)piperadine 1,1'-(Piperazine-1,4-diyl)bis(3-bromopropan-1-one) 3-bromo-1-[4-(3-bromopropanoyl)piperazin-1-yl]propan-1-one | HYDROMOX;Chemical raw materials |
| 674 | 56396-35-1 | 2-cyano-3-(1-phenylindol-3-yl)acrylate | UK 5099 PF-1005023 PF-06340678 BIZNHCWFGNKBBZ-JLHYYAGUSA-N 2-cyano-3-(1-phenylindol-3-yl)acrylate Mitochondrial Pyruvate Carrier Inhibitor, UK5099 (E)-2-cyano-3-(1-phenyl-1H-indol-3-yl)acrylic acid 2-Cyano-3-(1-phenyl-1H-indol-3-yl)-2-propenoicacid | Aromatics;Inhibitors;Heterocycles;Pharmaceuticals;Pfizer Compounds;Cell biology reagent;Intermediates & Fine Chemicals |
| 675 | 587850-67-7 | 4-Amino-N-phenethylbenzenesulfonamide | CS-1909 C7280948 C-7280948 C 7280948 ASISCHEM B51558 4-Amino-N-phenethylbenzenesulfonamide 4-AMINO-N-PHENETHYL-BENZENESULFONAMIDE 4-AMINO-N-(2-PHENYLETHYL)BENZENESULFONAMIDE | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 676 | 591778-70-0 | CP-640186 (hydrochloride) | CS-1253 CP640186 HCl CP-640186 (hydrochloride) (3R)-1'-(anthracene-9-carbonyl)-3-(morpholine-4-c arbonyl)-1,4'-bipiperidine hydrochloride (R)-ANTHRACEN-9-YL(3-(MORPHOLINE-4-CARBONYL)-[1,4'-BIPIPERIDIN]-1'-YL)METHANONE HYDROCHLORIDE | |
| 677 | 603148-36-3 | 1-PropanaMine, 3-[4-[2-butyl-1-[4-(4-chlorophenoxy)phenyl]-1H-iMidazol-4-yl]phenoxy]-N,N-diethyl- | Azeliragon AZELIRAGON Azeliragon (TTP488) Azeliragon(PF-04494700,TTP488) 3--4--2-Butyl-1--4--4-chlorphenoxy-phenyl--1H-imidazol-4-yl-phenoxy--N-N-diethylpropan-1-amin 3-(4-(2-butyl-1-(4-(4-chlorophenoxy)phenyl)-1H-imidazol-4-yl)phenoxy)-N,N-diethylpropan-1-amine N-[3-[4-[2-Butyl-1-[4-(4-chlorophenoxy)phenyl]-1H-imidazol-4-yl]phenoxy]propyl]-N,N-diethylamine 1-PropanaMine, 3-[4-[2-butyl-1-[4-(4-chlorophenoxy)phenyl]-1H-iMidazol-4-yl]phenoxy]-N,N-diethyl- | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 678 | 606101-58-0 | MK-0773 | MK0773 MK-0773 MK 0773 PF05314882 PF-05314882 PF 05314882 N-(3H-Imidazo[4,5-b]pyridin-2-ylmethyl)-2-fluoro-4-methyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide 1H-Indeno[5,4-f]quinoline-7-carboxamide, 3-fluoro-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-N-(3H-imidazo[4,5-b]pyridin-2-ylmethyl)-1,4a,6a-trimethyl-2-oxo-, (4aS,4bS,6aS,7S,9aS,9bS,11aR)- | Spot;SARM series;Pharmaceutical original drug series |
| 679 | 613677-28-4 | Lasmiditan (hydrochloride) | 613677-28-4 Lasmiditan HCl Lasmiditant HCl COL-144 hydrochloride) LY573144 hydrochloride Lasmiditan (hydrochloride) 2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)pyridin-2-yl]benzamide hydrochloride | Inhibitor;Cell biology reagent |
| 680 | 625115-52-8 | N-Desmethyl-riociguat | Nelociguat BAY 60-4552 DESMETHYL RIOCIGUAT methyl (4,6-diamino-2 N-Desmethyl Riociguat N-Desmethyl-riociguat Riociguat N-Desmethyl Impurity Methyl [4,6-diaMino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidin-5-yl]carbaMate methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]carbamate Carbamic acid, N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-, methyl ester | Standard;Leosiqua impurity;Medical raw materials;Reference substance-impurity reference substance |
| 681 | 627908-92-3 | SU14813 | SU14813 CS-1149 SU-14813 SU 14813 SU14813(Random Configuration) 5-[(Z)-(5-Fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N- [ 2-hydroxy-3-(4-morpholinyl)propyl]-2,4-dimethyl-1H-pyrrole-3-carb 5-[(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-(4-morpholinyl)propyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide 1H-Pyrrole-3-carboxamide, 5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-(4-morpholinyl)propyl]-2,4-dimethyl- | Inhibitors;Cell biology reagents;Protein tyrosine kinase |
| 682 | 630124-46-8 | AST 487 | CS-562 AST 487 NVP-AST 487 3-{4-[(4-ETHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL}-1-(4-{[6-(METHYLAMINO)PYRIMIDIN-4-YL]OXY}PHENYL)UREA 1-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-(4-((6-(methylamino)pyrimidin-4-yl)oxy)phenyl)urea 1-{4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl}-3-(4-{[6-(methylamino)-4-pyrimidinyl]oxy}phenyl)urea N-[4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-N'-[4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]urea N-[4-[(4-ETHYL-1-PIPERAZINYL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL]-N'-[4-[[6-(METHYLAMINO)-4-PYRIMIDINYL]OXY]PHENYL]UREA Urea,N-[4-[(4-ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-N'-[4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]- | Standard;Cell biology reagent |
| 683 | 638156-11-3 | 5-(3-Chlorophenyl)-N-[4-morpholin-4-ymethyl)phenyl]furan-2-carboxamide | CID2011756 CID-2011756 CID 2011756 CID-2011756 5-(3-chlorophenyl)-N-(4-(MorpholinoMethyl)phenyl)furan-2-carboxaMide 5-(3-Chlorophenyl)-N-[4-morpholin-4-ymethyl)phenyl]furan-2-carboxamide 5-(3-Chlorophenyl)-N-[4-(4-morpholinylmethyl)phenyl]-2-furancarboxamide 5-(3-Chlorophenyl)-N-[4-(morpholin-4-ylmethyl)phenyl]furan-2-carboxamide CID-2011756,5-(3-chlorophenyl)-N-(4-(MorpholinoMethyl)phenyl)furan-2-carboxaMide | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors |
| 684 | 64048-12-0 | 2,3,4,5-Tetra-(4-Pyridyl) Thiophene | GANT58 Nsc75503 2,3,4,5-TETRA-(4-PYRIDYL) THIOPHENE 2,3,4,5-Tetra-(4-Pyridyl) Thiophene 1,2,3,4-Tetrakis(4-pyridyl)thiophene -(2,3,4,5-Thiophentetrayl)tetrakis-pyridine Pyridine, 4,4',4'',4'''-(2,3,4,5-thiophenetetrayl)tetrakis- | organic compounds;Thiophene derivatives |
| 685 | 646502-53-6 | VcMMAE | VeMMAE VcMMAE MC-VC-PAB-MMAE MC-Val-Cit-PAB-MMAE MC-VC-PAB-MMAE VCMMAE BRENTUXIMAB IMPURITY 2 (VEDOTIN) maleimido-caproyl-val-Cit-PAB-MMAE MC-VC-PAB-MMAE,MC-Val-Cit-PAB-MMAE Maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl-monomethyl auristatin E 4-((S)-2-((S)-2-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido)-5-ureidopentanamido)benzyl((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-y | ADC;API;ADCs |
| 686 | 660868-91-7 | GW843682X | GW843682 GW843682X Polo-like Kinase Inhibitor III 5-(5,6-DIMETHOXYBENZIMIDAZOL-1-YL)-3-[[2-(TRIFLUOROMETHYL)PHENYL]METHOXY]THIOPHENE-2-CARBOXAMIDE 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(trifluoromethyl)-benzyl]oxy}thiophene-2-carboxamide 3-(2-(Trifluoromethyl)benzyloxy)-5-(5,6-dimethoxy-1H-benzo[d]imidazol-1-yl)thiophene-2-carboxamide 5-(5,6-dimethoxy-1H-benzo[d]imidazol-1-yl)-3-((2-(trifluoromethyl)benzyl)oxy)thiophene-2-carboxamide 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-[[2-(trifluoromethyl)phenyl]methoxy]-2-thiophenecarboxamide GW843682, 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(trifluoromethyl)-benzyl]oxy}thiophene-2-carboxamide | Cell cycle;Cell biology reagent |
| 687 | 664993-53-7 | JW-55 | JW55 JW-55 N-[4-[[4-(4-METHOXYPHENYL)OXAN-4-YL]METHYLCARBAMOYL]PHENYL]FURAN-2-CARBOXAMIDE N-(4-((4-(4-Methoxyphenyl)tetrahydro-2H-pyran-4-yl)MethylcarbaMoyl)phenyl)furan-2-carboxaMide N-(4-(((4-(4-Methoxyphenyl)tetrahydro-2H-pyran-4-yl)methyl)carbamoyl)phenyl)furan-2-carboxamid N-[4-[[[[Tetrahydro-4-(4-methoxyphenyl)-2H-pyran-4-yl]methyl]amino]carbonyl]phenyl]-2-furancarboxamide JW55 N-[4-[[[[Tetrahydro-4-(4-methoxyphenyl)-2H-pyran-4-yl]methyl]amino]carbonyl]phenyl]-2-furancarboxamide | Amines;Aromatics;Inhibitors;Heterocycles;Pharmaceuticals;Cell biology reagents;Small molecule inhibitors;Intermediates & Fine Chemicals;Small molecule inhibitors, natural products |
| 688 | 67469-81-2 | 1-(2-DIPHENYLMETHOXYETHYL)-4-(3-PHENYLPROPYL)PIPERAZINE DIHYDROCHLORIDE | GBR 12935 HCl GBR-12935 2HCL GBR 12935 DIHYDROCHLORIDE GBR-12935 dihydrochloride GBR 12935 (hydrochloride) GBR 12935 dihydrochloride 1-(2-DIPHENYLMETHOXYETHYL)-4-(3-PHENYLPROPYL)PIPERAZINE DIHYDROCHLORIDE 1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine dihydrochloride | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 689 | 681159-27-3 | CBR-5884 | CBR5884 CBR-5884 CBR 5884 ethyl 4-(cyanosulfanyl)-5-(furan-2-amido)-3-methylthiophene-2-carboxylate Ethyl 5-[(2-furanylcarbonyl)amino]-3-methyl-4-thiocyanato-2-thiophenecarboxylate 2-Thiophenecarboxylic acid, 5-[(2-furanylcarbonyl)amino]-3-methyl-4-thiocyanato-, ethyl ester | |
| 690 | 681492-22-8 | Delamanid | Delamanid OPC-67683 (2R)-2-METHYL-6-NITRO-2-[[4-[4-[4-(TRIFLUOROMETHOXY)PHENOXY]PIPERIDIN-1-YL]PHENOXY]METHYL]-3H-IMIDAZO[2,1-B][1,3]OXAZOLE (R)-2-Methyl-6-nitro-2-((4-(4-(4-(trifluoromethoxy)phenoxy)piperidin-1-yl)phenoxy)methyl)-2,3-dihydroimidazo[2,1-b]oxazole (2R)-2,3-Dihydro-2-methyl-6-nitro-2-[[4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidinyl]phenoxy]methyl]imidazo[2,1-b]oxazole | Chemical raw materials;Pharmaceutical raw materials |
| 691 | 690270-29-2 | Balapiravir | R-1626 CS-1493 Ro 4588161 Balapiravir Balapiravir (R1626) Balapiravir (R1626, Ro 4588161) 4'-C-Azidocytidine 2',3',5'-tris(2-methylpropanoate) (2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-azido-2-((isobutyryloxy)methyl)tetrahydrofuran-3,4-diyl bis(2-methylpropanoate) | Metabolism |
| 692 | 697235-38-4 | Silvestrol | Silvestrol (-)-Silvestrol (1R,2R,3S,3aR,8bS)-6-[[(2S,3R,6R)-6-[(1R)-1,2-Dihydroxyethyl]-3-methoxy-1,4-dioxan-2-yl]oxy]-2,3,3a,8b-tetrahydro-1,8b-dihydroxy-8-methoxy-3a-(4-methoxyphenyl)-3-phenyl-1H-cyclopenta[b]benzofuran-2-carboxylic acid methyl ester 1H-Cyclopenta[b]benzofuran-2-carboxylic acid, 6-[[(2S,3R,6R)-6-[(1R)-1,2-dihydroxyethyl]-3-Methoxy-1,4-dioxan-2-yl]o xy]-2,3,3a,8b-tetrahydro-1,8b-dihydroxy-8-Methoxy-3a-(4-Methoxypheny l)-3-phenyl-, Methyl ester, (1R,2R,3S,3aR,8bS)- | Protein tyrosine kinase;Other biochemical reagents |
| 693 | 71418-44-5 | mBBr [Monobromobimane] | MMB MBBR Bromobimane THIOLYTE(R) MB MONOBROMOBIMANE THIOLYTE(R) MB REAGENT mBBr [Monobromobimane] THIOLYTE MONOBROMOBIMANE REAGENT THIOLYTE(R) MONOBROMOBIMANE REAGENT THIOLYTE(R) MONOBROMOBIMANE REAGENT, FLUORESCENT LABELING COMPOUND | Pyrazole;Chemical reagent;Fluorescent Labels & Indicators;MTS & Sulfhydryl Active Reagents;Fluorescent Labels and Indicators |
| 694 | 72873-74-6 | 6-(4-FLUOROPHENYL)-2,3-DIHYDRO-5-(4-PYRIDINYL)IMIDAZO[2,1-B]THIAZOLE DIHYDROCHLORIDE | SKF-86002 SKF 86002 DIHYDROCHLORIDE 6-(4-FLUOROPHENYL)-2,3-DIHYDRO-5-(4-PYRIDYL)IMIDAZO[2,1-B]THIAZOLE 6-(4-FLUOROPHENYL)-2,3-DIHYDRO-5-(4-PRIDYL)IMIDAZO-[2,1,B]-THAIZOLE 6-(4-FLUOROPHENYL)-5-(4-PYRIDYL)-2,3-DIHYDROIMIDAZO[2,1-B]-THIAZOLE 6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole 4-(4-Pyridyl)-5-(4-fluorophenyl)-2,3-dihydro-1-thia-3a,6-diazapentalene 6-(4-FLUOROPHENYL)-2,3-DIHYDRO-5-(4-PYRIDINYL)IMIDAZO[2,1-B]THIAZOLE DIHYDROCHLORIDE | Inhibitors;Protein Kinase;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 695 | 72926-24-0 | N-(4-Acetyl-4,5-dihydro-5-methyl-5-phenyl-1,3,4-thiadiazol-2-yl)acetamide | K858 K 858 K-858 K858 (Racemic) N-(4-Acetyl-4,5-dihydro-5-methyl-5-phenyl-1,3,4-thiadiazol-2-yl)acetamide N-(4-acetyl-5-methyl-5-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl)a Cetamide Acetamide, N-(4-acetyl-4,5-dihydro-5-methyl-5-phenyl-1,3,4-thiadiazol-2-yl)- | Standard;Cell biology reagent |
| 696 | 73043-80-8 | 1-Methyl-7-nitroisatoic anhydride | 1M7 4-DIONE 3]OXAZINE-2 3]oxazine-2 7-NITRO-1-METHYL-1H-BENZO[D][1 7-nitro-1-methyl-1H-benzo[d][1 1-Methyl-7-nitroisatoic anhydride 1-METHYL-7-NITROISATOIC ANHYDRIDE(WX142523) 1-METHYL-7-NITRO-2H-3,1-BENZOXAZINE-2,4(1H)-DIONE 1-Methyl-7-nitro-1H-benzo[d][1,3]oxazine-2,4-dione 7-nitro-1-methyl-1H-benzo[d][1,3]oxazine-2,4-dione | |
| 697 | 752187-80-7 | Taprenepag | CP544326 CP-544326 CP 544326 TAPRENEPAG Taprenepag PF 04217329 CP544326 (Taprenepag) Taprenepag(CP-544326) 2-[3-[[(4-pyrazol-1-ylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]phenoxy]acetic Acid 2-[3-[[[[4-(1H-Pyrazol-1-yl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl]phenoxy]acetic acid | |
| 698 | 758679-97-9 | CID-2858522 | 100844 CID2858522 CID-2858522 CID 2858522 1-(3,5-Di-tert-butyl-4-hydroxyphenyl)-2-(2-(3-hydroxypropylamino)-5,6-dimethyl-1H-benzo[d]imid 1-(3,5-di-tert-butyl-4-hydroxyphenyl)-2-(2-(3-hydroxypropylaMino)-5,6-diMethyl-1H-benzo[d]iMidazol-1-yl)ethanone 1-[3,5-Bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-[2-[(3-hydroxypropyl)amino]-5,6-dimethyl-1H-benzimidazol-1-yl]-ethanone Ethanone, 1-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-[2-[(3-hydroxypropyl)amino]-5,6-dimethyl-1H-benzimidazol-1-yl]- | NF-kB |
| 699 | 761436-81-1 | 2-[[5-Bromo-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]amino]-N-methylbenzenesulfonamide | ALK inhibitor 1 2-[[5-bromo-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]amino]-N-methyl- 2-[[5-Bromo-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]amino]-N-methylbenzenesulfonamide BenzenesulfonaMide, 2-[[5-broMo-2-[[2-Methoxy-4-(4-Methyl-1-piperazinyl)phenyl]aMino]-4-pyriMidinyl]aMino]-N-Methyl- | Cell biology reagent;Biochemical industry |
| 700 | 774549-97-2 | KM11060 | KM11060 KM 11060 KM-11060 CFTR-F508del Corrector, KM11060 7-CHLORO-4-(4-(4-CHLOROPHENYLSULFONYL)PIPERAZIN-1-YL)QUINOLINE 7-CHLORO-4-[4-[4-CHLOROPHENYL)SULFONYL]-1-PIPERAZINYL]QUINOLINE Quinoline, 7-chloro-4-[4-[(4-chlorophenyl)sulfonyl]-1-piperazinyl]- | |
| 701 | 783348-36-7 | MLN120B | ML120B MLN120B MLN 120B MLN-120B MLN 120B MLN-120B N-(6-Chloro-7-methoxy-9H-pyrido[3,4-b]indol-8-yl)-2-methylnicotinamide N-(6-Chloro-7-methoxy-9H-pyrido[3,4-b]indol-8-yl)-2-methyl-3-pyridinecarboxamide | NF-kB;Cell biology reagent |
| 702 | 785835-79-2 | JDTic (dihydrochloride) | CS-648 JDTic (2HCl) JDTic (dihydrochloride) (R)-7-hydroxy-N-((S)-1-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)-3-methylbutan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (3R)-7-hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (R)-7-hydroxy-N-((S)-1-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)-3-methylbutan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide dihydrochloride (3R)-7-hydroxy-N-[(2S)-1-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]-3-methylbutan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide dihydrochloride (3R)-1,2,3,4-Tetrahydro-7-hydroxy-N-[(1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl]-3-isoquinolinecarboxamide hydrochloride | Standards;tetrahydroisoqu |
| 703 | 79756-69-7 | TPI-1 | TPI1 TPI 1 TPI-1 TPI1 TPI 1 2-(2,5-Dichlorophenyl)-1,4-benzoquinone 2',5'-Dichloro-[1,1'-biphenyl]-2,5-dione 2-(2,5-dichlorophenyl)cyclohexa-2,5-diene-1,4-dione 2,5-Cyclohexadiene-1,4-dione, 2-(2,5-dichlorophenyl)- | |
| 704 | 80306-38-3 | AR7 | AR7 ERBA CS-2649 ERB-T-1 c-ERBA-1 Atypical retinoid 7 Thyroid Hormone receptor,α1 human 7-Chloro-3-p-tolyl-2H-benzo[b][1,4]oxazine 7-Chloro-3-(4-methylphenyl)-2H-1,4-benzoxazine | APIs and Intermediates |
| 705 | 834903-43-4 | CID 16020046 | CS-1189 C390-0219 CID16020046 CID 16020046 CID16020046 (CID 16020046) 4-[4-(3-Hydroxyphenyl)-3-(4-methylphenyl)-6-oxo-4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl]benzoic acid 4-[4,6-Dihydro-4-(3-hydroxyphenyl)-3-(4-methylphenyl)-6-oxopyrrolo[3,4-c]pyrazol-5(1H)-yl]-benzoic acid Benzoic acid, 4-[4,6-dihydro-4-(3-hydroxyphenyl)-3-(4-methylphenyl)-6-oxopyrrolo[3,4-c]pyrazol-5(1H)-yl]- | Chemical industry;Synthetic material intermediates |
| 706 | 845533-86-0 | Bedaquiline (fumarate) | TMC207 TMC 207 TMC-207 R 403323 Bedaquiline (fuMarate) Bedaquiline (fumarate) Bedaquiline Fumarate salt (1R,2S)-1-(6-bromo-2-methoxy-3-quinolinyl)-4-(dimethylamino)-2-(1-naphthalenyl)-1-phenyl-2-butanol (1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol fumarate (1R,2S)-1-(6-broMo-2-Methoxyquinolin-3-yl)-4-(diMethylaMino)-2-naphthalen-1-yl-1-phenylbutan-2-ol,(E)-but-2-enedioic acid | Raw materials;Chemical reagents;Biochemical reagents;Biochemical industry;Medical raw materials;Pharmaceutical raw materials |
| 707 | 845614-11-1 | Bitopertin | RG1678 RG1679 RO4917838 Bitopertin Paliflutine Palufidine,RG-1678 (S)-[4-(3-Fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-(methanesulfonyl)-2-(2,2,2-trifluoro-1-methylethoxy)phenyl]methanone [4-(3-Fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-Methylsulfonyl-2-[((S)-2,2,2-trifluoro-1-methylethyl)oxy]phenyl]methanone | Amines;Aromatics;Heterocycles;Ion channels;Pharmaceuticals;Membrane transport;Sulfur & Selenium Compounds;Intermediates & Fine Chemicals |
| 708 | 84783-01-7 | K-Ras-IN-1 | Mdk-3017 K-RAS-IN-1 K-Ras-IN-1 K-Ras inhibitor 1 2-(Pyrrolidine-1-carbothioyl)phenol Methanethione, (2-hydroxyphenyl)-1-pyrrolidinyl- (2-Hydroxy-phenyl)-pyrrolidin-1-yl-methanethione | API;Cell biology reagent |
| 709 | 848193-68-0 | EX527 | EX527 CS-573 EX-527(S) EX-527(S-enantiomer) EX-527 (S-enantioMer) Selisistat S-enantiomer Selisistat S-enantiomer(EX-527 S-enantiomer) (1S)-6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide EX-527(S),(1S)-6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxaMide | Cell biology reagent |
| 710 | 848344-36-5 | 2-(1,3-benzothiazol-2-yl)-2-[2-({4-[(morpholin-4-yl)methyl]phenyl}methoxy)pyrimidin-4-yl]acetonitrile | CS-401 AS 602801 Bentamapimod Bentamapimod (AS 602801) AS 602801 (BentaMapiMod) Bentamapimod ( AS 602801) (1,3-Benzothiazol-2-yl)[2-[[4-[(morpholin-4-yl)methyl]benzyl]oxy]pyrimidin-4-yl]acetonitrile 2-(1,3-benzothiazol-2-yl)-2-[2-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]pyrimidin-4-yl]acetonitrile 2-(1,3-benzothiazol-2-yl)-2-[2-({4-[(morpholin-4-yl)methyl]phenyl}methoxy)pyrimidin-4-yl]acetonitrile (1,3-Benzothiazol-2-yl)[2-[[4-[(morpholin-4-yl)methyl]benzyl]oxy]pyrimidin-4-yl]acetonitrile AS602801(Bentamapimod) | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 711 | 848354-66-5 | PTACH | PTACH NCH 51 NCH-51 PTACH (NCH-51) HDAC Inhibitor XXII, NCH51 Cpd 51, S-[6-(4-Phenyl-2-thiazolylcarbamoyl)hexyl] thioisobutyrate S-(7-Oxo-7-((4-phenylthiazol-2-yl)amino)-heptyl) 2-methylpropanethioate 2-MethylpropanethioicacidS-[7-oxo-7-[(4-phenyl-2-thiazolyl)amino]heptyl]ester Propanethioic acid,2-methyl-, S-[7-oxo-7-[(4-phenyl-2-thiazolyl)amino]heptyl] ester | Standard |
| 712 | 849550-05-6 | 5-Chloro-6-[2,6-difluoro-4-[3-(methylamino)propoxy]phenyl]-N-((1S)-2,2,2-trifluoro-1-methylethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine | TTI237 D06576. CS-1680 TTI 237 D06576 Cevipabulin Unii-p14m0dws2j Cevipabulin (TTI-237) 5-Chloro-6-[2,6-difluoro-4-[3-(methylamino)propoxy]phenyl]-N-((1S)-2,2,2-trifluoro-1-methylethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine | cell biology reagents;Pharmaceutical active molecules |
| 713 | 85081-18-1 | [2R-(2a,3b,11bb)]-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-ol | NBI-98782 Tetrabenazine metabolite A Tetrabenazine metabolite B Tetrabenazine Related Impurity 27 NBI-98782((+)-α-Dihydrotetrabenazine) Tetrabenazine Related Impurity 27 (2R, 3R, 11bR) (2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-ol 2H-Benzo[a]quinolizin-2-ol, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-, (2R,3R,11bR)- [2R-(2a,3b,11bb)]-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-ol | Tetrabenazine;Impurities & Metabolites;Impurities and metabolites;Pharmaceutical intermediates |
| 714 | 85650-57-3 | Setiptiline (maleate) | MOD-20 MO-8282 Bisopool Sutitiptiline Einecs 288-065-3 etiptiline maleate Setiptiline maleate Setiptiline (maleate) | |
| 715 | 857066-90-1 | TMC353121 | TMC353121 TMC 353121 TMC-353121 2-[[6-[[[2-(3-Hydroxypropyl)-5-methylphenyl]amino]methyl]-2-[[3-(morpholin-4-yl)propyl]amino]benzimidazol-1-yl]methyl]-6-methylpyridin-3-ol 2-{[6-({[2-(3-Hydroxypropyl)-5-methylphenyl]amino}methyl)-2-{[3-(4-morpholinyl)propyl]amino}-1H-benzimidazol-1-yl]methyl}-6-methyl-3-pyridinol 3-Pyridinol, 2-[[6-[[[2-(3-hydroxypropyl)-5-methylphenyl]amino]methyl]-2-[[3-(4-morpholinyl)propyl]amino]-1H-benzimidazol-1-yl]methyl]-6-methyl- | Microbial Microbiology |
| 716 | 863774-58-7 | Dimethylenastron | enastron Dimethylenastron Eg5 Inhibitor III Eg5 Inhibitor III(Dimethylenastron) Dimethylenastron - Eg5 inhibitor III 2,3,4,6,7,8-Hexahydro-4-(3-hydroxyphenyl)-7,7-dimethyl-2-thioxo-5(1H)-quinazolinone 5(1H)-Quinazolinone, 2,3,4,6,7,8-hexahydro-4-(3-hydroxyphenyl)-7,7-dimethyl-2-thioxo- | Standard;Cell biology reagent |
| 717 | 865305-30-2 | 2,4-PyriMidinediaMine, 5-[5-iodo-4-Methoxy-2-(1-Methylethyl)phenoxy]- | Ro 4 AF353 AF 353 CS-2469 CHEMBL526307 AF-353 ( Ro-4) 2,4-PyriMidinediaMine, 5-[5-iodo-4-Methoxy-2-(1-Methylethyl)phenoxy]- 5-{[5-iodo-2-(1-Methylethyl)-4-(Methyloxy)phenyl]oxy}-2,4-pyriMidinediaMine 5-[5-iodo-4-methoxy-2-(1-methylethyl)phenoxy]-2,4-pyrimidinediamine hydrochloride Ro 4 hydrochloride | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 718 | 865479-71-6 | 5-R-Rivaroxaban | R-Rivaroxaban ent-Rivaroxaban 5-R-Rivaroxaban Rivaroxaban R-Isomer Rivaroxaban R-Isomer Impurity (R)-Rivaroxaban, ent-Rivaroxaban (R)-5-chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide 5-Chloro-N-[[(5R)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide | Impurity;Rivaroxaban;053-Rivaroxaban;Reference substance;Pharmaceutical intermediate;Impurity reference substance;Reference substance-Impurity reference substance |
| 719 | 865783-99-9 | Phenol, 2-Methoxy-5-[[[(1E)-2-(2,4,6-triMethoxyphenyl)ethenyl]sulfonyl]Methyl]-, 1-(dihydrogen phosphate) | ON014185 ON013105 BRICICLIB ON-013105 ON-014185 Briciclib Briciclib,ON-014185 Briciclib(ON 013105,ON 014185) (E)-5-[[(2,4,6-Trimethoxystyryl)sulfonyl]methyl]-2-methoxyphenyl dihydrogen phosphate 2-Methoxy-5-({[(E)-2-(2,4,6-trimethoxyphenyl)vinyl]sulfonyl}methy l)phenyl dihydrogen phosphate Phenol, 2-Methoxy-5-[[[(1E)-2-(2,4,6-triMethoxyphenyl)ethenyl]sulfonyl]Methyl]-, 1-(dihydrogen phosphate) | API;Small molecule inhibitors |
| 720 | 870843-42-8 | (E)-1-[(1S)-1-(4-Fluorophenyl)ethyl]-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene]piperidin-2-one | E2012 E-2012 E 2012 CS-510 1-[(1S)-1-(4-fluorophenyl)ethyl]-3-[[3-Methoxy-4-(4-Methyl-1H-iMidazol-1-yl)phenyl]Methylene]- (S,E)-1-(1-(4-fluorophenyl)ethyl)-3-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene)piperidin-2-one (E)-1-[(1S)-1-(4-Fluorophenyl)ethyl]-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene]piperidin-2-one (3E)-1-[(1S)-1-(4-Fluorophenyl)ethyl]-3-[[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]methylene]-2-piperidone 2-Piperidinone, 1-[(1S)-1-(4-fluorophenyl)ethyl]-3-[[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]methylene]-, (3E)- | API intermediates |
| 721 | 871543-07-6 | H-1152 Dihydrochloride | 871543-07-6 H-1152 2HCl H1152 Dihydrochloride H 1152 DIHYDROCHLORIDE H1152, DIHYDROCHLORIDE H-1152 Dihydrochloride H1152 DIHYDROCHLORIDE 4-methyl-5-[[(2S)-2-methyl-1,4-diazepan-1-yl]sulfonyl]isoquinoline 5-[[(2S)-Hexahydro-2-Methyl-1H-1,4-diazepin-1-yl]sulfonyl]-4-Methylisoquinoline H1152P2HCl,(S)-(+)-2-Methyl-1-[(4-methyl-5-isoquinolynyl)sulfonyl]homopiperazineDihydrochloride H1152P Dihydrochloride, (S)-(+)-2-Methyl-1-[(4-methyl-5-isoquinolynyl)sulfonyl]homopiperazine Dihydrochloride | Inhibitors;All Inhibitors;Pharmaceuticals;Cell biology reagents;Intermediates & Fine Chemicals;Protein Kinase Inhibitors and Activators |
| 722 | 873305-35-2 | AIM-100 | AIM100 AIM-100 AIM 100 5,6-Diphenyl-N-[[(2S)-tetrahydro-2-furanyl]methyl]furo[2,3-d]pyrimidin-4-amine Furo[2,3-d]pyrimidin-4-amine, 5,6-diphenyl-N-[[(2S)-tetrahydro-2-furanyl]methyl]- | API;Cell biology reagents;Protein tyrosine kinase |
| 723 | 878419-78-4 | Walrycin B | CS-1490 WALRYCIN B Walrycin B 1,6-dimethyl-3-[4-(trifluoromethyl)phenyl]pyrimido[5,4-e][1,2,4]triazine-5,7-dione 1,6-Dimethyl-3-[4-(trifluoromethyl)phenyl]pyrimido[5,4-e]-1,2,4-triazine-5,7(1H,6H)-dione 1,6-Dimethyl-3-[4-(trifluoromethyl)phenyl]pyrimido[5,4-e]-1,2,4-triazine-5,7(1H,6H)-dione Walrycin B Walrycin B 1,6-Dimethyl-3-[4-(trifluoromethyl)phenyl]pyrimido[5,4-e]-1,2,4-triazine-5,7(1H,6H)-dione | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 724 | 880549-30-4 | AMD-070 (hydrochloride) | AMD-070 HCl AMD070 hydrochloride AMD070 HYDROCHLORIDE AMD 070 hydrochloride AMD 070 HYDROCHLORIDE AMD-070 (hydrochloride) N1-(1H-Benzimidazol-2-ylmethyl)-N1-[(8S)-5,6,7,8-tetrahydro-8-quinolinyl]-1,4-butanediamine hydrochloride N-(1H-Benzimidazol-2-ylmethyl)-N-[(8S)-5,6,7,8-tetrahydro-8-quinolinyl]-1,4-butanediamine monohydrochloride | |
| 725 | 882531-87-5 | R1530 | R1530 R-1521 R 1530 R-1530 R-1530 CS-1111 5-(2-Chlorophenyl)-7-fluoro-1,2-dihydro-8-methoxy-3-methylpyrazolo[3,4-b][1,4]benzodiazepine | Apoptosis;Cell biology reagent |
| 726 | 882663-88-9 | AMG-47a | AMG47A AMG-47 AMG-47a CS-1025 GENETICIN 4-Methyl-3-(2-((2-morpholinoethyl)amino)quinazolin-6-yl)-N-(3-(trifluoromethyl)phenyl)benzamid 4-methyl-3-(2-((2-morpholinoethyl)amino)quinazolin-6-yl)-N-(3-(trifluoromethyl)phenyl)benzamide 4-Methyl-3-[2-[[2-(4-morpholinyl)ethyl]amino]-6-quinazolinyl]-N-[3-(trifluoromethyl)phenyl]benzamide 4-Methyl-3-[2-[[2-(4-morpholinyl)ethyl]amino]-6-quinazolinyl]-N-[3-(trifluoromethyl)phenyl]benzamide AMG-47A | APIs |
| 727 | 891494-64-7 | SCH900776 (S-isomer) | MK-8776 SCH-900776 SCH900776(S) SCH 900776 S-isoMer SCH-900776 S-isoMer SCH900776 (S-isomer) SCH900776 (S-isoMer) 6-Bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-(3S)-3-piperidinylpyrazolo[1,5-a]pyrimidin-7-amine 6-Bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-(3S)-3-piperidinylpyrazolo[1,5-a]pyrimidin-7-amine MK-8776 (SCH900776) | Cell biology reagent |
| 728 | 892549-43-8 | MF63 | MF63 MF-63 MF 63 MF-63 CS-2773 2-(9-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-1,3-Benzenedic 2-(6-chloro-1H-phenanthro-[9,10-d]iMidazol-2-yl)isophthalonitrile 2-(9-Chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-1,3-benzenedicarbonitrile 1,3-Benzenedicarbonitrile, 2-(9-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)- 2-(9-Chloro-1H-phenanthro[9, 10-d]imidazol-2-yl)benzene-1, 3-dicarbonitrile | Nerve signal |
| 729 | 894002-50-7 | LDN-212320 | LDN-212320 OSU-0212320 LDN-0212320 3-((2-methylbenzyl)thio)-6-(pyridin-2-yl)pyridazine (3-[(2-methylbenzyl)sulfenyl]-6-(pyridine-2-yl)pyridazine) 3-[[(2-Methylphenyl)methyl]thio]-6-(2-pyridinyl)-pyridazine | Chemical reagents |
| 730 | 894787-30-5 | ST 2825 | ST2825 ST 2825 (2R,4'R,8'aR)-1-[2-[4-[[2-(2,4-Dichlorophenoxy)acetyl]amino]phenyl]acetyl]tetrahydro-6'-oxospiro[pyrrolidine-2,7'(6'H)-[2H]pyrrolo[2,1-b][1,3]thiazine]-4'-carboxamide Spiro[pyrrolidine-2,7'(6'H)-[2H]pyrrolo[2,1-b][1,3]thiazine]-4'-carboxamide, 1-[2-[4-[[2-(2,4-dichlorophenoxy)acetyl]amino]phenyl]acetyl]tetrahydro-6'-oxo-, (2R,4'R,8'aR)- | |
| 731 | 897657-95-3 | MSX-122 | MSX122 CS-2430 MSX 222 MSX 122 MSX-122 1,4-Benzenedimethanamine, N1,N4-di-2-pyrimidinyl- N-[[4-[(pyrimidin-2-ylamino)methyl]phenyl]methyl]pyrimidin-2-amine | Standard |
| 732 | 903576-44-3 | 1-[3-[3-(4-Chlorophenyl)propoxy]propyl]-piperidinehydrochloride | BF 2649 PITOLISANT Ciproxidine Ciproxidine BF2649 CIPROXIDINE BF2649 Pitolisant hydrochloride Pitolisant (hydrochloride) 1-[3-[3-(4-Chlorophenyl)propoxy]propyl]-piperidinehydrochloride 1-[3-[3-(4-Chlorophenyl)propoxy]propyl]piperidine monohydrochloride Piperidine, 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-, hydrochloride | Inhibitor |
| 733 | 914295-16-2 | Fostamatinib Disodium Hexahydrate | Fostamatinib Na R788 (disodiuM hexahydrate) Fostamatinib Disodium Hexahydrate FostaMatinib DisodiuM Hexahydrate Fostamatinib disodium salt hexahydrate R788 Disodium Hexahydrate (Fostamatinib Disodium Hexahydrate) 6-[[5-Fluoro-2-[(3,4,5-triMethoxyphenyl)aMino]-4-pyriMidinyl]aMino]-2,2-diMethyl-4-[(phosphonooxy)Methyl]-2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one SodiuM Salt Hydrate 6-[[5-Fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-4-[(phosphonooxy)methyl]-2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one disodium salt hexahydrate 2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one, 6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-4-[(phosphonooxy)methyl]-, disodium salt, hexahydrate | API;Heterocycles;Pharmaceuticals;Intermediates & Fine Chemicals;Phosphorylating and Phosphitylating Agents;Pharmaceutical raw materials-scientific research raw materials |
| 734 | 916141-36-1 | N-[1,1'-Biphenyl]-2-yl-1-[2-[(1-methyl-1H-benzimidazol-2-yl)thio]acetyl-2-pyrrolidinedicarboxamide | TCS-102 TCS 1102 N-[1,1'-Biphenyl]-2-yl-1-[2-[(1-methyl-1H-benzimidazol-2-yl)thio]acetyl-2-pyrrolidinedicarboxamide (2S)-N-[1,1'-Biphenyl]-2-yl-1-[2-[(1-methyl-1H-benzimidazol-2-yl)thio]acetyl]-2-pyrrolidinecarboxamide (2S)- 2-Pyrrolidinecarboxamide, N-[1,1'-biphenyl]-2-yl-1-[2-[(1-methyl-1H-benzimidazol-2-yl)thio]acetyl] 2-PyrrolidinecarboxaMide, N-[1,1'-biphenyl]-2-yl-1-[2-[(1-Methyl-1H-benziMidazol-2-yl)thio]acetyl]-, (2S)- (2S)-N-[1,1'-Biphenyl]-2-yl-1-[2-[(1-methyl-1H-benzimidazol-2-yl)thio]acetyl]-2-pyrrolidinecarboxamide TCS1102 TCS 1102 N-[1,1'-Biphenyl]-2-yl-1-[2-[(1-methyl-1H-benzimidazol-2-yl)thio]acetyl-2-pyrrolidinedicarboxamide | Inhibitors;Heterocyclic;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 735 | 916170-19-9 | (2E)-2-[1-(3-Bromophenyl)ethylidene]α-(benzoylamino)-3,4-dihydro-4-oxo-1-phthalazineaceticacidhydrazide | AC55541 CS-2020 CS-1802 AC-55541 AC 55541 AC-55541 (2E)-2-[1-(3-Bromophenyl)ethylidene]α-(benzoylamino)-3,4-dihydro-4-oxo-1-phthalazineaceticacidhydrazide (E)-N-(2-(2-(1-(3-Bromophenyl)ethylidene)hydrazinyl)-2-oxo-1-(4-oxo-3,4-dihydrophthalazin-1-yl)ethyl)benzamide AC 55541,(2E)-2-[1-(3-Bromophenyl)ethylidene]α-(benzoylamino)-3,4-dihydro-4-oxo-1-phthalazineaceticacidhydrazide (2E)-2-[1-(3-Bromophenyl)ethylidene] α-(benzoylamino)-3,4-dihydro-4-oxo-1-phthalazineacetic acid hydrazide AC55541 | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 736 | 919351-41-0 | AZD1283 | CS-1176 AZD1283 AZD 1283 AZD-1283 AZD1283 , CID23649325 ETHYL 6-(4-{[(BENZYLSULFONYL)AMINO]CARBONYL}PIPERIDIN-1-YL)-5-CYANO-2-METHYLNICOTINATE 6-[4-[[(Benzylsulfonyl)amino]carbonyl]piperidin-1-yl]-5-cyano-2-methylnicotinic acid ethyl ester Ethyl 5-cyano-2-methyl-6-[4-[[[(phenylmethyl)sulfonyl]amino]carbonyl]-1-piperidinyl]-3-pyridinecarboxylate ethyl 6-(4-((benzylsulfonyl)carbamoyl)piperidin-1-yl)-5-cyano-2-methylnicotinate AZD1283 | |
| 737 | 919486-40-1 | 5-PyriMidinecarboxaMide, 2-[[2-(3-chloro-4-hydroxyphenyl)ethyl]aMino]-4-[(phenylMethyl)aMino]- | CS-2440 AS1517499 AS-1517499 AS1517499 AS 1517499 AS 1517499 919486-40-1 4-(Benzylamino)-2-((3-chloro-4-hydroxyphenethyl)amino)pyrimidine-5-carboxamide 5-PyriMidinecarboxaMide, 2-[[2-(3-chloro-4-hydroxyphenyl)ethyl]aMino]-4-[(phenylMethyl)aMino]- | Standard |
| 738 | 923262-96-8 | SAR407899 (hydrochloride) | SAR407899 SAR 407899 SAR-407899 SAR407899 HCl SAR407899 (hydrochloride) 6-(piperidin-4-yloxy)isoquinolin-1(2h)-one hcl 6-(4-Piperidinyloxy)-1(2H)-isoquinolinone hydrochloride 6-(piperidin-4-yloxy)isoquinolin-1(2H)-one hydrochloride | API;Biochemical industry;Cell biology reagents |
| 739 | 929007-72-7 | DB07268 | CS-2303 DB07268 DB 07268 DB-07268 DB07268 (DB 07268 2-(4-(3-hydroxyphenylamino)pyrimidin-2-ylamino)benzamide 2-[[2-[(3-Hydroxyphenyl)amino]-4-pyrimidinyl]amino]benzamide Benzamide, 2-[[2-[(3-hydroxyphenyl)amino]-4-pyrimidinyl]amino]- | MAPK;Inhibitor;Cell biology reagent |
| 740 | 931706-15-9 | PPQ-102 | PPQ-102 CS-1365 PPQ102 PPQ 102 CFTR Inhibitor CFTR INHIBITOR PPQ-102, CFTR Inhibitor | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 741 | 935467-97-3 | TH 237A | TH 237A CS-1205 TH237A meso-GS 164 MESO-GS 164 TH-237A, meso-GS 164 (3R,5S,7aS)-[3,5-Bis(4-fluorophenyl)tetrahydro-1H-oxazolo[3,4-c]oxazol-7a-yl]methanol 1H,3H,5H-Oxazolo[3,4-c]oxazole-7a(7H)-methanol, 3,5-bis(4-fluorophenyl)-, (3R,5S)-rel- | |
| 742 | 940908-79-2 | R-7128 | R-7128 R 7128 RG 7128 Mericitabine MERICITABINE PSI 6130 diisobutyrate PSI 6130 DIISOBUTYRATE (2'R)- 2'-Deoxy-2'-fluoro-2'-methylcytidine 3',5'-bis(2-methylpropanoate) Cytidine, 2'-deoxy-2'-fluoro-2'-methyl-, 3',5'-bis(2-methylpropanoate), (2'R)- | Metabolism;Biochemical Industry |
| 743 | 943962-47-8 | BMS-303141 | CS-887 BMS30314 BMS303141 BMS 303141 BMS-303141 3,5-dichloro-2-hydroxy-N-(4-Methoxybiphenyl-3-yl)benzenesulfonaMide 3,5-dichloro-2-hydroxy-N-(2-methoxy-5-phenylphenyl)benzenesulfonamide 3,5-Dichloro-2-hydroxy-N-(4-methoxy[1,1'-biphenyl]-3-yl)benzenesulfonamide 3,5-Dichloro-2-hydroxy-N-(4-methoxy[1,1'-biphenyl]-3-yl)-benzenesulfonamide BMS 303141 | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 744 | 946387-07-1 | 2,4-dichloro-N-isopropyl-N-[2-(isopropylamino)ethyl]benzenesulfonamide | RN-1734 RN 1734 TRPV4 Antagonist I, RN-1734 2,4-dichloro-N-isopropyl-N-[2-(isopropylamino)ethyl]benzenesulfonamide 2,4-dichloro-N-propan-2-yl-N-[2-(propan-2-ylamino)ethyl]benzenesulfonamide 2,4-Dichloro-N-isopropyl-N-(2-isopropylaminoethyl)benzenesulphonamide (RN-1734) 2,4-Dichloro-N-(1-methylethyl)-N-[2-[(1-methylethyl)amino]ethyl]benzenesulfonamide Benzenesulfonamide, 2,4-dichloro-N-(1-methylethyl)-N-[2-[(1-methylethyl)amino]ethyl]- | |
| 745 | 947914-18-3 | ML365 | ML365 ML365 ML-365 ML 365 CS-2437 2-methoxy-N-(3-(3-methylbenzamido)phenyl)benzamide 2-methoxy-N-[3-[(3-methylbenzoyl)amino]phenyl]benzamide Benzamide, 2-methoxy-N-[3-[(3-methylbenzoyl)amino]phenyl]- | API;Cell biology reagent |
| 746 | 950912-80-8 | PF-670462 | PF 67046 PF 670462 PF-670462 4-[1-Cyclohexyl-4-(4-fluorophenyl)-1H-imidazol-5-yl]-2-pyrimidinamine hydrochloride 4-[1-Cyclohexyl-4-(4-fluorophenyl)-1H-imidazol-5-yl]-2-pyrimidinaminedihydrochloride 4-[3-Cyclohexyl-5-(4-fluoro-phenyl)-3H-imidazol-4-yl]-pyrimidin-2-ylamine dihydrochloride 4-[1-Cyclohexyl-4-(4-fluorophenyl)-1H-imidazol-5-yl]-2-pyrimidinamine hydrochloride PF670462 | Aromatics;Inhibitors;Heterocycles;Intermediate;Pharmaceuticals;Cell biology reagents;Small molecule inhibitors;Intermediates & Fine Chemicals;Protein Kinase Inhibitors and Activators;Small molecule in |
| 747 | 95167-41-2 | DY131 | DY131 DY 131 GW4716 DY-131 GSK4716 GW574716 GSK 9089 DY131(GSK 9089) 4-Hydroxybenzoic acid 2-[[4-(diethylamino)phenyl]methylene]hydrazide | Inhibitors;Novel selective ago;Cell biology reagents;Intracellular receptor;Small molecule inhibitors;G protein coupled receptor & G protein;Small molecule inhibitors, natural products;Novel selective |
| 748 | 957118-49-9 | MK-3207 | MK3207 MK-3207 MK 3207 MK 3207 (8R)-8-(3,5-Difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-6,9-diazaspiro[4.5]decane-9-acetamide 6,9-Diazaspiro[4.5]decane-9-acetaMide,8-(3,5-difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-,(8R)- | Nerve signal |
| 749 | 957135-43-2 | SM-164 | SM164 SM 164 SM-164 SM164 SM 164 (pharmaceutical) (3S,3'S,6S,6'S,10aS,10'aS)-N,N'-[1,4-Phenylenebis[4,1-butanediyl-1H-1,2,3-triazole-1,4-diyl[(S)-phenylmethylene]]]bis[decahydro-6-[[(2S)-2-(methylamino)-1-oxopropyl]amino]-5-oxo-pyrrolo[1,2-a]azocine-3-carboxamide Pyrrolo[1,2-a]azocine-3-carboxamide, N,N'-[1,4-phenylenebis[4,1-butanediyl-1H-1,2,3-triazole-1,4-diyl[(S)-phenylmethylene]]]bis[decahydro-6-[[(2S)-2-(methylamino)-1-oxopropyl]amino]-5-oxo-, (3S,3'S,6S,6'S,10aS,10'aS)- (S,3S,3'S,6S,6'S,10aS,10a'S)-N,N'-((1S,1'S)-(1,1'-(4,4'-(1,4-phenylene)bis(butane-4,1-diyl))bis(1H-1,2,3-triazole-4,1-diyl))bis(phenylmethylene))bis(6-((S)-2-(2-methylamino)propanamido)-5-oxodecahydropyrrolo[1,2-a]azocine-3-carboxamide) | |
| 750 | 610318-54-2 | RGX-104 free Acid | RGX-104 SB742881 RGX-104 free Acid RGX-104 (free form) Abequolixron (RGX-104) 610318-54-2 (FREE FORM) 610318-03-1 (HCL) Benzeneacetic acid, 3-[(3R)-3-[[[2-chloro-3-(trifluoromethyl)phenyl]methyl](2,2-diphenylethyl)amino]butoxy]- | |
| 751 | 1009734-33-1 | 5-tert-butoxyquinazoline-2,4-diaMine | HZ1157 HZ-1157 HZ 1157 DHFR-inhibitor 5-tert-butoxyquinazoline-2,4-diaMine 2,4-Quinazolinediamine, 5-(1,1-dimethylethoxy)- 5-tert-butoxyquinazoline-2,4-diaMine 2,4-Quinazolinediamine, 5-(1,1-dimethylethoxy)- | |
| 752 | 174262-13-6 | SDZ285-428 | SDZ 285428 SDZ-285428 SDZ285-428 NVP-VID-400 N-(2-(1H-Imidazol-1-yl)-2-phenylethyl)-4'-chloro-[1,1'-biphenyl]-4-carboxamide [1,1'-Biphenyl]-4-carboxamide, 4'-chloro-N-[2-(1H-imidazol-1-yl)-2-phenylethyl]- | |
| 753 | 197250-15-0 | GAP 26 | VR-13 GAP26 GAP 26 GAP-26 GAP26 43Gap 26, Connexin Mimetic M.W. 1550.78 C70H107N19O19S Val-Cys-Tyr-Asp-Lys-Ser-Phe-Pro-Ile-Ser-His-Val-Arg H-VAL-CYS-TYR-ASP-LYS-SER-PHE-PRO-ILE-SER-HIS-VAL-ARG-OH L-Arginine, L-valyl-L-cysteinyl-L-tyrosyl-L-α-aspartyl-L-lysyl-L-seryl-L-phenylalanyl-L-prolyl-L-isoleucyl-L-seryl-L-histidyl-L-valyl- | CancerBiology;Various Peptides;Catalog peptides |
| 754 | 1922153-17-0 | MELK-8a | MELK-8a Piperazine, 1-methyl-4-[4-[4-[3-(4-piperidinylmethoxy)-4-pyridinyl]-1H-pyrazol-1-yl]phenyl]- | |
| 755 | 1450881-55-6 | SAR-20347 | CS-2527 SAR20347 CPDD1211 SAR-20347 SAR 20347 2-(2-chloro-6-fluorophenyl)-5-((4-(morpholine-4-carbonyl)phenyl)amino)oxazole-4-carboxamide 4-Oxazolecarboxamide, 2-(2-chloro-6-fluorophenyl)-5-[[4-(4-morpholinylcarbonyl)phenyl]amino]- 2-(2-chloro-6-fluorophenyl)-5-({4-[(morpholin-4-yl)carbonyl]phenyl}amino)-1,3-oxazole-4-carboxylic acid amide | JAK1 & TYK2;Standard substance;Cell biology reagent |
| 756 | 23555-00-2 | Hoechst 34580 | ProaMine HOE 34580 Hoechst 34580 HOECHST 34580 Hoechst 34580 (HOE 34580) 2,50-bibenzimidazole, 20-[p-(dimethylamino)phenyl]-5-(4-methyl-1-piperazinyl)- Benzenamine, N,N-dimethyl-4-[5-(4-methyl-1-piperazinyl)[2,5'-bi-1H-benzimidazol]-2'-yl]- | Benzimidazole |
| 757 | 1026680-07-8 | LB-100 | LB-100 CS-1762 LB-100, 1026680-07-8 3-(4-METHYLPIPERAZINE-1-CARBONYL)-7-OXABICYCLO[2.2.1]HEPTANE-2-CARBOXYLIC ACID 3-(1-methylpiperazine-4-carbonyl)-7-oxa-bicyclo[2.2.1]heptane-2-carboxylic acid methyl 2,5-dimethyl-1-[(2-methylpropan-2-yl)oxycarbonylamino]pyrrole-3-carboxylate LB-100 LB-100 3-(4-METHYLPIPERAZINE-1-CARBONYL)-7-OXABICYCLO[2.2.1]HEPTANE-2-CARBOXYLIC ACID | Inhibitors;Chemical raw materials;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 758 | 1047634-63-8 | GSK2110183 | CS-1729 GSK2110183 GSK 2110183 GSK-2110183 Afuresertib-F free base AFURESERTIB (GSK2110183) Afuresertib (GSK2110183) N-[(2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-2-methylpyrazol-3-yl)thiophene-2-carboxamide N-[(1S)-2-Amino-1-[(3,4-difluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide 2-Thiophenecarboxamide, N-[(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)- | Inhibitor;reference substance |
| 759 | 1070773-09-9 | RK-33 | RX33 RX 33 RK-33 RX 33 | |
| 760 | 1187990-87-9 | MK-8617 | MK8617 MK 8617 CS-2700 MK-8617 N-[BIS(4-METHOXYPHENYL)METHYL]-6-OXO-2-PYRIDAZIN-3-YL-1H-PYRIMIDINE-5-CARBOXAMIDE N-(bis(4-Methoxyphenyl)Methyl)-4-hydroxy-2-(pyridazin-3-yl)pyriMidine-5-carboxaMide 5-Pyrimidinecarboxamide,N-[bis(4-methoxyphenyl)methyl]-1,6-dihydro-6-oxo-2-(3-pyridazinyl)- N-(bis(4-methoxyphenyl)methyl)-6-oxo-2-(pyridazin-3-yl)-1,6-dihydropyrimidine-5-carboxamide | Inhibitor |
| 761 | 1223397-11-2 | WZB-117 | WZB117 WZB 117 CS-2648 WZB-117 Glucose Transporter Inhibitor IV, WZB117 3-Fluoro-1,2-phenylene bis(3-hydroxybenzoate) 3-Hydroxy-benzoic acid 1,1′-(3-fluoro-1,2-phenylene) ester Benzoic acid, 3-hydroxy-, 1,1'-(3-fluoro-1,2-phenylene) ester | API |
| 762 | 1226895-15-3 | FLLL-32 | FLLL32 CS-1778 FLLL 32 FLLL-32 EX-A1096 (2E,2'E)-1,1'-cyclohexylidenebis[3-(3,4-diMethoxyphenyl)-2-Propen-1-one (2E,2'E)-1,1'-(cyclohexane-1,1-diyl)bis(3-(3,4-dimethoxyphenyl)prop-2-en-1-one) (2E,2'E)-1,1'-(cyclohexane-1,1-diyl)bis(3-(3,4-dimethoxyphenyl)prop-2-en-1-one) FLLL32 | Standard;Inhibitor |
| 763 | 1256493-34-1 | Dyngo-4a | Dyng Dyngo-4a DYNGO-4A Dyngo-49 Hydroxy-Dynasore 3-Hydroxy-N′-[(2,4,5-trihydroxyphenyl)methylidene]naphthalene-2-carbohydrazide 3-Hydroxy-2-naphthalenecarboxylic acid 2-[(2,4,5-trihydroxyphenyl)methylene]hydrazide 3-Hydroxynaphthalene-2-carboxylic acid 2-[(2,4,5)-trihydroxyphenyl)methylene]hydrazide 2-Naphthalenecarboxylic acid, 3-hydroxy-, 2-[(2,4,5-trihydroxyphenyl)Methylene]hydrazide | Standard |
| 764 | 152095-12-0 | Dp44mT | Dp44mT de44mt CS-2521 Iron Chelator Iron Chelator, Dp44mT Di-2-pyridylketone-4,4,-dimethyl-3-thiosemicarbazone 2-(Di-2-pyridinylmethylene)-N,N-dimethyl-hydrazinecarbothioamide Hydrazinecarbothioamide, 2-(di-2-pyridinylmethylene)-N,N-dimethyl- | |
| 765 | 185039-89-8 | PD0166285 | PD0166285 PD-0166285 PD 0166285 6-(2,6-Dichloro-phenyl)-2-[4-(2-diethylaMino-ethoxy)-phenylaMino]-8-Methyl-8H-pyrido[2,3-d]pyriMidin-7-one Pyrido[2,3-d]pyriMidin-7(8H)-one, 6-(2,6-dichlorophenyl)-2-[[4-[2-(diethylaMino)ethoxy]phenyl]aMino]-8-Methyl- | |
| 766 | 440662-09-9 | CeMMEC1 HCl | CeMMEC1 cemmecl CeMMEC1 HCl 440662-09-9 CeMMEC1(free base) 4-Isoquinolinecarboxamide, N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1,2-dihydro-2-methyl-1-oxo- | |
| 767 | 459836-30-7 | PEAQX | 3 2 PEAQX CS-1513 NVP-AAM077 4-TETRAHYDRO-2 PEAQX(NVP-AAM 077) NVP-AAM077 TETRASODIUM HYDRATE NVP-AAM 077 TETRASODIUM HYDRATE PEAQX TETRASODIUM HYDRATE[[[(1S)-1-(4-BROMOPHENYL)ETHYL]AMINO](1 PEAQX tetrasodium hydrate [[[(1S)-1-(4-Bromophenyl)ethyl]amino](1 3-dioxo-5-quinoxalinyl)methyl] phosphonic acid tetrasodium hydrate 3-DIOXO-5-QUINOXALINYL)METHYL] PHOSPHONIC ACID TETRASODIUM HYDRATE [[[(1s)-1-(4-bromophenyl)ethyl]amino](1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl]phosphonic acid tetrasodium hydrate | API |
| 768 | 623152-17-0 | BMS-582949 | CS-2900 PS540446 BMS-582949 BMS 582949 BMS582949 BMS582949(HCl) 4-[5-(cyclopropylcarbamoyl)-2-methylanilino]-5-methyl-N-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide 4-[[5-[(Cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-N-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide Pyrrolo[2,1-f][1,2,4]triazine-6-carboxamide, 4-[[5-[(cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-N-propyl- | |
| 769 | 6314-70-1 | 4-(cyclohexylsulfamoyl)benzoic acid | NSC23005 NSC23005 free acid 4-(CYCLOHEXYLSULFAMOYL)BENZOIC ACID 4-(cyclohexylsulfamoyl)benzoic acid 4-(N-Cyclohexylsulfamoyl)benzoic acid | Reference substance |
| 770 | 878141-96-9 | S1RA | S1RA S1RA, 878141-96-9 4-[2-[[5-Methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine 4-(2-((5-Methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine 4-(2-(5-METHYL-1-(NAPHTHALEN-2-YL)-1H-PYRAZOL-3-YLOXY)ETHYL)MORPHOLINE. HCL 4-[2-[[5-Methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine S1RA S1RA 4-[2-[[5-Methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 771 | 947303-87-9 | 4-[(Diethylamino)methyl]-N-[2-(2-methoxyphenyl)ethyl]-N-(3R)-3-pyrrolidinylbenzamide | PF 429242 -4-((Diethylamino) PF-429242 dihydrochloride 4-((diethylaMino)Methyl)-N-(2-Methoxyphenethyl)-N-(pyrrolidin-3-yl)benzaMide o)Meth (2-MetR)-4-((diethylaMinyl)-Nhoxyphenethyl)-N-(pyrrolidin-3-yl)benzaMide 4-[(Diethylamino)methyl]-N-[2-(2-methoxyphenyl)ethyl]-N-(3R)-3-pyrrolidinylbenzamide Benzamide, 4-[(diethylamino)methyl]-N-[2-(2-methoxyphenyl)ethyl]-N-(3R)-3-pyrrolidinyl- 4-[(Diethylamino)methyl]-N-[2-(2-methoxyphenyl)ethyl]-N-(3R)-3-pyrrolidinyl-benzamide dihydrochloride | Chiral amines;Other biochemical reagents;Signal transduction pathway kinase inhibitors |
| 772 | 591778-68-6 | CP-640186 | CS-1316 CP-640186 CP 640186 (R)-Anthracen-9-yl(3-(morpholine-4-carbonyl)-[1,4'-bipiperidin]-1'-yl)methanone (R)-ANTHRACEN-9-YL(3-(MORPHOLINE-4-CARBONYL)-1,4'-BIPIPERIDIN-1'-YL)METHANONE.HCL (Anthracen-9-yl)[(3R)-3-[(morpholin-4-yl)carbonyl][1,4']bipiperidinyl-1'-yl]methanone [(3R)-1-[1-(anthracene-9-carbonyl)piperidin-4-yl]piperidin-3-yl]-morpholin-4-ylmethanone (R)-anthracen-9-yl(3-(morpholine-4-carbonyl)-[1,4'-bipiperidin]-1'-yl)metha none CP640186 CP 640186 (R)-ANTHRACEN-9-YL(3-(MORPHOLINE-4-CARBONYL)-1,4'-BIPIPERIDIN-1'-YL)METHANONE.HCL | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 773 | 1005334-57-5 | CVT-10216 | CS-1424 CVT10216 GS 455534 CVT 10216 CVT-10216 3-(((3-(4-(Methylsulfonamido)phenyl)-4-oxo-4H-chromen-7-yl)oxy)methyl)benzoic acid 3-[[[3-[4-[(Methylsulfonyl)amino]phenyl]-4-oxo-4H-chromen-7-yl]oxy]methyl]benzoic acid 3-[[[3-[4-[(Methylsulfonyl)amino]phenyl]-4-oxo-4H-1-benzopyran-7-yl]oxy]methyl]-benzoic acid Benzoic acid, 3-[[[3-[4-[(methylsulfonyl)amino]phenyl]-4-oxo-4H-1-benzopyran-7-yl]oxy]methyl]- | |
| 774 | 102961-72-8 | Dalbavancin IMpurity - A40926 | A 40926 Dalbavancin HCl ANTIBIOTIC A 40926 Antibiotic A 40926 DALBAVANCIN IMPURITY Dalbavancin hydrochloride Dalbavancin IMpurity - A40926 Dalbavancin IMpurity - A40926- Dalbavancin IMpurity - A40926-B0 | Chemical reagents;Biochemical industry;Medical raw materials;Small molecule inhibitors;Pharmaceutical raw materials |
| 775 | 1111556-37-6 | Takinib | Takinib EDHS-206 1111556-37-6 N-(1-Propyl-1H-benzo[d]imidazol-2-yl)isophthalamide N1-(1-Propyl-1H-benzo[d]imidazol-2-yl)isophthalamide 3-N-(1-propylbenzimidazol-2-yl)benzene-1,3-dicarboxamide 1,3-Benzenedicarboxamide, N1-(1-propyl-1H-benzimidazol-2-yl)- 1-N-(1-propyl-1H-1,3-benzodiazol-2-yl)benzene-1,3-dicarboxamide | Cell biology reagent |
| 776 | 1204669-37-3 | IDO inhibitor 1 | HY-15689 INCB 024360 IDO inhibitor 1 IDO inhibitor 1,Epacadostat Epacadostat (INCB024360, IDO inhibitor 1) N-(3-bromo-4-fluorophenyl)-N-hydroxy-4-{[2-(sulfamoylamino)ethyl]amino}-1,2,5-oxadiazole-3-carboximidamide 4-[[2-[(Aminosulfonyl)amino]ethyl]amino]-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide | |
| 777 | 1216665-49-4 | APY29 | APY29 APY 29 APY-29 CS-1412 N2-1H-Benzimidazol-6-yl-N4-(5-cyclopropyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine 2,4-Pyrimidinediamine,N2-1H-benzimidazol-5-yl-N4-(3-cyclopropyl-1H-pyrazol-5-yl)- 2,4-Pyrimidinediamine, N2-1H-benzimidazol-6-yl-N4-(5-cyclopropyl-1H-pyrazol-3-yl)- N2-(1H-benzo[d]imidazol-6-yl)-N4-(5-cyclopropyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine | |
| 778 | 1235481-43-2 | (R)-1-(3,6-dibroMo-9H-carbazol-9-yl)-3-(3-MethoxyphenylaMino)propan-2-ol | P7C3-OMe P7C3-Ome P7C3-OME (R)-P7C3-OMe O-METHOXY-P7C3 O-methoxy-P7C3 (R)-P7C3-OMe, 1235481-43-2 (S)-1-(3,6-DIBROMO-9H-CARBAZOL-9-YL)-3-(3-METHOXYPHENYLAMINO)PROPAN-2-OL (R)-1-(3,6-dibroMo-9H-carbazol-9-yl)-3-(3-MethoxyphenylaMino)propan-2-ol (R)-P7C3-OMe (R)-1-(3,6-dibroMo-9H-carbazol-9-yl)-3-(3-MethoxyphenylaMino)propan-2-ol | Inhibitors;Small molecule inhibitors;Other biochemical reagents;Small molecule inhibitors, natural products |
| 779 | 1261289-04-6 | O-304 | O-304 0 304 CS-2682 O-304 1261289-04-6 4-chloro-N-(2-(4-chlorobenzyl)-3-oxo-2,3-dihydro-1,2,4-thiadiazol-5-yl)benzamide Benzamide, 4-chloro-N-[2-[(4-chlorophenyl)methyl]-2,3-dihydro-3-oxo-1,2,4-thiadiazol-5-yl]- | |
| 780 | 1342276-76-9 | 1-(3-Methoxybenzyl)-3-(4-(pyridin-4-yl)thiazol-2-yl)urea | RKI1313 PKI1313 RKI-1313 RKI 1313 PKI 1313 RKI-1313 (Negative control of RKI-1447) 1-(3-METHOXYBENZYL)-3-(4-(PYRIDIN-4-YL)THIAZOL-2-YL)UREA 1-(3-Methoxybenzyl)-3-(4-(pyridin-4-yl)thiazol-2-yl)urea Urea, N-[(3-methoxyphenyl)methyl]-N'-[4-(4-pyridinyl)-2-thiazolyl]- | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 781 | 1345675-25-3 | E6446 (dihydrochloride) | E6446 E 6446 E-6446 CS-2089 E6446 HCl E6446 2HCl E-6446 DihydrochL E6446 hydrochloride E6446 (dihydrochloride) 6-(3-(Pyrrolidin-1-yl)propoxy)-2-(4-(3-(pyrrolidin-1-yl)propoxy)phenyl)benzo[d]oxazole dihydrochloride | API;Chemical reagent |
| 782 | 1513879-19-0 | KDU691 | KDU691 KDU-691 KDU 691 1513879-19-0 Imidazo[1,2-a]pyrazine-6-carboxamide, N-(4-chlorophenyl)-N-methyl-3-[4-[(methylamino)carbonyl]phenyl]- | |
| 783 | 1542135-76-1 | LML-134 | LML134 LML-134 1-Piperazinecarboxylic acid, 4-cyclobutyl-, 1-(1,6-dihydro-1-methyl-6-oxo-3-pyridazinyl)-4-piperidinyl ester | |
| 784 | 1802326-66-4 | JNJ 63533054 | CS-2223 JNJ 63533054 JNJ-63533054 (JNJ63533054 3-Chloro-N-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]benzamide Benzamide, 3-chloro-N-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]- | |
| 785 | 1811510-56-1 | PF-6260933 | PF6260933 PF-6260933 PF06260933 PF 6260933 PF 06260933 1811510-56-1 [3,3'-Bipyridine]-6,6'-diamine, 5-(4-chlorophenyl)- | |
| 786 | 21561-09-1 | 4-PHENYLAMINO-6,7-DIMETHOXYQUINAZOLINE | WHIP258 WHI P258 WHI-P258 JAK3 INHIBITOR NEGATIVE CONTROL JAK3 INHIBITOR, NEGATIVE CONTROL 4-PHENYLAMINO-6,7-DIMETHOXYQUINAZOLINE 6,7-DIMETHOXY-N-PHENYL-4-QUINAZOLINAMINE 6,7-dimethoxy-N-phenylquinazolin-4-amine 4-Quinazolinamine, 6,7-dimethoxy-N-phenyl- N-(6,7-DIMETHOXY-4-QUINAZOLINYL)-N-PHENYLAMINE | Standards;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 787 | 548470-11-7 | N,N'-((1R,4R)-CYCLOHEXANE-1,4-DIYL)BIS(2-(4-CHLOROPHENOXY)ACETAMIDE) | ISRIB Integrated Stress Response inhibitor N,N'-1,4-Cyclohexanediylbis[2-(4-chlorophenoxy)acetamide] trans-N,N′-1,4-Cyclohexanediylbis[2-(4-chlorophenoxy)-acetamide N,N'-((1R,4R)-CYCLOHEXANE-1,4-DIYL)BIS(2-(4-CHLOROPHENOXY)ACETAMIDE) 2-(4-chlorophenoxy)-N-(4-{[(4-chlorophenoxy)acetyl]amino}cyclohexyl)acetami de 2-(4-chlorophenoxy)-N-[4-[[2-(4-chlorophenoxy)acetyl]amino]cyclohexyl]acetamide ISRIB N,N'-((1R,4R)-CYCLOHEXANE-1,4-DIYL)BIS(2-(4-CHLOROPHENOXY)ACETAMIDE) | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 788 | 832714-46-2 | ISOPROPYL 4-(1-(2-FLUORO-4-(METHYLSULFONYL)PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLOXY)PIPERIDINE-1-CARBOXYLATE | APD668 APD 668 CS-1179 APD-668 ISOPROPYL 4-(1-(2-FLUORO-4-(METHYLSULFONYL)PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLOXY)PIPERIDINE-1-CARBOXYLATE 4-[[1-(2-Fluoro-4-methylsulfonylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]oxy]piperidine-1-carboxylic acid isopropyl ester 1-Piperidinecarboxylic acid,4-[[1-[2-fluoro-4-(methylsulfonyl)phenyl]-1H-pyrazolo[3,4-d]pyrimidin-4-yl]oxy]-, 1-methylethyl ester isopropyl 4-((1-(2-fluoro-4-(methylsulfonyl)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)oxy)piperidine-1-carboxylate APD668 APD668 ISOPROPYL 4-(1-(2-FLUORO-4-(METHYLSULFONYL)PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLOXY)PIPERIDINE-1-CARBOXYLATE | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 789 | 1094042-01-9 | 2-(4-(5-(3,4-Diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)ethanolhydrochloride | CYM5442 CYM 5442 CYM-5442 CYM 5442 HCl CYM5442 , 1094042-01-9 CYM 5442 hydrochloride 2-(4-(5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)ethanol Ethanol, 2-[[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]-2,3-dihydro-1H-inden-1-yl]amino]- 2-(4-(5-(3,4-Diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)ethanolhydrochloride | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 790 | 926037-48-1 | Radotinib(IY-5511) | IY5511 Supect CS-1712 Radotinib RADOTINIB IY5511 HCl. IY5511 HCL. Radotinib HCl Radotinib(IY-5511) | Standards;Inhibitors;Cell biology reagents;Organic photoelectricity;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 791 | 64862-96-0 | Ametantrone | HAQ NSC 196473 NSC-287513 NSC 290813 Ametantrone AMetantrone(NSC 196473) 1,4-BIS(2-(2-HYDROXYETHYLAMINO)ETHYLAMINO)ANTHRACENE-9,10-DIOL 1,4-Bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthraquinone | |
| 792 | 442908-10-3 | Vipadenant(BIIB-014; CEB-4520) | V 2006 CEB 4520 VER 11135 Vipadenant VER-ADO 49 VER-A 00-11 VER-A 00049 Vipadenant(BIIB 014) Vipadenant (BIIB 014) Vipadenant(BIIB-014 CEB-4520) 3-[(4-Amino-3-methylphenyl)methyl]-7-(2-furanyl)-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-amine | API;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 793 | 1033805-22-9 | LX1606 | LX1606 LX 1606 LX-1606 LX-1606 Hippurate TELOTRISTAT ETHYL Telotristat ethyl LX 1606 (Telotristat) ethyl (2S)-2-amino-3-[4-[2-amino-6-[(1R)-1-[4-chloro-2-(3-methylpyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]pyrimidin-4-yl]phenyl]propanoate L-Phenylalanine, 4-[2-aMino-6-[(1R)-1-[4-chloro-2-(3-Methyl-1H-pyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]-4-pyriMidinyl]-, ethyl ester, LX-1606 | |
| 794 | 389139-89-3 | Amadacycline | PTK-796 PTK 0796 PTK0796 PTK 0796 PTK-0796 OMADACYCLINE OMadacycline Amadacycline AMadacycline Omadacycline AMADACYCLINE Omadacycline-D9 2-Naphthacenecarboxamide 4,7-bis(dimethylamino)-9-[[(2,2-dimethylpropyl)amino]methyl]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)- 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-[[(2,2-dimethylpropyl)amino]methyl]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)- | Inhibitor;Microbial Microbiology |
| 795 | 371924-24-2 | MCU-i4 | MCU i4 MCU-i4 Ethyl 4-((4-(diethylamino)phenyl)amino)-6-methylquinoline-3-carboxylate ethyl 4-((4-(diethylamino)phenyl)imino)-6-methyl-1,4-dihydroquinoline-3-carboxylate | |
| 796 | 88235-25-0 | C-6 NBD | N316 C6-NBD C-6 NBD NBD Hexanoic Acid 7-nitrobenzoxadiazole-6-aminohexanoic acid 6-(7-NITROBENZOFURAZAN-4-YLAMINO)HEXANOIC ACID 6-(7-NITRO-2,1,3-BENZOXADIAZOL-4-YLAMINO)HEXANOIC ACID 6-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]hexanoic acid 6-(N-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)AMINO)HEXANOIC ACID | Amines;Aromatics;Heterocycles;Pharmaceuticals;Intermediates & Fine Chemicals;Fluorescent Labels & Indicators |
| 797 | 119894-20-1 | Fmoc-O-ethyl-L-tyrosine | FMoc-Tyr(Et) FMOC-TYR(ET)-OH Fmoc-Tyr(4-Et)-OH Amino Acid Impurity 51 Fmoc-O-ethyl-L-tyrosine FMOC-O-ETHYL-L-TYROSINE O-Ethyl-N-FMoc-L-tyrosine N-ALPHA-FMOC-O-ETHYL-L-TYROSINE O-Ethyl-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosine | Fmoc-protective amino acid |
| 798 | 1231929-97-7 | Abemaciclib | Abemaciclib LY 2835219 (free base) Abemaciclib (LY2835219) Bemaciclib(LY2835219, abemaciclib) | Synthetic material intermediates |
| 799 | 1261114-01-5 | GNF179 | GNF179 2-amino-1-[3-(4-chloroanilino)-2-(4-fluorophenyl)-8,8-dimethyl-5,6-dihydroimidazo[1,2-a]pyrazin-7-yl]ethanone 2-Amino-1-[3-[(4-chlorophenyl)amino]-2-(4-fluorophenyl)-5,6-dihydro-8,8-dimethylimidazo[1,2-a]pyrazin-7(8H)-yl]ethanone 2-amino-1-(3-((4-chlorophenyl)amino)-2-(4-fluorophenyl)-8,8-dimethyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)ethan-1-one Ethanone, 2-amino-1-[3-[(4-chlorophenyl)amino]-2-(4-fluorophenyl)-5,6-dihydro-8,8-dimethylimidazo[1,2-a]pyrazin-7(8H)-yl]- | |
| 800 | 133865-88-0 | (2S)-2-[[4-[(2-fluorophenyl)methoxy]phenyl]methylamino]propanamide | ralfinamide Safinamide-6 Guadecitabine Sodium (2S)-2-(4-(2-Fluorobenzyloxy)benzylamino)propanamide (S)-2-[[4-[(2-Fluorobenzyl)oxy]benzyl]amino]propanamide (2S)-2-[[4-[(2-fluorophenyl)methoxy]phenyl]methylamino]propanamide | Inhibitor;Impurities;Biochemistry;Standard products;Impurity reference substance |
| 801 | 13590-42-6 | benzyl (S)-2,5-dioxooxazolidine-4-acetate | H-ASP(OBZL)-NCA benzyl (S)-2,5-dioxooxazolidine-4-acetate Β-BENZYL L-ASPARTIC ACID N-CARBOXYANHYDRIDE (S)-Benzyl 2-(2,5-dioxooxazolidin-4-yl)acetate (4S)-2,5-Dioxooxazolidine-4-acetic acid benzyl ester (4S)-4-(Benzyloxycarbonylmethyl)oxazolidine-2,5-dione (4S)-4-[2-(Benzyloxy)-2-oxoethyl]oxazolidine-2,5-dione (S)-2,5-Dioxo-4-oxazolidineacetic acid phenylmethyl ester 2-[(4S)-2,5-Dioxooxazolidine-4-yl]acetic acid benzyl ester | Synthetic material intermediates |
| 802 | 139551-83-0 | FMOC-L-LEUCINOL | FMOC-LEU-OL Fmoc-L-Leu-OL FMOC-L-LEUCINOL N-FMOC-L-LEUCINOL N-ALPHA-FMOC-L-LEUCINOL N-(9-FLUORENYLMETHOXYCARBONYL)-L-LEUCINOL (S)-(9H-fluoren-9-yl)methyl 1-hydroxy-4-methylpentan-2-ylcarbamate Carbamic acid, N-[(1S)-1-(hydroxymethyl)-3-methylbutyl]-, 9H-fluoren-9-ylmethyl ester | Amino Acids;Amino acids;Amino Alcohols;Protecting amino acids;Fmoc-Amino acid series;Fmoc-Amino acid series |
| 803 | 1568-80-5 | SPIROBIINDANE | SPIROBIINDANE 3,3,3',3'-Tetramethyl-1,1'-spirobi[indan]-6,6'-diol tetrahydrotetramethyl-1,1'-spirobi-1H-indene-6,6'-diol 6,6'-Dihydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan 6,6'-Dihydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindane 3,3,3',3'-Tetramethyl-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-6,6'-diol 3,3,3',3'-Tetramethyl-2,2',3,3'-tetrahydro[1,1'-spirobi[1H-indene]]-6,6'-diol 2,2'',3,3''-TETRAHYDRO-3,3,3'',3''-TETRAMETHYL-1,1''-SPIROBI-1H-INDENE- 6,6''-DIOL | Alcohol;Chemical reagent |
| 804 | 168300-88-7 | FMOC-D-CYS(ACM)-OH | FMOC-D-CYS(ACM)-OH FMOC-D-CYSTEINE(ACM)-OH FMOC-D-ACETAMIDOMETHYL-L-CYSTEINE FMOC-S-ACETAMIDOMETHYL-D-CYSTEINE N-ALPHA-FMOC-S-ACETAMIDOMETHYL-D-CYSTEINE N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-S-ACETAMIDOMETHYL-D-CYSTEINE S-[(Acetylamino)methyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-D-cysteine N-alpha-(9-Fluorenylmethyloxycarbonyl)-S-(acetyl-aminomethyl)-D-cysteine | Amino Acids;Amino acids;Fmoc-protective amino acid |
| 805 | 171110-72-8 | Boc-Cis-4-Amino-L-Proline Methyl Ester Hydrochloride Salt | (S,S)-1-Boc-4-aminoproline methyl ester hydrochloride BOC-CIS-4-AMINO-L-PROLINE METHYL ESTER HYDROCHLORIDE SALT Boc-Cis-4-Amino-L-Proline Methyl Ester Hydrochloride Salt N-BOC-CIS-4-AMINO-L-PROLINE METHYL ESTER HYDROCHLORIDE SALT (2S,4S)-N-BOC-4-AMINO-L-PROLINE METHYL ESTER HYDROCHLORIDE SALT Methyl (2S,4S)-1-Boc-4-aMinopyrrolidine-2-carboxylate hydrochloride (2S,4S)-1-BOC-4-aMino Pyrrolidine-2-carboxylic acid Methylester-HCl (2S,4S)-1-tert-Butyl 2-methyl 4-aminopyrrolidine-1,2-dicarboxylate hydrochloride (2S-cis)-4-AMino-1,2-pyrrolidinedicarboxylic Acid 1-(1,1-DiMethylethyl) 2-Methyl Ester Hydrochloride | |
| 806 | 176644-21-6 | ENIPORIDE | ENIPORID ENIPORIDE EMD 96785 EMD 96785,ENIPORIDE N-CarbaMiMidoyl-2-Methyl-5-(Methylsulfonyl)-4-(1H-pyrrol-1-yl)benzaMide N-(diaMinoMethylidene)-2-Methyl-5-Methylsulfonyl-4-pyrrol-1-ylbenzaMide N-(Diaminomethylene)-2-methyl-5-(methylsulfonyl)-4-(1H-pyrrol-1-yl)benzamide N-(Aminoiminomethyl)-2-methyl-5-(methylsulfonyl)-4-(1H-pyrrol-1-yl)benzamide | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 807 | 18938-60-8 | Boc-Tyr-OtBu | Boc-Tyr-OtBu (Tert-Butoxy)Carbonyl Tyr-OtBu Boc-L-tyrosine tert-butyl ester N-Boc-L-tyrosine tert-Butyl Ester N-[(1,1-Dimethylethoxy)carbonyl]-L-tyrosine 1,1-dimethylethyl ester L-Tyrosine, N-[(1,1-dimethylethoxy)carbonyl]-, 1,1-dimethylethyl ester tert-butyl (2S)-2-{[(tert-butoxy)carbonyl]amino}-3-(4-hydroxyphenyl)propanoate (S)-2-[(tert-Butoxycarbonyl)amino]-3-(4-hydroxyphenyl)propionic acid tert-butyl ester | Boc-protective amino acid |
| 808 | 214630-00-9 | BOC-7-HYDROXY-D-TIC-OH | BOC-7-HYDROXY-D-TIC-OH Boc-D-7-Hydroxy-1,2,3,4-tetrahydroisoquinoline (R)-7-Hydroxy-2-Boc-3,4-dihydro-isoquinoline-3-carboxylic acid (R)-2-(tert-butoxycarbonyl)-1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid (R)-2-(tert-Butoxycarbonyl)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (3R)-2-(tert-Butoxycarbonyl)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid 2,3(1H)-Isoquinolinedicarboxylic acid, 3,4-dihydro-7-hydroxy, 2-(1,1-dimentylethyl) ester, (3R) 2,3(1H)-Isoquinolinedicarboxylic acid, 3,4-dihydro-7-hydroxy-, 2-(1,1-dimethylethyl) ester, (3R)- | Amino acid derivatives;Amino acid derivative compounds |
| 809 | 212201-70-2 | Ipfencarbazone | Ipfencarbazone IPFENCARBAZONE STANDARD Ipfencarbazone Standard 1-(2,4-dichlorophenyl)-N-(2,4-difluorophenyl)-5-oxo-N-(propa... 1-(2,4-Dichlorophenyl)-N-(2,4-difluorophenyl)-N-isopropyl-5-oxo-1H-1,2,4 triazole-4(5H)-carboxamide 1-(2,4-Dichlorophenyl)-2′,4′-difluoro-1,5-dihydro-N-isopropyl-5-oxo-4H-1,2,4-triazole-4-carboxanilide 1-(2,4-Dichlorophenyl)-N-(2,4-difluorophenyl)-1,5-dihydro-N-(1-methylethyl)-5-oxo-4H-1,2,4-triazol-4-carboxamide 1-(2,4-Dichlorophenyl)-N-(2,4-difluorophenyl)-1,5-dihydro-N-(1-Methylethyl)-5-oxo-4H-1,2,4-triazole-4-carboxaMide 4H-1,2,4-Triazole-4-carboxaMide, 1-(2,4-dichlorophenyl) -N-(2,4-difluorophenyl)-1,5-dihydro-N-(1-Methylethyl)- 5-oxo- | Reference substance;Medicine, pesticide intermediate |
| 810 | 36536-22-8 | 1,1',3,3,3',3'-HEXAMETHYLINDODICARBOCYANINE IODIDE | DIIC1(5) HIDC IODIDE Hexacyanine 2 3,3-trimethyl-nyl]-iodide 1,1,3,3,3',3'-HEXAMETHYLINDODICARBOCYANINE IODIDE 1,1',3,3,3',3'-HEXAMETHYLINDODICARBOCYANINE IODIDE 3h-indolium,2-[5-(1,3-dihydro-1,3,3-trimethyl-2h-indol-2-ylidene)-1,3-pentadie 1,3,3-TriMethyl-2-(5-(1,3,3-triMethylindolin-2-ylidene)penta-1,3-dien-1-yl)-3H-indol-1-iuM iodide 2-[5-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)penta-1,3-dienyl]-1,3,3-trimethyl-3H-indolium iodide | Cyanine |
| 811 | 1516895-53-6 | SEP-0372814 | CS-1706 SEP0372814 SEP-0372814 SEP 0372814 5,8-dimethyl-2-[(1R,2R)-2-{3-methylimidazo[2,1-f]1,6-naphthyridin-2-yl}cyclopropyl]-[1,2,4]triazolo[1,5-a]pyrazine rel-2-[(1R,2R)-2-(5,8-Dimethyl[1,2,4]triazolo[1,5-a]pyrazin-2-yl)cyclopropyl]-3-methylimidazo[2,1-f][1,6]naphthyridine Imidazo[2,1-f][1,6]naphthyridine, 2-[(1R,2R)-2-(5,8-dimethyl[1,2,4]triazolo[1,5-a]pyrazin-2-yl)cyclopropyl]-3-methyl-, rel- | Inhibitor |
| 812 | 1197196-48-7 | UNC0224 | CS-1635 UNC0224 UNC 0224 UNC-0224 UNC0224 UNC 0224 N-Debenzyl-N-Methyl-O-deMethyl-O-(3-diMethylaMinopropyl)-BIX 01294 7-[3-(dimethylamino)propoxy]-6-methoxy-2-(4-methyl-1,4-diazepan-1-yl)-N-(1-methylpiperidin-4-yl)quinazolin-4-amine 7-[3-(Dimethylamino)propoxy]-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6-methoxy-N-(1-methyl-4-piperidinyl)-4-quinazolinamine 4-QuinazolinaMine, 7-[3-(diMethylaMino)propoxy]-2-(hexahydro-4-Methyl-1H-1,4-diazepin-1-yl)-6-Methoxy-N-(1-Methyl-4-piperidinyl)- | Cell biology reagents;Amines, Aromatics, Heterocycles, Inhibitors, Pharmaceuticals, Intermediates & Fine Chemicals |
| 813 | 1247825-37-1 | 2-ThiophenecarboxaMide, 4-cyano-5-[(3,5-dichloro-4-pyridinyl)thio]-N-[4-(Methylsulfonyl)phenyl]- | P-50429 USP7-USP47 4-cyano-5-[(3 5-dichloro-4-pyridinyl)thio]-N-[4-(methylsulfonyl)phenyl]- 4-Cyano-5-[(3,5-dichloro-4-pyridinyl)thio]-N-[4-(methylsulfonyl)phenyl]-2-thiophenecarboxamide 2-ThiophenecarboxaMide, 4-cyano-5-[(3,5-dichloro-4-pyridinyl)thio]-N-[4-(Methylsulfonyl)phenyl]- | Cell biology reagent;Traditional Chinese medicine reference substance |
| 814 | 125314-64-9 | Ro 31-8220 | Ro 31-8220 RO-31-8220 RO 31-8220 MESYLATE RO 31-8220 METHANESULFONATE BISINDOLYLMALEIMIDE IX METHANESULFONATE BISINDOYLMALEIMIDINE IX METHANESULFONATE 3-[1-3-(AMIDINOTHIO)PROPYL-1H-INDOL-3-YL]-3-(1-METHYL-1H-INDOL-3-YL) MALEIMIDE 3-[1-[3-(AMIDINOTHIO)PROPYL-1H-INDOL-3-YL]-3-(1-METHYL-1H-INDOL-3-YL)MALEIMIDE METHANESULFONATE 3-[3-[2,5-DIHYDRO-4-(1-METHYL-1H-INDOL-3-YL)-2,5-DIOXO-1H-PYRROL-3-YL]-1H-INDOL-1-YL]PROPYL CARBAMIMIDOTHIOIC ACID ESTER MESYLATE | Protein Kinase;Cell biology reagent |
| 815 | 592542-59-1 | (2-METHOXY-5-[2-(2,4,6-TRIMETHOXY-PHENYL)-ETHENESULFONYLMETHYL]-PHENYLAMINO)-ACETIC ACID, SODIUM SALT | CS-1407 Rigosertib Rigosertib(acid) (E)-2-((2-Methoxy-5-(((2,4,6-triMethoxystyryl)sulfonyl)Methyl)phenyl)aMino)acetic acid N-[2-Methoxy-5-[[[(1E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]phenyl]glycine Glycine, N-[2-Methoxy-5-[[[(1E)-2-(2,4,6-triMethoxyphenyl)ethenyl]sulfonyl]Methyl]phenyl]- (2-METHOXY-5-[2-(2,4,6-TRIMETHOXY-PHENYL)-ETHENESULFONYLMETHYL]-PHENYLAMINO)-ACETIC ACID, SODIUM SALT | APIS;Standard;Antineoplastic protein Kinase inhibitors |
| 816 | 93129-94-3 | Tacalcitol Monohydrate | CB91456900 Tacalcitol monohydrate Tacalcitol Monohydrate 1,24(R)-DihydroxyvitaMin D3, Monohydrate 1-alpha,24(R)-Dihydroxyvitamin D3 monohydrate 9,10-Secocholesta-5,7,10(19)-triene-1,3,24-triol,Monohydrate, (1a,3b,5Z,7E,24R)- (9CI) (1R,3S)-5-[2-[(1R,3aR,7aS)-1-[(2R,5S)-5-hydroxy-6-Methyl-heptan-2-yl]-7a-Methyl-2,3,3a,5,6,7-hexahyd (1R,3S)-5-[2-[(1R,3aR,7aS)-1-[(2R,5S)-5-hydroxy-6-methyl-heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol 1,3-Cyclohexanediol, 4-methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,4R)-4-hydroxy-1,5-dimethylhexyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, hydrate , (1R,3S,5Z)- | |
| 817 | 501010-06-6 | GGTI-2418 | PTX 100 GGTI2418 GGTI-2418 GGTI 2418 (GGTI2418 (S)-3-benzyl-1-((4-methyl-1-trityl-1H-imidazol-5-yl)methyl)piperazin-2-one L-Leucine, N-[[(2S)-4-[(5-methyl-1H-imidazol-4-yl)methyl]-3-oxo-2-(phenylmethyl)-1-piperazinyl]carbonyl]- L-Leucine, N-[[(2S)-4-[(4-methyl-1H-imidazol-5-yl)methyl]-3-oxo-2-(phenylmethyl)-1-piperazinyl]carbonyl]- | |
| 818 | 1380087-89-7 | CPI-0610 | CPI0160 CPI-0610 Pelabresib BET bromodomain inhibitor (4S)-6-(4-Chlorophenyl)-1-methyl-4H-isoxazolo[5,4-d][2]benzazepine-4-acetamide 2-[6-(4-Chloro-phenyl)-1-Methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl]-acetaMide 4H-Isoxazolo[5,4-d][2]benzazepine-4-acetamide, 6-(4-chlorophenyl)-1-methyl-, (4S)- 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 819 | 1037592-40-7 | JPH203 | JPH203 JPH-203 KYT0353 CS-2494 JPH 203 KYT-0353 KYT 0353 JPH 203 KYT-0353 KYT 0353 KYT0353. JPH203 (KYT-0353 O-[(5-Amino-2-phenyl-7-benzoxazolyl)methyl]-3,5-dichloro-L-tyrosine | reference substance;Cell biology reagent |
| 820 | 47623-98-3 | BIS-(1,3-DIETHYLTHIOBARBITURIC ACID)TRIMETHINE OXONOL | DISBAC2(3) NEURODYE DISBAC2(3) DISBAC2(3), Voltage Sensitive Probe bis(1,3-diethylthiobarbiturate)trimethineoxonol BIS-(1,3-DIETHYLTHIOBARBITURIC ACID)TRIMETHINE OXONOL DiSBAC2(3) [Bis-(1,3-diethylthiobarbituric acid) triMethine oxonol] 5-[2-allylidene-3-(1,3-diethylhexahydro-4,6-dioxo-2-thioxopyrimidin-5-yl)]-1,3-diethyldihydro-2-thioxo-1H,5H-pyrimidine-4,6-dione 5-[3-(1,3-Diethylhexahydro-4,6-dioxo-2-thioxo-5-pyrimidinyl)-2-propen-1-ylidene]-1,3-diethyldihydro-2-thioxo-4,6(1H,5H)-pyrimidinedione | Oxonol;Biochemical reagents |
| 821 | 127274-91-3 | 1,1'-DIOCTADECYL-3,3,3',3'-TETRAMETHYLINDODICARBOCYANINE PERCHLORATE | DILC18(5) 1,1'-DIOCTADECYL-3,3,3',3'-TETRAMETHYLINDODICARBOCYANINE PERCHLORATE DiIC18(5) [DiD] [1,1'-Dioctadecyl-3,3,3',3'-tetraMethylindodicarbocyanine perchlorate] 3H-INDOLIUM, 2-[5-(1,3-DIHYDRO-3,3-DIMETHYL-1-OCTADECYL-2H-INDOL-2-YLIDENE)-1,3-PENTADIENYL]-3,3-DIMETHYL-1-OCTADECYL-, PERCHLORATE | Cell biology reagent |
| 822 | 136164-66-4 | (E)-2-((4,5-dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methylene)undecanoic acid | E3330 E 3330 E-3330 APX3330 CS-1756 APX 3330 (E)-2-((4,5-dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methylene)undecanoic acid (2E)-2-[(4,5-Dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)methylene]-undecanoic acid Undecanoic acid, 2-[(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)methylene]-, (2E)- (2E)-2-[(4,5-dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methylidene]undecanoic acid E3330 | Standard;Inhibitor;Pharmaceutical raw materials |
| 823 | 909115-33-9 | FMOC-GLU(OTBU)-SER(PSI-ME,MEPRO)-OH | Fmoc-Glu(OtBu)-Ser[Ψ(Me,Me)Pro]-OH FMOC-GLU(OTBU)-SER(PSI-ME,MEPRO)-OH Fmoc-Glu(tBu)-Ser[PSI(Me,Me)Pro]-OH (9H-Fluoren-9-yl)MethOxy]Carbonyl Glu(OtBu)-SerPsi(Me,Me)Pro-OH (S)-3-[Nα-(9-Fluorenylmethyloxycarbonyl)-L-glutamyl-tert-butyl ester]-2,2-dimethyloxazolidine-4-carboxylic acid (4S)-3-[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid (gammaS,4S)-4-Carboxy-gamma-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2,2-dimethyl-delta-oxo-3-oxazolidinepentanoic acid 3-(1,1-dimethylethyl) ester | peptide;False dipeptide |
| 824 | 170006-73-2 | FTI-277 | FTI277 FTI-277 FTI 277 METHYL[N-[2-PHENYL-4-N-[2(R)-AMINO-3-MERCAPTOPROPYLAMINO] BENZOYL]]-METHIONATE, TFA N-[[5-[[(2R)-2-Amino-3-mercaptopropyl]amino][1,1'-biphenyl]-2-yl]carbonyl]-L-methionine methyl ester N-[4-[2(R)-AMINO-3-MERCAPTOPROPYL]AMINO-2-PHENYLBENZOYL]METHIONINE METHYL ESTER TRIFLUOROACETATE SALT L-Methionine, N-[[5-[[(2R)-2-amino-3-mercaptopropyl]amino][1,1'-biphenyl]-2-yl]carbonyl]-, methyl ester N-[4-[2(R)-Amino-3-mercaptopropyl]amino-2-phenylbenzoyl]methionine methyl ester trifluoroacetate salt | |
| 825 | 13161-28-9 | Rhodamine 6G Perchlorate | Rhodamine 6G Perchlorate RHODAMINE 6G PERCHLORATE RHODAMINE 590 PERCHLORATE XANTHYLIUM, 9-[2-(ETHOXYCARBONYL)PHENYL]-3,6-BIS(ETHYLAMINO)-2,7-DIMETHYL-, PERCHLORATE BENZOIC ACID, O-[6-(ETHYLAMINO)-3-(ETHYLIMINO)-2,7-DIMETHYL-3H-XANTHEN-9-YL]-, ETHYL ESTER, MONOPERCHLORATE BENZOIC ACID, 2-[6-(ETHYLAMINO)-3-(ETHYLIMINO)-2,7-DIMETHYL-3H-XANTHEN-9-YL]-, ETHYL ESTER, MONOPERCHLORATE N-[9-[2-(ETHOXYCARBONYL)PHENYL]-6-(ETHYLAMINO)-2,7-DIMETHYL-3H-XANTHEN-3-YLIDENE]-1-ETHANAMINIUM PERCHLORATE | ;Stains&Dyes, A to;Chelators and Ion Probes;Laser DyesStains and Dyes;Fluorescent Indicators and Probes;Chelators and Ion Probes for Flow CytometryOrganic Electronics and Photonics |
| 826 | 1422144-42-0 | AR-13324 (mesylate) | AR-13324 AR13324 AR 13324 Rhopressa RHOPRESSA Netarsudil Mesylate AR-13324 (mesylate) NETARSUDIL MESYLATE Netarsudil Dimesylate Netarsudil Mesylate (AR-13324) (S)-4-(3-Amino-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate dimethanesulfonate | API;Inhibitor;Pharmaceutical raw materials |
| 827 | 131875-08-6 | Lexacalcitol | KH 106 KH 1060 Lexacalcitol Lenosacalcitol Lexacalcideferol (1S*,3R*,5Z),7aalpha))-(5Z,7E,20R)-20-((4-Ethyl-4-hydroxyhexyl)oxy)-9,10-secopregna-5,7,10(19)-triene-1alpha,3beta-diol 1,3-Cyclohexanediol, 5-[(2E)-2-[(1S,3aS,7aS)-1-[(1R)-1-[(4-ethyl-4-hydroxyhexyl)oxy]ethyl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-, (1R,3S,5Z)- (1R,3S,5Z)-5-[(2E)-2-[(1S,3aS,7aS)-1-[(1R)-1-(4-ethyl-4-hydroxyhexoxy)ethyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | |
| 828 | 1313498-08-6 | LSN2814617 | LSN2814617 LSN2814617 racemate 1,2,4-Triazolo[4,3-a]pyridine, 3-(1,1-dimethylethy 3-(1,1-Dimethylethyl)-7-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridine 1,2,4-Triazolo[4,3-a]pyridine, 3-(1,1-dimethylethyl)-7-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-5,6,7,8-tetrahydro- | raceme |
| 829 | 1391426-22-4 | N2-(7-Chloro-4-quinolinyl)-N1-[2-[(7-chloro-4-quinolinyl)amino]ethyl]-N1-methyl-1,2-ethanediamine | LYS05 LYS-05 LYS 05 CS-2372 LYS01 free base N2-(7-Chloro-4-quinolinyl)-N1-[2-[(7-chloro-4-quinolinyl)amino]ethyl]-N1-methyl-1,2-ethanediamine N1-(7-chloroquinolin-4-yl)-N2-(2-((7-chloroquinolin-4-yl)amino)ethyl)-N2-methylethane-1,2-diamine N2-(7-Chloro-4-quinolinyl)-N1-[2-[(7-chloro-4-quinolinyl)aMino]ethyl]-N1-Methyl-1,2-ethanediaMine | Pharmaceuticals, Intermediates & Fine Chemicals |
| 830 | 1304630-27-0 | NGP 555 | NGP 555 1304630-27-0 N-(5-ethyl-2,4-dimethylphenyl)-4-(3-fluoro-4-(4-methyl-1H-imidazol-1-yl)phenyl)thiazol-2-amine 2-Thiazolamine, N-(5-ethyl-2,4-dimethylphenyl)-4-[3-fluoro-4-(4-methyl-1H-imidazol-1-yl)phenyl]- | |
| 831 | 1038915-64-8 | (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxaMide | Zejula CS-787 MK-4827 MK-4827 (HCl) Niraparib hydrochloride MK-4827 (hydrochloride) Niraparib(MK4827) hydrochloride (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxaMide 2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide,hydrochloride | API;Pharmaceutical raw materials |
| 832 | 96736-11-7 | NOURSEOTHRICIN SULFATE | STREPTOTHRICIN Streptothricin sulfate NOURSEOTHRICIN SULFATE NOURSEOTHRICIN SULPHATE UDVWKDBCMFLRQW-TWRCRAKCSA-N nourseothricin,sulfate(salt) Nourseothricin (streptothricin) sulfate | |
| 833 | 1401031-39-7 | TRV-130 | TRV130 TRV-130 TRV130 TRV 130 TRV130 HCl OLICERIDINE Oliceridine HCl OLICERIDINE HCL TRV130 (hydrochloride) TRV130 HCl (Oliceridine) OLICERIDINE HYDROCHLORIDE TRV-130 HYDROCHLORIC ACID SALT (R)-N-((3-Methoxythiophen-2-yl)methyl)-2-(9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl)ethanamin [(3-Methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine TRV-130 | |
| 834 | 16201-96-0 | 4-Phenylazomaleinanil | ASISCHEM D13285 4-Phenylazomaleinanil 4-PHENYLAZOMALEINANIL P-PHENYLAZOMALEINANIL 4-(N-Maleimido)azobenzene 4-phenylazophenylmaleimide N-(p-Phenylazophenyl)maleimide 1-[4-(phenylazo)phenyl]-1h-pyrrole-5-dione 1H-Pyrrole-2,5-dione, 1-[4-(phenylazo)phenyl]- | P;Stains and Dyes;Stains&Dyes, A to |
| 835 | 171436-38-7 | H-SER-LEU-ILE-GLY-ARG-LEU-NH2 | H2N-SLIGRL-AMIDE PAR2-AP, SLIGRL-NH2 SER-LEU-ILE-GLY-ARG-LEU-NH2 Ser-Leu-Ile-Gly-Arg-Leu-NH2 H-SER-LEU-ILE-GLY-ARG-LEU-NH2 Ser-Leu-Ile-Gly-Arg-Leu-amide trifluoroacetate salt SLIGRL-NH2 Protease-Activated Receptor 2 (PAR2) Agonist COAGULATION FACTOR II RECEPTOR-LIKE 1 (1-6) AMIDE (MOUSE, RAT) ThroMbin Receptor-Like 1 (1-6) aMide (Mouse, rat), SLIGRLaMide, Proteinase Activated Receptor 2 (1-6) aMide (Mouse, rat), Coagulation Factor II Receptor-Like 1 (1-6) aMide (Mouse, rat) | peptide;Standards;Polypeptides;Peptide Receptors;Proteinase-activated receptor (PAR) |
| 836 | 1234708-04-3 | N-(3-(5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyriMidine-5-carboxaMide | CS-1754 SAR191801 hPGDS-IN-1 N-(3-(5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyriMidine-5-carboxaMide 2-(pyridin-2-yl)pyriMidine-5-carboxylic acid 3-[5-(1-hydroxy-1-Methylethyl)-1,2,4]oxadiazol-3-yl-benzylaMide N-[[3-[5-(1-Hydroxy-1-methylethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-2-(2-pyridinyl)-5-pyrimidinecarboxamide SAR191801,2-Pyridin-2-yl-pyrimidine-5-carboxylic acid 3-[5-(1-hydroxy-1-methyl-ethyl)-[1,2,4]oxadiazol-3-yl]-benzylamide tert-butyl(((3aR,4R,6aR)-5-fluoro-2,2-dimethyl-6-((trityloxy)methyl)-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)diphenylsilane SAR191801 | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 837 | 36099-95-3 | H-TRP-GLU-OH | WE G3335 TRP-GLU L-TRP-GLU H-TRP-GLU-OH TRP-GLU CRYSTALLINE PPARγ Antagonist III,G3335 L-TRYPTOPHYL-L-GLUTAMIC ACID 2-[[2-AMINO-3-(1H-INDOL-3-YL)PROPANOYL]AMINO]PENTANEDIOIC ACID | Amino Acid Derivatives;A cell-permeable dipeptide that acts as a selective and reversible PPAR./ antagonist |
| 838 | 161582-11-2 | (4-BROMOPHENYL)[3-FLUORO-4-[[6-(METHYL-2-PROPENYLAMINO)HEXYL]OXY]PHENYL]-METHANONE | RO 48-8071 (4-Bromophenyl)[2-fluoro-4-[[6-(methyl-2-propenylamino)hexyl]oxy]phenyl]methanone (4-BROMOPHENYL)[3-FLUORO-4-[[6-(METHYL-2-PROPENYLAMINO)HEXYL]OXY]PHENYL]-METHANONE Methanone, (4-broMophenyl)[2-fluoro-4-[[6-(Methyl-2-propenylaMino)hexyl]oxy]phenyl]- Methanone, (4-bromophenyl)[2-fluoro-4-[[6-(methyl-2-propen-1-ylamino)hexyl]oxy]phenyl]- | |
| 839 | 1781835-13-9 | RN-1 (hydrochloride) | RN1 RN 1 RN1 RN 1 RN-1 (hydrochloride) RN 1 dihydrochloride 1-(4-methyl-1-piperazinyl)-2-[[(1R*,2S*)-2-[4-phenylmethoxy)phenyl]cyclopropyl]amino]ethanone dihydrochloride | |
| 840 | 151823-14-2 | Sapacitabine | CNDAC Sapacitabine 1-(2-Deoxy-2-cyano-β-D-arabinofuranosyl)cytosine 1-(2-C-Cyano-2-deoxy-β-D-arabino-pentofuranosyl)cytosine 2'-cyano-2'-deoxy-N4-palMitoyl-1-β-D-arabinofuranosyl-cytosine, sapacitabine, CYC682 4-Amino-1-[(3β-cyano-4α-hydroxy-5β-hydroxymethyltetrahydrofuran)-2β-yl]pyrimidin-2(1H)-one 1-(2-cyano-2-deoxy-β-D-arabinofuranosyl)-4-(palMitoylaMino)pyriMidin-2(1H)-one,Sapacitabine N-[1-[(2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2- oxo-pyrimidin-4-yl]hexadecanamide | Nucleoside |
| 841 | 115104-28-4 | (E)-3-[[[3-[2-(7-CHLORO-2-QUINOLINYL)ETHENYL]PHENYL]-[[(3-DIMETHYLAMINO)-3-OXOPROPYL]THIO]METHYL]THIO]-PROPANOIC ACID, SODIUM SALT | MK-571 CS-2183 MK-571 NA MK-571 SODIUM SALT L 660711, SODIUM SALT 3-[[[3-[(E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propanoic acid 3-[[[3-[(E)-2-(7-Chloroquinolin-2-yl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propanoic acid (E)-3-[[[3-[2-(7-CHLORO-2-QUINOLINYL)ETHENYL]PHENYL]-[[(3-DIMETHYLAMINO)-3-OXOPROPYL]THIO]METHYL]THIO]-PROPANOIC ACID, SODIUM SALT | Aromatics;Inhibitor;Heterocycles;Pharmaceuticals;Sulfur & Selenium Compounds;Intermediates & Fine Chemicals |
| 842 | 106635-80-7 | Tafenoquine | Krintafe KRINTAFE WR238605 SB252263 WR 238605 SB-252263 WR-238605 SB 252263 TAFENOQUINE Tafenoquine TAFENOQUINE SB252263-AAB SB 252263-AAB WR-238605, WR 238605, WR238605, SB-252263-AAB 4-[5-[3-(Trifluoromethyl)phenoxy]-2,6-dimethoxy-4-methyl-8-quinolinylamino]-1-pentanamine N4-(2,6-diMethoxy-4-Methyl-5-(3-(trifluoroMethyl)phenoxy)quinolin-8-yl)pentane-1,4-diaMine N4-{2,6-Dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]-8-quinolinyl}-1,4-pentanediamine 8-[(4-Amino-1-methylbutyl)amino]-2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinoline | |
| 843 | 1354825-58-3 | WEHI-345 | WEHI345 CS-2140 WHI-345 WEHI 345 WEHI-345 N-[2-[4-Amino-3-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-pyridinecarboxamide 4-Pyridinecarboxamide, N-[2-[4-amino-3-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]- | Cell biology reagent |
| 844 | 78123-71-4 | DAGO | DAGO DAMGO Tyr-D-Ala-Gly-MePhe-Gly-ol TYR-D-ALA-GLY-N-ME-PHE-GLY-OL Tyr-D-Ala-Gly-MePhe-NH-(CH2)2OH TYR-D-ALA-GLY-N-METHYL-PHE-GLY-OL (D-ALA2,N-ME-PHE4,GLYCINOL5)-ENKEPHALIN Tyr-D-Ala-Gly-N-methylphenylalanine-glycinol | Peptide;Directory polypeptide;Opioid receptor and opioid-like receptor |
| 845 | 133367-34-7 | FMOC-HIS(MTT)-OH | FMOC-HIS(MTT)-OH (FMOC-HIS(MTT)-OH) FMOC-L-HIS(MTT)-OH FMOC-HISTIDINE(MTT)-OH FMOC-N-IM-METHYLTRITYL-L-HISTIDINE N-ALPHA-FMOC-N-IM-METHYLTRITYL-L-HISTIDINE N-ALPHA-FMOC-N(IM)-(4-METHYLTRITYL)-L-HISTIDINE N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-N-TAU-METHYLTRITYL-L-HISTIDINE N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N-IM-P-METHYLTRITYL-L-HISTIDINE | Amino Acids;Amino acids;Fmoc-protective amino acid |
| 846 | 265129-71-3 | GW7647 | GW647 GW7647 GW 7647X GWalpha 7647 2-(4-(2-(1-CYCLOHEXANEBUTYL)-3-CYCLOHEXYLUREIDO)ETHYL)PHENYLTHIO)-2-METHYLPROPIONIC ACID 2-[[4-[2-[[(CYCLOHEXYLAMINO)CARBONYL](4-CYCLOHEXYLBUTYL)AMINO]ETHYL]PHENYL]THIO]-2-METHYLPROPANOIC ACID 2-((4-(2-(((Cyclohexylamino)carbonyl)-(4-cyclohexylbutyl)amino)ethyl)phenyl)thio)-2-methylpropanoicacid Propanoic acid, 2-[[4-[2-[[(cyclohexylaMino)carbonyl](4-cyclohexylbutyl)aMino]ethyl]phenyl]thio]-2-Methyl- | Intracellular receptor;Antibody-secondary antibody |
| 847 | 871266-63-6 | PCI-27483 | CS-1599 PCI27483 PCI-27483 PCI 27483 (S)-2-[[2-[5-(5-Carbamimidoyl-1H-benzimidazol-2-yl)-6,2'-dihydroxy-5'-sulfamoylbiphenyl-3-yl]acetyl]amino]succinic acid (S)-2-(2-(5-(5-carbamimidoyl-1H-benzo[d]imidazol-2-yl)-2',6-dihydroxy-5'-sulfamoylbiphenyl-3-yl)acetamido)succinic acid L-Aspartic acid, N-[2-[5-[6-(aminoiminomethyl)-1H-benzimidazol-2-yl]-5'-(aminosulfonyl)-2',6-dihydroxy[1,1'-biphenyl]-3-yl]acetyl] | Pharmaceutical |
| 848 | 80724-19-2 | 5-TRITC; G isomer [Tetramethylrhodamine-5-isothiocyanate] | Gisomer 5-TRITC 5-TRITC, G isomer 5-TRITC, Xanthylium tetramethylrhodamine-5-isothiocyanate(5-tritc TETRAMETHYLRHODAMINE-5-ISOTHIOCYANATE, G-ISOMER G isoMer [TetraMethylrhodaMine-5-isothiocyanate] 5-TRITC G isomer [Tetramethylrhodamine-5-isothiocyanate] 9-(2-Carboxy-4-isothiocyanatophenyl)-3,6-bis(dimethylamino)xanthylium inner salt | fluorescent dye |
| 849 | 1347750-75-7 | Boc-9-AMino-4,7-Dioxanonanoic acid | Boc-N-amido-PEG3-acid Boc-PEG3- CH2 CH2COOH Boc-NH-PEG3-CH2CH2COOH t-Boc-N-amido-PEG3-acid T-BOC-NH-AMIDO-PEG3-COOH t-boc-N-amido-PEG3-propionic acid Boc-9-AMino-4,7-Dioxanonanoic acid 5,8,11-Trioxa-2-azatetradecanedioic acid 1-(1,1-dimethylethyl) ester | Additives;PEGylated Amino Acid |
| 850 | 1654740-73-4 | Fmoc-N-amido-PEG1-acid | Fmoc-AEP Fmoc-N-amido-PEG1-acid FMoc-NH-PEG1-CH2CH2COOH Fmoc-PEG1-propionic acid Fmoc-6-Amino-4-oxahexanoic acid 6-(Fmoc-amino)-4-oxahexanoic Acid 3-[2-(Fmoc-amino)ethoxy]propanoic acid 3-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethoxy)propanoic acid | Additive |
| 851 | 182959-73-5 | BOC-(2R,3S)-2-AMINO-3-HYDROXY-4-METHYLPENTANOIC ACID | BOC-(2R,3S)-2-AMINO-3-HYDROXY-4-METHYLPENTANOIC ACID (2R,3S)-2-(Boc-amino)-3-hydroxy-4-methylpentanoic Acid (3S)-N-[(1,1-Dimethylethoxy)carbonyl]-3-hydroxy-D-leucine D-Leucine, N-[(1,1-dimethylethoxy)carbonyl]-3-hydroxy-, (3S)- | unnatural amino acids |
| 852 | 214139-28-3 | N-Fmoc-DL-1-Aminoindane-1-Carboxylic Acid | Fmoc-1-aminoindane-1-carboxylic acid 1-(FMoc-aMino)indane-1-carboxylic Acid Fmoc-DL-1-aminoindan-1-carboxylic acid FMOC-DL-1-aminoindane-1-carboxylic acid N-FMOC-DL-1-AMINOINDANE-1-CARBOXYLIC ACID N-Fmoc-DL-1-Aminoindane-1-Carboxylic Acid 1-((((9H-Fluoren-9-yl)Methoxy)carbonyl)aMino)-2,3-dihydro-1H-indene-1-carboxylic acid 1H-Indene-1-carboxylicacid,1-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2,3-dihydro-(9CI) | FMOC;Amino acid derived compounds |
| 853 | 98569-12-1 | 2-(Tert-Butoxycarbonylamino)-1,2,3,4-Tetrahydronaphthalene-2-Carboxylic Acid | 2-N-Boc-amino-tetrahydro-2-naphthoicacid tert-butyl (1,2,3,4-tetrahydronaphthalen-2-yl)carbamate 2-(tert-Butoxycarbonylamino)-1,2,3,4-tetrahydronaphthalene-2-car 2-(TERT-BUTOXYCARBONYLAMINO)-1,2,3,4-TETRAHYDRONAPHTHALENE-2-CARBOXYLIC ACID 2-(Tert-Butoxycarbonylamino)-1,2,3,4-Tetrahydronaphthalene-2-Carboxylic Acid (2R)-2-[(tert-butoxycarbonyl)amino]-1,2,3,4-tetrahydronaphthalene-2-carboxylate N-BOC-DL-2-Aminotetralin-2-carboxylic acidTETRAHYDRONAPHTHALENE-2-CARBOXYLIC ACID 2-[(2-methylpropan-2-yl)oxycarbonylamino]-3,4-dihydro-1H-naphthalene-2-carboxylic acid 2-Naphthalenecarboxylicacid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,4-tetrahydro- | Amino acid-derived compounds;intermediates-organic intermediates |
| 854 | 100068-60-8 | DiR' [DiIC18(7)] | Cy7 DiC18 DiR' [DiIC18(7)] 1,1-dioctadecyl-3,3,3,3-tetramethylindotricarbocyaineiodide DiIC18(7) [1,1'-Dioctadecyl-3,3,3',3'-tetramethylindotricarbocyanine iodide] DiR'DiIC18(7) [1,1'-Dioctadecyl-3,3,3',3'-tetraMethylindotricarbocyanine iodide] Cy7 DiC18(DiR'DiIC18(7) [1,1'-Dioctadecyl-3,3,3',3'-tetraMethylindotricarbocyanine iodide]) 2-(7-(3,3-Dimethyl-1-octadecylindolin-2-ylidene)hepta-1,3,5-trien-1-yl)-3,3-dimethyl-1-octadecyl-3H-indol-1-ium iodide | fluorescent dye |
| 855 | 1028969-49-4 | 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-(3R)-3-piperidinyl-1H-benzimidazoletrihydrochloride | MCOPPB MCOPPB TRIHYDROCHLORIDE MCOPPB trihydrochloride MCOPPB trihydrochloride hydrate 1-[1-(1-methylcyclooctyl)piperidin-4-yl]-2-[(3R)-piperidin-3-yl]benzimidazole 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-(3R)-3-piperidinyl-1H-benzimidazoletrihydrochloride 1-(1-(1-Methylcyclooctyl)piperidin-4-yl)-2-(piperidin-3-yl)-1H-Benzo[d]imidazole trihydrochlor 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole trihydrochloride hydrate | |
| 856 | 104091-11-4 | FMOC-D-GLU(OBZL)-OH | FMOC-D-GLU(BZL)-OH FMOC-D-GLU(OBZL)-OH N-Fmoc-D-Glu γ-benzyl ester FMOC-D-GLUTAMIC ACID(OBZL)-OH FMOC-D-GLUTAMIC ACID GAMMA-BENZYL ESTER N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-D-GLUTAMIC ACID GAMMA-BENZYL ESTER N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-D-GLUTAMIC-ACID-GAMMA-BENZYL ESTER (2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-oxo-5-phenylmethoxypentanoic acid (2R)-5-(benzyloxy)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-oxopentanoic acid | Amino acids;Protective amino acids;Non-natural amino acids;Fmoc-protective amino acids |
| 857 | 1211877-36-9 | (R)-MG132 | (R)-MG132 MG-132(R) MG-132(S,R,S) Z-Leu-D-leu-leu-al (S,R,S)-(-)-MG-132 CBZ-LEU-D-LEU-LEU-CHO Cbz-L-leu-D-leu-L-leu-H N-[(Phenylmethoxy)carbonyl]-L-leucyl-N-[(1S)-1-formyl-3-methylbutyl]-D-leucinamide benzyl N-[(2S)-4-methyl-1-[[(2R)-4-methyl-1-[[(2S)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamate | peptides;Biochemical Industry |
| 858 | 1251012-82-4 | 5-Boc-5-aza-spiro[2.3]hexane-1-carboxylic acid | CS-1403 PB30239 PB 30239 PB-30239 5-aza-spiro[2.3]hexane-1 5-dicarboxylic acid 5-tert-butyl ester 5-Boc-5-aza-spiro[2.3]hexane-1-carboxylic acid 5-(tert-butoxycarbonyl)-5-azaspiro[2.3]hexane-1-carboxylic acid 5-[(2-methylpropan-2-yl)oxycarbonyl]-5-azaspiro[2.3]hexane-2-carboxylic acid | |
| 859 | 133367-33-6 | Fmoc-His(MMt)-OH | FMOC-HIS(MMT)-OH Fmoc-His(MMt)-OH FMOC-L-HIS(MMT)-OH FMOC-HIS(MEOTRT)-OH FMOC-N-IM-METHOXYTRITYL-L-HISTIDINE FMOC-NIM-(4-METHOXYTRITYL)-L-HISTIDINE N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-N-TAU-4-METHOXYTRITYL-L-HISTIDINE N-ALPHA-(9-FLUOROENYLMETHYLOXYCARBONYL)-N-IM-P-METHOXYTRITYL-L-HISTIDINE (2S)-2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-3-[1-[(4-METHOXYPHENYL)-DIPHENYLMETHYL]IMIDAZOL-4-YL]PROPANOIC ACID (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)((4-methoxyphenyl)diphenylmethyl)amino)-3-(1H-imidazol-4-yl)propanoic acid | Amino Acids;Amino acids;Chemical biology;Protecting amino acids;Amino acid derivatives;Fmoc-Amino acid series;Fmoc-Amino acid series;Fmoc-Amino Acids and Derivatives |
| 860 | 1346133-08-1 | LY2795050 | LY2795050 LY 2795050 LY-2795050 LY-2795050 1346133-08-1 3-chloro-4-[4-[ [ (2S)-2-(3-pyridyl)pyrrolidin-1-yl]methyl]phenoxy]benzamide (S)-3-chloro-4-(4-((2-(pyridin-3-yl)pyrrolidin-1-yl)methyl)phenoxy)benzamide Benzamide, 3-chloro-4-[4-[[(2S)-2-(3-pyridinyl)-1-pyrrolidinyl]methyl]phenoxy]- | G protein coupled receptor & G protein |
| 861 | 138775-48-1 | Fmoc-D-Tyr(Bzl)-OH | Fmoc-D-Tyr(Bzl)-OH FMOC-D-TYR(BZL)-OH FMOC-O-BENZYL-D-TYR FMOC-O-BENZYL-D-TYROSINE N-ALPHA-FMOC-O-BENZYL-D-TYROSINE FMOC-(R)-2-AMINO-3-(4'-BENZYLOXYPHENYL)PROPANOIC ACID N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-O-BENZYL-D-TYROSINE N-ALPHA-(9-FLUOROENYLMETHYLOXYCARBONYL)-O-BENZYL-D-TYROSINE (2R)-3-[4-(benzyloxy)phenyl]-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoic acid | Amino acid;Amino Acids;Amino Acid Derivatives;Fmoc-protective amino acid |
| 862 | 142335-42-0 | BOC-7-HYDROXY-TIC-OH | BOC-L-TIC(OH)-OH BOC-L-TIC(7-OH)-OH BOC-HYDROXY-TIC-OH BOC-7-HYDROXY-TIC-OH BOC-TIC(7-HYDROXY)-OH BOC-L-7-HYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID BOC-7-HYDROXY-(S)-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID BOC-[3S]-1,2,3,4-TETRAHYDROISOQUINOLINE-7-HYDROXY-3-CARBOXYLIC ACID | Amino acids;Amino acid derived compounds |
| 863 | 15790-91-7 | (Z)-2-decenoic acid | (Z)-2-decanoic acid (Z)-2-Decenoic acid (Z)-2-decenoic acid (Z)-dec-2-enoic acid 2-Decenoic acid, (2Z)- | Pharmaceutical, pesticide intermediates;Fluorescent probes, labeling, granules and staining |
| 864 | 158706-46-8 | (2R,5S)-1-[(2-methylpropan-2-yl)oxycarbonyl]-5-phenylpyrrolidine-2-carboxylic acid | RARECHEM EM WB 0184 BOC-(2R,5S)-5-PHENYLPYRROLIDINE-2-CARBOXYLIC ACID (2R,5S)-BOC-5-PHENYL-PYRROLIDINE-2-CARBOXYLIC ACID (2R,5S)-1-(tert-Butoxycarbonyl)-5-phenylpyrrolidine-2-carboxylic acid (2R,5S)-1-[(2-methylpropan-2-yl)oxycarbonyl]-5-phenylpyrrolidine-2-carboxylic acid 1,2-Pyrrolidinedicarboxylic acid, 5-phenyl-, 1-(1,1-dimethylethyl) ester, (2R,5S)- | Amino acid derived compound |
| 865 | 176504-01-1 | FMOC-4-AMINOMETHYL-PHENYLACETIC ACID | FMOK RARECHEM EM WB 0059 FMOC-4-AMINOMETHYL-PHENYLACETIC ACID 4-[(Fmoc-amino)methyl]benzeneacetic acid Fmoc-AMPAA FMOC-4-AMINOMETHYL-PHENYLACETIC ACID N-(9-fluorenylmethyloxycarbonyl)-4-(aminomethyl)phenylacetic acid 2-(4-(((((9H-Fluoren-9-yl)Methoxy)carbonyl)aMino)Methyl)phenyl)acetic acid | |
| 866 | 180576-05-0 | Fmoc-4-carboxymethyl-piperazine | FMOC-CMPI FMOC-CMPI-OH RARECHEM EM WB 0084 N4-FMOC-PIZ-2-CARBOXYLIC ACID FMOC-4-CARBOXYMETHYL-PIPERAZINE Fmoc-4-carboxymethyl-piperazine 4-FMOC-PIPERAZINE-2-CARBOXYLIC ACID N4-FMOC-PIPERAZINE-2-CARBOXYLIC ACID 4-N-FMOC-PIPERAZINE-2-CARBOXYLIC ACID | Amino acids;Heterocyclic compounds;Amino acid derivative compounds;Synthetic material intermediates |
| 867 | 201419-16-1 | BOC-HOMOCYS(TRT)-OH | BOC-HCY(TRT)-OH Boc-Hcys(Trt)-OH BOC-HOCYS(TRT)-OH BOC-HOMOCYS(TRT)-OH BOC-D-HOCYS(TRT)-OH BOC-HOMOCYSTEINE(TRT)-OH BOC-S-TRITYL-L-HOMOCYSTEINE (S)-2-(BOC-AMINO)-4-TRITYLSULFANYL-BUTYRIC ACID N-ALPHA-T-BUTOXYCARBONYL-S-TRITYL-L-HOMOCYSTEINE | amino acids;Amino acids;Unnatural amino acids;Protective amino acids |
| 868 | 201531-76-2 | FMOC-PEN(ACM)-OH | FMOC-PEN(ACM)-OH FMOC-CYS(ME 2)(ACM)-OH FMOC-BETA,BETA-DIMETHYL-CYS(ACM)-OH FMOC-S-ACETAMIDOMETHYL-L-PENICILLAMINE N-FMOC-S-ACETAMIDOMETHYL-L-PENICILLAMINE N-ALPHA-FMOC-S-ACETAMIDOMETHYL-L-PENICILLAMINE FMOC-PEN(ACM)-OH N-FMOC-S-ACETAMIDOMETHYL-L-PENICILLAMINE N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-S-ACETAMIDOMETHYL-L-PENICILLAMINE 3-(acetamidothio)-2-[[9H-fluoren-9-ylmethoxy(oxo)methyl]-methylamino]-3-methylbutanoic acid (2R)-3-[(acetamidomethyl)sulfanyl]-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-methylbutanoic acid | Unusual Amino Acids;Amino acid intermediates;Amino acid derivative compounds;Reagents for polypeptide synthesis;Unnatural amino acids and derivatives |
| 869 | 204697-37-0 | 5'(6)-FAM | 5'(6)-FAM 5'-(6-FAM) CEP 5'-FLUORESCEIN CEP 6-FAM-phosphoramidite 5'-6-FAM-PhosphoraMidite 5'-Fluorescein phosphoramidite 5-Fluorescein Phosphoramidite(6-FAM) (3',6'-Dipivaloylfluoresceinyl)-6-carboxamidohexyl)-1-O-(2-cyanoethyl)-(N,N-diisopropyl)phorphoramidite | Sigma-Pr;Modifiers;Sigma-Proligo;Chemical reagents;mRNA raw materials;Fluorescent dye-FAM;Biochemical reagents;Fluorescent Conjugates;Fluorescent Conjugates;Other Fluorescent Conjugates |
| 870 | 21438-60-8 | His-Ser | His-Ser HIS-SER Nsc374900 H-HIS-SER-OH histidylserine L-HISTIDYL-L-SERINE L-Serine, L-histidyl- 2-[[2-AMINO-3-(1H-IMIDAZOL-5-YL)PROPANOYL]AMINO]-3-HYDROXYPROPANOIC ACID (S)-2-((S)-2-Amino-3-(1H-imidazol-4-yl)propanamido)-3-hydroxypropanoic acid | Peptides;Dipeptides;Chemical biology;Peptide synthesis;Dipeptides and Tripeptides;Dipeptides and Tripeptides |
| 871 | 215190-21-9 | (2S,5R)-FMOC-5-PHENYL-PYRROLIDINE-2-CARBOXYLIC ACID | RARECHEM EM WB 0187 FMOC-(2S,5R)-5-PHENYLPYRROLIDINE-2-CARBOXYLIC ACID (2S,5R)-FMOC-5-PHENYL-PYRROLIDINE-2-CARBOXYLIC ACID N-Fmoc-(2S,5R)-5-phenylpyrrolidine-2-carboxylic acid (2S,5R)-5-phenyl-pyrrolidine-1,2-dicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester (2S,5R)-1-(((9H-Fluoren-9-yl)Methoxy)carbonyl)-5-phenylpyrrolidine-2-carboxylic acid 1,2-Pyrrolidinedicarboxylic acid, 5-phenyl-, 1-(9H-fluoren-9-ylmethyl) ester, (2S,5R)- | Amino acid derivatives;Amino acid derivative compounds |
| 872 | 221352-49-4 | (2S,5R)-BOC-5-PHENYL-PYRROLIDINE-2-CARBOXYLIC ACID | RARECHEM EM WB 0185 BOC-(2S,5R)-5-PHENYLPYRROLIDINE-2-CARBOXYLIC ACID (2S,5R)-BOC-5-PHENYL-PYRROLIDINE-2-CARBOXYLIC ACID (2S,5R)-1-(tert-Butoxycarbonyl)-5-phenylpyrrolidine-2-carboxylic acid (2S,5R)-1-[(2-methylpropan-2-yl)oxycarbonyl]-5-phenylpyrrolidine-2-carboxylic acid 1,2-Pyrrolidinedicarboxylic acid, 5-phenyl-, 1-(1,1-dimethylethyl) ester, (2S,5R)- | Amino acid derived compound |
| 873 | 223132-37-4 | inolitazone | RS5444 CS-1166 inolitazone Efatutazone Inolitazone (CS-7017) Inolitazone Efatutazone 5-[[4-[[6-(4-Amino-3,5-dimethylphenoxy)-1-methyl-1H-benzimidazol-2-yl]methoxy]phenyl]methyl]-2,4-thiazolidinedione 2,4-Thiazolidinedione, 5-[[4-[[6-(4-amino-3,5-dimethylphenoxy)-1-methyl-1H-benzimidazol-2-yl]methoxy]phenyl]methyl]- | Cell cycle |
| 874 | 244251-20-5 | BOC-L-BETA-HOMOMETHIONINE | BOC-HOMET-OH BOC-Β-HOMOMET-OH boc-β-homomet-oh BOC-BETA-HOMET-OH BOC-MET-(C*CH2)OH Boc-L-β-Homo-Met-OH BOC-BETA-HOMOMET-OH BOC-L-BETA-HOMOMETHIONINE (R)-3-(BOC-AMINO)-5-(METHYLTHIO)PENTANOIC ACID (R)-N-BETA-T-BUTOXYCARBONYL-3-AMINO-5-(METHYLTHIO)PENTANOIC ACID | amino acids;Amino acids;Beta amino acids;Beta-amino acids;β-Homo Amino Acids;Beta-Homo Amino Acids;Non-natural amino acids |
| 875 | 266359-48-2 | Fmoc-β-Homomet-OH | Fmoc-β-HoMet-OH Fmoc-b-HoMet-OH FMOC-Β-HOMOMET-OH Fmoc-β-Homomet-OH Fmoc-L-beta-HMet-OH FMOC-L-BETA-HOMOMETHIONINE FMoc-D-beta-hoMoMethionine (R)-3-(9H-Fluoren-9-ylmethoxycarbonylamino)-5- (S)-2-(FMoc-aMino)-5-Methylsulfanyl-pentanoic acid N-beta-(9-Fluorenylmethyloxycarbonyl)-L-homomethionine (R)-3-(Fmoc-amino)-5-(methylthio)pentanoic acid, Fmoc-L-β-homomethionine | amino acids;Amino acids;Beta amino acids;Chemical biology;Beta-amino acids;β-Homo Amino Acids;Unusual Amino Acids;Protective amino acids;Non-natural amino acid derivatives;Non-natural amino acids and |
| 876 | 3303-31-9 | Leu-Leu | Leu-Leu LEU-LEU Leu-Leu-OH H-LEU-LEU-OH L-Leu-L-Leu-OH leu-leu free base N-L-leucyl-L-leucine L-Leucine, L-leucyl- (S)-2-[[(S)-2-Amino-4-methylvaleryl]amino]-4-methylvaleric acid | Peptides;Dipeptides;Chemical biology;Peptide synthesis;Dipeptides and Tripeptides;Dipeptides and Tripeptides;Organic chemical raw materials |
| 877 | 34994-50-8 | Resorufin Sodium Salt | RESORUFIN resorufin sodium Resorufin Sodium Salt RESORUFIN, FOR MICROSCOPY 7-HYDROXY-3H-PHENOXAZIN-3-ONE SODIUM SALT 3H-Phenoxazin-3-one, 7-hydroxy-, sodium salt RESORUFIN, SODIUM SALT *FLUORESCENCE REFERENCE STANDARD* | biochemical reagent |
| 878 | 376594-67-1 | LY450108 | 100782 LY450108 LY 450108 LY-450108 Benzamide, 3,5-difluoro-N-[4-[(1R)-1-methyl-2-[[(1-methylethyl)sulfonyl]amino]ethyl]phenyl]- N-[4-[(1R)-1-Methyl-2-[[(1-methylethyl)sulfonyl]amino]ethyl]phenyl]-3,5-difluorophenylcarboxamide | Ion channels;Membrane transport |
| 879 | 38880-58-9 | (2-Hydroxyethyl)dimethyl(3-sulfopropyl)ammonium Hydroxide Inner Salt [for Biochemical Research] | NDSB-211 Dimethyl-2-hydroxyethylammoniumpropane sulfonate 3-[(2-Hydroxyethyl)dimethylaminio]propane-1-sulfonate 3-[Dimethyl(2-hydroxyethyl)aminio]propane-1-sulfonate 3-[Dimethyl-(2-hydroxyethyl)ammonio]-1-propanesulfonate 2-hydroxyethyl-dimethyl-(3-sulfopropyl)azanium hydroxide (2-hydroxyethyl)dimethyl(3-sulphopropyl)ammonium hydroxide Dimethyl(2-hydroxyethyl)(3-sulfopropyl)ammonium hydroxide inner salt (2-Hydroxyethyl)diMethyl(3-sulfopropyl)aMMoniuM Hydroxide Inner Salt [for BiocheMical Research] (2-Hydroxyethyl)dimethyl(3-sulfopropyl)ammonium Hydroxide Inner Salt [for Biochemical Research] | Detergent;Chemical raw materials |
| 880 | 50299-12-2 | H-THR-LEU-OH | THR-LEU L-THR-LEU H-THR-LEU-OH L-THREONYL-L-LEUCINE L-Leucine, L-threonyl- 2-[(2-AMINO-3-HYDROXYBUTANOYL)AMINO]-4-METHYLPENTANOIC ACID | Peptides;Dipeptides;Dipeptides and Tripeptides |
| 881 | 558447-26-0 | (S)-N1-((1H-benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine | AMD 070 AMD-070 AMD-11070 N-(1H-benzimidazol-2-ylmethyl)-N-[(8S)-5,6,7,8-tetrahydro-8-quinolinyl]- (9CI) AMD 070 N-(1H-benziMidazol-2-ylMethyl)-N-[(8S)-5,6,7,8-tetrahydro-8-quinolinyl]- (9CI) N'-(1H-Benzimidazol-2-ylmethyl)-N'-((S)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine 1,4-ButanediaMine, N-(1H-benziMidazol-2-ylMethyl)-N-[(8S)-5,6,7,8-tetrahydro-8-quinolinyl]- (S)-N1-((1H-benzo[d]iMidazol-2-yl)Methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diaMine (S)-N1-((1H-benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine | standard;G protein coupled receptor & G protein |
| 882 | 722543-31-9 | AZD1152 | CS-1053 AZD1152 AZD 1152 AZD-1152 BARASERTIB Barasertib (AZD1152) 5-[[7-[3-[Ethyl[2-(phosphonooxy)ethyl]amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-1H-pyrazole-3-acetamide 1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl[2-(phosphonooxy)ethyl]amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)- 2-[[3-({4-[(5-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]quinazolin-7-yl}oxy)propyl](ethyl)amino]ethyl dihydrogen phosphate | inhibitor;Cell cycle |
| 883 | 76863-28-0 | Fluorescein-5-thiosemicarbazide | 5-FTSC Fluorescein-5-thiosemicarbazide Fluorescein-5-thiosemicarbazide HCl FLUORESCEIN-5-THIOSEMICARBAZIDE [5-FTSC] Fluorescein-5-thiosemicarbazide Hydrochloride FLUORESCEIN-5-THIOSEMICARBAZIDE, FOR FLU ORESCENCE Hydrazinecarbothioamide, N-(3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5-yl)- | Analytical reagent-developer |
| 884 | 85118-33-8 | 4,5,6,7-Tetrahydroisoxazolo[5,4-c]Pyridin-3(2H)-One Monohydrochloride | Einecs 285-687-7 GABOXADOL HYDROCHLORIDE THIP HYDROCHLORIDE (GABOXADOL) POST-SYNA PTIC GABA RE 4,5,6,7-Tetrahydroisoxazolo[5,4-c]pyridin-3-ol, (HCl salt) 4,5,6,7-tetrahydro-[1,2]oxazolo[5,4-c]pyridin-6-ium-3-olate 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3(2H)-one monohydrochloride 4,5,6,7-Tetrahydroisoxazolo[5,4-c]Pyridin-3(2H)-One Monohydrochloride Isoxazolo[5,4-c]pyridin-3(2H)-one, 4,5,6,7-tetrahydro-, Monohydrochloride THIP hydrochloride, 4,5,6,7-Tetrahydroisoxazolo[5,4-c]pyridin-3-ol hydrochloride | Synthesis;Active Candidate |
| 885 | 88574-07-6 | FMOC-11-AMINOUNDECANOIC ACID | FMOC-11-AUN-OH FMOC-NH-(CH2)10-COOH FMOC-11-AMINOUNDECYLIC ACID FMOC-11-AMINOUNDECANOIC ACID 11-(FMOC-AMINO)UNDECANOIC ACID N-(9-FLUORENYLMETHOXYCARBONYL)-11-AMINOUNDECYLIC ACID N-(9-FLUORENYLMETHOXYCARBONYL)-11-AMINOUNDECANOIC ACID NALPHA-9-Fluorenylmethoxycarbonyl-11-aminoundecanoic acid | Amino Acids;Amino acids |
| 886 | 897383-62-9 | AST-1306 | CS-590 AST-1306 ALS 1306 Allitinib Allitinib (AST1306) N-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)quinazolin-6-yl)acrylamide N-[4-[[3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl]amino]quinazolin-6-yl]acrylamide N-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-propenamide | Advantage supply;Protein tyrosine kinase;Signal transduction pathway kinase inhibitor |
| 887 | 942142-51-0 | VTP 27999 | VTP27999 VTP-27999 VTP 27999 VTP 27999 Apixaban Impurity 126 Methyl (2-((R)-(3-chlorophenyl)((R)-1-(((S)-2-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)pr Methyl (2-((R)-(3-chlorophenyl)((R)-1-(((S)-2-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propy Methyl (2-((R)-(3-chlorophenyl)((R)-1-(((S)-2-(MethylaMino)-3-((R)-tetrahydro-2H-pyran-3-yl)propyl)carbaMoyl)piperidin-3-yl)Methoxy)ethyl)carbaMate N-[2-[(R)-(3-Chlorophenyl)[(3R)-1-[[[(2S)-2-(methylamino)-3-[(3R)-tetrahydro-2H-pyran-3-yl]propyl]amino]carbonyl]-3-piperidinyl]methoxy]ethyl]carbamic acid methyl ester CARBAMIC ACID, N-[2-[(R)-(3-CHLOROPHENYL)[(3R)-1-[[[(2S)-2-(METHYLAMINO)-3-[(3R)-TETRAHYDRO-2H-PYRAN-3-YL]PROPYL]AMINO]CARBONYL]-3-PIPERIDINYL]METHOXY]ETHYL]-, METHYL ESTER | |
| 888 | 943134-39-2 | GAP-134 | ZP1609 ZP-1609 ZP 1609 GAP-134 Danegaptide danegaptide,ZP1609 GAP-134 (Danegaptide) (2S,4R)-1-(2-Aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid | |
| 889 | 6403-16-3 | Ser-Glu | SER-GLU Ser-Glu H-SER-GLU-OH Serylglutamic acid DL-Seryl-L-glutaminsaeure L-Glutamic acid, L-seryl- N-L-Seryl-L-glutamic acid L-Selectin (human clone MMPLNHR_P6 fragment) (S)-2-((S)-2-aMino-3-hydroxypropanaMido)pentanedioic acid | Peptides;Dipeptides;Biochemical reagents;Dipeptides and Tripeptides;Dipeptides and Tripeptides |
| 890 | 71404-98-3 | BOC-BETA-CHLORO-ALA-OH | BOC-L-ALA(3-CL) BOC-ALA(3-CL)-OH BOC-ALA(BETA-CL)-OH Boc-β-chloro-Ala-OH BOC-BETA-CHLORO-ALA-OH BOC-BETA-CHLORO-ALANINE BOC-BETA-CHLORO-L-ALANINE N-(TERT-BUTOXYCARBONYL)-3-CHLORO-L-ALANINE | amino acids |
| 891 | 760952-88-3 | Tris(3-hydroxypropyltriazolylmethyl)amine | THPTA Tris(3-hydroxypropyltriazolylmethyl)amine 4,4',4''-Nitrilotris(4-(1H-1,2,3-triazol-4-yl)butan-1-ol) 3,3′,3′′-(4,4′,4′′-(Nitrilotris(methylene))tris(1H-1,2,3-triazole-4,1-diyl))tris(propan-1-ol) 3,3',3''-((4,4'4,”-nitrilotris(methylene))tris(1H-1,2,3-triazole-5,1-diyl))tris(propan-1-ol) -(THPTA) | biochemical reagent |
| 892 | 115532-50-8 | TMRM [Tetramethylrhodamine, methyl ester, perchlorate] | TMRM T 668 TMRM, PERCHLORATE Tetramethylrhodamin methylester perchlorate TETRAMETHYLRHODAMINE METHYL ESTER PERCHLORATE TMRM [Tetramethylrhodamine, methyl ester, perchlorate] 3,6-bis(diMethylaMino)-9-(2-(Methoxycarbonyl)phenyl)xanthyliuM perchlorate | Xanthene;Fluorescent probes, labeling, particles and staining |
| 893 | 1952360-91-6 | FmocNH-PEG12-CH2CH2COOH | Fmoc-nh-peg(16)-cooh Fmoc-nh-peg12-C2-cooh FmocNH-PEG12-CH2CH2COOH Carboxy-PEG12-(Fmoc-amine) (Fmoc-amino)-PEG12-C2-Carboxylic Acid 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28,31,34,37,40-tridecaoxa-4-azatritetracontan-43-oic Acid 5,8,11,14,17,20,23,26,29,32,35,38-Dodecaoxa-2-azahentetracontanedioic acid, 1-(9H-fluoren-9-ylmethyl) ester | PEG products-Fmoc-PEG;Other biochemical reagents |
| 894 | 62004-35-7 | LFM-A13 | LFM-A13 2-CYANO-N-(2,5-DIBROMOPHENYL)-3-HYDROXY-2-BUTENAMIDE 2-Cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide 2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-buteneamide 2-Butenamide, 2-cyano-N-(2,5-dibromophenyl)-3-hydroxy- 2-Cyano-3-hydroxy-but-2-enoic acid (2,5-dibromo-phenyl)-amide ALPHA-CYANO-BETA-HYDROXY-BETA-METHYL-N-(2,5-DIBROMOPHENYL)PROPENAMIDE | Protein Kinase;Cell biology reagent;Intracellular Signaling;Growth Factors and Cytokines |
| 895 | 286456-42-6 | L-838417 | L-838417 L-838417_x000b_ 5-({[7-tert-butyl-3-(2,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]oxy}methyl)-1-methyl-1,2,4-triazole 7-(tert-Butyl)-3-(2,5-difluorophenyl)-6-((1-methyl-1H-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine 3-(2,5-Difluorophenyl)-7-(1,1-dimethylethyl)-6-[(1-methyl-1H-1,2,4,-triazol-5-yl)methoxy]-1,2,4-triazolo[4,3-β]pyridazine 1,2,4-Triazolo[4,3-b]pyridazine,3-(2,5-difluorophenyl)-7-(1,1-dimethylethyl)-6-[(1-methyl-1H-1,2,4-triazol-5-yl)methoxy]- 3-(2,5-Difluorophenyl)-7-(1,1-dimethylethyl)-6-[(1-methyl-1H-1,2,4,-triazol-5-yl)methoxy]-1,2,4-triazolo[4,3-b]pyridazine | Heterocycles;Pharmaceuticals;Heterocyclic Compounds;Intermediates & Fine Chemicals |
| 896 | 165800-04-4 | (S)-N-((3-(3-Fluoro-4-(4-(2-hydroxyacetyl)piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide | U 100592 PNU 100592 eperezolid Eperezolid Eperezolid-d3 Eperezolid (PNU-100592 (S)-N-[[3-[3-Fluoro-4-[4-(hydroxyacetyl)-1-piperazinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide (S)-N-((3-(3-Fluoro-4-(4-(2-hydroxyacetyl)piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide N-[[(5S)-3-[3-fluoro-4-[4-(2-hydroxyacetyl)-1-piperazinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]-Acetamide | |
| 897 | 133565-45-4 | FMOC-ASPARTIMOL(OTBU) | FMOC-ASPARTIMOL(OTBU) Fmoc-L-Aspartimol(OtBu) Nα-Fmoc-Nγ-tert-butyl-L-asparaginol FMOC-BETA-T-BUTYL ESTER-L-ASPARTIMOL (S)-tert-Butyl 3-(Fmoc-amino)-4-hydroxybutanoate (S)-tert-butyl 3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-hydroxybutanoate tert-butyl (3S)-3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-hydroxybutanoate | Amino alcohol;Fmoc-Amino acid series;Fmoc-Amino acid series |
| 898 | 2812-47-7 | DL-Prolinamide | H-DL-PRO-NH2 DL-Prolinamide Proline Impurity 3 IFLAB-BB F2124-0727 2-PYRROLIDINECARBOXAMIDE PYRROLIDINE-2-CARBOXAMIDE | Catalyst;Aromatics;Heterocycles;Proline [Pro, P];Amino Acids Derivatives |
| 899 | 13588-95-9 | H-LEU-VAL-OH | LEU-VAL Leu-Val-OH H-LEU-VAL-OH L-Leu-L-Val-OH L-LEUCYL-L-VALINE leu-valcrystalline N-L-Leucyl-L-valine | |
| 900 | 115532-52-0 | TMRE [Tetramethylrhodamine, ethyl ester, perchlorate] | TMRE TMRE, PERCHLORATE 3,6-Bis(dimethylamino) TETRAMETHYLRHODAMINE ETHYL ESTER PERCHLORATE TMRE [Tetramethylrhodamine, ethyl ester, perchlorate] TMRE [TetraMethylrhodaMine, ethyl ester, perchlorate] 3,6-bis(diMethylaMino)-9-(2-(ethoxycarbonyl)phenyl)xanthyliuM 3,6-Bis(diMethylaMino)-9-(2-(ethoxycarbonyl)phenyl)xanthyliuM perchlorate | Xanthene;Fluorescent dyes;Pharmaceutical intermediates;Fluorescent probes, labels, particles and staining |
| 901 | 203866-20-0 | FMOC-TRANS-4-FLUORO-PRO-OH | FMOC-TRANS-4-FLUORO-PRO-OH FMOC-TRANS-4-FLUORO-PROLINE FMOC-TRANS-4-FLUORO-L-PROLINE N-FMOC-TRANS-4-FLUORO-L-PROLINE (2S,4R)-N-Fmoc-trans-4-Fluoro-L-proline N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-TRANS-4-FLUORO-L-PROLINE (2S,4R)-1-(9H-fluoren-9-ylmethoxycarbonyl)-4-fluoropyrrolidine-2-carboxylic acid N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-(2S,4R)-4-FLUORO-PYRROLIDINE-2-CARBOXYLIC ACID 1,2-Pyrrolidinedicarboxylic acid, 4-fluoro-, 1-(9H-fluoren-9-ylmethyl) ester, (2S,4R)- | Amino acid derived compound |
| 902 | 924641-59-8 | [4-[[5-Fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]-2-pyrimidinyl]amino]phenyl][(3S)-3-(methylamino)-1-pyrrolidinyl]Methanone | CS-1058 AZD 5597 pyrimidin-2-yl) (3-(methylamino) -(4-((5-Fluoro-4-(1-isopropyl-2-methyl-1H-imidazol-5-yl) (S)-(4-((5-Fluoro-4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)pyrimidin-2-yl)amino)phenyl)(3-(methyl (S)-(4-((5-Fluoro-4-(1-isopropyl-2-Methyl-1H-iMidazol-5-yl)pyriMidin-2-yl)aMino)phenyl)(3-(MethylaMino)pyrrolidin-1-yl)Methanone [4-[[5-Fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]-2-pyrimidinyl]amino]phenyl][(3S)-3-(methylamino)-1-pyrrolidinyl]Methanone | |
| 903 | 127500-84-9 | RO 41-1049 HCL MAO-A INHIBITOR | CS-2324 CS-2355 RO41 1049 Ro 41-1049 RO 41 1049 RO41-1049HCL RO 41-1049 HCL MAO-A INHIBITOR RO 41-1049 HCL MAO-A INHIBITOR RO 41-1049 HYDROCHLORIDE MAO-A INHIBITOR N-(2-Aminoethyl)-5-(3-fluorophenyl)thiazole-4-carboxamide N-(2-Aminoethyl)-5-(3-fluorophenyl)-4-thiazolecarboxamide | Inhibitor;A selective, reversible, orally active inhibitor of MAO-A. |
| 904 | 1239262-52-2 | Tubastatin A Trifluoroacetic Acid Salt | Tubastain A Tubastatin A TUBASTANTIN A TubaststinA HCl Tubastatin A_HCl Tubastatin A TFA Tubastatin A Trifluoroacetic Acid Salt N-Hydroxy-4-((2-Methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)Methyl)benzaMide 2,2,2-trifluoroacetate N-Hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide 2,2,2-Trifluoroacetate | Aromatics;Heterocycles;Pharmaceuticals;Cell biology reagents;Intermediates & Fine Chemicals |
| 905 | 207117-28-0 | FMOC-ALPHA-METHYL-L-SER | Fmoc-2-Me-Ser-OH FMOC-ALPHA-METHYL-L-SER FMOC-L-ALPHA-METHYLSERINE FMOC-(S)-2-AMINO-2-METHYL-3-HYDROXYPROPANOIC ACID N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-serine L-Serine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methyl- (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-hydroxy-2-methylpropanoic acid (S)-2-((((9H-Fluoren-9-yl)Methoxy)carbonyl)aMino)-3-hydroxy-2-Methylpropanoic acid | unnatural amino acids |
| 906 | 118684-31-4 | BOC-3-AMINOBENZYLALCOHOL | BOC-3-AMINOBENZYLALCOHOL 3-(Boc-aMino)benzyl alcohol N-Boc-3-hydroxymethylaniline TERT-BUTYL 3-(HYDROXYMETHYL)PHENYLCARBAMATE ert-Butyl (3-(hydroxymethyl)phe nyl)carbamate tert-butyl N-[3-(hydroxymethyl)phenyl]carbamate Carbamic acid, N-[3-(hydroxymethyl)phenyl]-, 1,1-dimethylethyl ester | |
| 907 | 1254036-77-5 | GSK-2269557 | CS-2463 GSK2269557 GSK-2269557 GSK2269557 HCL GSK-2269557 HCl salt GSK-2269557 (Nemiralisib HCl) 2-(6-(1H-Indol-4-yl)-1H-indazol-4-yl)-5-((4-isopropylpiperazin-1-yl)methyl)oxazole hydrochloride 6-(1H-indol-4-yl)-4-(5-{[4-(1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1H-indazole hydrochloride | Reference substance |
| 908 | 1063331-94-1 | N-(4-chlorophenyl)-2-(3,5-diMethyl-1H-pyrazol-1-yl)-9-Methyl-9H-purin-6-aMine | 104258 NS13001 AK174154 N-(4-chlorophenyl)-2-(3,5-dimethylpyrazol-1-yl)-9-methylpurin-6-amine N-(4-chlorophenyl)-2-(3,5-diMethyl-1H-pyrazol-1-yl)-9-Methyl-9H-purin-6-aMine (4-chloro-phenyl)-[2-(3,5-dimethyl-pyrazol-1-yl)-9-methyl-9H-purin-6-yl]-amine 9H-Purin-6-amine, N-(4-chlorophenyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-9-methyl- | Reference substance |
| 909 | 210473-10-2 | FMOC-D-MET-OPFP | FMOC-D-MET-OPFP FMOC-D-METHIONINE PENTAFLUOROPHENYL ESTER (9H-Fluoren-9-yl)MethOxy]Carbonyl D-Met-OPfp N-ALPHA-FMOC-D-METHIONINE PENTAFLUOROPHENYL ESTER N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-methionine pentafluorophenyl ester D-Methionine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, pentafluorophenyl ester (9CI) (2,3,4,5,6-pentafluorophenyl) (2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methylsulfanylbutanoate | Protecting amino acids;Fmoc-Amino acid series;Fmoc-Amino acid series;Fmoc-protected amino acids;Fmoc-Amino Acids and Derivatives |
| 910 | SP SEPHAROSE | SP SEPHAROSE SP Sepharose(R) SP Sepharose FF SP SEPHAROSE XL Sulfopropyl-Sepharose SP-Sepharose Fast Flow Sulfopropyl-Sepharose(R) SP SEPHAROSE HIGH PERFORMANCE | Biochemical Reagents-Separation Materials and Consumables | |
| 911 | 869062-42-0 | rhamnolipid | rhamnolipid R 90 (Rhamnolipids) | Biochemical Reagents-Surfactants |
| 912 | 15769-56-9 | guluronic acid | G2013 guluronic acid Einecs 239-860-9 Guluronic acid sodium salt | Chemical industry;Brown algae oligosaccharide series;Biochemical reagents, oligosaccharide;Standard-brown algae oligosaccharide series |
| 913 | 34725-61-6 | Bromophenol blue sodium salt | BROMPHENOL BLUE LABOTEST-BB LT00159731 BROMOPHENOL BLUE NA-SALT BROMPHENOL BLUE, SODIUM SALT Bromophenol blue sodium salt BROMOPHENOL BLUE, WATER SOLUBLE BROMPHENOL BLUE SODIUM SALT, WATER SOLUBLE 3',3'',5',5''-TETRABROMOPHENOLSULFONPHTHALEIN SODIUM SALT | Chemical reagent |
| 914 | Freund 's Adjuvant Incomplete | FICA F5506 abs9271 Freund's Adjuvant Freund 's Adjuvant Incomplete | biochemical reagent | |
| 915 | 60842-46-8 | FLUORESCEIN ISOTHIOCYANATE-DEXTRAN | FITC Dextran FITC-Dextran 4 FITC-Dextran 70 FITC-Dextran 150 FITC–Dextran 2000 FLUORESCEIN ISOTHIOCYANATE-DEXTRAN | Carbohydrate;Fluorescent dye |
| 916 | 387334-31-8 | BMPO | BMPO MDMUYJRRYYXDLZ-UHFFFAOYSA-N 2H-Pyrrole-2-carboxylic acid, 3,4-dihydro-2-methyl-, 1,1-dimethylethyl ester, 1-oxide | Kit-Cell Analysis Kit |
| 917 | 488-86-8 | Croconic Acid | Crocic acid Croconic Acid 4-Cyclopentene-1,2,3-trione 1,2-Dihydroxycyclopentene-3,4,5-trione 4,5-DIHYDROXY-4-CYCLOPENTENE-1,2,3-TRIONE 4-Cyclopentene-1,2,3-trione,4,5-dihydroxy- 4,5-DIHYDROXY-CYCLOPENT-4-ENE-1,2,3-TRIONE | Organic acid |
| 918 | FMOC-LYS(BOC)-WANG RESIN | FMOC-L-LYS(BOC)-WANG 100 FMOC-LYS(BOC)-WANG RESIN FMOC-L-LYS(BOC)-WANG 200 FMOC-L-LYS(BOC)-WANG RESIN FMOC-L-LYS(BOC)-CAT(R) RESIN FMOC-L-LYS(BOC)-DAS(R) RESIN FMOC-L-LYS(BOC)-WANG TENTAGEL S FMOC-L-LYS(BOC)-MPPA(WANG) RESIN FMOC-L-LYS(BOC)-DASRIN-3(R) RESIN | Chemical biology;Solid phase Peptide Synthesis | |
| 919 | Hematoxylin staining solution | Hematoxylin staining solution | Cell Analysis;Cell tissue staining | |
| 920 | 134150-51-9 | Fmoc-Tyr(PO3Bzl2)-OH | FMOC-TYR(PO3BZL2)-OH Fmoc-Tyr(PO3Bzl2)-OH FMOC-O-DIBENZYLPHOSPHO-L-TYROSINE NΑ-FMOC-O-[BIS(BENZYLOXY)PHOSPHORYL]-L-TYROSINE Nα-Fmoc-O-[bis(benzyloxy)phosphoryl]-L-tyrosine N(alpha)-fmoc-O-[bis(benzyloxy)phos-phoryl]-L-tyrosine (2S)-3-[4-BIS(PHENYLMETHOXY)PHOSPHORYLOXYPHENYL]-2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)PROPANOIC ACID (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(4-(bis(benzyloxy)phosphoryloxy)phenyl)propanoic acid | Amino Acids;Amino acids;Chemical biology;Amino acid derivatives;Protecting amino acids;Fmoc-Amino acid series;Fmoc-Amino acid series;Other biochemical reagents;Fmoc-Amino Acids and Derivatives |
| 921 | 81279-39-2 | 5'-O-DMT-2'-O-iBu-N-Bz-Guanosine | 5'-DMT-2'-TBDMS-iBu-rG 5'-O-DMT-2'-O-iBu-N-Bz-Guanosine 5'-O-DMT-N-isobutyryl-2'-O-TBDMS-guanosine 5-O-(4,4-Dimethoxytrityl)-2-O-(tertbutyldimethylsilyl)-N-isobutyryl-Guanosine N2-Isobutyryl-2''-O-(tert-butyldimethylsilyl)-5''-O-(4,4''-dimethoxytrityl)-gu 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-[(tert-butyl)dimethylsilyl]-N-(2-methyl-1-oxopropyl)guanosine 5'-O-[bis(4-Methoxyphenyl)phenylMethyl]-2'-O-[(1,1-diMethylethyl)diMethylsilyl]-N-(2-Methyl-1-oxopropyl)-Guanosine N-(9-((2R,3R,4R,5R)-5-((Bis(4-Methoxyphenyl)(phenyl)Methoxy)Methyl)-3-((tert-butyldiMethylsilyl)oxy)-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyraMide | Nucleic acid;Other biochemical reagents |
| 922 | 1177827-73-4 | AP-III-a4(ENOblock) | CS-1077 ENOBLOCK AP-III-A4 AP-III-a4 AP-III-a4(ENOblock) ENOblock (AP-III-a4) ENOBLOCK HYDROCHLORIDE N-[2-[2-(2-Aminoethoxy)ethoxy]ethyl]-4-[[4-[(cyclohexylmethyl)amino]-6-[[(4-fluorophenyl)methyl]amino]-1,3,5-triazin-2-yl]amino]benzeneacetamide AP-III-A4 Benzeneacetamide, N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]-4-[[4-[(cyclohexylmethyl)amino]-6-[[(4-fluorophenyl)methyl]amino]-1,3,5-triazin-2-yl]amino]- | |
| 923 | 301836-43-1 | D4476 | D4476 D-4476 D 4476 4-(4-(2,3-DIHYDROBENZO[1,4]DIOXIN-6-YL)-5-PYRIDIN-2-YL-1H-IMIDAZOL-2-YL)BENZAMIDE 4-[4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]benzamide Benzamide,4-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]- 4-[4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]benzamide D4476 | Inhibitors;Signalling;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 924 | 32343-73-0 | N-(5-Aminopentyl)acetamide | N-Acetylcadaverine monoacetylcadaverine N-(5-Aminopentyl)acetamide N-(5-AMinopentyl)acetaMide N-Acetyl-1,5-pentanediamine Acetamide, N-(5-aminopentyl)- | Amides;Standard;Amide compounds |
| 925 | 1137916-97-2 | MK0941 | MK0941 MK-0914 CS-2679 MK-0941 MK-0941 mesylate | |
| 926 | 911714-45-9 | SP-420 | SP420 SP-420 SP 420 CS-2097 (4S)-4,5-Dihydro-2-[2-hydroxy-4-[2-(2-methoxyethoxy)ethoxy]phenyl]-4-methyl-4-thiazolecarboxylic acid 4-Thiazolecarboxylic acid, 4,5-dihydro-2-[2-hydroxy-4-[2-(2-methoxyethoxy)ethoxy]phenyl]-4-methyl-, (4S)- (2E,4S)-2-[4-[2-(2-methoxyethoxy)ethoxy]-6-oxocyclohexa-2,4-dien-1-ylidene]-4-methyl-1,3-thiazolidine-4-carboxylic acid | |
| 927 | 71977-09-8 | Substance P, Free Acid | SUBSTANCE P RPKPQQFFGLM [MET-OH11]-SUBSTANCE P Substance P, Free Acid SUBSTANCE P (FREE ACID) Substance P, 11-L-methionine- ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-MET H-ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-MET-OH | Peptide;Agonist;Standards;Tachykinins;Polypeptides;Peptides for Cell Biology;Peptides for Cell Biology |
| 928 | 497833-27-9 | Givinostat | CS-2025 Givinostat Gavinostat Givinostat(ITF-2357) Givinostat(free base) [6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate [4-[(Hydroxyamino)carbonyl]phenyl]carbamic acid [6-[(diethylamino)methyl]-2-naphthalenyl]methyl ester Carbamic acid, N-[4-[(hydroxyamino)carbonyl]phenyl]-, [6-[(diethylamino)methyl]-2-naphthalenyl]methylester | Organic chemical raw materials |
| 929 | 223652-90-2 | Garenoxacin Mesylate hydrate | Garenoxacin Garenoxacin mesylate [USAN] Garenoxacin Mesylate hydrate Garenoxacin mesylate hydrate BMS284756 (Mesylate hydrate) 1-cyclopropyl-8-(difluoromethoxy)-4-keto-7-[(1R)-1-methylisoindolin-5-yl]quinoline-3-carboxylic acid 1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid methanesulfonate hydrate Garenoxacin mesylate hydrate 1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid methanesulfonate hydrate | |
| 930 | 404001-62-3 | 1-Hexadecyl-3-methylimidazolium chloride monohydrate | 1-hexadecyl-3-methylimidazolium 1-HEXADECYL-3-METHYLIMIDAZOLIUM CHLORIDE MONOHYDRATE 1-Hexadecyl-3-methylimidazolium chloride monohydrate 1-Hexadecyl-3-methyl-1H-imidazol-3-ium chloride hydrate | |
| 931 | 229305-39-9 | Golotimod (SCV-07) | GLU-TRP GAMMA-GLU-TRP Unii-637C487Y09 H-g-D-Glu-Trp-OH gamma-D-Glu-L-Trp Golotimod (SCV-07) H-D-GLU(TRP-OH)-OH H-GAMMA-GLU-TRP-OH H-GAMMA-D-GLU-TRP-OH | short peptide |
| 932 | 56715-13-0 | (R)-(+)-Atenolol | (R)-(+)-Atenolol (R)-(+)-AtenololHCl R(+)-ATENOLOL LESS ACTIVE ENANTIOME 2-[4-[(2R)-2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide 2-[4-[(2R)-2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide 4-[(R)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide (+)-4-[2-HYDROXY-3-[(1-METHYLETHYL)-AMINO]PROPOXY]BENZENEACETAMIDE 2-[4-[(2R)-2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]ethanamide Benzeneacetamide, 4-[(2R)-2-hydroxy-3-[(1-methylethyl)amino]propoxy]- (R)-(+)-Atenolol,(+)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide | Amines;Aromatics;Pharmaceuticals;Small molecule inhibitors;Intermediates & Fine Chemicals |
| 933 | 1032678-07-1 | Cy5 carboxylic acid | Cyanine5 COOH Cy5 carboxylic acid CY5 (non-sulfonated) Cyanine5 carboxylic acid 2-(5-(1-(5-Carboxypentyl)-3,3-dimethylindolin-2-ylidene)penta-1,3-dien-1-yl)-1,3,3-trimethyl-3H-indol-1-ium chloride 2-((1E)-5-(1-(5-carboxypentyl)-3,3-dimethylindolin-2-ylidene)penta-1,3-dien-1-yl)-1,3,3-trimethyl-3H-indol-1-ium chloride 2-((1E)-5-(1-(5-CARBOXYPENTYL)-3,3-DIMETHYLINDOLIN-2-YLIDENE)PENTA-1,3-DIEN-1-YL)-1,3,3-TRIMETHYL-3H-INDOL-1-IUM CHLORIDE | Chemical reagent;Reference reagent;Fluorescent material |
| 934 | 840504-21-4 | (3AS,8aS)-4,4,8,8-tetrakis(3,5-dimethylphenyl)tetrahydro-N,N,2,2-tetramethyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-amine | (1S,7S)-4-Dimethylamino-9,9-dimethyl-2,2,6,6-tetrakis(3,5-dimethylphenyl)-3,5,8,10-tetraoxa-4-phosphabicyclo[5.3.0]decane (3AS,8aS)-4,4,8,8-tetrakis(3,5-dimethylphenyl)tetrahydro-N,N,2,2-tetramethyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-amine 1,3-Dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-amine, 4,4,8,8-tetrakis(3,5-dimethylphenyl)tetrahydro-N,N,2,2-tetramethyl-, (3aS,8aS)- (3aS,8aS)-4,4,8,8-tetrakis(3,5- dimethylphenyl)tetrahydro-N, N,2,2-tetramethyl-1,3-Dioxolo [4,5-e][1,3,2]dioxaphosphepin -6-amine | |
| 935 | 1000873-98-2 | (3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione | ARQ-197 (3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione | |
| 936 | 6509-19-9 | Adenine Sulfate Dihydrate | Adenine Sulfate Dihydrate 9H-Purin-6-aMine heMisulfate dihydrate FERROUS SULFATE HEPTAHYDRATE ACS GRADE 7H-purin-6-amine,sulfuric acid,dihydrate | Sulfinates;Sulfonic acids;Inorganic compounds and salts;General biochemical reagents-nucleic acids;Biochemical reagents-plant hormones and nucleic acids |
| 937 | 10318-62-4 | 2')adenosine>cytidylyl(5'->2')adenosine | adenylyl(2'-5')cytidine CYTIDYLYL(5'→2')ADENOSINE 2'-O-(5'-Cytidylyl)adenosine | |
| 938 | 733767-34-5 | NSC 23766 TETRAHYDROCHLORIDE | CS-594 CS-1187 NSC23766 NSC 23766 NSC-23766 free base NSC 23766 TETRAHYDROCHLORIDE N6-[2-(4-Diethylamino-1-methylbutylamino)-6-methylpyrimidin-4-yl]-2-methylquinoline-4,6-diamine tetrahydrochloride N6-[2-[[4-(DIETHYLAMINO)-1-METHYLBUTYL]AMINO]-6-METHYL-4-PYRIMIDINYL]-2-METHYL-4,6-QUINOLINEDIAMINE TRIHYDROCHLORIDE | G-Protein;Rac1 Inhibitor.;Other enzyme inhibitors and activators |
| 939 | 798577-91-0 | BAL27862 | BA27862 BAL27862 BAL 27862 Avanbulin CB62731021 Avanbulin (BAL27862 3-[[4-[1-[2-(4-Aminophenyl)-2-oxoethyl]-1H-benzimidazol-2-yl]-1,2,5-oxadiazol-3-yl]amino]propanenitrile 3-((4-(1-(2-(4-Aminophenyl)-2-oxoethyl)-1H-benzo[d]imidazol-2-yl)-1,2,5-oxadiazol-3-yl)amino)propanenitrile | |
| 940 | 1341215-17-5 | 3-(4-((bis((1-(tert-butyl)-1H-1,2,3-triazol-4-yl)methyl)amino)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol | BTTP 3-(4-((bis(1-tert-butyl-1H-1,2,3-triazol-4-yl)methyl)amino)methyl)-1H-1,2,3-triazol-1-yl)-propanol 3-(4-((bis((1-(tert-butyl)-1H-1,2,3-triazol-4-yl)methyl)amino)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol | |
| 941 | 877049-90-6 | 6-TET phosphoramidite [5'-Tetrachlorofluorescein phosphoramidite] | TET phosphoramidite, 6-isomer 5'-Tetrachlorofluorescein CEP 6-TET phosphoramidite [5'-Tetrachlorofluorescein phosphoramidite] 6-(4,7,2', 7'-Tetrachloro-3', 6'-dipivaloylfluoresceinyl-6-carboxamido)-hexyl-1-O-[(2-cyanoethyI)-(N, N-diisopropyD)]-phosphoramidite | mRNA starting material |
| 942 | 1175006-92-4 | sodium tetrahydrojasmonate | Mexoryl SBO sodium tetrahydrojasmonate Sodium Tetrahydrojasmonate,Mexoryl SBO, LR2412 | Sodium tetrahydro-jasmonate |
| 943 | 1027512-13-5 | Fluorescein II CEP | Fluorescein II CEP | Fluorescent Dye |
| 944 | 71353-94-1 | 3,3'-bis(hydroxymethyl)-2,2'-bipyridine | [2,2'-Bipyridine]-3,3'-dimethanol 3,3'-bis(hydroxymethyl)-2,2'-bipyridine ([2,2'-BIPYRIDINE]-3,3'-diyl)-dimethanol | Organic photoelectric |
| 945 | 168332-12-5 | (S)-DMT-glycidol-T | (S)-DMT-glycidol-T (S)-DMT-glycidol-thymine (S)-1-[3-(4,4′-Dime thoxytrityloxy)-2-hydroxypropyl]thymine (S)-1-(3-(bis(4-methoxyphenyl)(phenyl)methoxy)-2-hydroxypropyl)-5-methylpyrimidine-2,4(1H,3H)-dione | |
| 946 | 2183473-20-1 | BDP 581/591 azide | Tool molecules-fluorescent probes | |
| 947 | 217075-36-0 | Borate(1-), difluoro[5-[[5-[(1E,3E)-4-phenyl-1,3-butadien-1-yl]-2H-pyrrol-2-ylidene-κN]methyl]-1H-pyrrole-2-undecanoato(2-)-κN1]-, hydrogen (1:1), (T-4)- | Tool molecules-fluorescent probes | |
| 948 | 209252-17-5 | Fmoc-L-beta-glutamic acid 5-tert-butyl ester | FMOC-Β-GLU(OTBU)-OH FMOC-BETA-GLU(OTBU)-OH FMOC-BETA-HOMOASPARTIC ACID(OTBU) FMOC-L-BETA-HOMOASPARTIC ACID(OTBU) Fmoc-L-beta-glutamic acid 5-tert-butyl ester FMOC-L-BETA-GLUTAMIC ACID 5-TERT-BUTYL ESTER FMOC-L-BETA-HOMOASPARTIC ACID 5-TERT-BUTYL ESTER FMOC-L-BETA-HOMOASPARTIC ACID GAMMA-T-BUTYL ESTER N-BETA-(9-FLUORENYLMETHOXYCARBONYL)-L-BETA-HOMOASPARTIC ACID GAMMA-T-BUTYL ESTER (R)-N-BETA-(9-FLUORENYLMETHOXYCARBONYL)-3-AMINO-5-T-BUTYL ESTER-5-OXOPENTANOIC ACID | ;Beta amino acids;beta-amino acids;Chemical biology;U sum amino Acids;β-Homo Amino Acids;Unusual Amino Acids;Protected Amino Acids;Amino acid derivatives;Non-natural Amino Acids |
| 949 | 45172-44-9 | BOC-L-SELENOMETHIONINE | BOC-L-SELENOMETHIONINE BOC-SELENO-L-METHIONINE (S)-2-((tert-butoxycarbonyl)aMino)-4-(Methylselanyl)butanoic acid Butanoic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-4-(methylseleno)-, (2S)- | amino acids;Seleno Amino Acid |
| 950 | 1135416-11-3 | Z-DEVD-AFC | Z-DEVD-AFC Z-ASP-GLU-VAL-ASP-AFC 7-AMINO-4-TRIFLUOROMETHYLCOUMARIN, N-CBZ-L-ASPARTYL-L-GLUTAMYL-L-VALYL-L-ASPARTIC ACID AMIDE | peptide;Pepetides;Caspase/Related Products |
| 951 | 17355-11-2 | H-TYR-PHE-OH | YF TYR-PHE H-TYR-PHE-OH tyr-phecrystalline L-TYROSYL-L-PHENYLALANINE 2-[[2-AMINO-3-(4-HYDROXYPHENYL)PROPANOYL]AMINO]-3-PHENYLPROPANOIC ACID (S)-2-((S)-2-AMino-3-(4-hydroxyphenyl)propanaMido)-3-phenylpropanoic acid | Peptides;Dipptides;Dipeptides;Biochemical reagents;Amino Acid Derivatives;Dipptides and trippides;Dipeptides and Tripeptides |
| 952 | 1886-13-1 | 4,5-bis(4-dimethylaminophenyl)-2-(3,5-dimethoxy-4-hydroxyphenyl)imidazole | Photosensitizer-1 4,5-bis(4-dimethylaminophenyl)-2-(3,5-dimethoxy-4-hydroxyphenyl)imidazole Phenol, 4-[4,5-bis[4-(dimethylamino)phenyl]-1H-imidazol-2-yl]-2,6-dimethoxy- | API;Synthetic material intermediates;Biochemical diagnosis-liver function |
| 953 | 1159490-85-3 | PF-04217903 | PF-04217903 aka PF-04217903 PF-04217903 phenolsulfonate PF04217903 4-hydroxybenzenesulfonate 4-[1-(6-Quinolinylmethyl)-1H-1,2,3-triazolo[4,5-b]pyrazin-6-yl]-1H-pyrazole-1-ethanol 4-hydroxybenzenesulfonate | Signal transduction pathway kinase inhibitor |
| 954 | 1207283-85-9 | TP-434 | TP-434 TP434 TP 434 ERAVACYCLINE Eravacycline Eravacycline TP-434 TP-434(Eravacycline) (4S,12aS)-4-(dimethylamino)-7-fluoro-3,10,12,12a-tetrahydroxy-1,11-dioxo-9-(2-(pyrrolidin-1-yl)acetamido)-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide 1-Pyrrolidineacetamide, N-[(5aR,6aS,7S,10aS)-9-(aminocarbonyl)-7-(dimethylamino)-4-fluoro-5,5a,6,6a,7,10,10a,12-octahydro-1,8,10a,11-tetrahydroxy-10,12-dioxo-2-naphthacenyl]- 4-Dimethylamino-7-fluoro-3,10,12,12a-tetrahydroxy-1,11-dioxo-9-(2-pyrrolidin-1-yl-cetylamino)-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide (ERAVACYCLINE) | Reagents;Inhibitors;Off-the-shelf;Fine chemical products |
| 955 | 1360547-55-2 | Propanoic acid, 2,2-dimethyl-, 1,1'-[6-[10-[bis(1-methylethyl)amino]-13-cyano-1-oxo-9,11-dioxa-2-aza-10-phosphatridec-1-yl]-2',4,4',5',7,7'-hexachloro-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3',6'-diyl] ester | Hex-C6-amidite 5'-HEX phosphoramidite 6-Hexachloro-Fluorescein Phosphoramidite configured for ABI Propanoic acid, 2,2-dimethyl-, 1,1'-[6-[10-[bis(1-methylethyl)amino]-13-cyano-1-oxo-9,11-dioxa-2-aza-10-phosphatridec-1-yl]-2',4,4',5',7,7'-hexachloro-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3',6'-diyl] ester | Fluorescent dye;mRNA raw material |
| 956 | 2231670-91-8 | sulfo-Cyanine3.5 NHS ester | Sulfo cy3.5 NHS ester sulfo-Cyanine3.5 NHS ester | Fluorescent dyes;Chemical reagents |
| 957 | 1424433-17-9 | Sulfo-Cyanine3 NHS ester | Sulfo-Cy3 NHS Methyl Sulfo-Cyanine3 NHS ester | Cy;cy3;Small molecule drug |
| 958 | 1355330-47-0 | R6G phosphoramidite, 6-isomer | R6G phosphoramidite Rhodamine?6G phosphoramidite R6G phosphoramidite, 6-isomer | |
| 959 | 2213445-35-1 | BDP 630/650 X NHS ester | Tool molecules-fluorescent probes | |
| 960 | 1228307-80-9 | 1,2-Pyrrolidinedicarboxylic acid, 3-methyl-, 1-(9H-fluoren-9-ylmethyl) ester, (2S,3S)- | Fmoc-trans-3-Methyl-L-proline (2S,3S)-3-Methyl-pyrrolidine-1,2-dicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester (2S,3S)-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}-3-methylpyrrolidine-2-carboxylic acid 1,2-Pyrrolidinedicarboxylic acid, 3-methyl-, 1-(9H-fluoren-9-ylmethyl) ester, (2S,3S)- | Amino acids |
| 961 | 1417618-71-3 | 9H-Carbazole-3-carbonitrile, 9,9'-[1,1'-biphenyl]-4,4'-diylbis- | 9H-Carbazole-3-carbonitrile, 9,9'-[1,1'-biphenyl]-4,4'-diylbis- | |
| 962 | 15868-40-3 | 4H-1-Benzopyran-4-one, 2-(3,5-dihydroxy-4-methoxyphenyl)-5-hydroxy-3,7-dimethoxy- | 2-(3,5-dihydroxy-4-methoxyphenyl)-5-hydroxy-3,7-dimethoxy-4H-chromen-4-one 4H-1-Benzopyran-4-one, 2-(3,5-dihydroxy-4-methoxyphenyl)-5-hydroxy-3,7-dimethoxy- | Probe reagent |
| 963 | 6814-36-4 | Mannuronic acid | MANURONICACID Mannuronic acid Einecs 229-889-5 | Reference substance;Organic chemical industry;Biochemical reagents, oligosaccamide;Biochemical reagents, oligosaccharide;Standard substance-alginate oligosaccharide series |
| 964 | 1204416-97-6 | TMC-647055 | CS-1838 TMC647055 MTC647055 TMC-647055 TMC 647055 11BD024G7J TMC 647055 SURECN1239667 AGN-PC-078RUU CHEMBL2043025 | Control |
| 965 | 1219333-83-1 | BOC-7-METHYL-DL-TRYPTOPHAN | BOC-7-METHYL-DL-TRYPTOPHAN Tryptophan, N-[(1,1-dimethylethoxy)carbonyl]-7-methyl- 2-{[(tert-butoxy)carbonyl]amino}-3-(7-methyl-1H-indol-3-yl)propanoic acid | Amino acids |